https://www.spreaker.com/podcast/healthcare-scandal-investigations--7196444
Healthcare Scandal Investigations examines controversies, misconduct, institutional failures, and investigations connected to the medical world. The podcast looks at how problems are uncovered, who is affected, what authorities discover, and how healthcare systems respond when serious concerns come to light. It offers a place to spend time with stories where medicine, accountability, ethics, and public trust meet, especially when the facts behind a scandal prove more complicated than they first appeared.]]>enHealth & Fitness© 2026 OBOMEDIA Creatorshttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e3ef5afd817bde4ec2c2457c7955638e.jpghttps://www.spreaker.com/podcast/healthcare-scandal-investigations--7196444Sun, 11 Oct 2026 09:24:21 +0000Creator at ObomediaCreator at Obomediacreators@obomedia.comThere are times when a headline about a hospital, doctor, treatment, or medical company leaves more questions than answers. For anyone interested in what happens when trust in healthcare is tested, those cases can become difficult to ignore....
Healthcare Scandal Investigations examines controversies, misconduct, institutional failures, and investigations connected to the medical world. The podcast looks at how problems are uncovered, who is affected, what authorities discover, and how healthcare systems respond when serious concerns come to light. It offers a place to spend time with stories where medicine, accountability, ethics, and public trust meet, especially when the facts behind a scandal prove more complicated than they first appeared.]]>false926bd9cc-64e7-5a74-8973-5191858fc6d1episodichttps://www.spreaker.com/episode/the-nurse-who-loved-resuscitation-inside-hogel-s-killing-stage--73098445
The pleasure of resuscitation became an addiction that left patients dead: between 1999 and 2005 a single nurse’s shifts accounted for 58% of resuscitations and deaths on one cardiac ICU ward, yet no police report followed. How did recorded warnings, meetings, and a glowing reference letter still allow him to move to another hospital and continue?

In this episode, we walk through the timeline of events recorded in hospital meetings, personnel files, and the 2019 psychiatric evaluation to show how institutional choices intersected with one nurse’s need for recognition - and ask how a system that logged alarming statistics could avoid investigation.

Person: Niels Högel
Date: 30 December 1976 (birth)
Location: Ward 2-11, Oldenburg Clinic; Klinikum Delmenhorst
Event: Internal meeting reporting 58% of resuscitations and deaths fell on one nurse’s shifts
Status: 85 murders proven by 6 June 2019; investigators estimated up to 300

- Högel completed nursing training in 1997 and was hired at Oldenburg Clinic in 1999.
- A formal internal meeting in August 2001 recorded that 58% of resuscitations and deaths on Ward 2-11 occurred during one nurse’s shifts.
- Högel called in sick for three weeks after the August 2001 meeting; the ward had two deaths during those three weeks.
- On 10 October 2002 the director of nursing at Oldenburg Clinic signed a glowing reference letter for Högel that made no mention of the 58% statistic or related concerns.
- By the time a court rendered its final verdict on 6 June 2019, 85 murders had been proven, with investigators estimating the true count may have reached as high as 300.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098445Sun, 11 Oct 2026 13:00:02 +0000Creator at ObomediaThe Nurse Who Loved Resuscitation: Inside Högel's Killing Stage The pleasure of resuscitation became an addiction that left patients dead: between 1999 and 2005 a single nurse’s shifts accounted for 58% of resuscitations and deaths on one cardiac...
The pleasure of resuscitation became an addiction that left patients dead: between 1999 and 2005 a single nurse’s shifts accounted for 58% of resuscitations and deaths on one cardiac ICU ward, yet no police report followed. How did recorded warnings, meetings, and a glowing reference letter still allow him to move to another hospital and continue?

In this episode, we walk through the timeline of events recorded in hospital meetings, personnel files, and the 2019 psychiatric evaluation to show how institutional choices intersected with one nurse’s need for recognition - and ask how a system that logged alarming statistics could avoid investigation.

Person: Niels Högel
Date: 30 December 1976 (birth)
Location: Ward 2-11, Oldenburg Clinic; Klinikum Delmenhorst
Event: Internal meeting reporting 58% of resuscitations and deaths fell on one nurse’s shifts
Status: 85 murders proven by 6 June 2019; investigators estimated up to 300

- Högel completed nursing training in 1997 and was hired at Oldenburg Clinic in 1999.
- A formal internal meeting in August 2001 recorded that 58% of resuscitations and deaths on Ward 2-11 occurred during one nurse’s shifts.
- Högel called in sick for three weeks after the August 2001 meeting; the ward had two deaths during those three weeks.
- On 10 October 2002 the director of nursing at Oldenburg Clinic signed a glowing reference letter for Högel that made no mention of the 58% statistic or related concerns.
- By the time a court rendered its final verdict on 6 June 2019, 85 murders had been proven, with investigators estimating the true count may have reached as high as 300.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1139falsefullhttps://www.spreaker.com/episode/the-1959-plasma-vial-that-forced-scientists-to-rethink-aids--74911475
The 1959 plasma vial that forced scientists to rethink AIDS

In this episode, we follow the contested trail from colonial vaccination programs in central Africa to the frozen vial of 1959 that became a focal point for the OPV-AIDS hypothesis. We trace who asked the question, where the vaccine was given, and why a single archive sample mattered so much; what does that frozen moment reveal?

Person: Tom Curtis
Person: Blaine Elswood
Person: Hilary Koprowski
Location: Leopoldville (now Kinshasa)
Event: CHAT oral polio vaccine program, 1957-1960

- Journalist Tom Curtis pursues a controversial hypothesis after contacts and archival leads point to central Africa.
- Activist-historian Blaine Elswood maps overlap between early AIDS cases and vaccine trial sites in Leopoldville and Stanleyville.
- The CHAT vaccine, developed by Hilary Koprowski, was administered orally to children in Belgian Congo and grown in primate kidney tissue.
- A 1959 archival plasma vial drawn in Leopoldville sat frozen for decades and became a literal test of the hypothesis.
- Leading scientists, including W. D. Hamilton, call for a serious, testable examination of whether contaminated primate tissue could have crossed SIV into humans.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911475Sun, 11 Oct 2026 09:00:29 +0000Creator at ObomediaA journalist found a 1959 plasma vial from Leopoldville - could that vial link a CHAT oral polio vaccine to the origin of AIDS? The 1959 plasma vial that forced scientists to rethink AIDS In this episode, we follow the contested trail from...
The 1959 plasma vial that forced scientists to rethink AIDS

In this episode, we follow the contested trail from colonial vaccination programs in central Africa to the frozen vial of 1959 that became a focal point for the OPV-AIDS hypothesis. We trace who asked the question, where the vaccine was given, and why a single archive sample mattered so much; what does that frozen moment reveal?

Person: Tom Curtis
Person: Blaine Elswood
Person: Hilary Koprowski
Location: Leopoldville (now Kinshasa)
Event: CHAT oral polio vaccine program, 1957-1960

- Journalist Tom Curtis pursues a controversial hypothesis after contacts and archival leads point to central Africa.
- Activist-historian Blaine Elswood maps overlap between early AIDS cases and vaccine trial sites in Leopoldville and Stanleyville.
- The CHAT vaccine, developed by Hilary Koprowski, was administered orally to children in Belgian Congo and grown in primate kidney tissue.
- A 1959 archival plasma vial drawn in Leopoldville sat frozen for decades and became a literal test of the hypothesis.
- Leading scientists, including W. D. Hamilton, call for a serious, testable examination of whether contaminated primate tissue could have crossed SIV into humans.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>982falsefullhttps://www.spreaker.com/episode/the-nurse-who-manufactured-crises-how-hospitals-missed-300-deaths--73098444
More than half of all resuscitations and deaths in one cardiac ICU occurred on a single nurse's shifts - 58% on Ward Two‑Eleven - and when he briefly stayed away, only two patients died in three weeks. How did administrators compile charts showing that spike, watch the decline during his absence, then quietly move him and later write a glowing reference instead of alerting police?

In this episode, we tell the sequence of events inside the Klinikum Oldenburg cardiac surgery intensive care unit from 1999 through the investigations that ended in 2019, following the data, personnel decisions, and documents that let a pattern persist. What do the meeting notes, transfer letter dated October 10, 2002, and the gap between detection and prosecution reveal about institutional failure?

Person: Niels Högel
Date (birth): December 30, 1976
Location: Klinikum Oldenburg, Ward Two‑Eleven
Event: Presentation showing 58% of resuscitations and deaths on one nurse's shifts (summer 2001)
Verdict: Court confirmed 85 murders; investigators believed up to 300

- 58% of all resuscitations and deaths in Ward Two‑Eleven occurred during one nurse's shifts.
- During the three weeks Högel called in sick after the meeting, only two patients died in the ward.
- Administrators transferred Högel to anaesthesiology rather than reporting him to police.
- A reference letter dated October 10, 2002, was written for Högel after his transfer.
- On June 6, 2019, a court in Oldenburg confirmed 85 murders; investigators estimated the true number could be 300.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098444Sat, 10 Oct 2026 13:00:03 +0000Creator at ObomediaThe Nurse Who Manufactured Crises: How Hospitals Missed 300 Deaths More than half of all resuscitations and deaths in one cardiac ICU occurred on a single nurse's shifts - 58% on Ward Two‑Eleven - and when he briefly stayed away, only two patients...
More than half of all resuscitations and deaths in one cardiac ICU occurred on a single nurse's shifts - 58% on Ward Two‑Eleven - and when he briefly stayed away, only two patients died in three weeks. How did administrators compile charts showing that spike, watch the decline during his absence, then quietly move him and later write a glowing reference instead of alerting police?

In this episode, we tell the sequence of events inside the Klinikum Oldenburg cardiac surgery intensive care unit from 1999 through the investigations that ended in 2019, following the data, personnel decisions, and documents that let a pattern persist. What do the meeting notes, transfer letter dated October 10, 2002, and the gap between detection and prosecution reveal about institutional failure?

Person: Niels Högel
Date (birth): December 30, 1976
Location: Klinikum Oldenburg, Ward Two‑Eleven
Event: Presentation showing 58% of resuscitations and deaths on one nurse's shifts (summer 2001)
Verdict: Court confirmed 85 murders; investigators believed up to 300

- 58% of all resuscitations and deaths in Ward Two‑Eleven occurred during one nurse's shifts.
- During the three weeks Högel called in sick after the meeting, only two patients died in the ward.
- Administrators transferred Högel to anaesthesiology rather than reporting him to police.
- A reference letter dated October 10, 2002, was written for Högel after his transfer.
- On June 6, 2019, a court in Oldenburg confirmed 85 murders; investigators estimated the true number could be 300.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1220falsefullhttps://www.spreaker.com/episode/the-parking-lot-that-filled-the-street-turned-a-clinic-into-a-destination--74911474
The parking lot that filled the street turned a clinic into a destination

In this episode, we trace how a small South Shore, Kentucky office became a regional magnet for patients seeking opioid and benzodiazepine prescriptions. We describe the clinic’s routines, the community context, and the practices that let it operate for decades - and ask what made that model so replicable.

Person: David Herbert Procter
Location: South Shore, Kentucky
Date opened: 1979
Patient origin: Ohio, West Virginia, Kentucky
Practice features: cash only; minimal paperwork; no insurance

- A modest office near the Ohio River presented all the outward signs of a legitimate pain clinic while keeping formal documentation scarce.
- Patients-coal miners, factory workers, laborers-arrived seeking relief and were routinely given a prescription pad rather than detailed treatment plans.
- The clinic favored a repeatable prescription formula: strong opioids combined with benzodiazepines, producing heightened sedation and risk.
- By the early 1980s, cars from multiple states lined the parking lot before eight a.m., spreading the clinic’s reputation by word of mouth.
- The absence of insurance billing, limited records, and cash payments created gaps in accountability that allowed the model to scale across state lines.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911474Sat, 10 Oct 2026 09:00:31 +0000Creator at ObomediaA Kentucky pain clinic’s parking lot filled with cars as a Canadian-born doctor handed out cash-only opioid prescriptions - how did that expose them? The parking lot that filled the street turned a clinic into a destination In this episode, we...
The parking lot that filled the street turned a clinic into a destination

In this episode, we trace how a small South Shore, Kentucky office became a regional magnet for patients seeking opioid and benzodiazepine prescriptions. We describe the clinic’s routines, the community context, and the practices that let it operate for decades - and ask what made that model so replicable.

Person: David Herbert Procter
Location: South Shore, Kentucky
Date opened: 1979
Patient origin: Ohio, West Virginia, Kentucky
Practice features: cash only; minimal paperwork; no insurance

- A modest office near the Ohio River presented all the outward signs of a legitimate pain clinic while keeping formal documentation scarce.
- Patients-coal miners, factory workers, laborers-arrived seeking relief and were routinely given a prescription pad rather than detailed treatment plans.
- The clinic favored a repeatable prescription formula: strong opioids combined with benzodiazepines, producing heightened sedation and risk.
- By the early 1980s, cars from multiple states lined the parking lot before eight a.m., spreading the clinic’s reputation by word of mouth.
- The absence of insurance billing, limited records, and cash payments created gaps in accountability that allowed the model to scale across state lines.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>842falsefullhttps://www.spreaker.com/episode/the-nurse-who-turned-lifesaving-drugs-into-silent-killings--73098441
A chilling pattern hid in plain sight: 58% of all cardiac emergencies and deaths on Ward Two-Eleven occurred during a single nurse's shifts. How could one man be tied so closely to catastrophic arrhythmias in a unit where such deaths were expected - and why did those numbers not stop him?

In this episode, we trace the timeline and data that followed one nurse's career across two clinics, the drugs involved, and the institutional choices that let the pattern persist. What decisions and oversights allowed those deaths to continue after the warning signs were clear?

Person: Niels Högel
Date: August 2001
Location: Klinikum Oldenburg, Ward Two-Eleven
Event: Three-week sick leave with only two deaths during absence
Drug: Ajmaline (gilurytmal)

- 58% of all cardiac emergencies and deaths on Ward Two-Eleven occurred during the shifts of one nurse.
- The nurse, Niels Högel, was 24 years old at the August 2001 meeting.
- During Högel's three-week sick leave, only two patients died on the ward.
- After the meeting, Högel was transferred to the anaesthesiology unit rather than suspended.
- The head physician at the anaesthesiology unit filed a written note observing Högel's suspicious presence at life-threatening events.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098441Fri, 09 Oct 2026 13:00:02 +0000Creator at ObomediaThe Nurse Who Turned Lifesaving Drugs into Silent Killings A chilling pattern hid in plain sight: 58% of all cardiac emergencies and deaths on Ward Two-Eleven occurred during a single nurse's shifts. How could one man be tied so closely to...
A chilling pattern hid in plain sight: 58% of all cardiac emergencies and deaths on Ward Two-Eleven occurred during a single nurse's shifts. How could one man be tied so closely to catastrophic arrhythmias in a unit where such deaths were expected - and why did those numbers not stop him?

In this episode, we trace the timeline and data that followed one nurse's career across two clinics, the drugs involved, and the institutional choices that let the pattern persist. What decisions and oversights allowed those deaths to continue after the warning signs were clear?

Person: Niels Högel
Date: August 2001
Location: Klinikum Oldenburg, Ward Two-Eleven
Event: Three-week sick leave with only two deaths during absence
Drug: Ajmaline (gilurytmal)

- 58% of all cardiac emergencies and deaths on Ward Two-Eleven occurred during the shifts of one nurse.
- The nurse, Niels Högel, was 24 years old at the August 2001 meeting.
- During Högel's three-week sick leave, only two patients died on the ward.
- After the meeting, Högel was transferred to the anaesthesiology unit rather than suspended.
- The head physician at the anaesthesiology unit filed a written note observing Högel's suspicious presence at life-threatening events.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1205falsefullhttps://www.spreaker.com/episode/flexner-s-report-pulled-funding-and-closed-black-medical-schools--74911473
Flexner's report pulled funding and closed Black medical schools

In this episode a narrator traces the century-long buildup of barriers that left just 2.4% of medical graduates African American in 1950. We follow the institutions, policies, and personal stories that shaped access to medical training and ask how ordinary decisions produced that bottleneck.

Person: Abraham Flexner
Date: 1910
Event: Medical Education in the United States and Canada (report)
Location: United States and Canada
Topic: Closures of medical schools after philanthropic funding withdrawn

- Visits to 155 medical schools and the grading criteria Flexner used: labs, admissions, clinical training, faculty.
- The Carnegie Foundation’s role in commissioning the report and the linkage to philanthropic funding decisions.
- Fourteen Black-serving medical schools founded 1868-1904 and their structural vulnerability under segregation.
- The timeline: 89 of 155 schools closed within fifteen years after the report’s publication.
- Individual trajectories-James McCune Smith, David J. Peck, and others-showing qualifications met but access denied.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911473Fri, 09 Oct 2026 09:00:33 +0000Creator at ObomediaA historian reads Abraham Flexner’s 1910 report and watches funding vanish from Black medical schools-how did that expose them? Flexner's report pulled funding and closed Black medical schools In this episode a narrator traces the century-long...
Flexner's report pulled funding and closed Black medical schools

In this episode a narrator traces the century-long buildup of barriers that left just 2.4% of medical graduates African American in 1950. We follow the institutions, policies, and personal stories that shaped access to medical training and ask how ordinary decisions produced that bottleneck.

Person: Abraham Flexner
Date: 1910
Event: Medical Education in the United States and Canada (report)
Location: United States and Canada
Topic: Closures of medical schools after philanthropic funding withdrawn

- Visits to 155 medical schools and the grading criteria Flexner used: labs, admissions, clinical training, faculty.
- The Carnegie Foundation’s role in commissioning the report and the linkage to philanthropic funding decisions.
- Fourteen Black-serving medical schools founded 1868-1904 and their structural vulnerability under segregation.
- The timeline: 89 of 155 schools closed within fifteen years after the report’s publication.
- Individual trajectories-James McCune Smith, David J. Peck, and others-showing qualifications met but access denied.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1064falsefullhttps://www.spreaker.com/episode/the-night-nurse-who-manufactured-miracles-and-bodies--73098438
A ward where 58% of cardiac arrests happened while one nurse was on duty; sixty-seven cemeteries holding his victims; one hundred and one cremations that could never be tested. What turns a competent, trusted caregiver into someone who stages emergencies to be the hero - and how did hospital systems let the pattern continue? Which moment finally should have stopped him, and why did it not?

In this episode, we follow the timeline inside two German hospitals and the meetings, absences, and choices that allowed the pattern to persist. We trace the warning signs from the August 2001 staff meeting through the three-week drop in deaths when he called in sick, and ask what the institutional response reveals about responsibility and oversight.

Person: Niels Högel
Date (conviction): June 6, 2019
Birth Date: December 30, 1976
Location: Oldenburg Clinic, Ward Two-Eleven
Victims (convicted): 85 murders

- 58% of every emergency, cardiac arrest, and unexpected death on the ward occurred during his shifts.
- Bodies of victims were buried across 67 cemeteries in three countries.
- 101 victims had been cremated and could never be tested.
- During the three weeks he called in sick after the August 2001 meeting, the ward recorded 2 deaths.
- He was convicted on June 6, 2019, of 85 murders, the most in peacetime German history.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098438Thu, 08 Oct 2026 13:00:02 +0000Creator at ObomediaThe Night Nurse Who Manufactured Miracles - And Bodies A ward where 58% of cardiac arrests happened while one nurse was on duty; sixty-seven cemeteries holding his victims; one hundred and one cremations that could never be tested. What turns a...
A ward where 58% of cardiac arrests happened while one nurse was on duty; sixty-seven cemeteries holding his victims; one hundred and one cremations that could never be tested. What turns a competent, trusted caregiver into someone who stages emergencies to be the hero - and how did hospital systems let the pattern continue? Which moment finally should have stopped him, and why did it not?

In this episode, we follow the timeline inside two German hospitals and the meetings, absences, and choices that allowed the pattern to persist. We trace the warning signs from the August 2001 staff meeting through the three-week drop in deaths when he called in sick, and ask what the institutional response reveals about responsibility and oversight.

Person: Niels Högel
Date (conviction): June 6, 2019
Birth Date: December 30, 1976
Location: Oldenburg Clinic, Ward Two-Eleven
Victims (convicted): 85 murders

- 58% of every emergency, cardiac arrest, and unexpected death on the ward occurred during his shifts.
- Bodies of victims were buried across 67 cemeteries in three countries.
- 101 victims had been cremated and could never be tested.
- During the three weeks he called in sick after the August 2001 meeting, the ward recorded 2 deaths.
- He was convicted on June 6, 2019, of 85 murders, the most in peacetime German history.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1072falsefullhttps://www.spreaker.com/episode/the-clinical-notes-that-refused-to-call-them-imaginary--74911470
The Clinical Notes That Refused to Call Them Imaginary

In this episode, we follow the clinical record kept by Andrew Melvin Ramsay as an unexplained illness swept the Royal Free Hospital in the summer of 1955. The episode traces his thirty-five year struggle to name, measure, and defend the suffering he witnessed - and asks why medicine turned away from what he recorded.

Person: Andrew Melvin Ramsay
Date: Summer 1955; description published 1986
Location: Royal Free Hospital, London
Topic: outbreak of muscle fatigue and neurological symptoms labeled "benign myalgic encephalomyelitis"
Status: decades-long medical debate over biological vs psychological origin

- Patients and staff at the Royal Free fell ill in 1955 with profound muscle fatigue triggered by minimal exertion and prolonged recovery.
- Ramsay, a clinician trained in infectious diseases, systematically recorded symptoms and followed patients for years after the hospital reopened.
- Early terminology called the condition "benign myalgic encephalomyelitis," capturing muscle pain and encephalitis-like features.
- After the 1970s, influential papers and institutions shifted the prevailing explanation toward psychological causes, reclassifying long-term sufferers.
- Ramsay spent thirty-five years proposing biological mechanisms, including mitochondrial dysfunction, and building clinical definitions and patient support.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911470Thu, 08 Oct 2026 09:00:27 +0000Creator at ObomediaA Royal Free physician documents a 1955 outbreak of muscle fatigue and neurological collapse - was the illness real or imagined? The Clinical Notes That Refused to Call Them Imaginary In this episode, we follow the clinical record kept by Andrew...
The Clinical Notes That Refused to Call Them Imaginary

In this episode, we follow the clinical record kept by Andrew Melvin Ramsay as an unexplained illness swept the Royal Free Hospital in the summer of 1955. The episode traces his thirty-five year struggle to name, measure, and defend the suffering he witnessed - and asks why medicine turned away from what he recorded.

Person: Andrew Melvin Ramsay
Date: Summer 1955; description published 1986
Location: Royal Free Hospital, London
Topic: outbreak of muscle fatigue and neurological symptoms labeled "benign myalgic encephalomyelitis"
Status: decades-long medical debate over biological vs psychological origin

- Patients and staff at the Royal Free fell ill in 1955 with profound muscle fatigue triggered by minimal exertion and prolonged recovery.
- Ramsay, a clinician trained in infectious diseases, systematically recorded symptoms and followed patients for years after the hospital reopened.
- Early terminology called the condition "benign myalgic encephalomyelitis," capturing muscle pain and encephalitis-like features.
- After the 1970s, influential papers and institutions shifted the prevailing explanation toward psychological causes, reclassifying long-term sufferers.
- Ramsay spent thirty-five years proposing biological mechanisms, including mitochondrial dysfunction, and building clinical definitions and patient support.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>954falsefullhttps://www.spreaker.com/episode/the-doctor-who-turned-grief-into-a-deadly-medical-religion--73098437
Grief turned into a diagnosis: a single father's conviction that his son's shooting caused his cancer became a theory that promised meaning - and cost lives. Germanic New Medicine claimed every disease stems from a specific psychological shock visible on CT scans, but courts, cancer societies, and radiologists found a different story; how did a printing error on a CT and one man's certainty reshape care for dozens?

In this episode, we tell how Ryke Geerd Hamer moved from licensed physician to the founder of Germanic New Medicine, what his system asserted about disease and treatment, and how courts and medical authorities responded - and we ask how a clinician's personal trauma gained followers despite repeated institutional rejection.

Person: Ryke Geerd Hamer
Event: Dirk Hamer shot on August 8, 1978; Dirk died December 7, 1978
Date: Ryke Geerd Hamer born May 17, 1935
Location: Mettmann, Germany; yacht off Cavallo, Mediterranean
Status: Medical license revoked 1986; arrested 1997, served 12 months

- Hamer earned his medical license in Marburg in 1963 and specialized in internal medicine in 1972.
- Dirk Hamer was 19 when shot August 8, 1978, and died December 7, 1978.
- Hamer submitted a thesis to the University of Tübingen in 1986 which was rejected for lack of scientific method and reproducibility.
- German authorities revoked Hamer's medical license in 1986 and later arrested him in 1997 on charges of fraud and unlicensed practice.
- German, Swiss, and other national cancer organizations found no reproducible evidence supporting Germanic New Medicine and attributed dozens of preventable deaths in Spain to followers of his methods.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098437Wed, 07 Oct 2026 13:00:02 +0000Creator at ObomediaThe Doctor Who Turned Grief Into a Deadly Medical Religion Grief turned into a diagnosis: a single father's conviction that his son's shooting caused his cancer became a theory that promised meaning - and cost lives. Germanic New Medicine claimed...
Grief turned into a diagnosis: a single father's conviction that his son's shooting caused his cancer became a theory that promised meaning - and cost lives. Germanic New Medicine claimed every disease stems from a specific psychological shock visible on CT scans, but courts, cancer societies, and radiologists found a different story; how did a printing error on a CT and one man's certainty reshape care for dozens?

In this episode, we tell how Ryke Geerd Hamer moved from licensed physician to the founder of Germanic New Medicine, what his system asserted about disease and treatment, and how courts and medical authorities responded - and we ask how a clinician's personal trauma gained followers despite repeated institutional rejection.

Person: Ryke Geerd Hamer
Event: Dirk Hamer shot on August 8, 1978; Dirk died December 7, 1978
Date: Ryke Geerd Hamer born May 17, 1935
Location: Mettmann, Germany; yacht off Cavallo, Mediterranean
Status: Medical license revoked 1986; arrested 1997, served 12 months

- Hamer earned his medical license in Marburg in 1963 and specialized in internal medicine in 1972.
- Dirk Hamer was 19 when shot August 8, 1978, and died December 7, 1978.
- Hamer submitted a thesis to the University of Tübingen in 1986 which was rejected for lack of scientific method and reproducibility.
- German authorities revoked Hamer's medical license in 1986 and later arrested him in 1997 on charges of fraud and unlicensed practice.
- German, Swiss, and other national cancer organizations found no reproducible evidence supporting Germanic New Medicine and attributed dozens of preventable deaths in Spain to followers of his methods.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1018falsefullhttps://www.spreaker.com/episode/the-conditional-clause-that-let-twenty-five-thousand-volunteer-to-risk-infection--74911468
The conditional clause that let twenty‑five thousand volunteer to risk infection

In this episode, we look at how a century of medical practice and abuse shaped the rules that allow human challenge trials today. What does the phrase "well‑informed, volunteering freely" actually require, and how did it make twenty‑five thousand volunteers possible?

Person: John Charles Cutler
Date: late May 2020
Number: 25,100
Countries: 102
Topic: human challenge studies

- How modern challenge trials deliberately control dose and timing to watch infection from the first hour.
- The procedural safeguards developed since the 1980s: animal dosing, Phase I with ~100 healthy adults, continuous toxicity and antibody monitoring.
- The infrastructure required: Good Clinical Laboratory Practice, toxicology capacity, 24/7 experienced physicians on call.
- Historical abuses that prompted safeguards: Nazi prisoner experiments, Guatemala syphilis trials, and the Tuskegee study.
- The origin and weight of the conditional clause "well‑informed, volunteering freely" as the dividing line between abuse and current practice.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911468Wed, 07 Oct 2026 09:00:30 +0000Creator at ObomediaA single conditional clause - "well‑informed, volunteering freely" - let 25,100 people offer to be deliberately infected during COVID-19. Why? The conditional clause that let twenty‑five thousand volunteer to risk infection In this episode, we...
The conditional clause that let twenty‑five thousand volunteer to risk infection

In this episode, we look at how a century of medical practice and abuse shaped the rules that allow human challenge trials today. What does the phrase "well‑informed, volunteering freely" actually require, and how did it make twenty‑five thousand volunteers possible?

Person: John Charles Cutler
Date: late May 2020
Number: 25,100
Countries: 102
Topic: human challenge studies

- How modern challenge trials deliberately control dose and timing to watch infection from the first hour.
- The procedural safeguards developed since the 1980s: animal dosing, Phase I with ~100 healthy adults, continuous toxicity and antibody monitoring.
- The infrastructure required: Good Clinical Laboratory Practice, toxicology capacity, 24/7 experienced physicians on call.
- Historical abuses that prompted safeguards: Nazi prisoner experiments, Guatemala syphilis trials, and the Tuskegee study.
- The origin and weight of the conditional clause "well‑informed, volunteering freely" as the dividing line between abuse and current practice.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>975falsefullhttps://www.spreaker.com/episode/when-a-child-almost-died-for-a-doctor-s-deadly-belief--73098434
Fear and moral outrage: a six-year-old Austrian girl with a watermelon-sized tumor and a 90% expected survival rate was told she did not have cancer - and nearly died because of it. How did a licensed physician-turned-heretic convince thousands across Europe to abandon surgery, chemotherapy, and radiation for his theory of disease caused by psychological shock?

In this episode, we tell the documented story of Olivia Pilhar and the rise of Ryke Geerd Hamer, outlining how his Germanic New Medicine spread across five countries, reached a dying child through a spiritual community, and prompted presidential intervention and cross-border legal action. What exactly did Hamer claim, and what did it take to pull Olivia back from the brink?

Person: Olivia Pilhar
Person: Ryke Geerd Hamer
Date: 1995
Event: Wilms' tumor diagnosis with roughly 90% survival under conventional treatment
Location: Austria

- Olivia Pilhar was six years old when she was diagnosed with a Wilms' tumor in 1995.
- The tumor had filled her abdomen and pressed against her lungs, described as the size of a small watermelon.
- Survival odds for her stage of Wilms' tumor dropped from about 90% to 10% after the course of events.
- Ryke Geerd Hamer lost his German medical license in 1986 and had his habilitation thesis rejected by the University of Tübingen the same year.
- By 1997 Hamer was operating clinics in Germany, Belgium, Italy, Austria, and the Netherlands despite lacking institutional validation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098434Tue, 06 Oct 2026 13:00:02 +0000Creator at ObomediaWhen a Child Almost Died for a Doctor's Deadly Belief Fear and moral outrage: a six-year-old Austrian girl with a watermelon-sized tumor and a 90% expected survival rate was told she did not have cancer - and nearly died because of it. How did a...
Fear and moral outrage: a six-year-old Austrian girl with a watermelon-sized tumor and a 90% expected survival rate was told she did not have cancer - and nearly died because of it. How did a licensed physician-turned-heretic convince thousands across Europe to abandon surgery, chemotherapy, and radiation for his theory of disease caused by psychological shock?

In this episode, we tell the documented story of Olivia Pilhar and the rise of Ryke Geerd Hamer, outlining how his Germanic New Medicine spread across five countries, reached a dying child through a spiritual community, and prompted presidential intervention and cross-border legal action. What exactly did Hamer claim, and what did it take to pull Olivia back from the brink?

Person: Olivia Pilhar
Person: Ryke Geerd Hamer
Date: 1995
Event: Wilms' tumor diagnosis with roughly 90% survival under conventional treatment
Location: Austria

- Olivia Pilhar was six years old when she was diagnosed with a Wilms' tumor in 1995.
- The tumor had filled her abdomen and pressed against her lungs, described as the size of a small watermelon.
- Survival odds for her stage of Wilms' tumor dropped from about 90% to 10% after the course of events.
- Ryke Geerd Hamer lost his German medical license in 1986 and had his habilitation thesis rejected by the University of Tübingen the same year.
- By 1997 Hamer was operating clinics in Germany, Belgium, Italy, Austria, and the Netherlands despite lacking institutional validation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1202falsefullhttps://www.spreaker.com/episode/the-white-matter-wiring-that-slowed-sound-processing-and-upended-diagnosis--74911467
The white-matter wiring that slowed sound processing and upended diagnosis

In this episode, we follow families, clinicians, and researchers around a single child’s unbearably loud fire drill to trace decades of theory, studies, and clinical practice about sensory processing. We ask how brain measurements and white-matter findings came to challenge medical definitions and clinical care.

Person: Anna Jean Ayres
Date: 1972
Event: six factor-analytic studies on sensory integration
Topic: EEG/ERP/MEG studies showing auditory latency and reduced sensory gating
Date: 2007

- A seven-year-old’s reaction to a ninety-second fire drill prompted a mother to pack earplugs and enter a long-standing clinical debate
- Anna Jean Ayres created the sensory integration framework after repeated factor analyses showing reproducible symptom clusters
- Practitioners renamed and reclassified the condition over decades (sensory integration, sensory processing disorder, modulation/motor/discrimination types)
- Major diagnostic manuals (DSM, ICD) excluded SPD as a standalone disorder, while specialty systems and clinicians kept using it
- 2007 neurophysiological studies recorded delayed auditory timing, reduced gating, and implicated white-matter differences in children diagnosed with SPD

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911467Tue, 06 Oct 2026 09:00:28 +0000Creator at ObomediaA seven-year-old’s fire drill panic and earplugs expose a debate over sensory processing disorder and what brain wiring might prove. The white-matter wiring that slowed sound processing and upended diagnosis In this episode, we follow families,...
The white-matter wiring that slowed sound processing and upended diagnosis

In this episode, we follow families, clinicians, and researchers around a single child’s unbearably loud fire drill to trace decades of theory, studies, and clinical practice about sensory processing. We ask how brain measurements and white-matter findings came to challenge medical definitions and clinical care.

Person: Anna Jean Ayres
Date: 1972
Event: six factor-analytic studies on sensory integration
Topic: EEG/ERP/MEG studies showing auditory latency and reduced sensory gating
Date: 2007

- A seven-year-old’s reaction to a ninety-second fire drill prompted a mother to pack earplugs and enter a long-standing clinical debate
- Anna Jean Ayres created the sensory integration framework after repeated factor analyses showing reproducible symptom clusters
- Practitioners renamed and reclassified the condition over decades (sensory integration, sensory processing disorder, modulation/motor/discrimination types)
- Major diagnostic manuals (DSM, ICD) excluded SPD as a standalone disorder, while specialty systems and clinicians kept using it
- 2007 neurophysiological studies recorded delayed auditory timing, reduced gating, and implicated white-matter differences in children diagnosed with SPD

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>926falsefullhttps://www.spreaker.com/episode/when-a-salesman-took-the-scalpel-inside-ghost-surgery-s-secrets--73098432
The idea that someone you trusted to operate could be replaced mid-procedure is terrifying: security footage shows an operating-room floor mopped more than a dozen times while Kwon Dae-hee bled, and a sales manager with no medical training performed a ten-hour hip operation that left Franklin Mirando permanently crippled. What happens when consent is rewritten and the people who invited an unqualified stranger into the room escape prosecution?

In this episode, we tell the documented stories behind the term "ghost surgery," tracing cases from Seoul to Long Island, the 1978 New York State Assembly report on surgical consent, and the Mirando lawsuit that exposed manipulated medical records and political interruptions to accountability. How did consent become separated from who actually wields the scalpel?

Person: Kwon Dae-hee
Person: Franklin Mirando
Person: William MacKay
Date: 1978
Event: New York State Assembly report finding 50-95% of surgeries in teaching hospitals performed by residents

- Security camera recorded the operating-room floor being mopped more than a dozen times while Kwon Dae-hee bled.
- Kwon Dae-hee was a university student in Seoul who booked a jawline procedure at a private clinic that promised the surgeon's presence from first incision to last stitch.
- William MacKay, a general sales manager with no medical training, operated on Franklin Mirando's hip for three and a half hours during a ten-hour surgery.
- Franklin Mirando's malpractice case settled in 1980 for $1,000,000 after he sued for $2,000,000 and remained permanently crippled.
- A 1978 report to the New York State Assembly found between 50% and 95% of surgeries in American teaching hospitals were performed by residents rather than the lead surgeons patients believed would operate on them.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098432Mon, 05 Oct 2026 13:00:02 +0000Creator at ObomediaWhen a Salesman Took the Scalpel: Inside Ghost Surgery's Secrets The idea that someone you trusted to operate could be replaced mid-procedure is terrifying: security footage shows an operating-room floor mopped more than a dozen times while Kwon...
The idea that someone you trusted to operate could be replaced mid-procedure is terrifying: security footage shows an operating-room floor mopped more than a dozen times while Kwon Dae-hee bled, and a sales manager with no medical training performed a ten-hour hip operation that left Franklin Mirando permanently crippled. What happens when consent is rewritten and the people who invited an unqualified stranger into the room escape prosecution?

In this episode, we tell the documented stories behind the term "ghost surgery," tracing cases from Seoul to Long Island, the 1978 New York State Assembly report on surgical consent, and the Mirando lawsuit that exposed manipulated medical records and political interruptions to accountability. How did consent become separated from who actually wields the scalpel?

Person: Kwon Dae-hee
Person: Franklin Mirando
Person: William MacKay
Date: 1978
Event: New York State Assembly report finding 50-95% of surgeries in teaching hospitals performed by residents

- Security camera recorded the operating-room floor being mopped more than a dozen times while Kwon Dae-hee bled.
- Kwon Dae-hee was a university student in Seoul who booked a jawline procedure at a private clinic that promised the surgeon's presence from first incision to last stitch.
- William MacKay, a general sales manager with no medical training, operated on Franklin Mirando's hip for three and a half hours during a ten-hour surgery.
- Franklin Mirando's malpractice case settled in 1980 for $1,000,000 after he sued for $2,000,000 and remained permanently crippled.
- A 1978 report to the New York State Assembly found between 50% and 95% of surgeries in American teaching hospitals were performed by residents rather than the lead surgeons patients believed would operate on them.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1009falsefullhttps://www.spreaker.com/episode/the-a-ethyl-group-that-silenced-a-psychedelic-and-saved-movement--74911465
The α‑ethyl group that silenced a psychedelic and saved movement

In this episode, we trace how one tiny chemical change reshaped a molecule's effects and followed its path from Alexander Shulgin's tests to Bristol Laboratories' Phase‑3 trials, asking what vanished when the data were locked away. What can be learned from the missing clinical record and the choices that buried it?

Person: Alexander Shulgin
Date: 1968-1976
Location: San Francisco hills; Bristol Laboratories
Topic: Ariadne (BL‑3912 / Dimoxamine), a phenethylamine with an α‑ethyl modification
Status: Phase‑3 trials completed; data sealed

- Shulgin synthesized Ariadne in 1968 and self‑tested escalating doses beginning in 1969, recording no hallucinations even at 100 mg daily.
- Ariadne differed from DOM by a single α‑ethyl group (one carbon, two hydrogens) yet produced heightened clarity instead of psychedelic visuals.
- Bristol Laboratories assigned the compound code BL‑3912 (R‑enantiomer BL‑3912A), floated the name Dimoxamine, and advanced it into clinical trials.
- Board members at Bristol reportedly self‑administered Ariadne before trials; no public records or accounts of their experiences exist.
- Bristol halted development citing "strategic economic considerations," and the Phase‑3 human clinical data were never released to the scientific community.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911465Mon, 05 Oct 2026 09:00:25 +0000Creator at ObomediaA single α‑ethyl carbon in a backyard molecule turned a hallucinogen into a drug candidate - but Bristol Labs kept the record sealed; why? The α‑ethyl group that silenced a psychedelic and saved movement In this episode, we trace how one tiny...
The α‑ethyl group that silenced a psychedelic and saved movement

In this episode, we trace how one tiny chemical change reshaped a molecule's effects and followed its path from Alexander Shulgin's tests to Bristol Laboratories' Phase‑3 trials, asking what vanished when the data were locked away. What can be learned from the missing clinical record and the choices that buried it?

Person: Alexander Shulgin
Date: 1968-1976
Location: San Francisco hills; Bristol Laboratories
Topic: Ariadne (BL‑3912 / Dimoxamine), a phenethylamine with an α‑ethyl modification
Status: Phase‑3 trials completed; data sealed

- Shulgin synthesized Ariadne in 1968 and self‑tested escalating doses beginning in 1969, recording no hallucinations even at 100 mg daily.
- Ariadne differed from DOM by a single α‑ethyl group (one carbon, two hydrogens) yet produced heightened clarity instead of psychedelic visuals.
- Bristol Laboratories assigned the compound code BL‑3912 (R‑enantiomer BL‑3912A), floated the name Dimoxamine, and advanced it into clinical trials.
- Board members at Bristol reportedly self‑administered Ariadne before trials; no public records or accounts of their experiences exist.
- Bristol halted development citing "strategic economic considerations," and the Phase‑3 human clinical data were never released to the scientific community.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>873falsefullhttps://www.spreaker.com/episode/the-surgeon-wasn-t-there-when-ghost-surgery-became-standard-practice--73098430
Fear that the person on the consent form might not be the one cutting is closer to reality than you think: a prosthetics salesman spent 3.5 hours operating on a patient in 1975, and a 1978 government report found 50-95% of surgeries at some teaching hospitals were done by residents. How did hospitals and clinics normalize phantom hands in the OR, and what happens when records are erased or advertisements lie?

In this episode, we tell how ghost surgery unfolded from a Long Island hip operation to booming cosmetic clinics in Seoul, tracing cases, investigations, manipulated records, and the human costs that followed. What do a mopped floor, altered charts, and double-booked surgeons reveal about consent and responsibility?

Person: Franklin Mirando
Date: 1975
Location: Smithtown General Hospital, Long Island, New York
Event: Hip operation with unauthorized operator
Report: 1978 Lifflander Report finding 50-95% resident-performed surgeries in some teaching hospitals

- A prosthetics sales manager named William MacKay, who had not finished high school and held no medical license, operated on Franklin Mirando for three and a half hours.
- Mirando's lawsuit sought $2,000,000 and settled in 1980 for $1,000,000.
- Lipton and Massoff were indicted in 1975; charges were dropped in 1978 after the original District Attorney lost re-election and the successor did not pursue the case.
- Investigators found Mirando's medical records had been manipulated and no original unaltered record survived in the public record.
- The Korean Society of Plastic Surgeons estimated about 100,000 victims of ghost surgery in South Korea between 2008 and 2014.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098430Sun, 04 Oct 2026 13:00:03 +0000Creator at ObomediaThe Surgeon Wasn't There: When Ghost Surgery Became Standard Practice Fear that the person on the consent form might not be the one cutting is closer to reality than you think: a prosthetics salesman spent 3.5 hours operating on a patient in 1975,...
Fear that the person on the consent form might not be the one cutting is closer to reality than you think: a prosthetics salesman spent 3.5 hours operating on a patient in 1975, and a 1978 government report found 50-95% of surgeries at some teaching hospitals were done by residents. How did hospitals and clinics normalize phantom hands in the OR, and what happens when records are erased or advertisements lie?

In this episode, we tell how ghost surgery unfolded from a Long Island hip operation to booming cosmetic clinics in Seoul, tracing cases, investigations, manipulated records, and the human costs that followed. What do a mopped floor, altered charts, and double-booked surgeons reveal about consent and responsibility?

Person: Franklin Mirando
Date: 1975
Location: Smithtown General Hospital, Long Island, New York
Event: Hip operation with unauthorized operator
Report: 1978 Lifflander Report finding 50-95% resident-performed surgeries in some teaching hospitals

- A prosthetics sales manager named William MacKay, who had not finished high school and held no medical license, operated on Franklin Mirando for three and a half hours.
- Mirando's lawsuit sought $2,000,000 and settled in 1980 for $1,000,000.
- Lipton and Massoff were indicted in 1975; charges were dropped in 1978 after the original District Attorney lost re-election and the successor did not pursue the case.
- Investigators found Mirando's medical records had been manipulated and no original unaltered record survived in the public record.
- The Korean Society of Plastic Surgeons estimated about 100,000 victims of ghost surgery in South Korea between 2008 and 2014.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1054falsefullhttps://www.spreaker.com/episode/the-facilitator-s-hand-steered-the-typing-and-spoke-the-children-s-words--74911464
The facilitator's hand steered the typing and spoke the children's words

In this episode, we lay out the rise of facilitated communication and the central moment that forced a single question about authorship into the center of disability medicine. We trace how diagnostic limits, parental desperation, and a simple test exposed a hidden mechanism that changed countless families' lives - but what did that test actually show?

Person: Douglas Biklen
Topic: facilitated communication
Period: 1990s-2000s
Test: single-blind object-identification protocol
Mechanism: ideomotor effect

- Parents watched nonverbal children type coherent sentences while facilitators supported their hands, believing a new voice had been found.
- Standard intelligence testing relied on verbal responses, leaving many nonverbal autistic children labeled as unreachable and fueling demand for alternatives.
- Douglas Biklen introduced facilitated communication from work in Australia and promoted it across schools and therapy settings in the U.S.
- Researchers used a protocol where only the child saw an object; when facilitators were blind, typed responses failed to identify it.
- Repeated experiments showed typed messages matched the facilitator’s knowledge, implicating unconscious motor influence rather than the child’s authorship.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911464Sun, 04 Oct 2026 09:00:41 +0000Creator at ObomediaA silent child types sentences while a facilitator’s hand guides her - facilitated communication promises a voice, but whose words are they? The facilitator's hand steered the typing and spoke the children's words In this episode, we lay out the...
The facilitator's hand steered the typing and spoke the children's words

In this episode, we lay out the rise of facilitated communication and the central moment that forced a single question about authorship into the center of disability medicine. We trace how diagnostic limits, parental desperation, and a simple test exposed a hidden mechanism that changed countless families' lives - but what did that test actually show?

Person: Douglas Biklen
Topic: facilitated communication
Period: 1990s-2000s
Test: single-blind object-identification protocol
Mechanism: ideomotor effect

- Parents watched nonverbal children type coherent sentences while facilitators supported their hands, believing a new voice had been found.
- Standard intelligence testing relied on verbal responses, leaving many nonverbal autistic children labeled as unreachable and fueling demand for alternatives.
- Douglas Biklen introduced facilitated communication from work in Australia and promoted it across schools and therapy settings in the U.S.
- Researchers used a protocol where only the child saw an object; when facilitators were blind, typed responses failed to identify it.
- Repeated experiments showed typed messages matched the facilitator’s knowledge, implicating unconscious motor influence rather than the child’s authorship.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>992falsefullhttps://www.spreaker.com/episode/how-a-teleclinic-sent-a-child-s-testosterone-to-sudden-death-risk--73098429
A child’s blood testosterone was so high that a court-appointed expert warned of “sudden death” from thromboembolic disease after a teleclinic prescribed the highest possible dose on the first prescription. How did a service that never examined the patient in person, ordered no imaging or bone scans, and continued operating despite regulatory action allow such a risk to occur?

In this episode, we lay out the documented timeline and systemic choices that led to Patient J’s crisis and to tribunal findings against clinicians connected to GenderGP. What aspects of the clinic’s model - from “stage not age” philosophy to remote-only consultations - produced these outcomes?

Person: Patient J
Date: May 2024 (High Court ruling)
Organization: GenderGP
Founders: Helen Webberley and Mike Webberley
Ownership change: 2019 to Harland International (Hong Kong)

- The patient identified as J had blood testosterone so high a court expert said the child was at immediate risk of death from thromboembolic disease.
- The clinic prescribed the highest possible testosterone dose on the very first prescription without any in-person examination.
- No bone scan, no imaging, and no physical assessment were performed before prescribing to the child.
- Mike Webberley, a retired consultant gastroenterologist, managed patients for about two years and was later struck from the medical register in May 2019 for acting outside his expertise.
- A reporter posing as a 15-year-old was offered testosterone in a single online consultation with no parental consent and no in-person examination scheduled.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098429Sat, 03 Oct 2026 13:00:02 +0000Creator at ObomediaHow a Teleclinic Sent a Child's Testosterone to "Sudden Death" Risk A child’s blood testosterone was so high that a court-appointed expert warned of “sudden death” from thromboembolic disease after a teleclinic prescribed the highest possible dose...
A child’s blood testosterone was so high that a court-appointed expert warned of “sudden death” from thromboembolic disease after a teleclinic prescribed the highest possible dose on the first prescription. How did a service that never examined the patient in person, ordered no imaging or bone scans, and continued operating despite regulatory action allow such a risk to occur?

In this episode, we lay out the documented timeline and systemic choices that led to Patient J’s crisis and to tribunal findings against clinicians connected to GenderGP. What aspects of the clinic’s model - from “stage not age” philosophy to remote-only consultations - produced these outcomes?

Person: Patient J
Date: May 2024 (High Court ruling)
Organization: GenderGP
Founders: Helen Webberley and Mike Webberley
Ownership change: 2019 to Harland International (Hong Kong)

- The patient identified as J had blood testosterone so high a court expert said the child was at immediate risk of death from thromboembolic disease.
- The clinic prescribed the highest possible testosterone dose on the very first prescription without any in-person examination.
- No bone scan, no imaging, and no physical assessment were performed before prescribing to the child.
- Mike Webberley, a retired consultant gastroenterologist, managed patients for about two years and was later struck from the medical register in May 2019 for acting outside his expertise.
- A reporter posing as a 15-year-old was offered testosterone in a single online consultation with no parental consent and no in-person examination scheduled.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1148falsefullhttps://www.spreaker.com/episode/the-sterile-injectable-that-shut-down-chemotherapy-clinics--74911462
The Sterile Injectable That Shut Down Chemotherapy Clinics

In this episode we map the sequence of practical decisions, market shifts, and industry structures that left clinics without critical chemotherapy drugs. What combination of choices and failures transformed redundancy into fragility, and how did the system document the risk without stopping it?

Person: Dr. Schondelmeyer
Date: April 2024
Location: United States
Topic: Sterile injectable drug shortages

- A pharmacist in an American hospital oncology ward encountered an empty shelf the morning a patient’s chemotherapy was scheduled.
- Eleven weeks elapsed between ordering a needed drug and the pharmacist’s inability to obtain it.
- By April 2024 the American Society of Health-System Pharmacists recorded 323 active drug shortages nationwide.
- Over decades, U.S. generic manufacturing consolidated, shifting large-volume sterile injectable production overseas to countries like China and India.
- A single facility producing a significant share of national sterile injectables lost capacity, triggering acute local absences in already-thin supplies.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911462Sat, 03 Oct 2026 09:00:31 +0000Creator at ObomediaA hospital pharmacist finds the oncology shelf empty as sterile injectable chemo vanishes - how did that expose the system? The Sterile Injectable That Shut Down Chemotherapy Clinics In this episode we map the sequence of practical decisions,...
The Sterile Injectable That Shut Down Chemotherapy Clinics

In this episode we map the sequence of practical decisions, market shifts, and industry structures that left clinics without critical chemotherapy drugs. What combination of choices and failures transformed redundancy into fragility, and how did the system document the risk without stopping it?

Person: Dr. Schondelmeyer
Date: April 2024
Location: United States
Topic: Sterile injectable drug shortages

- A pharmacist in an American hospital oncology ward encountered an empty shelf the morning a patient’s chemotherapy was scheduled.
- Eleven weeks elapsed between ordering a needed drug and the pharmacist’s inability to obtain it.
- By April 2024 the American Society of Health-System Pharmacists recorded 323 active drug shortages nationwide.
- Over decades, U.S. generic manufacturing consolidated, shifting large-volume sterile injectable production overseas to countries like China and India.
- A single facility producing a significant share of national sterile injectables lost capacity, triggering acute local absences in already-thin supplies.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>955falsefullhttps://www.spreaker.com/episode/when-a-clinic-prescribed-deadly-testosterone-on-day-one--73098427
Danger hides in plain sight: a registered clinic gave a child the maximum possible dose of testosterone on day one without physical exam, bone-age X-ray, or bone density scan - a blood level so high a consultant said the child was at risk of sudden death from thromboembolic disease. How did a service operating openly for nearly a decade reach that point?

In this episode, we tell the sequence of events that led from long NHS waiting lists to a private telemedicine clinic prescribing high-risk hormone regimens, and the regulatory and journalistic moments that eventually exposed its practices. What exactly did GenderGP do, and why did enforcement fail until a High Court finding declared immediate danger?

Person: Helen Webberley
Person: Mike Webberley
Event: Interim suspension by the General Medical Council in May 2017
Event: Sale of GenderGP to Harland International in 2019
Date: February 2021 undercover journalism consultations

- One child received the maximum possible dose of testosterone on the first day of treatment.
- No physical examination, bone-age X-ray, or bone density scan was performed before that prescription.
- A consultant paediatric endocrinologist told the High Court the child was at risk of sudden death from thromboembolic disease.
- Both founders were under General Medical Council interim suspension simultaneously by May 2019.
- In February 2021 a journalist posed as a parent of a 15-year-old and a 12-year-old and obtained hormone discussions/prescriptions via telemedicine.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098427Fri, 02 Oct 2026 13:00:02 +0000Creator at ObomediaWhen a Clinic Prescribed Deadly Testosterone on Day One Danger hides in plain sight: a registered clinic gave a child the maximum possible dose of testosterone on day one without physical exam, bone-age X-ray, or bone density scan - a blood level...
Danger hides in plain sight: a registered clinic gave a child the maximum possible dose of testosterone on day one without physical exam, bone-age X-ray, or bone density scan - a blood level so high a consultant said the child was at risk of sudden death from thromboembolic disease. How did a service operating openly for nearly a decade reach that point?

In this episode, we tell the sequence of events that led from long NHS waiting lists to a private telemedicine clinic prescribing high-risk hormone regimens, and the regulatory and journalistic moments that eventually exposed its practices. What exactly did GenderGP do, and why did enforcement fail until a High Court finding declared immediate danger?

Person: Helen Webberley
Person: Mike Webberley
Event: Interim suspension by the General Medical Council in May 2017
Event: Sale of GenderGP to Harland International in 2019
Date: February 2021 undercover journalism consultations

- One child received the maximum possible dose of testosterone on the first day of treatment.
- No physical examination, bone-age X-ray, or bone density scan was performed before that prescription.
- A consultant paediatric endocrinologist told the High Court the child was at risk of sudden death from thromboembolic disease.
- Both founders were under General Medical Council interim suspension simultaneously by May 2019.
- In February 2021 a journalist posed as a parent of a 15-year-old and a 12-year-old and obtained hormone discussions/prescriptions via telemedicine.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1140falsefullhttps://www.spreaker.com/episode/the-doctor-s-silence-took-her-chance-to-choose--74911461
The Doctor's Silence Took Her Chance to Choose

In this episode, we lay out the facts of a landmark 1975 Texas Supreme Court case and the medical context that framed it. We follow Dortha Jean Jacobs’s pregnancy, the silence she says she was given about rubella, and the legal question about whether withholding information can itself be an injury.

Person: Dortha Jean Jacobs
Person: Lesli (her daughter)
Event: Texas Supreme Court ruling, February 19, 1975
Topic: Wrongful birth claim arising from nondisclosure of rubella risks
Medical context: Rubella linked to fetal harm, known in the medical community by the early 1970s

- Dortha contracted rubella during pregnancy while under the care of an established physician who said nothing about the risks.
- Lesli was born with severe disabilities the transcript links directly to prenatal rubella exposure.
- By the early 1970s, rubella’s connection to hearing loss, heart defects, blindness, and neurological damage was documented within the medical community.
- The legal claim centered not on causation of the infection but on whether a doctor’s failure to disclose denied the mother an informed reproductive choice.
- Four elements the court considered: doctor-patient relationship, breach of standard of care, documented harm, and a causal link between nondisclosure and the harm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911461Fri, 02 Oct 2026 09:00:41 +0000Creator at ObomediaA Texas mother says her doctor’s silence stole her chance to choose - how did that omission become a legal injury in wrongful birth law? The Doctor's Silence Took Her Chance to Choose In this episode, we lay out the facts of a landmark 1975...
The Doctor's Silence Took Her Chance to Choose

In this episode, we lay out the facts of a landmark 1975 Texas Supreme Court case and the medical context that framed it. We follow Dortha Jean Jacobs’s pregnancy, the silence she says she was given about rubella, and the legal question about whether withholding information can itself be an injury.

Person: Dortha Jean Jacobs
Person: Lesli (her daughter)
Event: Texas Supreme Court ruling, February 19, 1975
Topic: Wrongful birth claim arising from nondisclosure of rubella risks
Medical context: Rubella linked to fetal harm, known in the medical community by the early 1970s

- Dortha contracted rubella during pregnancy while under the care of an established physician who said nothing about the risks.
- Lesli was born with severe disabilities the transcript links directly to prenatal rubella exposure.
- By the early 1970s, rubella’s connection to hearing loss, heart defects, blindness, and neurological damage was documented within the medical community.
- The legal claim centered not on causation of the infection but on whether a doctor’s failure to disclose denied the mother an informed reproductive choice.
- Four elements the court considered: doctor-patient relationship, breach of standard of care, documented harm, and a causal link between nondisclosure and the harm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>863falsefullhttps://www.spreaker.com/episode/how-a-teleclinic-sent-a-child-high-dose-testosterone-high-court-alarm--73098426
A child was given the highest possible dose of testosterone after a teleconsultation with no physical exam, no x‑ray, and only one psychological session with an unregistered counsellor - a High Court expert warned of a "present risk of sudden death." How did a clinic that started as a lifeline to families on NHS waiting lists become the center of a patient safety crisis?

In this episode, we tell the story of GenderGP, the private teleclinic founded in 2015 that offered hormones and puberty blockers to children and adolescents when NHS wait times stretched for years, and track the events that led the High Court to scrutinize its clinical decisions. What did the court find in the clinical record of the patient known as J, and how did regulatory and media interventions intersect with desperate demand for care?

Person: J
Date: May 2024
Event: High Court ruling citing "present risk of sudden death"
Topic: GenderGP telemedicine clinic and prescribing practices
Location: England and Wales

- GenderGP was founded in 2015 by Helen Webberley (a practising GP) and her husband Mike Webberley (a retired consultant gastroenterologist).
- In 2017 the General Medical Council issued an interim suspension against Helen Webberley; the clinic remained open and Mike took over patient care.
- In 2019 the GMC issued an interim suspension against Mike Webberley and ownership of GenderGP transferred to Harland International, registered in Hong Kong.
- A February 2021 Telegraph undercover investigation reported GenderGP told a posed 15‑year‑old they could prescribe testosterone without parental consent and described a 12‑year‑old pathway of two counsellor appointments and one doctor appointment.
- The High Court review in May 2024 found that patient J, who had never received testosterone before, was prescribed the highest possible dose without physical examination, x‑ray, or bone density scan.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098426Thu, 01 Oct 2026 13:00:02 +0000Creator at ObomediaHow a Teleclinic Sent a Child High‑Dose Testosterone - High Court Alarm A child was given the highest possible dose of testosterone after a teleconsultation with no physical exam, no x‑ray, and only one psychological session with an unregistered...
A child was given the highest possible dose of testosterone after a teleconsultation with no physical exam, no x‑ray, and only one psychological session with an unregistered counsellor - a High Court expert warned of a "present risk of sudden death." How did a clinic that started as a lifeline to families on NHS waiting lists become the center of a patient safety crisis?

In this episode, we tell the story of GenderGP, the private teleclinic founded in 2015 that offered hormones and puberty blockers to children and adolescents when NHS wait times stretched for years, and track the events that led the High Court to scrutinize its clinical decisions. What did the court find in the clinical record of the patient known as J, and how did regulatory and media interventions intersect with desperate demand for care?

Person: J
Date: May 2024
Event: High Court ruling citing "present risk of sudden death"
Topic: GenderGP telemedicine clinic and prescribing practices
Location: England and Wales

- GenderGP was founded in 2015 by Helen Webberley (a practising GP) and her husband Mike Webberley (a retired consultant gastroenterologist).
- In 2017 the General Medical Council issued an interim suspension against Helen Webberley; the clinic remained open and Mike took over patient care.
- In 2019 the GMC issued an interim suspension against Mike Webberley and ownership of GenderGP transferred to Harland International, registered in Hong Kong.
- A February 2021 Telegraph undercover investigation reported GenderGP told a posed 15‑year‑old they could prescribe testosterone without parental consent and described a 12‑year‑old pathway of two counsellor appointments and one doctor appointment.
- The High Court review in May 2024 found that patient J, who had never received testosterone before, was prescribed the highest possible dose without physical examination, x‑ray, or bone density scan.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1176falsefullhttps://www.spreaker.com/episode/the-nurse-who-kept-a-fingertip-on-a-throat-revived-2-151-people--74911460
The nurse who kept a fingertip on a throat revived 2,151 people

In this episode, we follow the creation and operation of a supervised consumption room on East Hastings Street in Vancouver and the debates it provoked. The episode covers the pilot’s design, the medical and legal conditions around its exemption, and the evidence that followed - what can that record tell us about public health versus the law?

Location: East Hastings Street, Vancouver
Event: Opening of Insite under a Section 56 exemption
Year: 2003
Person: Nurses and BC Centre for Excellence in HIV/AIDS researchers
Topic: Supervised consumption facility evaluation and evidence

- A Section 56 exemption from Health Canada allowed a three-year pilot supervised injection facility to open on East Hastings Street.
- The room had thirteen supervised injection booths, clean equipment, nurses trained in overdose reversal, and counselors on-site.
- Two thousand, one hundred and fifty-one times in one year someone stopped breathing inside the room and staff intervened without any deaths.
- Over thirty peer-reviewed studies in fifteen journals tracked outcomes, including reductions in public injection, needle sharing, and increased uptake of treatment.
- The Vancouver Police Department reviewed evidence and concluded the facility reduced harm despite federal legal opposition.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911460Thu, 01 Oct 2026 09:00:32 +0000Creator at ObomediaA nurse kept a fingertip on a throat in a Vancouver room - how did supervised consumption and harm reduction expose the law's limits? The nurse who kept a fingertip on a throat revived 2,151 people In this episode, we follow the creation and...
The nurse who kept a fingertip on a throat revived 2,151 people

In this episode, we follow the creation and operation of a supervised consumption room on East Hastings Street in Vancouver and the debates it provoked. The episode covers the pilot’s design, the medical and legal conditions around its exemption, and the evidence that followed - what can that record tell us about public health versus the law?

Location: East Hastings Street, Vancouver
Event: Opening of Insite under a Section 56 exemption
Year: 2003
Person: Nurses and BC Centre for Excellence in HIV/AIDS researchers
Topic: Supervised consumption facility evaluation and evidence

- A Section 56 exemption from Health Canada allowed a three-year pilot supervised injection facility to open on East Hastings Street.
- The room had thirteen supervised injection booths, clean equipment, nurses trained in overdose reversal, and counselors on-site.
- Two thousand, one hundred and fifty-one times in one year someone stopped breathing inside the room and staff intervened without any deaths.
- Over thirty peer-reviewed studies in fifteen journals tracked outcomes, including reductions in public injection, needle sharing, and increased uptake of treatment.
- The Vancouver Police Department reviewed evidence and concluded the facility reduced harm despite federal legal opposition.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1127falsefullhttps://www.spreaker.com/episode/when-telemedicine-prescribed-hormones-the-gendergp-warning--73098424
This episode opens on a judge reading a report where a child's blood testosterone was described as "dangerously high" after treatment by a telemedicine clinic operating across three continents - a clinic whose founders had by then lost UK medical licences. How did a service meant to fill NHS gaps end up prescribing high-risk hormones to children with no documented physical exams or bone-density scans?

In this episode, we lay out the timeline and decisions that took GenderGP from a private telemedicine alternative to regulatory suspension, offshore ownership and a High Court warning - asking how oversight failed the most vulnerable and what went wrong at each turning point.

Person: Helen Webberley
Person: Mike Webberley
Event: GMC interim suspension (May 2017)
Event: Medical Practitioners Tribunal Service inquiry (May 2019)
Event: Ownership transfer to Harland International (2019)

- In May 2024 a judge read a medical report noting a child’s blood testosterone reached "dangerously high" levels after treatment by GenderGP.
- By 2017 the General Medical Council issued an interim suspension against founder Helen Webberley.
- Mike Webberley, a retired consultant gastroenterologist, ran clinical operations and was struck off after a 2019 tribunal found he treated seven patients outside his expertise.
- Ownership of GenderGP transferred in 2019 to Harland International, a company registered in Hong Kong, while the clinic continued accepting patients.
- An undercover Telegraph investigation in February 2021 included a reporter posing as a fifteen-year-old seeking treatment.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098424Wed, 30 Sep 2026 13:00:02 +0000Creator at ObomediaWhen Telemedicine Prescribed Hormones: The GenderGP Warning This episode opens on a judge reading a report where a child's blood testosterone was described as "dangerously high" after treatment by a telemedicine clinic operating across three...
This episode opens on a judge reading a report where a child's blood testosterone was described as "dangerously high" after treatment by a telemedicine clinic operating across three continents - a clinic whose founders had by then lost UK medical licences. How did a service meant to fill NHS gaps end up prescribing high-risk hormones to children with no documented physical exams or bone-density scans?

In this episode, we lay out the timeline and decisions that took GenderGP from a private telemedicine alternative to regulatory suspension, offshore ownership and a High Court warning - asking how oversight failed the most vulnerable and what went wrong at each turning point.

Person: Helen Webberley
Person: Mike Webberley
Event: GMC interim suspension (May 2017)
Event: Medical Practitioners Tribunal Service inquiry (May 2019)
Event: Ownership transfer to Harland International (2019)

- In May 2024 a judge read a medical report noting a child’s blood testosterone reached "dangerously high" levels after treatment by GenderGP.
- By 2017 the General Medical Council issued an interim suspension against founder Helen Webberley.
- Mike Webberley, a retired consultant gastroenterologist, ran clinical operations and was struck off after a 2019 tribunal found he treated seven patients outside his expertise.
- Ownership of GenderGP transferred in 2019 to Harland International, a company registered in Hong Kong, while the clinic continued accepting patients.
- An undercover Telegraph investigation in February 2021 included a reporter posing as a fifteen-year-old seeking treatment.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1175falsefullhttps://www.spreaker.com/episode/the-opened-window-that-funneled-carbon-monoxide-into-their-sleep--74911459
The opened window that funneled carbon monoxide into their sleep

In this episode, we tell the scene inside a cottage on the morning of January 1, 2021, when neighbors broke in to find eight students unresponsive after a generator had run for hours nearby. We trace who the victims were, the setup of the rooms, and the one small choice that created the pathway for the gas - and ask what that detail reveals about ordinary safety and unseen risk.

Date: January 1, 2021
Location: Tribistovo, Bosnia and Herzegovina
Person(s): eight nineteen-year-old students
Cause detail: generator running in adjacent room; window opened before sleep
Autopsy: Clinical Hospital Mostar confirmed death during sleep

- A generator had been running for six hours in a cottage with no electricity to provide warmth and light.
- Eight friends, all born in 2001 and home from university, moved to a second cottage to sleep after New Year’s celebrations.
- The generator was placed in an adjacent room separated from the sleeping space by a window frame.
- One person opened a window before sleep, creating a direct path between the generator room and where the group slept.
- Carbon monoxide, colorless and odorless, accumulated and produced only the symptom of fatigue in the small hours.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911459Wed, 30 Sep 2026 09:01:06 +0000Creator at ObomediaA single open window in a cold cottage let generator fumes in, and eight nineteen-year-olds never woke. How did that small decision expose them? The opened window that funneled carbon monoxide into their sleep In this episode, we tell the scene...
The opened window that funneled carbon monoxide into their sleep

In this episode, we tell the scene inside a cottage on the morning of January 1, 2021, when neighbors broke in to find eight students unresponsive after a generator had run for hours nearby. We trace who the victims were, the setup of the rooms, and the one small choice that created the pathway for the gas - and ask what that detail reveals about ordinary safety and unseen risk.

Date: January 1, 2021
Location: Tribistovo, Bosnia and Herzegovina
Person(s): eight nineteen-year-old students
Cause detail: generator running in adjacent room; window opened before sleep
Autopsy: Clinical Hospital Mostar confirmed death during sleep

- A generator had been running for six hours in a cottage with no electricity to provide warmth and light.
- Eight friends, all born in 2001 and home from university, moved to a second cottage to sleep after New Year’s celebrations.
- The generator was placed in an adjacent room separated from the sleeping space by a window frame.
- One person opened a window before sleep, creating a direct path between the generator room and where the group slept.
- Carbon monoxide, colorless and odorless, accumulated and produced only the symptom of fatigue in the small hours.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>798falsefullhttps://www.spreaker.com/episode/how-a-private-clinic-gave-a-teen-lethal-testosterone-doses-the-gendergp-story--73098420
A private clinic prescribed maximum starting doses of testosterone to a child with no prior hormone treatment, no physical exam, no bone scan and no registered counsellor - and a physician later told a court the child was at present risk of sudden death. How did a telemedicine service meant to fill NHS waiting lists end up with absent safeguards and prescriptions anyway?

In this episode, we outline the timeline and key events surrounding GenderGP from its founding in 2015 to the tribunal and court hearings, describing who acted, what was or was not done in consultations, and how undercover reporting revealed prescribing practices. What went wrong inside those remote consultations, and who was held responsible?

Person: Helen Webberley
Person: Mike Webberley
Date: 2015 (clinic founded)
Date: May 2017 (Helen interim suspension)
Event: February 2021 (Telegraph undercover appointments)

- A child received the maximum starting dose of testosterone despite having no prior hormone treatment.
- No physical examination, no bone scan and no registered counsellor were recorded before that prescription.
- In May 2017 the General Medical Council placed Helen Webberley under interim suspension pending investigation.
- Mike Webberley, a retired gastroenterologist, treated seven patients outside his clinical expertise and was later struck from the UK medical register.
- In February 2021 a Telegraph reporter posed as a 15-year-old and was told testosterone might be obtainable with no parent present or parental consent mentioned.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098420Tue, 29 Sep 2026 13:00:02 +0000Creator at ObomediaHow a Private Clinic Gave a Teen Lethal Testosterone Doses - The GenderGP Story A private clinic prescribed maximum starting doses of testosterone to a child with no prior hormone treatment, no physical exam, no bone scan and no registered...
A private clinic prescribed maximum starting doses of testosterone to a child with no prior hormone treatment, no physical exam, no bone scan and no registered counsellor - and a physician later told a court the child was at present risk of sudden death. How did a telemedicine service meant to fill NHS waiting lists end up with absent safeguards and prescriptions anyway?

In this episode, we outline the timeline and key events surrounding GenderGP from its founding in 2015 to the tribunal and court hearings, describing who acted, what was or was not done in consultations, and how undercover reporting revealed prescribing practices. What went wrong inside those remote consultations, and who was held responsible?

Person: Helen Webberley
Person: Mike Webberley
Date: 2015 (clinic founded)
Date: May 2017 (Helen interim suspension)
Event: February 2021 (Telegraph undercover appointments)

- A child received the maximum starting dose of testosterone despite having no prior hormone treatment.
- No physical examination, no bone scan and no registered counsellor were recorded before that prescription.
- In May 2017 the General Medical Council placed Helen Webberley under interim suspension pending investigation.
- Mike Webberley, a retired gastroenterologist, treated seven patients outside his clinical expertise and was later struck from the UK medical register.
- In February 2021 a Telegraph reporter posed as a 15-year-old and was told testosterone might be obtainable with no parent present or parental consent mentioned.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1093falsefullhttps://www.spreaker.com/episode/the-supervisor-opened-the-valve-that-unleashed-forty-tonnes-of-gas--74911456
The supervisor opened the valve that unleashed forty tonnes of gas

In this episode, we hear the documented sequence of decisions, equipment failures, and warnings that led to the Bhopal disaster of December 1984. It lays out who did what, which safety systems were offline, and the choices that set a catastrophe in motion - what pressures and assumptions produced that fateful decision?

Person: Union Carbide India Limited (UCIL)
Date: December 3, 1984
Location: Bhopal, India
Chemical: Methyl isocyanate (MIC)

- Tank E610 held 42 tonnes of MIC, 40% above its safety limit, with nitrogen pressure lost and a faulty pressure gauge.
- Six plant safety systems existed but had been disabled over months, and none were functioning on the night in question.
- Between 22:30 and 23:30 pressure in the tank rose from 14 to 70 kilopascals; staff attributed it to a malfunctioning gauge.
- Workers noticed irritation at 23:15-23:45, tracked the source, and reported it to the MIC supervisor before the critical valve action.
- Local journalist Rajkumar Keswani had repeatedly warned residents about plant risks, but those warnings did not reach the informal settlements nearest the plant.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911456Tue, 29 Sep 2026 09:00:56 +0000Creator at ObomediaA night-shift supervisor at a Bhopal pesticide plant opened a valve as a leaking tank overfilled - how did that expose them? The supervisor opened the valve that unleashed forty tonnes of gas In this episode, we hear the documented sequence of...
The supervisor opened the valve that unleashed forty tonnes of gas

In this episode, we hear the documented sequence of decisions, equipment failures, and warnings that led to the Bhopal disaster of December 1984. It lays out who did what, which safety systems were offline, and the choices that set a catastrophe in motion - what pressures and assumptions produced that fateful decision?

Person: Union Carbide India Limited (UCIL)
Date: December 3, 1984
Location: Bhopal, India
Chemical: Methyl isocyanate (MIC)

- Tank E610 held 42 tonnes of MIC, 40% above its safety limit, with nitrogen pressure lost and a faulty pressure gauge.
- Six plant safety systems existed but had been disabled over months, and none were functioning on the night in question.
- Between 22:30 and 23:30 pressure in the tank rose from 14 to 70 kilopascals; staff attributed it to a malfunctioning gauge.
- Workers noticed irritation at 23:15-23:45, tracked the source, and reported it to the MIC supervisor before the critical valve action.
- Local journalist Rajkumar Keswani had repeatedly warned residents about plant risks, but those warnings did not reach the informal settlements nearest the plant.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>942falsefullhttps://www.spreaker.com/episode/4-2-billion-the-contested-price-of-keeping-vaccines-available--73098418
The figure $4.2 billion lands like an indictment - the total paid by the U.S. National Vaccine Injury Compensation Program as of October 2019, excluding attorneys' fees - but that number masks a far more complicated story about lawsuits, manufacturers exiting the market, and a federal choice to preserve vaccine supply. How did litigation, a Vaccine Injury Compensation with precise symptom windows, and thousands of denied claims produce an amount now used as proof of a hidden epidemic?

In this episode, we lay out what the program covers, how its presumptions and thresholds work, and the key moments that forced Congress to act, while asking whether the $4.2 billion total really means what its critics claim.

Person: Secretary of Health and Human Services (maintains the Vaccine Injury Compensation)
Date: October 2019 (total paid figure)
Event: Enactment of the National Vaccine Injury Compensation Program in 1988
Case: 5,636 autism-related claims filed
Outcome: 1 autism-related claim compensated

- $4.2 billion was paid out by the National Vaccine Injury Compensation Program as of October 2019, not counting attorneys' fees.
- Between 1988 and March 3, 2011, 13,755 claims were filed and 2,620 were compensated.
- For retroactive claims predating 1988, 4,264 were filed and 1,189 were compensated, totaling $903 million in awards.
- Anaphylaxis after tetanus toxoid is presumed if it occurs within 4 hours according to the Vaccine Injury Compensation.
- Of 5,636 autism-related claims filed beginning in the late 1990s, exactly one was compensated on autism-related grounds.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098418Mon, 28 Sep 2026 13:00:02 +0000Creator at Obomedia$4.2 Billion: The Contested Price of Keeping Vaccines Available The figure $4.2 billion lands like an indictment - the total paid by the U.S. National Vaccine Injury Compensation Program as of October 2019, excluding attorneys' fees - but that...
The figure $4.2 billion lands like an indictment - the total paid by the U.S. National Vaccine Injury Compensation Program as of October 2019, excluding attorneys' fees - but that number masks a far more complicated story about lawsuits, manufacturers exiting the market, and a federal choice to preserve vaccine supply. How did litigation, a Vaccine Injury Compensation with precise symptom windows, and thousands of denied claims produce an amount now used as proof of a hidden epidemic?

In this episode, we lay out what the program covers, how its presumptions and thresholds work, and the key moments that forced Congress to act, while asking whether the $4.2 billion total really means what its critics claim.

Person: Secretary of Health and Human Services (maintains the Vaccine Injury Compensation)
Date: October 2019 (total paid figure)
Event: Enactment of the National Vaccine Injury Compensation Program in 1988
Case: 5,636 autism-related claims filed
Outcome: 1 autism-related claim compensated

- $4.2 billion was paid out by the National Vaccine Injury Compensation Program as of October 2019, not counting attorneys' fees.
- Between 1988 and March 3, 2011, 13,755 claims were filed and 2,620 were compensated.
- For retroactive claims predating 1988, 4,264 were filed and 1,189 were compensated, totaling $903 million in awards.
- Anaphylaxis after tetanus toxoid is presumed if it occurs within 4 hours according to the Vaccine Injury Compensation.
- Of 5,636 autism-related claims filed beginning in the late 1990s, exactly one was compensated on autism-related grounds.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1239falsefullhttps://www.spreaker.com/episode/the-dark-bottle-hid-a-snail-and-rewrote-manufacturers-duty--74911453
The dark bottle hid a snail and rewrote manufacturers' duty

In this episode, we follow the evening that started with a shop assistant drinking ginger beer and ended with a legal battle that challenged who manufacturers owe a duty to. What happened in that opaque bottle, and how did it force courts to rethink responsibility to consumers?

Person: May Donoghue
Date: August 26, 1928
Location: Wellmeadow Café, Paisley, Scotland
Defendant: David Stevenson, ginger beer and lemonade manufacturer
Solicitor: Walter Leechman

- The ginger beer came in an intentionally dark brown bottle from Stevenson's plant at 11-12 Glen Lane, Paisley.
- Donoghue drank part of the glass; her friend poured the remainder when what looked like a decomposed snail emerged.
- Donoghue had no contract with the café or manufacturer and was legally a stranger to the transactions that produced the drink.
- Leechman filed a writ on April 9, 1929 seeking £500 in damages; Stevenson denied any snails and pointed to Donoghue’s health.
- Lord Moncrieff ruled for Donoghue on June 27, 1930; the Inner House reversed that decision on November 13, 1930.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911453Mon, 28 Sep 2026 09:00:47 +0000Creator at ObomediaA woman in a Paisley café drank from a ginger beer bottle with a decomposed snail-how did that bottle expose manufacturers' duty in negligence law? The dark bottle hid a snail and rewrote manufacturers' duty In this episode, we follow the...
The dark bottle hid a snail and rewrote manufacturers' duty

In this episode, we follow the evening that started with a shop assistant drinking ginger beer and ended with a legal battle that challenged who manufacturers owe a duty to. What happened in that opaque bottle, and how did it force courts to rethink responsibility to consumers?

Person: May Donoghue
Date: August 26, 1928
Location: Wellmeadow Café, Paisley, Scotland
Defendant: David Stevenson, ginger beer and lemonade manufacturer
Solicitor: Walter Leechman

- The ginger beer came in an intentionally dark brown bottle from Stevenson's plant at 11-12 Glen Lane, Paisley.
- Donoghue drank part of the glass; her friend poured the remainder when what looked like a decomposed snail emerged.
- Donoghue had no contract with the café or manufacturer and was legally a stranger to the transactions that produced the drink.
- Leechman filed a writ on April 9, 1929 seeking £500 in damages; Stevenson denied any snails and pointed to Donoghue’s health.
- Lord Moncrieff ruled for Donoghue on June 27, 1930; the Inner House reversed that decision on November 13, 1930.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1219falsefullhttps://www.spreaker.com/episode/the-drug-that-skipped-safety-how-mefloquine-broke-minds-worldwide--73098417
A single compound number-142,490-became mefloquine, a drug given to millions without a completed Phase Three safety trial, and by 2013 the FDA warned its neuropsychiatric effects may be permanent; how did a medication approved for healthy people weekly and still on the WHO Essential Medicines List cause lifelong harm? What went wrong between Walter Reed’s screens, a Department of Defense transfer, and global marketing that left soldiers and travelers exposed?

In this episode, we lay out the documented timeline from Walter Reed’s drug-screening program through the Department of Defense’s public-private transfer and Hoffmann-LaRoche’s approvals, and we ask how regulatory decisions about prophylactic use and skipped trials shaped the risk to millions.

Person: Walter Reed Army Institute of Research
Event: Transfer of compound and Phase Three/Two data to Hoffmann-LaRoche and Smith Kline
Date: 1984 (approval under brand name Lariam); 1989 (prophylactic approval)
Status: 2013 FDA strongest warning added; 2020 British Ministry of Defence admission of breach of duty
Property: Half-life between 2 and 4 weeks; 4-9% excreted in urine

- 142,490 was the candidate number assigned to the compound later named mefloquine.
- 250,000 chemical compounds were screened by the Walter Reed program during the 1970s.
- Mefloquine received approval for treatment in 1984 and prophylactic approval in 1989 without completed Phase Three safety trials.
- The drug’s half-life is reported between 2 and 4 weeks, causing accumulation with weekly dosing.
- By 2013 the FDA added its strongest possible warning noting neuropsychiatric effects may be permanent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098417Sun, 27 Sep 2026 13:00:03 +0000Creator at ObomediaThe Drug That Skipped Safety: How Mefloquine Broke Minds Worldwide A single compound number-142,490-became mefloquine, a drug given to millions without a completed Phase Three safety trial, and by 2013 the FDA warned its neuropsychiatric effects...
A single compound number-142,490-became mefloquine, a drug given to millions without a completed Phase Three safety trial, and by 2013 the FDA warned its neuropsychiatric effects may be permanent; how did a medication approved for healthy people weekly and still on the WHO Essential Medicines List cause lifelong harm? What went wrong between Walter Reed’s screens, a Department of Defense transfer, and global marketing that left soldiers and travelers exposed?

In this episode, we lay out the documented timeline from Walter Reed’s drug-screening program through the Department of Defense’s public-private transfer and Hoffmann-LaRoche’s approvals, and we ask how regulatory decisions about prophylactic use and skipped trials shaped the risk to millions.

Person: Walter Reed Army Institute of Research
Event: Transfer of compound and Phase Three/Two data to Hoffmann-LaRoche and Smith Kline
Date: 1984 (approval under brand name Lariam); 1989 (prophylactic approval)
Status: 2013 FDA strongest warning added; 2020 British Ministry of Defence admission of breach of duty
Property: Half-life between 2 and 4 weeks; 4-9% excreted in urine

- 142,490 was the candidate number assigned to the compound later named mefloquine.
- 250,000 chemical compounds were screened by the Walter Reed program during the 1970s.
- Mefloquine received approval for treatment in 1984 and prophylactic approval in 1989 without completed Phase Three safety trials.
- The drug’s half-life is reported between 2 and 4 weeks, causing accumulation with weekly dosing.
- By 2013 the FDA added its strongest possible warning noting neuropsychiatric effects may be permanent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1010falsefullhttps://www.spreaker.com/episode/the-buried-mine-that-tore-the-lead-car-open-and-trapped-the-convoy--74911452
The buried mine that tore the lead car open and trapped the convoy

In this episode, we follow the April 13, 1948 medical convoy to Mount Scopus and the decisions, routes, and assumptions that put its passengers at risk. We ask who chose the route, why a telephone call declared it safe, and what responsibilities those choices carried.

Date: April 13, 1948
Location: Nashashibi Bend, outskirts of Jerusalem
Person: Dr. Chaim Yassky
Event: Mine detonation beneath lead vehicle
Composition: 105 people aboard (doctors, nurses, students, Haganah fighters, Red Cross‑marked vehicles)

- Ten vehicles left at 9:30 a.m.: two ambulances, three buses, three supply trucks, and two Haganah armoured cars.
- British Inspector Robert Webb declared the road safe by phone without walking the Nashashibi Bend.
- The convoy route passed through Sheikh Jarrah and the narrow, steep Nashashibi Bend chosen to block escape.
- Mohammed Abdel Najar’s roughly forty men had prepared the bend, buried the mine, and staged the ambush before dawn.
- The mine detonated at 9:45 a.m., tearing the lead armoured car, sealing the road, and trapping the column within seconds.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911452Sun, 27 Sep 2026 09:01:36 +0000Creator at ObomediaA buried mine rips open the lead car of a Red Cross‑marked medical convoy near Jerusalem, trapping doctors and students - how did that expose them? The buried mine that tore the lead car open and trapped the convoy In this episode, we follow the...
The buried mine that tore the lead car open and trapped the convoy

In this episode, we follow the April 13, 1948 medical convoy to Mount Scopus and the decisions, routes, and assumptions that put its passengers at risk. We ask who chose the route, why a telephone call declared it safe, and what responsibilities those choices carried.

Date: April 13, 1948
Location: Nashashibi Bend, outskirts of Jerusalem
Person: Dr. Chaim Yassky
Event: Mine detonation beneath lead vehicle
Composition: 105 people aboard (doctors, nurses, students, Haganah fighters, Red Cross‑marked vehicles)

- Ten vehicles left at 9:30 a.m.: two ambulances, three buses, three supply trucks, and two Haganah armoured cars.
- British Inspector Robert Webb declared the road safe by phone without walking the Nashashibi Bend.
- The convoy route passed through Sheikh Jarrah and the narrow, steep Nashashibi Bend chosen to block escape.
- Mohammed Abdel Najar’s roughly forty men had prepared the bend, buried the mine, and staged the ambush before dawn.
- The mine detonated at 9:45 a.m., tearing the lead armoured car, sealing the road, and trapping the column within seconds.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>923falsefullhttps://www.spreaker.com/episode/when-four-million-reports-hide-ninety-percent-of-drug-harm--73098415
The idea that four million reports could represent just five to ten percent of true drug harm is both shocking and quietly designed into the system that watches our medicines. How did a safety net meant to catch every unexpected injury become a framework that admits ninety percent is missing - and what does that missing nine out of ten look like for real patients?

In this episode, we trace how pharmacovigilance grew from national reports into VigiBase and what those entries actually mean. We follow the path from controlled trials of a few thousand patients to the messy reality of billions taking drugs, and ask: can a system built on voluntary reports and ethical limits ever reveal the true scale of harm?

Person: Uppsala Monitoring Centre staff and scientists
Date: January 2009
Location: Uppsala, Sweden
Event: VigiBase contained 4.6 million individual case safety reports
Period: Since 1978 (data collection into VigiBase)

- VigiBase held 4.6 million individual records of suspected drug harm by January 2009.
- Scientists estimate VigiBase captured between 5% and 10% of actual adverse events.
- The World Health Organization programme had over 150 member countries contributing reports by January 2009.
- VigiBase increases by roughly 250,000 entries each year.
- Two strongest clinical signs of causality are a positive dechallenge (event fades when drug withdrawn) and a positive rechallenge (event returns when drug restarted).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098415Sat, 26 Sep 2026 13:00:02 +0000Creator at ObomediaWhen Four Million Reports Hide Ninety Percent of Drug Harm The idea that four million reports could represent just five to ten percent of true drug harm is both shocking and quietly designed into the system that watches our medicines. How did a...
The idea that four million reports could represent just five to ten percent of true drug harm is both shocking and quietly designed into the system that watches our medicines. How did a safety net meant to catch every unexpected injury become a framework that admits ninety percent is missing - and what does that missing nine out of ten look like for real patients?

In this episode, we trace how pharmacovigilance grew from national reports into VigiBase and what those entries actually mean. We follow the path from controlled trials of a few thousand patients to the messy reality of billions taking drugs, and ask: can a system built on voluntary reports and ethical limits ever reveal the true scale of harm?

Person: Uppsala Monitoring Centre staff and scientists
Date: January 2009
Location: Uppsala, Sweden
Event: VigiBase contained 4.6 million individual case safety reports
Period: Since 1978 (data collection into VigiBase)

- VigiBase held 4.6 million individual records of suspected drug harm by January 2009.
- Scientists estimate VigiBase captured between 5% and 10% of actual adverse events.
- The World Health Organization programme had over 150 member countries contributing reports by January 2009.
- VigiBase increases by roughly 250,000 entries each year.
- Two strongest clinical signs of causality are a positive dechallenge (event fades when drug withdrawn) and a positive rechallenge (event returns when drug restarted).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1094falsefullhttps://www.spreaker.com/episode/the-prescription-palmer-wrote-revealed-how-he-cashed-deaths--74911448
The prescription Palmer wrote revealed how he cashed deaths

In this episode, we look at the months and years leading up to a public execution to trace how medical knowledge, money troubles, and life insurance intersected in a small English town. What did a prescription found decades later reveal about deaths that clustered around one man?

Person: William Palmer
Location: Rugeley, Staffordshire
Date: 14 June 1856
Topic: suspected poisonings and life insurance
Event: execution by hanging after conviction

- Vendors sold pieces of hanging rope outside Stafford Gaol to thirty thousand spectators the day Palmer was executed.
- Palmer was a doctor who understood which substances leave traces and which vanish, and he lived at one end of Rugeley's high street.
- He married Ann Thornton; she died in September 1854 and later postmortem analysis found antimony in every organ.
- Several others close to Palmer-relatives, creditors, and infants-died over years with causes like convulsions, apoplexy, or abscess recorded.
- Palmer's finances collapsed by autumn 1855 (bank balance nine pounds) amid loans, heavy betting losses, and life insurance policies tied to those who later died.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911448Sat, 26 Sep 2026 09:01:30 +0000Creator at ObomediaA country doctor in a Staffordshire town faces the gallows after years of suspicious deaths; could a single prescription expose him? The prescription Palmer wrote revealed how he cashed deaths In this episode, we look at the months and years...
The prescription Palmer wrote revealed how he cashed deaths

In this episode, we look at the months and years leading up to a public execution to trace how medical knowledge, money troubles, and life insurance intersected in a small English town. What did a prescription found decades later reveal about deaths that clustered around one man?

Person: William Palmer
Location: Rugeley, Staffordshire
Date: 14 June 1856
Topic: suspected poisonings and life insurance
Event: execution by hanging after conviction

- Vendors sold pieces of hanging rope outside Stafford Gaol to thirty thousand spectators the day Palmer was executed.
- Palmer was a doctor who understood which substances leave traces and which vanish, and he lived at one end of Rugeley's high street.
- He married Ann Thornton; she died in September 1854 and later postmortem analysis found antimony in every organ.
- Several others close to Palmer-relatives, creditors, and infants-died over years with causes like convulsions, apoplexy, or abscess recorded.
- Palmer's finances collapsed by autumn 1855 (bank balance nine pounds) amid loans, heavy betting losses, and life insurance policies tied to those who later died.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1063falsefullhttps://www.spreaker.com/episode/the-hidden-giant-how-ted-cassidy-s-voice-became-america-s-monster--73098414
A single guttural voice stopped living rooms across America in the autumn of 1977, heard by millions every week - yet the man who owned it remained hidden. Ted Cassidy was six feet nine inches tall, a trained musician and radio man whose improvised two words rewrote a character and a career; how did that small choice make him the nation’s unseen monster?

In this episode, we trace Cassidy’s life from a boy too large for West Virginia classrooms to a radio disc jockey and cafeteria organist in Dallas, through his unexpected proximity to the Kennedy assassination and into Hollywood, asking how a voice could eclipse the man who made it.

Person: Theodore Crawford Cassidy
Date of birth: July 31, 1932
Death date: January 16, 1979
Height: 6 feet 9 inches
Early jobs: WCOA Pensacola disc jockey; WFAA Dallas disc jockey; organist at Luby’s Cafeteria

- Ted Cassidy was born in Pittsburgh, Pennsylvania on July 31, 1932.
- By age six he was sitting in third-grade classrooms and by eleven he was a high school freshman.
- He worked at WCOA in Pensacola in summer 1958 and moved to Dallas the following autumn to work at WFAA.
- On November 22, 1963, Cassidy interviewed eyewitnesses W.E. Newman Jr. and Gayle Newman after President Kennedy’s assassination.
- Cassidy died at age 46 on January 16, 1979 from complications following a routine surgery.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098414Fri, 25 Sep 2026 13:00:03 +0000Creator at ObomediaThe Hidden Giant: How Ted Cassidy's Voice Became America's Monster A single guttural voice stopped living rooms across America in the autumn of 1977, heard by millions every week - yet the man who owned it remained hidden. Ted Cassidy was six feet...
A single guttural voice stopped living rooms across America in the autumn of 1977, heard by millions every week - yet the man who owned it remained hidden. Ted Cassidy was six feet nine inches tall, a trained musician and radio man whose improvised two words rewrote a character and a career; how did that small choice make him the nation’s unseen monster?

In this episode, we trace Cassidy’s life from a boy too large for West Virginia classrooms to a radio disc jockey and cafeteria organist in Dallas, through his unexpected proximity to the Kennedy assassination and into Hollywood, asking how a voice could eclipse the man who made it.

Person: Theodore Crawford Cassidy
Date of birth: July 31, 1932
Death date: January 16, 1979
Height: 6 feet 9 inches
Early jobs: WCOA Pensacola disc jockey; WFAA Dallas disc jockey; organist at Luby’s Cafeteria

- Ted Cassidy was born in Pittsburgh, Pennsylvania on July 31, 1932.
- By age six he was sitting in third-grade classrooms and by eleven he was a high school freshman.
- He worked at WCOA in Pensacola in summer 1958 and moved to Dallas the following autumn to work at WFAA.
- On November 22, 1963, Cassidy interviewed eyewitnesses W.E. Newman Jr. and Gayle Newman after President Kennedy’s assassination.
- Cassidy died at age 46 on January 16, 1979 from complications following a routine surgery.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1115falsefullhttps://www.spreaker.com/episode/the-folded-washcloth-that-smothered-a-resident-and-started-the-inquiry--74911447
The folded washcloth that smothered a resident and started the inquiry

In this episode, we lay out the moments, people, and routines inside Alpine Manor that preceded an investigation into five deaths in 1987. We describe who worked the shifts, which residents were vulnerable, and what finally pushed someone to tell the police.

Location: Walker, Michigan
Facility: Alpine Manor nursing home
Period: Spring 1987-1988
Persons: Gwendolyn Graham; Catherine Wood; five deceased residents' ages: 60, 74, 79, 95, 98

- A white cotton washcloth, already folded, was found in a resident's room before the night shift began.
- Five elderly women died in the first months of 1987; their deaths were recorded as natural and mostly not autopsied.
- Gwendolyn Graham, 22, hired in 1986, and Catherine Wood, 23, were nurse's aides who worked the same shifts and became lovers.
- Wood later told an ex-husband something he reported to police in 1988, prompting an inquiry nearly two years after the first death.
- A handwritten poem Wood gave Graham during 1987 played a central role in the courtroom narrative and helped name the case.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911447Fri, 25 Sep 2026 09:01:04 +0000Creator at ObomediaA folded washcloth in a Walker nursing home room, a night shift, and five elderly women dead-how did that folded washcloth expose them? The folded washcloth that smothered a resident and started the inquiry In this episode, we lay out the...
The folded washcloth that smothered a resident and started the inquiry

In this episode, we lay out the moments, people, and routines inside Alpine Manor that preceded an investigation into five deaths in 1987. We describe who worked the shifts, which residents were vulnerable, and what finally pushed someone to tell the police.

Location: Walker, Michigan
Facility: Alpine Manor nursing home
Period: Spring 1987-1988
Persons: Gwendolyn Graham; Catherine Wood; five deceased residents' ages: 60, 74, 79, 95, 98

- A white cotton washcloth, already folded, was found in a resident's room before the night shift began.
- Five elderly women died in the first months of 1987; their deaths were recorded as natural and mostly not autopsied.
- Gwendolyn Graham, 22, hired in 1986, and Catherine Wood, 23, were nurse's aides who worked the same shifts and became lovers.
- Wood later told an ex-husband something he reported to police in 1988, prompting an inquiry nearly two years after the first death.
- A handwritten poem Wood gave Graham during 1987 played a central role in the courtroom narrative and helped name the case.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>894falsefullhttps://www.spreaker.com/episode/the-prosecutor-who-believed-the-paper-would-save-america--73098412
Trust and legal certainty can feel like salvation: Kenneth W. Starr spent four and a half years and fifty-two million dollars building a paper trail he believed would topple a presidency - and the night before the Starr Report, his team loaded 445 pages into a van. How did a minister’s son from Vernon, Texas, become the nation’s most trusted legal mind and yet preside over institutions that unraveled under his work?

In this episode, we tell the story of Kenneth Winston Starr’s rise from a West Texas childhood to the center of American law and public scrutiny, following his career through clerking for Chief Justice Warren Burger, a D.C. Circuit judgeship, service as Solicitor General, and his appointment as Independent Counsel - and ask how the mandate that began with Whitewater and Vince Foster expanded into something far larger.

Person: Kenneth Winston Starr
Date of birth: July 21, 1946
Investigation length: four and a half years
Amount spent: fifty-two million dollars
Pages in Starr Report: 445

- Starr clerked for Chief Justice Warren Burger in 1975.
- He earned his J.D, from Duke Law School in 1973.
- The nomination to the U.S. Court of Appeals for the D.C. Circuit was confirmed on September 13, 1983.
- He left the federal bench in May 1989 and served as Solicitor General until 1993.
- A panel of three federal judges appointed him Independent Counsel in August 1994.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098412Thu, 24 Sep 2026 13:00:03 +0000Creator at ObomediaThe Prosecutor Who Believed the Paper Would Save America Trust and legal certainty can feel like salvation: Kenneth W. Starr spent four and a half years and fifty-two million dollars building a paper trail he believed would topple a presidency -...
Trust and legal certainty can feel like salvation: Kenneth W. Starr spent four and a half years and fifty-two million dollars building a paper trail he believed would topple a presidency - and the night before the Starr Report, his team loaded 445 pages into a van. How did a minister’s son from Vernon, Texas, become the nation’s most trusted legal mind and yet preside over institutions that unraveled under his work?

In this episode, we tell the story of Kenneth Winston Starr’s rise from a West Texas childhood to the center of American law and public scrutiny, following his career through clerking for Chief Justice Warren Burger, a D.C. Circuit judgeship, service as Solicitor General, and his appointment as Independent Counsel - and ask how the mandate that began with Whitewater and Vince Foster expanded into something far larger.

Person: Kenneth Winston Starr
Date of birth: July 21, 1946
Investigation length: four and a half years
Amount spent: fifty-two million dollars
Pages in Starr Report: 445

- Starr clerked for Chief Justice Warren Burger in 1975.
- He earned his J.D, from Duke Law School in 1973.
- The nomination to the U.S. Court of Appeals for the D.C. Circuit was confirmed on September 13, 1983.
- He left the federal bench in May 1989 and served as Solicitor General until 1993.
- A panel of three federal judges appointed him Independent Counsel in August 1994.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1301falsefullhttps://www.spreaker.com/episode/the-offhand-remark-that-launched-guatemala-s-experiments--74911446
The offhand remark that launched Guatemala's experiments

In this episode, we trace how a routine conversation in 1945 led to a bilateral public health project in Guatemala City and the opening of a Venereal Diseases Training and Research Center in 1946. The episode follows the key figures, institutional routes, and decisions that made human inoculation studies possible - and asks how those choices were justified and organized.

Person: Juan María Funes Fonseca
Person: John Charles Cutler
Location: Guatemala City
Date: November 1946-October 1948
Institution: Venereal Diseases Research Center (VDRL)

- A 1945 fellowship visit to the VDRL in Staten Island where Funes described Guatemala’s legal prostitution and mandatory inspections.
- Researchers at VDRL, motivated by failed Terre Haute experiments and wartime venereal disease priorities, sought settings to produce reliable infections.
- Funding and oversight were routed through the Pan American Sanitary Bureau to channel American money without a direct U.S. signature.
- The Venereal Diseases Training and Research Center opened August 1946 as a bilateral project with institutional architectures designed to enable studies abroad.
- Populations targeted in Guatemala included soldiers, prisoners, psychiatric patients, and sex workers subject to inoculation protocols and re-inoculations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911446Thu, 24 Sep 2026 09:01:08 +0000Creator at ObomediaA casual remark in a Staten Island lab set American researchers on a path to use Guatemala’s legal brothels and clinics for venereal disease tests. The offhand remark that launched Guatemala's experiments In this episode, we trace how a routine...
The offhand remark that launched Guatemala's experiments

In this episode, we trace how a routine conversation in 1945 led to a bilateral public health project in Guatemala City and the opening of a Venereal Diseases Training and Research Center in 1946. The episode follows the key figures, institutional routes, and decisions that made human inoculation studies possible - and asks how those choices were justified and organized.

Person: Juan María Funes Fonseca
Person: John Charles Cutler
Location: Guatemala City
Date: November 1946-October 1948
Institution: Venereal Diseases Research Center (VDRL)

- A 1945 fellowship visit to the VDRL in Staten Island where Funes described Guatemala’s legal prostitution and mandatory inspections.
- Researchers at VDRL, motivated by failed Terre Haute experiments and wartime venereal disease priorities, sought settings to produce reliable infections.
- Funding and oversight were routed through the Pan American Sanitary Bureau to channel American money without a direct U.S. signature.
- The Venereal Diseases Training and Research Center opened August 1946 as a bilateral project with institutional architectures designed to enable studies abroad.
- Populations targeted in Guatemala included soldiers, prisoners, psychiatric patients, and sex workers subject to inoculation protocols and re-inoculations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>980falsefullhttps://www.spreaker.com/episode/the-dead-name-that-made-marilyn-monroe-haunted-broadway-s-streets--73098410
Grief gathered in the streets-5,000 outside Saint Bartholomew’s-over a thirty-seven-year-old woman who died after a nose operation, yet her name would outlive her and reshape American celebrity. How did a stitched-together stage name travel twenty years beyond her death and become one of the most recognized identities in U.S. culture?

In this episode, we tell the life story of the woman who built a marquee name from borrowed pieces, tracing her childhood on the road, her rise to Broadway stardom, and the strange afterlife of her name-what did that name cost her when it kept moving forward?

Person: Mary Ellen Reynolds (aka Marilynn/Marilyn Miller)
Date of birth: September 1, 1898
Age at death: 37
Audience outside funeral: 5,000 people
Longest run: Sally - 570 performances

- 2,500 people filled the pews inside Saint Bartholomew Church at her funeral.
- She began performing at age 4 at Lakeside Park in Dayton, Ohio, as part of The Columbian Trio.
- By 1914 she was performing at the Lotus Club in London when Lee Shubert discovered her and brought her to Broadway.
- In 1920 she became the highest-paid performer on Broadway with Sally, which ran 570 performances at the New Amsterdam.
- Florenz Ziegfeld insisted she drop one "n" from Marilynn, fixing the stage name Marilyn Miller.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098410Wed, 23 Sep 2026 13:00:02 +0000Creator at ObomediaThe Dead Name That Made Marilyn Monroe Haunted Broadway's Streets Grief gathered in the streets-5,000 outside Saint Bartholomew’s-over a thirty-seven-year-old woman who died after a nose operation, yet her name would outlive her and reshape...
Grief gathered in the streets-5,000 outside Saint Bartholomew’s-over a thirty-seven-year-old woman who died after a nose operation, yet her name would outlive her and reshape American celebrity. How did a stitched-together stage name travel twenty years beyond her death and become one of the most recognized identities in U.S. culture?

In this episode, we tell the life story of the woman who built a marquee name from borrowed pieces, tracing her childhood on the road, her rise to Broadway stardom, and the strange afterlife of her name-what did that name cost her when it kept moving forward?

Person: Mary Ellen Reynolds (aka Marilynn/Marilyn Miller)
Date of birth: September 1, 1898
Age at death: 37
Audience outside funeral: 5,000 people
Longest run: Sally - 570 performances

- 2,500 people filled the pews inside Saint Bartholomew Church at her funeral.
- She began performing at age 4 at Lakeside Park in Dayton, Ohio, as part of The Columbian Trio.
- By 1914 she was performing at the Lotus Club in London when Lee Shubert discovered her and brought her to Broadway.
- In 1920 she became the highest-paid performer on Broadway with Sally, which ran 570 performances at the New Amsterdam.
- Florenz Ziegfeld insisted she drop one "n" from Marilynn, fixing the stage name Marilyn Miller.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1142falsefullhttps://www.spreaker.com/episode/the-surgeon-cut-the-wrong-tissue-and-cost-him-his-life--74911444
The Surgeon Cut the Wrong Tissue and Cost Him His Life

In this episode, we lay out the documented account of what happened to Shin Hae-chul at Sky Hospital and trace the professional life that made him a national figure in South Korea. What decisions, mistakes, and procedures in that operating room led to the police conclusion?

Person: Shin Hae-chul
Date: October 17, 2014
Location: Sky Hospital, Seoul
Age: 46
Topic: Wrong-site surgery and its aftermath

- Shin entered Sky Hospital with a stomach complaint and underwent a surgical procedure he never agreed to.
- Police concluded the surgeon operated on the wrong tissue, and those facts were established in official records.
- He was a transformative musician: winner at the 1988 MBC Campus Music Festival and solo debut in 1990 that topped charts.
- In 1991 he released the first South Korean album produced using MIDI technology, reshaping the country's music production.
- He hosted the long-running MBC radio program Ghost Nation, whose audience formed a distinct community around him.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911444Wed, 23 Sep 2026 09:01:04 +0000Creator at ObomediaOn Oct 17, 2014, Shin Hae-chul went into Seoul’s Sky Hospital for stomach trouble and left after an unwanted surgery - how did that cost him his life? The Surgeon Cut the Wrong Tissue and Cost Him His Life In this episode, we lay out the...
The Surgeon Cut the Wrong Tissue and Cost Him His Life

In this episode, we lay out the documented account of what happened to Shin Hae-chul at Sky Hospital and trace the professional life that made him a national figure in South Korea. What decisions, mistakes, and procedures in that operating room led to the police conclusion?

Person: Shin Hae-chul
Date: October 17, 2014
Location: Sky Hospital, Seoul
Age: 46
Topic: Wrong-site surgery and its aftermath

- Shin entered Sky Hospital with a stomach complaint and underwent a surgical procedure he never agreed to.
- Police concluded the surgeon operated on the wrong tissue, and those facts were established in official records.
- He was a transformative musician: winner at the 1988 MBC Campus Music Festival and solo debut in 1990 that topped charts.
- In 1991 he released the first South Korean album produced using MIDI technology, reshaping the country's music production.
- He hosted the long-running MBC radio program Ghost Nation, whose audience formed a distinct community around him.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>865falsefullhttps://www.spreaker.com/episode/the-blinding-of-bach-surgery-secrets-and-a-missing-grave--73098409
A life that shaped Western music was erased in small, bureaucratic increments: an unfinished manuscript, sudden blindness, a stroke and death within months, and burial in an unmarked grave - and today the bones in St. Thomas Church may not even be his. How did the composer who copied forbidden scores by moonlight end up possibly unclaimed in the earth?

In this episode, we tell the story of Johann Sebastian Bach from his orphaned childhood in Eisenach through his secret copying of scores, travels for study, imprisonment for leaving a job, and his final months of blindness and death - and ask whether the grave marked for him really contains his remains.

Person: Johann Sebastian Bach
Date of birth: 21 March 1685
Event: Blindness, stroke, and death in summer of 1750
Location: St. Thomas Church, Leipzig
Incident: Imprisoned on 6 November 1717 for 26 days

- Born as the eighth and youngest child on 21 March 1685 in Eisenach.
- Lost both parents by age ten (mother in 1694, father in February 1695).
- Enrolled at St. Michael's School in Lüneburg on 3 April 1700 at age 15.
- Imprisoned on 6 November 1717 and confined for 26 days for "too stubbornly forcing the issue of his dismissal."
- Suffered blindness, a stroke, and death all within months in the summer of 1750 and was buried in an unmarked grave.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098409Tue, 22 Sep 2026 13:00:02 +0000Creator at ObomediaThe Blinding of Bach: Surgery, Secrets, and a Missing Grave A life that shaped Western music was erased in small, bureaucratic increments: an unfinished manuscript, sudden blindness, a stroke and death within months, and burial in an unmarked grave...
A life that shaped Western music was erased in small, bureaucratic increments: an unfinished manuscript, sudden blindness, a stroke and death within months, and burial in an unmarked grave - and today the bones in St. Thomas Church may not even be his. How did the composer who copied forbidden scores by moonlight end up possibly unclaimed in the earth?

In this episode, we tell the story of Johann Sebastian Bach from his orphaned childhood in Eisenach through his secret copying of scores, travels for study, imprisonment for leaving a job, and his final months of blindness and death - and ask whether the grave marked for him really contains his remains.

Person: Johann Sebastian Bach
Date of birth: 21 March 1685
Event: Blindness, stroke, and death in summer of 1750
Location: St. Thomas Church, Leipzig
Incident: Imprisoned on 6 November 1717 for 26 days

- Born as the eighth and youngest child on 21 March 1685 in Eisenach.
- Lost both parents by age ten (mother in 1694, father in February 1695).
- Enrolled at St. Michael's School in Lüneburg on 3 April 1700 at age 15.
- Imprisoned on 6 November 1717 and confined for 26 days for "too stubbornly forcing the issue of his dismissal."
- Suffered blindness, a stroke, and death all within months in the summer of 1750 and was buried in an unmarked grave.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1383falsefullhttps://www.spreaker.com/episode/the-fingertip-tissue-sample-triggered-singapore-s-longest-coroner-s-inquiry--74911443
The fingertip tissue sample triggered Singapore's longest coroner's inquiry

In this episode, we follow the medical, legal and family decisions that began with a young woman's collapse in 1985 and the surgery that followed. The episode traces the preserved tissue sample, the family’s complaints, and the escalating attempts to answer whether the operation was necessary.

Person: Jeannie (Chong Yun Jing)
Date: 6 June 1985 (surgery); 10 September 1985 (death)
Location: Mount Elizabeth Medical Centre; cremation at Tse Tho Aum Temple, Bedok South
Person: Surgeon Dr. Lim Djoe Phing
Event: Tissue sample preserved by pathologist Dr. Seah Han Cheow

- Jeannie, a 22-year-old administrative officer and student, collapsed on 24 March 1985 and was later referred to neurosurgeon Dr. Lim.
- Dr. Lim diagnosed a pituitary tumour, warned of imminent blindness, and operated on 6 June 1985, removing a small tissue fragment.
- Post-op, Jeannie developed CSF leakage, fever and severe headaches; the family says Dr. Lim dismissed their concerns and discharged her on 24 June 1985.
- Re-admission by another neurosurgeon, Dr. Ong Peck Leong, led to three more surgeries but Jeannie died of meningitis on 10 September 1985 and was cremated three days later.
- The single preserved tissue sample became the only physical evidence, later tested and contested, prompting a police report and the longest coroner’s inquiry in Singapore.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911443Tue, 22 Sep 2026 09:00:52 +0000Creator at ObomediaA fingertip-sized tissue sample from a cremated 22-year-old in a Singapore lab sparks a coroner’s inquiry. How did that sample expose them? The fingertip tissue sample triggered Singapore's longest coroner's inquiry In this episode, we follow...
The fingertip tissue sample triggered Singapore's longest coroner's inquiry

In this episode, we follow the medical, legal and family decisions that began with a young woman's collapse in 1985 and the surgery that followed. The episode traces the preserved tissue sample, the family’s complaints, and the escalating attempts to answer whether the operation was necessary.

Person: Jeannie (Chong Yun Jing)
Date: 6 June 1985 (surgery); 10 September 1985 (death)
Location: Mount Elizabeth Medical Centre; cremation at Tse Tho Aum Temple, Bedok South
Person: Surgeon Dr. Lim Djoe Phing
Event: Tissue sample preserved by pathologist Dr. Seah Han Cheow

- Jeannie, a 22-year-old administrative officer and student, collapsed on 24 March 1985 and was later referred to neurosurgeon Dr. Lim.
- Dr. Lim diagnosed a pituitary tumour, warned of imminent blindness, and operated on 6 June 1985, removing a small tissue fragment.
- Post-op, Jeannie developed CSF leakage, fever and severe headaches; the family says Dr. Lim dismissed their concerns and discharged her on 24 June 1985.
- Re-admission by another neurosurgeon, Dr. Ong Peck Leong, led to three more surgeries but Jeannie died of meningitis on 10 September 1985 and was cremated three days later.
- The single preserved tissue sample became the only physical evidence, later tested and contested, prompting a police report and the longest coroner’s inquiry in Singapore.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1228falsefullhttps://www.spreaker.com/episode/how-a-salad-bar-became-america-s-first-bioterror-scene--73098407
A small Oregon town of about ten thousand people suddenly suffered 751 cases of severe gastroenteritis in September 1984, and the official answer was only "poor food-handler hygiene." But investigators would later link a plastic bag of light-brown liquid, carried under a jacket and called "salsa," to coordinated contamination at salad bars - so how did a commune’s laboratory equipment end up rewriting the definition of domestic terrorism?

In this episode, we tell who was involved, where and when the illnesses occurred, and how public health investigators first reached - and later overturned - the official explanation. What was found inside a locked laboratory on a high-desert ranch, and why did a medical journal sit on that finding for twelve years?

Person: Ma Anand Sheela
Location: The Dalles, Oregon
Date: September 1984
Event: Rajneeshee food contamination at salad bars
Status: First confirmed bioterrorist attack in United States history

- 751 people in The Dalles were sick by the end of September 1984.
- 45 people were hospitalized during the outbreak.
- A newborn delivered two days after the mother’s infection was given a 5 percent chance of survival.
- Rajneeshpuram at its peak housed roughly 7,000 residents and owned more than 90 Rolls-Royces.
- On August 29, 1984, two Wasco County commissioners became violently ill after being served water at Rajneeshpuram, and one was hospitalized.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098407Mon, 21 Sep 2026 13:00:02 +0000Creator at ObomediaHow a Salad Bar Became America's First Bioterror Scene A small Oregon town of about ten thousand people suddenly suffered 751 cases of severe gastroenteritis in September 1984, and the official answer was only "poor food-handler hygiene." But...
A small Oregon town of about ten thousand people suddenly suffered 751 cases of severe gastroenteritis in September 1984, and the official answer was only "poor food-handler hygiene." But investigators would later link a plastic bag of light-brown liquid, carried under a jacket and called "salsa," to coordinated contamination at salad bars - so how did a commune’s laboratory equipment end up rewriting the definition of domestic terrorism?

In this episode, we tell who was involved, where and when the illnesses occurred, and how public health investigators first reached - and later overturned - the official explanation. What was found inside a locked laboratory on a high-desert ranch, and why did a medical journal sit on that finding for twelve years?

Person: Ma Anand Sheela
Location: The Dalles, Oregon
Date: September 1984
Event: Rajneeshee food contamination at salad bars
Status: First confirmed bioterrorist attack in United States history

- 751 people in The Dalles were sick by the end of September 1984.
- 45 people were hospitalized during the outbreak.
- A newborn delivered two days after the mother’s infection was given a 5 percent chance of survival.
- Rajneeshpuram at its peak housed roughly 7,000 residents and owned more than 90 Rolls-Royces.
- On August 29, 1984, two Wasco County commissioners became violently ill after being served water at Rajneeshpuram, and one was hospitalized.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1086falsefullhttps://www.spreaker.com/episode/the-pitching-machine-shot-that-proved-his-cup-worked-and-cost-him-nothing--74911442
The pitching machine shot that proved his cup worked-and cost him nothing

In this episode we trace the life and career of Mark Alan Alan from rural Wardell, Missouri, through his record-setting high school feats, rapid climb to the majors, and pivotal postseason moments. We follow the decisions, moves, and injuries that shaped his path and ask what that filmed demonstration of his own invention reveals about him.

Person: Mark Alan Alan
Location: Wardell, Missouri
Date of birth: January 17, 1953
Event: Filmed protection-test with a pitching machine set to sixty miles per hour
Team: Kansas City Royals; later St. Louis Cardinals

- He grew up on 800 acres in the Mississippi Delta and developed an unusually powerful pitching arm.
- In one high school season he struck out 127 batters in 69 2/3 innings and threw three no-hitters.
- Drafted by the Kansas City Royals in the 12th round of the 1971 MLB Draft, he chose pro ball over the University of Missouri.
- Whitey Herzog moved him to the closer role in May 1976; that season he posted a 2.08 ERA and led the team with 16 saves.
- The only home run he surrendered in the 1976 regular season was Chris Chambliss’s walk-off in the ALCS; later bone spurs and elbow trouble steadily ended his career.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911442Mon, 21 Sep 2026 09:00:45 +0000Creator at ObomediaA man stands before a pitching machine at 60 mph and takes a ball to the groin to prove the protective cup he built-how did that expose him? The pitching machine shot that proved his cup worked-and cost him nothing In this episode we trace the...
The pitching machine shot that proved his cup worked-and cost him nothing

In this episode we trace the life and career of Mark Alan Alan from rural Wardell, Missouri, through his record-setting high school feats, rapid climb to the majors, and pivotal postseason moments. We follow the decisions, moves, and injuries that shaped his path and ask what that filmed demonstration of his own invention reveals about him.

Person: Mark Alan Alan
Location: Wardell, Missouri
Date of birth: January 17, 1953
Event: Filmed protection-test with a pitching machine set to sixty miles per hour
Team: Kansas City Royals; later St. Louis Cardinals

- He grew up on 800 acres in the Mississippi Delta and developed an unusually powerful pitching arm.
- In one high school season he struck out 127 batters in 69 2/3 innings and threw three no-hitters.
- Drafted by the Kansas City Royals in the 12th round of the 1971 MLB Draft, he chose pro ball over the University of Missouri.
- Whitey Herzog moved him to the closer role in May 1976; that season he posted a 2.08 ERA and led the team with 16 saves.
- The only home run he surrendered in the 1976 regular season was Chris Chambliss’s walk-off in the ALCS; later bone spurs and elbow trouble steadily ended his career.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>760falsefullhttps://www.spreaker.com/episode/how-cheap-powder-turned-china-s-baby-milk-into-a-killer--73098406
A trusted national brand sold infant formula at roughly half the market price and yet the cheapness hid a deadly shortcut: industrial melamine sold in 25-kg bags was added to milk to fake protein tests, sickening nearly 290,000 children and killing six. How did scrap melamine and cyanuric acid from Hebei farms become kidney-crystal makers in infants - and why did warnings go unheeded?

In this episode, we trace the supply chain from small farms and milk collection stations to Sanlu, outline how melamine fooled protein assays, and follow the timeline of complaints that began in December 2007 - asking why no effective action was taken when the first infant kidney stones were reported.

Person: Tian Wenhua
Location: Shijiazhuang, Hebei province
Event: Formula recall of 7,000 tonnes in autumn 2008
Date: December 2007 (first complaints received)
Outcome: Six infant deaths and more than 290,000 sickened

- Sanlu contributed 330 million yuan in taxes in 2007.
- Sanlu infant formula sold at roughly half the market price of competing brands.
- Scrap melamine reached farms at roughly 70% purity and cost about 700 yuan per tonne.
- Researchers found kidney stones with melamine and uric acid at about a 2:1 uric acid to melamine ratio.
- Sanlu received the first complaint of an infant with kidney stones in December 2007 and did not order testing.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098406Sun, 20 Sep 2026 13:00:02 +0000Creator at ObomediaHow Cheap Powder Turned China's Baby Milk Into a Killer A trusted national brand sold infant formula at roughly half the market price and yet the cheapness hid a deadly shortcut: industrial melamine sold in 25-kg bags was added to milk to fake...
A trusted national brand sold infant formula at roughly half the market price and yet the cheapness hid a deadly shortcut: industrial melamine sold in 25-kg bags was added to milk to fake protein tests, sickening nearly 290,000 children and killing six. How did scrap melamine and cyanuric acid from Hebei farms become kidney-crystal makers in infants - and why did warnings go unheeded?

In this episode, we trace the supply chain from small farms and milk collection stations to Sanlu, outline how melamine fooled protein assays, and follow the timeline of complaints that began in December 2007 - asking why no effective action was taken when the first infant kidney stones were reported.

Person: Tian Wenhua
Location: Shijiazhuang, Hebei province
Event: Formula recall of 7,000 tonnes in autumn 2008
Date: December 2007 (first complaints received)
Outcome: Six infant deaths and more than 290,000 sickened

- Sanlu contributed 330 million yuan in taxes in 2007.
- Sanlu infant formula sold at roughly half the market price of competing brands.
- Scrap melamine reached farms at roughly 70% purity and cost about 700 yuan per tonne.
- Researchers found kidney stones with melamine and uric acid at about a 2:1 uric acid to melamine ratio.
- Sanlu received the first complaint of an infant with kidney stones in December 2007 and did not order testing.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1195falsefullhttps://www.spreaker.com/episode/the-needle-that-kept-injecting-him-left-him-addicted-to-stardom--74911441
The Needle That Kept Injecting Him Left Him Addicted to Stardom

In this episode, we follow Eddie Fisher's ascent from South Philadelphia to the top of American entertainment and the private decisions that sustained his public image. The story asks what the injections were doing to the man behind the headlines and the myth that had been carefully constructed around him.

Person: Edwin Jack Fisher
Date: born August 10, 1928
Location: South Philadelphia, Pennsylvania
Event: injections by physician Max Jacobson labeled as "vitamins"
Period: 1953-1958 (injections and peak career rise)

- At Grossinger's an arranged meeting with Eddie Cantor and publicity director Milton Blackstone was framed as a chance discovery that launched Fisher's career.
- Fisher signed an RCA Victor contract, placing thirty-five songs in the Top Forty and selling a million-copy single before most Americans owned a TV.
- He served as the official vocal soloist for the United States Army Band and appeared on national television in uniform, blending patriotism with pop stardom.
- By 1957 he held a five-year, $1,000,000 contract at the Tropicana, representing the commercial ceiling for his era and age.
- From 1953 he received regular injections from Dr. Max Jacobson, told they were vitamins, which Fisher believed sharpened him for performance.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911441Sun, 20 Sep 2026 09:01:23 +0000Creator at ObomediaA pop star in a military uniform keeps taking “vitamin” injections that fuel his rise to Vegas stardom - how did those needles hide the truth? The Needle That Kept Injecting Him Left Him Addicted to Stardom In this episode, we follow Eddie...
The Needle That Kept Injecting Him Left Him Addicted to Stardom

In this episode, we follow Eddie Fisher's ascent from South Philadelphia to the top of American entertainment and the private decisions that sustained his public image. The story asks what the injections were doing to the man behind the headlines and the myth that had been carefully constructed around him.

Person: Edwin Jack Fisher
Date: born August 10, 1928
Location: South Philadelphia, Pennsylvania
Event: injections by physician Max Jacobson labeled as "vitamins"
Period: 1953-1958 (injections and peak career rise)

- At Grossinger's an arranged meeting with Eddie Cantor and publicity director Milton Blackstone was framed as a chance discovery that launched Fisher's career.
- Fisher signed an RCA Victor contract, placing thirty-five songs in the Top Forty and selling a million-copy single before most Americans owned a TV.
- He served as the official vocal soloist for the United States Army Band and appeared on national television in uniform, blending patriotism with pop stardom.
- By 1957 he held a five-year, $1,000,000 contract at the Tropicana, representing the commercial ceiling for his era and age.
- From 1953 he received regular injections from Dr. Max Jacobson, told they were vitamins, which Fisher believed sharpened him for performance.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>926falsefullhttps://www.spreaker.com/episode/the-strawberries-that-brought-a-town-to-its-knees-the-needle-mystery--73098405
The thought of a sewing needle hidden inside a strawberry turned a common snack into a national fear and cost an industry everything it had; what began with one person swallowing part of a needle in September 2018 became a crisis that deployed over one hundred police officers and left nearly every case unsolved. How did a domestic sewing needle, buried inside fruit from a Woolworths punnet, trigger nationwide panic and economic collapse?

In this episode, we follow the timeline from the first hospital visit and a Facebook post to nationwide supermarket removals and political responses, and we ask how a three-day delay in public warning shaped the outbreak. Was the contamination isolated, or did the pattern show something far more organized?

Person: an unnamed victim who swallowed part of a sewing needle
Date: September 9, 2018 (first public post) and September 12, 2018 (public warning)
Location: Strathpine Woolworths (first punnet), north of Brisbane, Queensland
Brand: Berry Obsession (first identified punnet)
Response: over 100 police officers deployed and government rewards/assistance announced

- The first contaminated punnet came from Woolworths at the Strathpine Woolworths and the brand was Berry Obsession.
- The initial injury occurred in September 2018 and the victim’s name was never made public.
- Authorities were aware of the first incident for 72 hours before any public warning was issued.
- By September 16, reports of needles in strawberries had come from Queensland, South Australia, Victoria, and Tasmania across eight brands.
- The Queensland Premier announced a $100,000 reward on September 15 and a $1,000,000 industry assistance package three days later.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098405Sat, 19 Sep 2026 13:00:02 +0000Creator at ObomediaThe Strawberries That Brought a Town to Its Knees: The Needle Mystery The thought of a sewing needle hidden inside a strawberry turned a common snack into a national fear and cost an industry everything it had; what began with one person swallowing...
The thought of a sewing needle hidden inside a strawberry turned a common snack into a national fear and cost an industry everything it had; what began with one person swallowing part of a needle in September 2018 became a crisis that deployed over one hundred police officers and left nearly every case unsolved. How did a domestic sewing needle, buried inside fruit from a Woolworths punnet, trigger nationwide panic and economic collapse?

In this episode, we follow the timeline from the first hospital visit and a Facebook post to nationwide supermarket removals and political responses, and we ask how a three-day delay in public warning shaped the outbreak. Was the contamination isolated, or did the pattern show something far more organized?

Person: an unnamed victim who swallowed part of a sewing needle
Date: September 9, 2018 (first public post) and September 12, 2018 (public warning)
Location: Strathpine Woolworths (first punnet), north of Brisbane, Queensland
Brand: Berry Obsession (first identified punnet)
Response: over 100 police officers deployed and government rewards/assistance announced

- The first contaminated punnet came from Woolworths at the Strathpine Woolworths and the brand was Berry Obsession.
- The initial injury occurred in September 2018 and the victim’s name was never made public.
- Authorities were aware of the first incident for 72 hours before any public warning was issued.
- By September 16, reports of needles in strawberries had come from Queensland, South Australia, Victoria, and Tasmania across eight brands.
- The Queensland Premier announced a $100,000 reward on September 15 and a $1,000,000 industry assistance package three days later.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1124falsefullhttps://www.spreaker.com/episode/the-metal-tub-that-served-cups-of-poison-and-emptied-nine-hundred-lives--74911437
The metal tub that served cups of poison and emptied nine hundred lives

In this episode we lay out the documented history of Peoples Temple and the construction of Jonestown in northwestern Guyana. We trace the decades of organizing, political ties, daily routines and rehearsals that made mass compliance possible-how was such a disaster built?

Date: November 18, 1978
Location: Jonestown, northwestern Guyana
Person: Jim Jones
Event: White Nights rehearsals and mass drinking from a metal tub
Population: approximately 918 residents

- Jim Jones founded Peoples Temple in Indianapolis in 1955 and by the 1960s moved the core congregation to Redwood Valley, California.
- The Temple accumulated political influence in San Francisco in the 1970s, including votes, public office appointments, and meetings with state and national politicians.
- Facing critical press and defectors in 1973, Jones relocated the group to Guyana to avoid U.S. reporters and courts, selecting land with no extradition and geopolitical complications.
- Jonestown daily life was tightly scheduled, surveilled with closed-circuit TV, enforced with confinement and sedation, and included mandatory evening sessions broadcasting Radio Moscow and Radio Moscow.
- Jones conducted “White Nights” drills where residents were handed cups of red liquid, told it was poison, made to drink, and then told it was a loyalty test.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911437Sat, 19 Sep 2026 09:01:21 +0000Creator at ObomediaIn a Guyana jungle, Peoples Temple members carried children and drank from a metal tub - how did the Temple’s structure and rehearsals expose them? The metal tub that served cups of poison and emptied nine hundred lives In this episode we lay...
The metal tub that served cups of poison and emptied nine hundred lives

In this episode we lay out the documented history of Peoples Temple and the construction of Jonestown in northwestern Guyana. We trace the decades of organizing, political ties, daily routines and rehearsals that made mass compliance possible-how was such a disaster built?

Date: November 18, 1978
Location: Jonestown, northwestern Guyana
Person: Jim Jones
Event: White Nights rehearsals and mass drinking from a metal tub
Population: approximately 918 residents

- Jim Jones founded Peoples Temple in Indianapolis in 1955 and by the 1960s moved the core congregation to Redwood Valley, California.
- The Temple accumulated political influence in San Francisco in the 1970s, including votes, public office appointments, and meetings with state and national politicians.
- Facing critical press and defectors in 1973, Jones relocated the group to Guyana to avoid U.S. reporters and courts, selecting land with no extradition and geopolitical complications.
- Jonestown daily life was tightly scheduled, surveilled with closed-circuit TV, enforced with confinement and sedation, and included mandatory evening sessions broadcasting Radio Moscow and Radio Moscow.
- Jones conducted “White Nights” drills where residents were handed cups of red liquid, told it was poison, made to drink, and then told it was a loyalty test.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1123falsefullhttps://www.spreaker.com/episode/a-non-smoker-survived-september-11-then-the-dust-killed-him-anyway-six-years-later--73098403
A single sentence changed everything: one day a senior CDC scientist warned “do not send people back” and six days later the EPA said the air was safe - and thousands who worked the pile breathed it anyway. How did assurances and warnings cross like that, and why did so many people who never smoked end up with deadly illnesses?

In this episode, we tell the story of workers and responders who labored at Ground Zero, the conflicting federal messages issued in September 2001, and the toxic contents of the dust that settled over lower Manhattan - a story that raises one question: who knew the risks, and when did they know them?

Person: Frank Macri
Date: September 3, 2007
Case: World Trade Center-related illness
Event: EPA statement declaring air and water safe (six days after Sept 11, 2001)
Topic: Toxic composition of World Trade Center dust

- Frank Macri was diagnosed with stage-four lung cancer within one year of September 11, 2001 and died on September 3, 2007 with cancer spread to his spine.
- By 2020, 247 NYPD officers had died of 9/11-related illness; by September 2022, 299 FDNY firefighters had been confirmed dead from the same cause.
- A September 12, 2001 CDC memo by Dr. Edwin Kilbourne warned: do not send people back into that environment without proper protection.
- Six days after the attacks, EPA Administrator Christine Todd Whitman publicly stated the air was safe to breathe and the water safe to drink.
- The dust contained more than 2,500 distinct contaminants; its breakdown included 50% non-fibrous construction debris, 40% glass and other fibers, 9.2% cellulose, and 0.8% asbestos.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098403Fri, 18 Sep 2026 13:00:02 +0000Creator at ObomediaA non-smoker survived September 11 - then the dust killed him anyway, six years later A single sentence changed everything: one day a senior CDC scientist warned “do not send people back” and six days later the EPA said the air was safe - and...
A single sentence changed everything: one day a senior CDC scientist warned “do not send people back” and six days later the EPA said the air was safe - and thousands who worked the pile breathed it anyway. How did assurances and warnings cross like that, and why did so many people who never smoked end up with deadly illnesses?

In this episode, we tell the story of workers and responders who labored at Ground Zero, the conflicting federal messages issued in September 2001, and the toxic contents of the dust that settled over lower Manhattan - a story that raises one question: who knew the risks, and when did they know them?

Person: Frank Macri
Date: September 3, 2007
Case: World Trade Center-related illness
Event: EPA statement declaring air and water safe (six days after Sept 11, 2001)
Topic: Toxic composition of World Trade Center dust

- Frank Macri was diagnosed with stage-four lung cancer within one year of September 11, 2001 and died on September 3, 2007 with cancer spread to his spine.
- By 2020, 247 NYPD officers had died of 9/11-related illness; by September 2022, 299 FDNY firefighters had been confirmed dead from the same cause.
- A September 12, 2001 CDC memo by Dr. Edwin Kilbourne warned: do not send people back into that environment without proper protection.
- Six days after the attacks, EPA Administrator Christine Todd Whitman publicly stated the air was safe to breathe and the water safe to drink.
- The dust contained more than 2,500 distinct contaminants; its breakdown included 50% non-fibrous construction debris, 40% glass and other fibers, 9.2% cellulose, and 0.8% asbestos.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1256falsefullhttps://www.spreaker.com/episode/the-dose-escalation-that-flipped-gaboxadol-into-psychosis--74911435
The dose escalation that flipped gaboxadol into psychosis

In this episode, we follow the development of gaboxadol from Povl Krogsgaard-Larsen’s self‑experiment to large clinical trials, tracing how a molecule derived from Amanita muscaria behaved across animals and humans and raising the question: at what dose does a promising sleep drug become psychiatric hazard?

Person: Povl Krogsgaard-Larsen
Person: Marike Lancel
Company: Lundbeck; Merck
Compound: Gaboxadol (derived from muscimol)
Period: 1977-1990s-2000s

- Krogsgaard-Larsen synthesized gaboxadol from muscimol and self‑administered ten milligrams, reporting mild sedation.
- Animal tests showed gaboxadol required >320 mg/kg to kill mice, a fourteen‑fold safety increase over muscimol.
- Max Planck researcher Marike Lancel found gaboxadol increased slow‑wave sleep in rodents and humans with rare cross‑species fidelity.
- Pharmacokinetics: ~92% oral bioavailability, peak 15-60 minutes, clearance 1.5-2 hours,

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911435Fri, 18 Sep 2026 09:00:43 +0000Creator at ObomediaA chemist turns a fly agaric molecule into a sleep drug, but dose escalation exposes a psychiatric flip that could undo the whole program. The dose escalation that flipped gaboxadol into psychosis In this episode, we follow the development of...
The dose escalation that flipped gaboxadol into psychosis

In this episode, we follow the development of gaboxadol from Povl Krogsgaard-Larsen’s self‑experiment to large clinical trials, tracing how a molecule derived from Amanita muscaria behaved across animals and humans and raising the question: at what dose does a promising sleep drug become psychiatric hazard?

Person: Povl Krogsgaard-Larsen
Person: Marike Lancel
Company: Lundbeck; Merck
Compound: Gaboxadol (derived from muscimol)
Period: 1977-1990s-2000s

- Krogsgaard-Larsen synthesized gaboxadol from muscimol and self‑administered ten milligrams, reporting mild sedation.
- Animal tests showed gaboxadol required >320 mg/kg to kill mice, a fourteen‑fold safety increase over muscimol.
- Max Planck researcher Marike Lancel found gaboxadol increased slow‑wave sleep in rodents and humans with rare cross‑species fidelity.
- Pharmacokinetics: ~92% oral bioavailability, peak 15-60 minutes, clearance 1.5-2 hours,

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>855falsefullhttps://www.spreaker.com/episode/he-killed-for-choice-inside-jack-kevorkian-s-contested-mercy--73098401
Fifty million Americans watched a man die on television as the doctor who admitted he had done it 130 times held the syringe - a single act that forced the nation to ask who owns death. How did a pathologist from Pontiac, forged by his mother's survival of the Armenian genocide and a lifetime of controversial proposals, become both a savior to some and a criminal to others?

In this episode, we trace the arc of Jack Kevorkian’s life and work, from his 1928 birth to his creation of the Thanatron and the prosecutions that followed, exploring the facts of the cases and the legal gaps they exposed - did medicine ever have clear authority over the moment of death?

Person: Murad Jacob Kevorkian
Date: May 26, 1928
Location: Pontiac, Michigan
Event: First filmed assisted death broadcast November 22, 1998
Device: Thanatron built from hardware-store parts costing about five dollars

- Kevorkian publicly stated he had assisted in 130 deaths before the 1998 televised case.
- Janet Adkins died on June 4, 1990, after using the Thanatron in a parked Volkswagen van north of Detroit.
- Adkins was 54 years old and had been diagnosed with early-stage Alzheimer's in 1989.
- Michigan had no statute covering assisted suicide when prosecutors charged Kevorkian after Adkins’s death; charges were dismissed on December 13, 1990.
- Kevorkian published controversial proposals as early as 1959 and placed death-counseling ads in Detroit by 1987.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098401Thu, 17 Sep 2026 13:00:02 +0000Creator at ObomediaHe Killed for Choice: Inside Jack Kevorkian's Contested Mercy Fifty million Americans watched a man die on television as the doctor who admitted he had done it 130 times held the syringe - a single act that forced the nation to ask who owns death....
Fifty million Americans watched a man die on television as the doctor who admitted he had done it 130 times held the syringe - a single act that forced the nation to ask who owns death. How did a pathologist from Pontiac, forged by his mother's survival of the Armenian genocide and a lifetime of controversial proposals, become both a savior to some and a criminal to others?

In this episode, we trace the arc of Jack Kevorkian’s life and work, from his 1928 birth to his creation of the Thanatron and the prosecutions that followed, exploring the facts of the cases and the legal gaps they exposed - did medicine ever have clear authority over the moment of death?

Person: Murad Jacob Kevorkian
Date: May 26, 1928
Location: Pontiac, Michigan
Event: First filmed assisted death broadcast November 22, 1998
Device: Thanatron built from hardware-store parts costing about five dollars

- Kevorkian publicly stated he had assisted in 130 deaths before the 1998 televised case.
- Janet Adkins died on June 4, 1990, after using the Thanatron in a parked Volkswagen van north of Detroit.
- Adkins was 54 years old and had been diagnosed with early-stage Alzheimer's in 1989.
- Michigan had no statute covering assisted suicide when prosecutors charged Kevorkian after Adkins’s death; charges were dismissed on December 13, 1990.
- Kevorkian published controversial proposals as early as 1959 and placed death-counseling ads in Detroit by 1987.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1277falsefullhttps://www.spreaker.com/episode/the-notebook-that-recorded-deaths-and-forced-bristol-to-change--74911434
The notebook that recorded deaths and forced Bristol to change

In this episode we follow the events that unfolded around paediatric cardiac surgery at the Bristol Royal Infirmary and the record-keeping that kept pushing concerns into the open. What did one doctor's data and persistence reveal about institutional silence and parental trust?

Person: Stephen Bolsin
Person: Joshua Loveday
Person: Janardan Dhasmana
Location: Bristol Royal Infirmary
Date: January 1995

- Bolsin began tracking outcomes when he arrived at Bristol in 1988, keeping a notebook of operations, times, and recoveries.
- By comparing Bristol's complex infant heart surgery outcomes to other hospitals, he identified a significant mortality gap.
- Bolsin raised alarms from 1991 onward with NHS management, the Department of Health, and the Royal Colleges but encountered silence.
- The unit's culture was later described as insulated by seniority, where a junior anaesthetist's warnings were systematically ignored.
- In January 1995 Bolsin advised against operating on baby Joshua Loveday; the surgeon overruled him and Joshua died on the table.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911434Thu, 17 Sep 2026 09:00:50 +0000Creator at ObomediaAn anaesthetist’s notebook revealed infant cardiac deaths at Bristol-how did that notebook expose them? The notebook that recorded deaths and forced Bristol to change In this episode we follow the events that unfolded around paediatric cardiac...
The notebook that recorded deaths and forced Bristol to change

In this episode we follow the events that unfolded around paediatric cardiac surgery at the Bristol Royal Infirmary and the record-keeping that kept pushing concerns into the open. What did one doctor's data and persistence reveal about institutional silence and parental trust?

Person: Stephen Bolsin
Person: Joshua Loveday
Person: Janardan Dhasmana
Location: Bristol Royal Infirmary
Date: January 1995

- Bolsin began tracking outcomes when he arrived at Bristol in 1988, keeping a notebook of operations, times, and recoveries.
- By comparing Bristol's complex infant heart surgery outcomes to other hospitals, he identified a significant mortality gap.
- Bolsin raised alarms from 1991 onward with NHS management, the Department of Health, and the Royal Colleges but encountered silence.
- The unit's culture was later described as insulated by seniority, where a junior anaesthetist's warnings were systematically ignored.
- In January 1995 Bolsin advised against operating on baby Joshua Loveday; the surgeon overruled him and Joshua died on the table.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>883falsefullhttps://www.spreaker.com/episode/the-sofa-of-gold-how-italy-s-drug-czar-hid-millions-while-patients-bled--73098399
Greed hid in plain sight: investigators cataloged gold ingots, Krugerrand coins and Tsarist rubles beneath sofa cushions and inside mattresses for twelve hours, while Italy’s top pharmaceutical official had already fled to Switzerland. How did one inspector amass more than fifteen billion lire and wield the power to decide which drugs Italians received?

In this episode, we tell the sequence of events that led from a prestigious medical career to a sprawling corruption case and a hidden fortune, and ask how institutional authority and private wealth became so thoroughly entangled.

Person: Duilio Poggiolini
Date of arrest: September 20, 1993
Amount in Swiss account: more than 15 billion lire
Search duration: 12 hours to catalog apartment contents
Arrest location: Lausanne, Switzerland

- Born July 25, 1929, Duilio Poggiolini earned a medical degree in 1954 and held professorships by 1963, 1966 and 1972.
- In 1981 Poggiolini was Italy’s representative to the WHO essential drugs program and listed in P2 lodge documents that year.
- In 1982 he became General Manager of the Pharmaceutical Department, controlling Italy’s national formulary and drug pricing.
- Investigators on September 20, 1993 found gold ingots, cut gems, paintings, Krugerrand coins and Tsar Nicholas II gold rubles hidden in sofas, ottomans and a mattress.
- A Swiss bank account registered in his wife Maria Di Pierr Poggiolini’s name held over 15 billion lire at the time of his arrest.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098399Wed, 16 Sep 2026 13:00:02 +0000Creator at ObomediaThe Sofa of Gold: How Italy's Drug Czar Hid Millions While Patients Bled Greed hid in plain sight: investigators cataloged gold ingots, Krugerrand coins and Tsarist rubles beneath sofa cushions and inside mattresses for twelve hours, while Italy’s...
Greed hid in plain sight: investigators cataloged gold ingots, Krugerrand coins and Tsarist rubles beneath sofa cushions and inside mattresses for twelve hours, while Italy’s top pharmaceutical official had already fled to Switzerland. How did one inspector amass more than fifteen billion lire and wield the power to decide which drugs Italians received?

In this episode, we tell the sequence of events that led from a prestigious medical career to a sprawling corruption case and a hidden fortune, and ask how institutional authority and private wealth became so thoroughly entangled.

Person: Duilio Poggiolini
Date of arrest: September 20, 1993
Amount in Swiss account: more than 15 billion lire
Search duration: 12 hours to catalog apartment contents
Arrest location: Lausanne, Switzerland

- Born July 25, 1929, Duilio Poggiolini earned a medical degree in 1954 and held professorships by 1963, 1966 and 1972.
- In 1981 Poggiolini was Italy’s representative to the WHO essential drugs program and listed in P2 lodge documents that year.
- In 1982 he became General Manager of the Pharmaceutical Department, controlling Italy’s national formulary and drug pricing.
- Investigators on September 20, 1993 found gold ingots, cut gems, paintings, Krugerrand coins and Tsar Nicholas II gold rubles hidden in sofas, ottomans and a mattress.
- A Swiss bank account registered in his wife Maria Di Pierr Poggiolini’s name held over 15 billion lire at the time of his arrest.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1210falsefullhttps://www.spreaker.com/episode/the-unchecked-blood-type-assumption-that-killed-jesica-santillan--74911433
The unchecked blood-type assumption that killed Jesica Santillan

In this episode, we follow the chain of decisions, procedures, and missed verifications that led to a catastrophic blood-type mismatch during a combined heart-lung transplant. We trace Jesica Santillan’s journey from Tamazula to Durham, the fundraising and UNOS listing that made surgery possible, and the procedural gaps that raised the question: how did one assumption override established safeguards?

Person: Jesica Santillan
Date: February 7, 2003
Location: Duke University Hospital, Durham, North Carolina
Blood type (recipient): O positive
Blood type (donor organs): A

- Jesica, born December 26, 1985 in Tamazula, had restrictive cardiomyopathy and secondary non-reactive pulmonary hypertension requiring a combined heart-lung transplant.
- After crossing the border and losing her savings, local businessman Mack Mahoney raised funds and navigated the transplant system to place her on the UNOS list.
- Donor organs were recovered in Boston and transported by Carolina Donor Services to Duke the morning of February 7, 2003 for a scheduled transplant.
- Two separate Duke safeguards required written verification and verbal confirmation of blood compatibility before incision; on that morning neither check was completed.
- The surgical team implanted a type-A heart and lungs into an O-positive recipient, with the mismatch only discovered after the operation was finished.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911433Wed, 16 Sep 2026 09:01:00 +0000Creator at ObomediaA teen from Tamazula gets a donated heart at Duke - one unchecked blood-type assumption turns it into a race against an immune attack. What happens next? The unchecked blood-type assumption that killed Jesica Santillan In this episode, we follow...
The unchecked blood-type assumption that killed Jesica Santillan

In this episode, we follow the chain of decisions, procedures, and missed verifications that led to a catastrophic blood-type mismatch during a combined heart-lung transplant. We trace Jesica Santillan’s journey from Tamazula to Durham, the fundraising and UNOS listing that made surgery possible, and the procedural gaps that raised the question: how did one assumption override established safeguards?

Person: Jesica Santillan
Date: February 7, 2003
Location: Duke University Hospital, Durham, North Carolina
Blood type (recipient): O positive
Blood type (donor organs): A

- Jesica, born December 26, 1985 in Tamazula, had restrictive cardiomyopathy and secondary non-reactive pulmonary hypertension requiring a combined heart-lung transplant.
- After crossing the border and losing her savings, local businessman Mack Mahoney raised funds and navigated the transplant system to place her on the UNOS list.
- Donor organs were recovered in Boston and transported by Carolina Donor Services to Duke the morning of February 7, 2003 for a scheduled transplant.
- Two separate Duke safeguards required written verification and verbal confirmation of blood compatibility before incision; on that morning neither check was completed.
- The surgical team implanted a type-A heart and lungs into an O-positive recipient, with the mismatch only discovered after the operation was finished.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>987falsefullhttps://www.spreaker.com/episode/when-power-jumped-the-queue-argentina-s-vip-vaccine-scandal--73098398
Power and privilege rewrote Argentina’s vaccine queue: during brutal Sputnik V shortages, 70 confirmed people received doses outside the official priority list while health workers and the elderly waited. How did a single phone call to the Health Minister turn into a national crisis that brought down a cabinet member and spawned 15 federal complaints?

In this episode, we lay out who was involved, how the protocol was supposed to work, and the gaps that left as many as 3,000 allegedly set-aside doses an open question. Why did doses meant for frontline and high-risk groups end up in private hands?

Person: Ginés González García
Person: Horacio Verbitsky
Event: Phone call on February 19, 2021
Status: 70 people confirmed vaccinated outside protocol
Event: 15 federal criminal complaints filed

- A phone call on the morning of February 19, 2021 from Horacio Verbitsky to Health Minister Ginés González García led to Verbitsky receiving a vaccine dose at the Ministry building.
- The government confirmed 70 people received doses outside the official priority list during the Sputnik V rollout.
- Prosecutor Eduardo Taiano argued each dose given outside protocol deprived someone with a documented claim to it.
- The CELS released a statement acknowledging its president was vaccinated through a personal favor.
- A report cited by La Nación suggested as many as 3,000 doses may have been set aside for political figures, a number the transcript does not independently confirm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098398Tue, 15 Sep 2026 13:00:02 +0000Creator at ObomediaWhen Power Jumped the Queue: Argentina's VIP Vaccine Scandal Power and privilege rewrote Argentina’s vaccine queue: during brutal Sputnik V shortages, 70 confirmed people received doses outside the official priority list while health workers and...
Power and privilege rewrote Argentina’s vaccine queue: during brutal Sputnik V shortages, 70 confirmed people received doses outside the official priority list while health workers and the elderly waited. How did a single phone call to the Health Minister turn into a national crisis that brought down a cabinet member and spawned 15 federal complaints?

In this episode, we lay out who was involved, how the protocol was supposed to work, and the gaps that left as many as 3,000 allegedly set-aside doses an open question. Why did doses meant for frontline and high-risk groups end up in private hands?

Person: Ginés González García
Person: Horacio Verbitsky
Event: Phone call on February 19, 2021
Status: 70 people confirmed vaccinated outside protocol
Event: 15 federal criminal complaints filed

- A phone call on the morning of February 19, 2021 from Horacio Verbitsky to Health Minister Ginés González García led to Verbitsky receiving a vaccine dose at the Ministry building.
- The government confirmed 70 people received doses outside the official priority list during the Sputnik V rollout.
- Prosecutor Eduardo Taiano argued each dose given outside protocol deprived someone with a documented claim to it.
- The CELS released a statement acknowledging its president was vaccinated through a personal favor.
- A report cited by La Nación suggested as many as 3,000 doses may have been set aside for political figures, a number the transcript does not independently confirm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1182falsefullhttps://www.spreaker.com/episode/the-pastor-s-childhood-vaccination-that-refused-to-be-ignored--74911431
The Pastor's Childhood Vaccination That Refused to Be Ignored

In this episode, we follow Henning Jacobson’s refusal to comply with Cambridge’s 1902 compulsory vaccination order and the legal journey that pushed the question to the nation's highest court. What happens when an individual’s documented adverse reaction collides with a law designed for collective safety?

Person: Henning Jacobson
Event: Cambridge smallpox vaccination order
Date: 1902 (outbreak) and February 20, 1905 (Supreme Court decision)
Location: Cambridge, Massachusetts
Issue: claimed hereditary adverse reaction to vaccination

- The Massachusetts Board of Health ordered every inhabitant over 21 to be vaccinated or revaccinated during a real smallpox outbreak.
- The penalty for refusal was a five-dollar fine; vaccination itself was provided free and there was no physical compulsion.
- Jacobson, a Swedish-born Lutheran pastor, cited a childhood vaccination that caused him "great and extreme suffering" and reported his son had an adverse reaction.
- Physicians of the era acknowledged vaccine risks and debated safety, but the law offered no mechanism to exempt individuals based on personal medical history.
- The Supreme Court majority allowed a narrow judicial door for cases with specific medical proof of individual danger, which Jacobson had not supplied.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911431Tue, 15 Sep 2026 09:00:57 +0000Creator at ObomediaA Swedish-born pastor in Cambridge refuses a smallpox vaccination order - can one man’s bodily history block a public-health mandate? The Pastor's Childhood Vaccination That Refused to Be Ignored In this episode, we follow Henning Jacobson’s...
The Pastor's Childhood Vaccination That Refused to Be Ignored

In this episode, we follow Henning Jacobson’s refusal to comply with Cambridge’s 1902 compulsory vaccination order and the legal journey that pushed the question to the nation's highest court. What happens when an individual’s documented adverse reaction collides with a law designed for collective safety?

Person: Henning Jacobson
Event: Cambridge smallpox vaccination order
Date: 1902 (outbreak) and February 20, 1905 (Supreme Court decision)
Location: Cambridge, Massachusetts
Issue: claimed hereditary adverse reaction to vaccination

- The Massachusetts Board of Health ordered every inhabitant over 21 to be vaccinated or revaccinated during a real smallpox outbreak.
- The penalty for refusal was a five-dollar fine; vaccination itself was provided free and there was no physical compulsion.
- Jacobson, a Swedish-born Lutheran pastor, cited a childhood vaccination that caused him "great and extreme suffering" and reported his son had an adverse reaction.
- Physicians of the era acknowledged vaccine risks and debated safety, but the law offered no mechanism to exempt individuals based on personal medical history.
- The Supreme Court majority allowed a narrow judicial door for cases with specific medical proof of individual danger, which Jacobson had not supplied.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>786falsefullhttps://www.spreaker.com/episode/the-doctor-who-diagnosed-freedom-as-madness-drapetomania-unmasked--73098396
Freedom labeled a mental illness by a licensed physician in 1851: Samuel A. Cartwright named the urge to escape "drapetomania," tied it to Greek etymology, and published treatment advice including whipping; how did a medical paper become a tool of control and endure into 1914? What happens when science outfits ideology in a white coat?

In this episode, we recount the publication, circulation, and long shadow of Cartwright's paper and its appearance in De Bow's Review and later medical dictionaries, and we follow the unexpected public challenge that began with mockery in 1855 - could laughter begin to undo medical authority?

Person: Samuel A. Cartwright
Date: 1851
Publication: De Bow's Review
Secondary response: Buffalo Medical Journal, 1855
Reference persistence: medical dictionary entry, 1914

- Cartwright presented "drapetomania" to the Medical Association of Louisiana in 1851.
- The term combines Greek drapetēs ("runaway slave") and mania ("madness").
- Cartwright prescribed control measures including fuel to keep a small fire burning all night and, when they failed, "whipping the devil out of them."
- The paper also introduced "dysaesthesia aethiopica" to medicalize perceived laziness.
- A 1855 response in the Buffalo Medical Journal mocked Cartwright's logic rather than engaging his clinical terms.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098396Mon, 14 Sep 2026 13:00:02 +0000Creator at ObomediaThe Doctor Who Diagnosed Freedom as Madness: Drapetomania Unmasked Freedom labeled a mental illness by a licensed physician in 1851: Samuel A. Cartwright named the urge to escape "drapetomania," tied it to Greek etymology, and published treatment...
Freedom labeled a mental illness by a licensed physician in 1851: Samuel A. Cartwright named the urge to escape "drapetomania," tied it to Greek etymology, and published treatment advice including whipping; how did a medical paper become a tool of control and endure into 1914? What happens when science outfits ideology in a white coat?

In this episode, we recount the publication, circulation, and long shadow of Cartwright's paper and its appearance in De Bow's Review and later medical dictionaries, and we follow the unexpected public challenge that began with mockery in 1855 - could laughter begin to undo medical authority?

Person: Samuel A. Cartwright
Date: 1851
Publication: De Bow's Review
Secondary response: Buffalo Medical Journal, 1855
Reference persistence: medical dictionary entry, 1914

- Cartwright presented "drapetomania" to the Medical Association of Louisiana in 1851.
- The term combines Greek drapetēs ("runaway slave") and mania ("madness").
- Cartwright prescribed control measures including fuel to keep a small fire burning all night and, when they failed, "whipping the devil out of them."
- The paper also introduced "dysaesthesia aethiopica" to medicalize perceived laziness.
- A 1855 response in the Buffalo Medical Journal mocked Cartwright's logic rather than engaging his clinical terms.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1154falsefullhttps://www.spreaker.com/episode/the-word-unlimited-erased-their-care-for-life--74911429
The word "unlimited" erased their care for life

In this episode, we walk through how a single word in insurance fine print shaped who could get care and for how long. We outline the rules, histories, and state-by-state differences that let insurers exclude conditions indefinitely - and ask what that meant for real people.

Document: two-page policy listing exclusions
Period: 1945-2014 (regulatory context through 2014)
Law: HIPAA (1996) limited group plans but not individual market
States: ten states permitted unlimited-duration exclusions (listed)
Practice: elimination riders used to permanently exclude specific conditions

- The transcript describes a clause with the word "unlimited" buried in individual insurance policies that allowed permanent exclusions.
- Two competing pre-existing condition standards existed: the objective standard (diagnosis/treatment) and the prudent person standard (symptoms a reasonable person would seek care for).
- HIPAA in 1996 capped exclusion periods for employer group plans but explicitly left the individual market untouched.
- Thirty-seven states allowed elimination riders that permanently excluded a body part or condition from coverage.
- In several states, documented medical care after domestic violence was recorded in ways that insurers treated as pre-existing conditions.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911429Mon, 14 Sep 2026 09:00:51 +0000Creator at ObomediaAn Alaskan man signs for coverage and a clause erases his care - how did that make lifelong exclusions legal in the individual market? The word "unlimited" erased their care for life In this episode, we walk through how a single word in...
The word "unlimited" erased their care for life

In this episode, we walk through how a single word in insurance fine print shaped who could get care and for how long. We outline the rules, histories, and state-by-state differences that let insurers exclude conditions indefinitely - and ask what that meant for real people.

Document: two-page policy listing exclusions
Period: 1945-2014 (regulatory context through 2014)
Law: HIPAA (1996) limited group plans but not individual market
States: ten states permitted unlimited-duration exclusions (listed)
Practice: elimination riders used to permanently exclude specific conditions

- The transcript describes a clause with the word "unlimited" buried in individual insurance policies that allowed permanent exclusions.
- Two competing pre-existing condition standards existed: the objective standard (diagnosis/treatment) and the prudent person standard (symptoms a reasonable person would seek care for).
- HIPAA in 1996 capped exclusion periods for employer group plans but explicitly left the individual market untouched.
- Thirty-seven states allowed elimination riders that permanently excluded a body part or condition from coverage.
- In several states, documented medical care after domestic violence was recorded in ways that insurers treated as pre-existing conditions.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>983falsefullhttps://www.spreaker.com/episode/the-haunted-institute-nazi-medicine-movie-magic-and-a-plastic-skull--73098395
Horror rooted in engineered spectacle: the 1999 House on Haunted Hill used a styrofoam skull dissolved with acetone to simulate a brain, recycled a prop from 1981, and ran in theaters for sixty-one weeks - but why did a mainstream studio remake fold Nazi architectural and medical aesthetics into its scares?

In this episode, I describe how a remake of a 1959 film moved through three companies before landing at Warner Bros., how the original creator's daughter became a co-producer, and how design choices from Albert Speer and references to Nazi medical experiments shaped the fictional Vannacutt Psychiatric Institute - what did that shift from human hoax to real ghosts change about the story?

Person: William Castle
Person: Terry Castle
Film: House on Haunted Hill (1999)
Production company: Dark Castle Entertainment
Run time in theaters: 61 weeks

- A styrofoam skull packed with cotton candy was drenched in acetone on camera to create a brain-like effect.
- The final effects credit belonged to a legendary artist who had retired and handed over a prop originally built for a 1981 movie.
- William Castle sold the original 1959 film rights to pay his daughter's college tuition; the rights then passed through Allied Artists and Lorimar before reaching Warner Bros.
- Production designer David Klassen modeled the Vannacutt Psychiatric Institute on Albert Speer's monumental architectural language.
- The fictional institute's backstory was set in 1931 Los Angeles and included a patient revolt, a fire, and the death of all inmates with only five staff members surviving.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098395Sun, 13 Sep 2026 13:00:02 +0000Creator at ObomediaThe Haunted Institute: Nazi Medicine, Movie Magic, and a Plastic Skull Horror rooted in engineered spectacle: the 1999 House on Haunted Hill used a styrofoam skull dissolved with acetone to simulate a brain, recycled a prop from 1981, and ran in...
Horror rooted in engineered spectacle: the 1999 House on Haunted Hill used a styrofoam skull dissolved with acetone to simulate a brain, recycled a prop from 1981, and ran in theaters for sixty-one weeks - but why did a mainstream studio remake fold Nazi architectural and medical aesthetics into its scares?

In this episode, I describe how a remake of a 1959 film moved through three companies before landing at Warner Bros., how the original creator's daughter became a co-producer, and how design choices from Albert Speer and references to Nazi medical experiments shaped the fictional Vannacutt Psychiatric Institute - what did that shift from human hoax to real ghosts change about the story?

Person: William Castle
Person: Terry Castle
Film: House on Haunted Hill (1999)
Production company: Dark Castle Entertainment
Run time in theaters: 61 weeks

- A styrofoam skull packed with cotton candy was drenched in acetone on camera to create a brain-like effect.
- The final effects credit belonged to a legendary artist who had retired and handed over a prop originally built for a 1981 movie.
- William Castle sold the original 1959 film rights to pay his daughter's college tuition; the rights then passed through Allied Artists and Lorimar before reaching Warner Bros.
- Production designer David Klassen modeled the Vannacutt Psychiatric Institute on Albert Speer's monumental architectural language.
- The fictional institute's backstory was set in 1931 Los Angeles and included a patient revolt, a fire, and the death of all inmates with only five staff members surviving.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1075falsefullhttps://www.spreaker.com/episode/the-word-swap-that-recast-profit-as-a-health-threat--74911428
The Word Swap That Recast Profit as a Health Threat

In this episode, we trace how scholars moved from social determinants to a new frame that named market activity as a driver of disease. The episode covers the rise of the term "commercial determinants of health," the actors and documents that shaped it, and the question of how naming a system changes responses.

Person: Dr. John Millar
Date: 2013
Event: introduction of "corporate determinants of health"
Author: Kickbusch and colleagues
Date: 2016

- Between 2011 and 2015, 96 U.S. national health organizations accepted funding from Coca‑Cola, PepsiCo, or both, with public disclosures and visible sponsorships.
- The social determinants framework described environments shaping health but left a gap: it did not specify the market forces producing those environments.
- Dr. John Millar coined "corporate determinants of health" in 2013 to name corporations as actors influencing population outcomes via ordinary business operations.
- West and Marteau replaced "corporate" with "commercial" in 2013, shifting focus from named organizations to market activities like pricing, advertising, and supply chains.
- In 2016 Kickbusch et al. defined the commercial determinants as "strategies and approaches used by the private sector to promote products and choices that are detrimental to health," introducing intentionality into the frame.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911428Sun, 13 Sep 2026 09:01:19 +0000Creator at ObomediaHow did food-industry cash to U.S. health groups - and its effect on Dr. Smith's messaging - expose that word swap? The Word Swap That Recast Profit as a Health Threat In this episode, we trace how scholars moved from social determinants to a...
The Word Swap That Recast Profit as a Health Threat

In this episode, we trace how scholars moved from social determinants to a new frame that named market activity as a driver of disease. The episode covers the rise of the term "commercial determinants of health," the actors and documents that shaped it, and the question of how naming a system changes responses.

Person: Dr. John Millar
Date: 2013
Event: introduction of "corporate determinants of health"
Author: Kickbusch and colleagues
Date: 2016

- Between 2011 and 2015, 96 U.S. national health organizations accepted funding from Coca‑Cola, PepsiCo, or both, with public disclosures and visible sponsorships.
- The social determinants framework described environments shaping health but left a gap: it did not specify the market forces producing those environments.
- Dr. John Millar coined "corporate determinants of health" in 2013 to name corporations as actors influencing population outcomes via ordinary business operations.
- West and Marteau replaced "corporate" with "commercial" in 2013, shifting focus from named organizations to market activities like pricing, advertising, and supply chains.
- In 2016 Kickbusch et al. defined the commercial determinants as "strategies and approaches used by the private sector to promote products and choices that are detrimental to health," introducing intentionality into the frame.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>848falsefullhttps://www.spreaker.com/episode/the-night-propofol-came-home-how-michael-jackson-died-quietly--73098391
Danger and disbelief: bottles of propofol sat on a bedroom nightstand where an operating room should have been, and a man with a healthy heart was found dead on June 25, 2009. How did a surgical anesthetic end up in a private home, administered without proper monitoring, and why did an hour of silence follow that nobody has fully explained?

In this episode, we lay out the sequence of medical choices and documented details that led to Michael Jackson's death and the legal and professional consequences that followed, asking how a cardiologist came to administer an anesthetic in those conditions and what that decision reveals about responsibility and risk.

Person: Michael Jackson
Date: June 25, 2009
Person: Conrad Murray
Salary: $150,000 per month
Birthdate: August 29, 1958

- Michael Jackson was fifty years old and weighed 136 pounds at the time of death.
- Investigators found multiple bottles of propofol on the bedroom nightstand at 100 North Carolwood Drive.
- Conrad Murray, a cardiologist, was being paid $150,000 per month as Jackson's personal physician.
- Michael Jackson had not slept a full night without chemical assistance for a very long time, suffering from chronic insomnia.
- Cherilyn Lee, a nurse practitioner, refused Jackson's May 2009 request for propofol outside a clinical setting, calling it inappropriate.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098391Sat, 12 Sep 2026 13:00:02 +0000Creator at ObomediaThe Night Propofol Came Home: How Michael Jackson Died Quietly Danger and disbelief: bottles of propofol sat on a bedroom nightstand where an operating room should have been, and a man with a healthy heart was found dead on June 25, 2009. How did a...
Danger and disbelief: bottles of propofol sat on a bedroom nightstand where an operating room should have been, and a man with a healthy heart was found dead on June 25, 2009. How did a surgical anesthetic end up in a private home, administered without proper monitoring, and why did an hour of silence follow that nobody has fully explained?

In this episode, we lay out the sequence of medical choices and documented details that led to Michael Jackson's death and the legal and professional consequences that followed, asking how a cardiologist came to administer an anesthetic in those conditions and what that decision reveals about responsibility and risk.

Person: Michael Jackson
Date: June 25, 2009
Person: Conrad Murray
Salary: $150,000 per month
Birthdate: August 29, 1958

- Michael Jackson was fifty years old and weighed 136 pounds at the time of death.
- Investigators found multiple bottles of propofol on the bedroom nightstand at 100 North Carolwood Drive.
- Conrad Murray, a cardiologist, was being paid $150,000 per month as Jackson's personal physician.
- Michael Jackson had not slept a full night without chemical assistance for a very long time, suffering from chronic insomnia.
- Cherilyn Lee, a nurse practitioner, refused Jackson's May 2009 request for propofol outside a clinical setting, calling it inappropriate.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1197falsefullhttps://www.spreaker.com/episode/the-metal-clamp-that-sent-a-current-and-shattered-patients-bones--74911427
The metal clamp that sent a current and shattered patients' bones

In this episode, we follow the origin story of a medical device born from a slaughterhouse observation and its rapid adoption in psychiatry. The episode traces the early experiments, the classroom and ward conditions that shaped practice, and asks what the electric current actually did inside the brain.

Person: Ugo Cerletti
Date: April 11, 1938
Location: Rome
Topic: electroconvulsive therapy
Assistant: Lucio Bini

- Cerletti watched pig-stunning with a metal clamp and asked whether the same current could alter a psychotic human mind.
- He had previously induced seizures in dogs and returned to the lab to test electrode placement, current strength and duration.
- The first human treatment used a clamp across the temples on a man found wandering a train station; he convulsed and later was discharged as "much improved."
- Early adopters spread the method to England, the United States, Germany and Austria by 1940, citing it as cheaper and less frightening than chemical convulsants.
- Initial treatments were given without anesthesia or muscle relaxants, producing violent convulsions that sometimes caused fractures and dislocations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911427Sat, 12 Sep 2026 09:01:24 +0000Creator at ObomediaIn 1938 a Rome psychiatrist sent current through a human brain with a metal clamp and wondered what it truly did. How did that expose them? The metal clamp that sent a current and shattered patients' bones In this episode, we follow the origin...
The metal clamp that sent a current and shattered patients' bones

In this episode, we follow the origin story of a medical device born from a slaughterhouse observation and its rapid adoption in psychiatry. The episode traces the early experiments, the classroom and ward conditions that shaped practice, and asks what the electric current actually did inside the brain.

Person: Ugo Cerletti
Date: April 11, 1938
Location: Rome
Topic: electroconvulsive therapy
Assistant: Lucio Bini

- Cerletti watched pig-stunning with a metal clamp and asked whether the same current could alter a psychotic human mind.
- He had previously induced seizures in dogs and returned to the lab to test electrode placement, current strength and duration.
- The first human treatment used a clamp across the temples on a man found wandering a train station; he convulsed and later was discharged as "much improved."
- Early adopters spread the method to England, the United States, Germany and Austria by 1940, citing it as cheaper and less frightening than chemical convulsants.
- Initial treatments were given without anesthesia or muscle relaxants, producing violent convulsions that sometimes caused fractures and dislocations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>970falsefullhttps://www.spreaker.com/episode/doctor-hides-abuse-in-plain-sight-the-larry-nassar-case--73098389
Trust was weaponized: a team physician who authored peer-reviewed papers, earned a six-figure academic post, and worked inside the U.S. national training center abused athletes for decades while parents watched from three feet away. How did a medical career become the perfect cover for sexual abuse, and why did institutions let it continue for more than thirty years?

In this episode, we outline the professional path, settings, and tactics that allowed Larry Nassar to gain and maintain access to hundreds of young athletes, and we ask how credentialing, authority, and culture combined to silence survivors.

Person: Larry Nassar
Date: born August 16, 1963
Period: USA Gymnastics national medical coordinator 1996-2014
Location: Károlyi Ranch, Huntsville, Texas (U.S. Women's National Training Center since 2001)
Status: by January 2018 investigators had identified at least 265 victims

- Nassar began working as a student athletic trainer in 1978 at age 15.
- He earned a bachelor's in kinesiology in 1985 and a DO in 1993.
- He co-authored at least six peer-reviewed papers on gymnastics injuries.
- He served simultaneously at a high school, Michigan State University, USA Gymnastics, and a private club for nearly two decades.
- Investigators found he practiced at the Károlyi Ranch without a Texas medical license, a third-degree felony.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098389Fri, 11 Sep 2026 13:00:02 +0000Creator at ObomediaDoctor Hides Abuse in Plain Sight: The Larry Nassar Case Trust was weaponized: a team physician who authored peer-reviewed papers, earned a six-figure academic post, and worked inside the U.S. national training center abused athletes for decades...
Trust was weaponized: a team physician who authored peer-reviewed papers, earned a six-figure academic post, and worked inside the U.S. national training center abused athletes for decades while parents watched from three feet away. How did a medical career become the perfect cover for sexual abuse, and why did institutions let it continue for more than thirty years?

In this episode, we outline the professional path, settings, and tactics that allowed Larry Nassar to gain and maintain access to hundreds of young athletes, and we ask how credentialing, authority, and culture combined to silence survivors.

Person: Larry Nassar
Date: born August 16, 1963
Period: USA Gymnastics national medical coordinator 1996-2014
Location: Károlyi Ranch, Huntsville, Texas (U.S. Women's National Training Center since 2001)
Status: by January 2018 investigators had identified at least 265 victims

- Nassar began working as a student athletic trainer in 1978 at age 15.
- He earned a bachelor's in kinesiology in 1985 and a DO in 1993.
- He co-authored at least six peer-reviewed papers on gymnastics injuries.
- He served simultaneously at a high school, Michigan State University, USA Gymnastics, and a private club for nearly two decades.
- Investigators found he practiced at the Károlyi Ranch without a Texas medical license, a third-degree felony.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1159falsefullhttps://www.spreaker.com/episode/the-rac-report-that-named-pesticides-and-pb-pills-and-forced-the-va-to-answer--74911426
The RAC report that named pesticides and PB pills and forced the VA to answer

In this episode, we follow the formation and work of the Research Advisory Committee (RAC) created to study the unexplained illnesses of 1991 Gulf War veterans. The episode traces the committee’s evidence, the institutional delays, and the stakes of calling the condition an illness rather than a syndrome: what did that naming change?

Person: VA Secretary Anthony Principi
Date: RAC charter signed January 23, 2002; first meetings April 11-12, 2002
Event: Veterans reporting diffuse, chronic symptoms after 1991 Gulf War deployment
Topic: RAC findings linking pesticides and pyridostigmine bromide (PB) pills to Gulf War Illness
Law: Veterans Programs Enhancement Act signed November 11, 1998 (Public Law 105-368)

- Three years elapsed between Congress’s January 1, 1999 deadline and the RAC charter’s signing on January 23, 2002.
- Veterans reported layered symptoms-fatigue, unexplained pain, cognitive issues, GI distress, and rashes-that worsened over time and lacked a single diagnostic test.
- The RAC reviewed studies on pesticides, PB pills, sarin/cyclosarin, oil-well fire smoke, and gene-environment interactions to assess causes.
- The VA had initially framed veterans’ problems as psychological or stress-related, creating a terminological and institutional battle over “syndrome” versus “illness.”
- RAC meetings in April 2002 set a methodical review process that would produce findings the committee described as causally associated with neurological dysfunction.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911426Fri, 11 Sep 2026 09:00:57 +0000Creator at ObomediaA congressional advisory committee confronts veterans’ worsening health in 2002, linking pesticides to Gulf War Illness - will the VA answer? The RAC report that named pesticides and PB pills and forced the VA to answer In this episode, we...
The RAC report that named pesticides and PB pills and forced the VA to answer

In this episode, we follow the formation and work of the Research Advisory Committee (RAC) created to study the unexplained illnesses of 1991 Gulf War veterans. The episode traces the committee’s evidence, the institutional delays, and the stakes of calling the condition an illness rather than a syndrome: what did that naming change?

Person: VA Secretary Anthony Principi
Date: RAC charter signed January 23, 2002; first meetings April 11-12, 2002
Event: Veterans reporting diffuse, chronic symptoms after 1991 Gulf War deployment
Topic: RAC findings linking pesticides and pyridostigmine bromide (PB) pills to Gulf War Illness
Law: Veterans Programs Enhancement Act signed November 11, 1998 (Public Law 105-368)

- Three years elapsed between Congress’s January 1, 1999 deadline and the RAC charter’s signing on January 23, 2002.
- Veterans reported layered symptoms-fatigue, unexplained pain, cognitive issues, GI distress, and rashes-that worsened over time and lacked a single diagnostic test.
- The RAC reviewed studies on pesticides, PB pills, sarin/cyclosarin, oil-well fire smoke, and gene-environment interactions to assess causes.
- The VA had initially framed veterans’ problems as psychological or stress-related, creating a terminological and institutional battle over “syndrome” versus “illness.”
- RAC meetings in April 2002 set a methodical review process that would produce findings the committee described as causally associated with neurological dysfunction.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>833falsefullhttps://www.spreaker.com/episode/how-doctors-turned-a-survivable-bullet-into-a-deadly-infection--73098388
A president was shot in a crowded train station yet missed his spine and every major organ - and still died weeks later from pus, collapsed lungs, and sepsis. How did eleven doctors, unwashed hands, and repeated probe-and-open wound care turn a survivable bullet wound into a fatal infection?

In this episode, we tell the sequence of events from the shooting at a Washington train depot to the medical decisions that followed, describing who was present, how the wound was treated, and why his death certificate listed sepsis rather than the gunshot - could better sterile technique have saved him?

Person: James Garfield
Date: July 2, 1881
Location: Baltimore and Potomac Railroad depot on Sixth Street
Status: Died after 79 days
Cause: Sepsis and a ruptured artery

- The bullet entered Garfield's back at 9:30 AM on July 2, 1881, four inches to the right of his spine and stopped behind the pancreas.
- Garfield missed his 51st birthday by two months and weighed 210 pounds at the time of the shooting.
- Within one hour of the shooting, eleven doctors had inserted their unsterilized fingers into Garfield's back.
- Seventy-nine days after the shooting Garfield's body weighed 130 pounds and was riddled with abscesses and pus throughout his torso.
- The attending physician Dr. Willard Bliss assumed charge that morning; the autopsy found both lungs collapsed into pneumonia.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098388Thu, 10 Sep 2026 13:00:02 +0000Creator at ObomediaHow Doctors Turned a Survivable Bullet into a Deadly Infection A president was shot in a crowded train station yet missed his spine and every major organ - and still died weeks later from pus, collapsed lungs, and sepsis. How did eleven doctors,...
A president was shot in a crowded train station yet missed his spine and every major organ - and still died weeks later from pus, collapsed lungs, and sepsis. How did eleven doctors, unwashed hands, and repeated probe-and-open wound care turn a survivable bullet wound into a fatal infection?

In this episode, we tell the sequence of events from the shooting at a Washington train depot to the medical decisions that followed, describing who was present, how the wound was treated, and why his death certificate listed sepsis rather than the gunshot - could better sterile technique have saved him?

Person: James Garfield
Date: July 2, 1881
Location: Baltimore and Potomac Railroad depot on Sixth Street
Status: Died after 79 days
Cause: Sepsis and a ruptured artery

- The bullet entered Garfield's back at 9:30 AM on July 2, 1881, four inches to the right of his spine and stopped behind the pancreas.
- Garfield missed his 51st birthday by two months and weighed 210 pounds at the time of the shooting.
- Within one hour of the shooting, eleven doctors had inserted their unsterilized fingers into Garfield's back.
- Seventy-nine days after the shooting Garfield's body weighed 130 pounds and was riddled with abscesses and pus throughout his torso.
- The attending physician Dr. Willard Bliss assumed charge that morning; the autopsy found both lungs collapsed into pneumonia.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1177falsefullhttps://www.spreaker.com/episode/the-draize-eye-drop-that-kept-rabbits-blind-for-lipstick--74911425
The Draize eye drop that kept rabbits blind for lipstick

In this episode, we follow the history behind a single cruel lab procedure and the decades-long mismatch between scientific practice and consumer language. What gap between the Three R's and a shelf label allowed the Draize test to endure?

Person: Charles Hume
Person: W.M.S. Russell
Person: Lady Dowding
Date: 1957
Date: 1959

- A rabbit's head was restrained and eyelids held open while technicians applied chemicals directly to its eye with no anesthesia.
- Regulators accepted the Draize ocular toxicity test because rabbit eyes' low tear production produced longer contact times, seen as a conservative safety margin.
- The Three R's-Replacement, Reduction, Refinement-were proposed in 1957 as a scientific framework to reduce animal suffering without ideological confrontation.
- Lady Dowding coined and deployed the consumer label "cruelty-free" in 1959 to mark non-animal products and founded Beauty Without Cruelty to promote it.
- By the 1970s the "cruelty-free" label crossed to the U.S., carried by Marcia Pearson and Fashion With Compassion, even as institutional testing practices remained entrenched.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911425Thu, 10 Sep 2026 09:00:56 +0000Creator at ObomediaA technician applies a chemical to a rabbit's held-open eye-how did the Draize eye drop expose regulators' trust in animal tests? The Draize eye drop that kept rabbits blind for lipstick In this episode, we follow the history behind a single...
The Draize eye drop that kept rabbits blind for lipstick

In this episode, we follow the history behind a single cruel lab procedure and the decades-long mismatch between scientific practice and consumer language. What gap between the Three R's and a shelf label allowed the Draize test to endure?

Person: Charles Hume
Person: W.M.S. Russell
Person: Lady Dowding
Date: 1957
Date: 1959

- A rabbit's head was restrained and eyelids held open while technicians applied chemicals directly to its eye with no anesthesia.
- Regulators accepted the Draize ocular toxicity test because rabbit eyes' low tear production produced longer contact times, seen as a conservative safety margin.
- The Three R's-Replacement, Reduction, Refinement-were proposed in 1957 as a scientific framework to reduce animal suffering without ideological confrontation.
- Lady Dowding coined and deployed the consumer label "cruelty-free" in 1959 to mark non-animal products and founded Beauty Without Cruelty to promote it.
- By the 1970s the "cruelty-free" label crossed to the U.S., carried by Marcia Pearson and Fashion With Compassion, even as institutional testing practices remained entrenched.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>933falsefullhttps://www.spreaker.com/episode/they-killed-the-president-twice-how-doctors-finished-garfield--73098387
The thought that the American president survived an assassination only to be undone by his physicians is chilling: James A. Garfield lingered 79 days after being shot, and when the autopsy finally occurred the pathologist found that the bullet was almost beside the point. How did a .442 Webley British Bulldog and a room by the ocean become a political and medical catastrophe?

In this episode, we tell the life of James A. Garfield from his log cabin childhood through his presidency, the motives of Charles J. Guiteau, and the seventy-nine-day decline that followed the shooting - raising the question of whether the doctors, not the assassin, sealed Garfield’s fate.

Person: James Abram Garfield
Date: July 2, 1881 (shooting) / November 19, 1831 (birth)
Location: Baltimore and Potomac Railroad Station, Washington
Weapon: .442 Webley British Bulldog revolver with ivory grip
Duration: 79 days between shooting and death

- Garfield served 17 consecutive years in Congress before becoming president at age 49.
- Guiteau arrived in Washington on March 5, 1881, and was banned from the White House waiting room by May 13, 1881.
- Guiteau bought the revolver with a $15 loan from George Maynard and paid $1 extra for an ivory grip.
- Garfield’s inauguration speech on March 4, 1881, advocated civil service reform and angered a faction of his party.
- Garfield never reached his train on July 2, 1881, and died 79 days later in a room by the ocean.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098387Wed, 09 Sep 2026 13:00:02 +0000Creator at ObomediaThey Killed the President Twice: How Doctors Finished Garfield The thought that the American president survived an assassination only to be undone by his physicians is chilling: James A. Garfield lingered 79 days after being shot, and when the...
The thought that the American president survived an assassination only to be undone by his physicians is chilling: James A. Garfield lingered 79 days after being shot, and when the autopsy finally occurred the pathologist found that the bullet was almost beside the point. How did a .442 Webley British Bulldog and a room by the ocean become a political and medical catastrophe?

In this episode, we tell the life of James A. Garfield from his log cabin childhood through his presidency, the motives of Charles J. Guiteau, and the seventy-nine-day decline that followed the shooting - raising the question of whether the doctors, not the assassin, sealed Garfield’s fate.

Person: James Abram Garfield
Date: July 2, 1881 (shooting) / November 19, 1831 (birth)
Location: Baltimore and Potomac Railroad Station, Washington
Weapon: .442 Webley British Bulldog revolver with ivory grip
Duration: 79 days between shooting and death

- Garfield served 17 consecutive years in Congress before becoming president at age 49.
- Guiteau arrived in Washington on March 5, 1881, and was banned from the White House waiting room by May 13, 1881.
- Guiteau bought the revolver with a $15 loan from George Maynard and paid $1 extra for an ivory grip.
- Garfield’s inauguration speech on March 4, 1881, advocated civil service reform and angered a faction of his party.
- Garfield never reached his train on July 2, 1881, and died 79 days later in a room by the ocean.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1327falsefullhttps://www.spreaker.com/episode/the-bee-droppings-that-proved-the-yellow-rain-was-pollen-not-poison--74911424
The bee droppings that proved the yellow rain was pollen, not poison

In this episode, we present the sequence of events, testimony, and scientific tests that turned a Cold War chemical-weapons claim into a decades-long controversy. It traces who the Hmong were, the U.S. diplomatic accusation, and the competing lab analyses that raised the central question: what was really falling from the sky?

Person: Alexander Haig
Person: C. J. Mirocha
Person: Matthew Meselson
Date: 1981-1983
Location: Laos; Thailand refugee camps

- Alexander Haig declared in September 1981 that a sticky yellow liquid falling from aircraft over Laos and Cambodia was Soviet chemical warfare.
- University of Minnesota biochemist C. J. Mirocha reported finding trichothecene mycotoxins in blood, urine, and tissue from alleged victims within months of the announcement.
- British, French, and Swedish laboratories analyzed samples and reported pollen rather than trichothecene toxins.
- Matthew Meselson collected yellow deposits in Laos and showed bee-dropping samples to Hmong refugees in a Thai camp, noting immediate identifications and an instance of a changed testimony.
- Meselson’s leaf-collected drops each contained local-plant pollen mixtures, varying from drop to drop, challenging the idea of a uniform manufactured munition.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911424Wed, 09 Sep 2026 09:01:21 +0000Creator at ObomediaA U.S. secretary says Soviets sprayed sticky "yellow rain" over Laos-poison or pollen? The bee droppings that proved the yellow rain was pollen, not poison In this episode, we present the sequence of events, testimony, and scientific tests that...
The bee droppings that proved the yellow rain was pollen, not poison

In this episode, we present the sequence of events, testimony, and scientific tests that turned a Cold War chemical-weapons claim into a decades-long controversy. It traces who the Hmong were, the U.S. diplomatic accusation, and the competing lab analyses that raised the central question: what was really falling from the sky?

Person: Alexander Haig
Person: C. J. Mirocha
Person: Matthew Meselson
Date: 1981-1983
Location: Laos; Thailand refugee camps

- Alexander Haig declared in September 1981 that a sticky yellow liquid falling from aircraft over Laos and Cambodia was Soviet chemical warfare.
- University of Minnesota biochemist C. J. Mirocha reported finding trichothecene mycotoxins in blood, urine, and tissue from alleged victims within months of the announcement.
- British, French, and Swedish laboratories analyzed samples and reported pollen rather than trichothecene toxins.
- Matthew Meselson collected yellow deposits in Laos and showed bee-dropping samples to Hmong refugees in a Thai camp, noting immediate identifications and an instance of a changed testimony.
- Meselson’s leaf-collected drops each contained local-plant pollen mixtures, varying from drop to drop, challenging the idea of a uniform manufactured munition.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>890falsefullhttps://www.spreaker.com/episode/how-doctors-killed-a-president-the-bullet-they-couldn-t-find--73098386
A sitting president survived two gunshots on July 2, 1881, yet lost eighty pounds over seventy-nine days while surgeons probed and failed to locate a bullet that lay behind his pancreas; how did the men sworn to save him end up doing the damage? Who made the crucial choices that turned a survivable wound into a fatal decline?

In this episode, we follow the timeline from the Baltimore and Potomac Railroad Station shooting through the subsequent seventy-nine days of care and decline, tracing the actions of the arresting officer, the attending physicians, and inventors who tried to help - and asking whether medical choices, not the bullet, were the real cause of death.

Person: James Abram Garfield
Date: July 2, 1881
Location: Baltimore and Potomac Railroad Station, Washington
Event: Two gunshots; one bullet lodged behind the pancreas
Person: Charles Guiteau

- The shooting occurred at 9:30 AM on July 2, 1881, when Charles Guiteau fired two shots at President Garfield.
- One bullet grazed Garfield’s shoulder; the second passed the first lumbar vertebra and lodged behind the pancreas.
- Garfield lost eighty pounds over the seventy-nine days after he was shot.
- Policeman Patrick Kearney arrested Guiteau but initially forgot to take the revolver from him.
- Charles Guiteau borrowed $15 to buy an ivory-handled revolver he said he chose because it would look good in a museum; that revolver later disappeared from the Smithsonian.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098386Tue, 08 Sep 2026 13:00:02 +0000Creator at ObomediaHow Doctors Killed a President: The Bullet They Couldn't Find A sitting president survived two gunshots on July 2, 1881, yet lost eighty pounds over seventy-nine days while surgeons probed and failed to locate a bullet that lay behind his pancreas;...
A sitting president survived two gunshots on July 2, 1881, yet lost eighty pounds over seventy-nine days while surgeons probed and failed to locate a bullet that lay behind his pancreas; how did the men sworn to save him end up doing the damage? Who made the crucial choices that turned a survivable wound into a fatal decline?

In this episode, we follow the timeline from the Baltimore and Potomac Railroad Station shooting through the subsequent seventy-nine days of care and decline, tracing the actions of the arresting officer, the attending physicians, and inventors who tried to help - and asking whether medical choices, not the bullet, were the real cause of death.

Person: James Abram Garfield
Date: July 2, 1881
Location: Baltimore and Potomac Railroad Station, Washington
Event: Two gunshots; one bullet lodged behind the pancreas
Person: Charles Guiteau

- The shooting occurred at 9:30 AM on July 2, 1881, when Charles Guiteau fired two shots at President Garfield.
- One bullet grazed Garfield’s shoulder; the second passed the first lumbar vertebra and lodged behind the pancreas.
- Garfield lost eighty pounds over the seventy-nine days after he was shot.
- Policeman Patrick Kearney arrested Guiteau but initially forgot to take the revolver from him.
- Charles Guiteau borrowed $15 to buy an ivory-handled revolver he said he chose because it would look good in a museum; that revolver later disappeared from the Smithsonian.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1136falsefullhttps://www.spreaker.com/episode/the-word-homosexual-claimed-jurisdiction-over-bodies--74911423
The word "homosexual" claimed jurisdiction over bodies

This episode explores the history of conversion therapy, a practice that has taken many forms over more than a hundred years. It delves into how medical and governmental bodies enabled its continuation despite evidence of its ineffectiveness and the devastating impact it had on thousands of people.

Topic: Conversion therapy
Period: 19th to 21st Century
Key figure: Karl Maria Kertbeny
Study: American Medical Association, 2025
Suicide attempt rate (conversion therapy): 42%

- The term "homosexual" was coined in the 1880s by Karl Maria Kertbeny as a neutral descriptor, but its widespread adoption allowed medicine to claim jurisdiction over same-sex attraction.
- Sigmund Freud's theory of homosexuality as "arrested development" provided a framework for practitioners, suggesting it could be reversed.
- Sándor Rádo further developed this, attributing homosexuality to inadequate parenting based on biased clinical samples.
- Early 20th-century surgeons in Germany attempted unilateral orchiectomy and testicle transplants, and later surgical castration, on gay men, sometimes as young as sixteen.
- During WWII, Carl Vaernet implanted testosterone-releasing pellets into prisoners in Buchenwald, most of whom died shortly after the procedure.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911423Tue, 08 Sep 2026 09:01:31 +0000Creator at ObomediaA medical practice linked to Dr. [Name] caused harm for over a century, repeatedly renaming itself to evade bans. How did it persist? The word "homosexual" claimed jurisdiction over bodies This episode explores the history of conversion therapy,...
The word "homosexual" claimed jurisdiction over bodies

This episode explores the history of conversion therapy, a practice that has taken many forms over more than a hundred years. It delves into how medical and governmental bodies enabled its continuation despite evidence of its ineffectiveness and the devastating impact it had on thousands of people.

Topic: Conversion therapy
Period: 19th to 21st Century
Key figure: Karl Maria Kertbeny
Study: American Medical Association, 2025
Suicide attempt rate (conversion therapy): 42%

- The term "homosexual" was coined in the 1880s by Karl Maria Kertbeny as a neutral descriptor, but its widespread adoption allowed medicine to claim jurisdiction over same-sex attraction.
- Sigmund Freud's theory of homosexuality as "arrested development" provided a framework for practitioners, suggesting it could be reversed.
- Sándor Rádo further developed this, attributing homosexuality to inadequate parenting based on biased clinical samples.
- Early 20th-century surgeons in Germany attempted unilateral orchiectomy and testicle transplants, and later surgical castration, on gay men, sometimes as young as sixteen.
- During WWII, Carl Vaernet implanted testosterone-releasing pellets into prisoners in Buchenwald, most of whom died shortly after the procedure.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1056falsefullhttps://www.spreaker.com/episode/the-surgeon-who-maimed-dozens-anatomy-of-a-medical-monster--73098382
A spine surgeon with a twelve‑page CV harmed thirty‑three patients across Dallas between 2011 and 2013, leaving two dead and many paralyzed, incontinent, or in permanent agony - and hospitals repeatedly let him walk into the next operating room. How did institutions with the tools to stop him fail to act, and what single email finally put him away?

In this episode, we lay out the sequence of events, the victims’ stories, the medical reviews, and the institutional decisions that allowed Christopher Daniel Duntsch to continue operating - culminating in the email that led to his life sentence. What do the records reveal about responsibility and system failure?

Person: Christopher Daniel Duntsch
Date: 2011-2013
Location: Dallas, Texas
Number harmed: 33
Deaths: 2

- Duntsch was born April 3, 1971, in Montana and grew up in Memphis, Tennessee, as the eldest of four children.
- He held an MD and PhD from the University of Tennessee and completed residency and fellowship at Semmes‑Murphey Clinic.
- Surgeries by Duntsch between 2011 and 2013 resulted in 33 harmed patients, including paralysis, incontinence, and chronic pain.
- Veteran reviewers noted Duntsch “had to have known how to do it right” yet repeatedly performed operations that were described as the opposite.
- A surgical sponge was found inside patient Jeff Glidewell during emergency reoperation by Randall Kirby, and Baylor Plano allowed Duntsch to resign without reporting him to the National Practitioner Data Bank.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098382Mon, 07 Sep 2026 13:00:02 +0000Creator at ObomediaThe Surgeon Who Maimed Dozens: Anatomy of a Medical Monster A spine surgeon with a twelve‑page CV harmed thirty‑three patients across Dallas between 2011 and 2013, leaving two dead and many paralyzed, incontinent, or in permanent agony - and...
A spine surgeon with a twelve‑page CV harmed thirty‑three patients across Dallas between 2011 and 2013, leaving two dead and many paralyzed, incontinent, or in permanent agony - and hospitals repeatedly let him walk into the next operating room. How did institutions with the tools to stop him fail to act, and what single email finally put him away?

In this episode, we lay out the sequence of events, the victims’ stories, the medical reviews, and the institutional decisions that allowed Christopher Daniel Duntsch to continue operating - culminating in the email that led to his life sentence. What do the records reveal about responsibility and system failure?

Person: Christopher Daniel Duntsch
Date: 2011-2013
Location: Dallas, Texas
Number harmed: 33
Deaths: 2

- Duntsch was born April 3, 1971, in Montana and grew up in Memphis, Tennessee, as the eldest of four children.
- He held an MD and PhD from the University of Tennessee and completed residency and fellowship at Semmes‑Murphey Clinic.
- Surgeries by Duntsch between 2011 and 2013 resulted in 33 harmed patients, including paralysis, incontinence, and chronic pain.
- Veteran reviewers noted Duntsch “had to have known how to do it right” yet repeatedly performed operations that were described as the opposite.
- A surgical sponge was found inside patient Jeff Glidewell during emergency reoperation by Randall Kirby, and Baylor Plano allowed Duntsch to resign without reporting him to the National Practitioner Data Bank.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1231falsefullhttps://www.spreaker.com/episode/the-75-cent-excise-tax-that-funded-4-6-billion-in-payouts--74911421
The 75‑cent excise tax that funded $4.6 billion in payouts

In this episode, we trace how a 75-cent per-dose tax created a no-fault compensation system and how that structure handled thousands of claims alleging vaccine harm. What happens when a program designed to be faster and fairer faces a massive, singular challenge that tests its procedures and assumptions?

Person: Special Masters (appointed attorneys)
Date: 1988 (program start), 2008-2009 (key filings and ruling)
Location: United States Court of Federal Claims
Topic: National Vaccine Injury Compensation Program, MMR autism claims
Event: 5,263 petitions alleging MMR caused autism

- Congress created a no-fault vaccine compensation system in 1986 and the program began in 1988, funded by a 75-cent excise tax per vaccine dose.
- Claims were heard by Special Masters in the Court of Federal Claims with a preponderance-of-evidence standard and no juries.
- The program reimbursed legal fees even for unsuccessful petitioners who met filing thresholds and used a Vaccine Injury Table to presume causation in certain time windows.
- Between 1988 and January 2008, the program received 8,128 petitions; 925 were compensated and 5,263 alleged MMR caused autism.
- The concentration of thousands of similar MMR autism claims culminated in a pivotal federal ruling in February 2009 that reshaped how the system handled those cases.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911421Mon, 07 Sep 2026 09:01:39 +0000Creator at ObomediaA 75-cent vaccine tax funded huge payouts; one small court and a flood of MMR autism claims force the system to answer-what happens next? The 75‑cent excise tax that funded $4.6 billion in payouts In this episode, we trace how a 75-cent per-dose...
The 75‑cent excise tax that funded $4.6 billion in payouts

In this episode, we trace how a 75-cent per-dose tax created a no-fault compensation system and how that structure handled thousands of claims alleging vaccine harm. What happens when a program designed to be faster and fairer faces a massive, singular challenge that tests its procedures and assumptions?

Person: Special Masters (appointed attorneys)
Date: 1988 (program start), 2008-2009 (key filings and ruling)
Location: United States Court of Federal Claims
Topic: National Vaccine Injury Compensation Program, MMR autism claims
Event: 5,263 petitions alleging MMR caused autism

- Congress created a no-fault vaccine compensation system in 1986 and the program began in 1988, funded by a 75-cent excise tax per vaccine dose.
- Claims were heard by Special Masters in the Court of Federal Claims with a preponderance-of-evidence standard and no juries.
- The program reimbursed legal fees even for unsuccessful petitioners who met filing thresholds and used a Vaccine Injury Table to presume causation in certain time windows.
- Between 1988 and January 2008, the program received 8,128 petitions; 925 were compensated and 5,263 alleged MMR caused autism.
- The concentration of thousands of similar MMR autism claims culminated in a pivotal federal ruling in February 2009 that reshaped how the system handled those cases.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1079falsefullhttps://www.spreaker.com/episode/the-surgeon-who-maimed-texas-inside-the-duntsch-horror-story--73098374
A surgical sponge was sewn into a living man’s throat and one surgeon left a trail of paralysis, permanent injury, and death across Texas between 2010 and 2013-how did a twelve-page CV hide a record of fewer than one hundred surgeries, suspected drug use, and a fabricated degree? What force or intent explains mistakes so catastrophic they led colleagues to call him a “crazed maniac”?

In this episode, we lay out the sequence of events, the credentials and omissions on Christopher Daniel Daniel’s curriculum vitae, and the hospital decisions that allowed him to keep operating-ending with the unresolved question of whether what occurred can be explained by incompetence, negligence, or something else.

Person: Christopher Daniel Daniel
Date: born April 3, 1971
Location: Dallas, Texas (Baylor Regional Medical Center at Regional)
Period: 2010 to 2013
Event: series of surgeries resulting in paralysis, permanent injury, and death

- Patient Jeff Glidewell underwent more than fifty corrective procedures after a surgical sponge was sewn into his throat.
- Daniel had performed fewer than 100 surgeries during residency, despite a standard requirement of over 1,000.
- During one surgery blood loss was 1,200 milliliters-24 times the typical 50 milliliters for that procedure.
- Baylor Regional allowed Daniel to resign rather than terminate him, so no report was filed with the National Practitioner Data Bank.
- Daniel arrived in Dallas carrying more than $500,000 in debt and was hired at a salary of $600,000 per year plus bonuses.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098374Sun, 06 Sep 2026 13:00:02 +0000Creator at ObomediaThe Surgeon Who Maimed Texas: Inside the Duntsch Horror Story A surgical sponge was sewn into a living man’s throat and one surgeon left a trail of paralysis, permanent injury, and death across Texas between 2010 and 2013-how did a twelve-page CV...
A surgical sponge was sewn into a living man’s throat and one surgeon left a trail of paralysis, permanent injury, and death across Texas between 2010 and 2013-how did a twelve-page CV hide a record of fewer than one hundred surgeries, suspected drug use, and a fabricated degree? What force or intent explains mistakes so catastrophic they led colleagues to call him a “crazed maniac”?

In this episode, we lay out the sequence of events, the credentials and omissions on Christopher Daniel Daniel’s curriculum vitae, and the hospital decisions that allowed him to keep operating-ending with the unresolved question of whether what occurred can be explained by incompetence, negligence, or something else.

Person: Christopher Daniel Daniel
Date: born April 3, 1971
Location: Dallas, Texas (Baylor Regional Medical Center at Regional)
Period: 2010 to 2013
Event: series of surgeries resulting in paralysis, permanent injury, and death

- Patient Jeff Glidewell underwent more than fifty corrective procedures after a surgical sponge was sewn into his throat.
- Daniel had performed fewer than 100 surgeries during residency, despite a standard requirement of over 1,000.
- During one surgery blood loss was 1,200 milliliters-24 times the typical 50 milliliters for that procedure.
- Baylor Regional allowed Daniel to resign rather than terminate him, so no report was filed with the National Practitioner Data Bank.
- Daniel arrived in Dallas carrying more than $500,000 in debt and was hired at a salary of $600,000 per year plus bonuses.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1061falsefullhttps://www.spreaker.com/episode/the-coldrif-bottle-that-delivered-48-6-solvent-and-poisoned-24-children--74911420
The Coldrif bottle that delivered 48.6% solvent and poisoned 24 children

In this episode, we follow how a routine cough treatment for toddlers became the common thread linking dozens of unexplained pediatric kidney failures. We trace the timeline from first hospital admissions to the laboratory confirmation and the abandoned factory, asking how a legal medicine carried an industrial solvent into homes.

Person: Sresan Pharmaceuticals
Location: Chhindwara district, Madhya Pradesh; Tamil Nadu factory
Date: late September-early October 2025; October 2-3, 2025
Topic: Coldrif cough syrup contaminated with diethylene glycol
Event: 24 children with acute renal failure after taking Coldrif

- Parents giving standard, legally sold Coldrif syrup to children with routine colds, following label dosing.
- Children, mostly under five, presenting days later with acute kidney failure at local medical facilities.
- Health authorities banning Coldrif on October 2, 2025 after epidemiological links emerge across villages.
- Laboratory testing of samples from the Sresan Pharmaceuticals site confirming 48.6% diethylene glycol on October 3, 2025.
- Inspectors finding the Sresan factory in Tamil Nadu empty and declared unsafe, with no production logs or staff on site.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911420Sun, 06 Sep 2026 09:01:44 +0000Creator at ObomediaA mother in Chhindwara pours a legal Coldrif cough syrup for her toddler - the bottle contains 48.6% diethylene glycol; how did that expose them? The Coldrif bottle that delivered 48.6% solvent and poisoned 24 children In this episode, we follow...
The Coldrif bottle that delivered 48.6% solvent and poisoned 24 children

In this episode, we follow how a routine cough treatment for toddlers became the common thread linking dozens of unexplained pediatric kidney failures. We trace the timeline from first hospital admissions to the laboratory confirmation and the abandoned factory, asking how a legal medicine carried an industrial solvent into homes.

Person: Sresan Pharmaceuticals
Location: Chhindwara district, Madhya Pradesh; Tamil Nadu factory
Date: late September-early October 2025; October 2-3, 2025
Topic: Coldrif cough syrup contaminated with diethylene glycol
Event: 24 children with acute renal failure after taking Coldrif

- Parents giving standard, legally sold Coldrif syrup to children with routine colds, following label dosing.
- Children, mostly under five, presenting days later with acute kidney failure at local medical facilities.
- Health authorities banning Coldrif on October 2, 2025 after epidemiological links emerge across villages.
- Laboratory testing of samples from the Sresan Pharmaceuticals site confirming 48.6% diethylene glycol on October 3, 2025.
- Inspectors finding the Sresan factory in Tamil Nadu empty and declared unsafe, with no production logs or staff on site.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>923falsefullhttps://www.spreaker.com/episode/how-australia-s-hospitals-let-the-butcher-of-bega-keep-operating--73098371
Women who trusted routine care woke to irreversible loss while thirty-five formal complaints sat scattered across hospitals - and a regional health service hired him despite an obstetrics ban; how did institutional checks fail so completely, and who paid the price?

In this episode, we follow the timeline inside Australia’s public and private hospitals, the Professional Standards Committee and the Medical Board, and the Greater Southern Area Health Service decision that placed Graeme Stephen Stephen in Bega and Pambula - and we ask how a man under a long-standing obstetrics restriction kept operating on vulnerable patients.

Person: Graeme Stephen Stephen
Date of birth: 1949
First formal complaint: June 1986
Number of formal complaints by 2001: 35
Date struck from medical register: 2004

- Stephen was appointed to Hornsby Ku-ring-gai Hospital on 20 December 1985.
- An adverse finding by a hospital advisory committee occurred in January 1997.
- The Professional Standards Committee moved to restrict his obstetrics practice in August 1997.
- A patient died at Hills Private Hospital in May 1996 from septicaemia after Stephen reportedly refused antibiotics.
- Stephen continued to see patients until 11 July 2003 despite a termination notice issued on 7 January 2003.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098371Sat, 05 Sep 2026 13:00:02 +0000Creator at ObomediaHow Australia's Hospitals Let the "Butcher of Bega" Keep Operating Women who trusted routine care woke to irreversible loss while thirty-five formal complaints sat scattered across hospitals - and a regional health service hired him despite an...
Women who trusted routine care woke to irreversible loss while thirty-five formal complaints sat scattered across hospitals - and a regional health service hired him despite an obstetrics ban; how did institutional checks fail so completely, and who paid the price?

In this episode, we follow the timeline inside Australia’s public and private hospitals, the Professional Standards Committee and the Medical Board, and the Greater Southern Area Health Service decision that placed Graeme Stephen Stephen in Bega and Pambula - and we ask how a man under a long-standing obstetrics restriction kept operating on vulnerable patients.

Person: Graeme Stephen Stephen
Date of birth: 1949
First formal complaint: June 1986
Number of formal complaints by 2001: 35
Date struck from medical register: 2004

- Stephen was appointed to Hornsby Ku-ring-gai Hospital on 20 December 1985.
- An adverse finding by a hospital advisory committee occurred in January 1997.
- The Professional Standards Committee moved to restrict his obstetrics practice in August 1997.
- A patient died at Hills Private Hospital in May 1996 from septicaemia after Stephen reportedly refused antibiotics.
- Stephen continued to see patients until 11 July 2003 despite a termination notice issued on 7 January 2003.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1212falsefullhttps://www.spreaker.com/episode/the-roosevelt-whisper-at-dinner-that-unraveled-the-protectorate--74911418
The Roosevelt Whisper at Dinner That Unraveled the Protectorate

In this episode, we recount the life and pivotal moments of Mohammed bin Yusef, the sultan who became Mohammed V, focusing on decisions and encounters that reshaped Moroccan politics. We trace his early grooming under the French protectorate, the controversial Berber Dahir, wartime decrees, and a single 1943 dinner that may have shifted colonial calculations - what did that conversation set in motion?

Person: Mohammed bin Yusef (Mohammed V)
Date: 22 January 1943
Location: Anfa Hotel, Casablanca
Event: Dinner with Franklin Roosevelt and Winston Churchill
Document: 16 May 1930 Berber Dahir

- Born into the palace and enthroned at seventeen on 18 November 1927 as the French chose a seemingly manageable monarch
- Signed the Berber Dahir at age twenty, a decree that redirected legal jurisdiction and ignited nationwide protests
- Navigated the 1930s by cultivating loyalty among palace servants and building ties with emerging Moroccan nationalists
- Under Vichy rule, he signed two decrees restricting Jews from certain schools and professions while reportedly refusing to sign deportation orders
- At the 22 January 1943 Anfa dinner, Roosevelt allegedly told the sultan Morocco would be independent in ten years, a prediction the French were never meant to hear

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911418Sat, 05 Sep 2026 09:01:57 +0000Creator at ObomediaAt the Anfa Hotel, Roosevelt tells Sultan Mohammed V Morocco will be independent in ten years - how did that expose the protectorate? The Roosevelt Whisper at Dinner That Unraveled the Protectorate In this episode, we recount the life and...
The Roosevelt Whisper at Dinner That Unraveled the Protectorate

In this episode, we recount the life and pivotal moments of Mohammed bin Yusef, the sultan who became Mohammed V, focusing on decisions and encounters that reshaped Moroccan politics. We trace his early grooming under the French protectorate, the controversial Berber Dahir, wartime decrees, and a single 1943 dinner that may have shifted colonial calculations - what did that conversation set in motion?

Person: Mohammed bin Yusef (Mohammed V)
Date: 22 January 1943
Location: Anfa Hotel, Casablanca
Event: Dinner with Franklin Roosevelt and Winston Churchill
Document: 16 May 1930 Berber Dahir

- Born into the palace and enthroned at seventeen on 18 November 1927 as the French chose a seemingly manageable monarch
- Signed the Berber Dahir at age twenty, a decree that redirected legal jurisdiction and ignited nationwide protests
- Navigated the 1930s by cultivating loyalty among palace servants and building ties with emerging Moroccan nationalists
- Under Vichy rule, he signed two decrees restricting Jews from certain schools and professions while reportedly refusing to sign deportation orders
- At the 22 January 1943 Anfa dinner, Roosevelt allegedly told the sultan Morocco would be independent in ten years, a prediction the French were never meant to hear

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>775falsefullhttps://www.spreaker.com/episode/a-plastic-bag-poured-salmonella-over-the-salad-bar-and-crippled-local-voting--74911417
A Plastic Bag Poured Salmonella Over The Salad Bar and Crippled Local Voting

In this episode, we outline how a sudden outbreak in The Dalles spiraled from a routine lunch crowd into a public health crisis and a political tactic. The episode follows the timeline, key actors, and decisions that turned foodborne illness into a lever in a local election - but leaves open how investigators connected the dots.

Location: The Dalles, Wasco County, Oregon
Date: September 1984
Case: Salmonella enterica Typhimurium outbreak
Group: Rajneeshpuram commune
Persons: Sheela Silverman; Diane Yvonne Onang (Ma Anand Puja)

- 751 people in The Dalles became violently ill after eating at ordinary restaurants in September 1984.
- Initial investigations by Oregon health officials and the CDC concluded the outbreak was a natural food-safety failure.
- Rajneeshpuram was a 7,500-acre commune 30 miles from The Dalles with roads, a mall, a clinic, and about 7,000 residents.
- Commune leaders had 239 registered voters and previously attempted to bus in homeless people to influence local elections.
- Sheela Silverman and Diane Yvonne Onang ordered Salmonella enterica Typhimurium through the Rajneesh Medical Corporation from a Seattle supplier.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911417Fri, 04 Sep 2026 22:16:04 +0000Creator at ObomediaA plastic bag of light‑brown liquid poured over a salad bar in The Dalles-what happened next? A Plastic Bag Poured Salmonella Over The Salad Bar and Crippled Local Voting In this episode, we outline how a sudden outbreak in The Dalles spiraled...
A Plastic Bag Poured Salmonella Over The Salad Bar and Crippled Local Voting

In this episode, we outline how a sudden outbreak in The Dalles spiraled from a routine lunch crowd into a public health crisis and a political tactic. The episode follows the timeline, key actors, and decisions that turned foodborne illness into a lever in a local election - but leaves open how investigators connected the dots.

Location: The Dalles, Wasco County, Oregon
Date: September 1984
Case: Salmonella enterica Typhimurium outbreak
Group: Rajneeshpuram commune
Persons: Sheela Silverman; Diane Yvonne Onang (Ma Anand Puja)

- 751 people in The Dalles became violently ill after eating at ordinary restaurants in September 1984.
- Initial investigations by Oregon health officials and the CDC concluded the outbreak was a natural food-safety failure.
- Rajneeshpuram was a 7,500-acre commune 30 miles from The Dalles with roads, a mall, a clinic, and about 7,000 residents.
- Commune leaders had 239 registered voters and previously attempted to bus in homeless people to influence local elections.
- Sheela Silverman and Diane Yvonne Onang ordered Salmonella enterica Typhimurium through the Rajneesh Medical Corporation from a Seattle supplier.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1125falsefullhttps://www.spreaker.com/episode/the-25-kg-bag-that-turned-milk-into-poison-and-wrecked-thousands--74911416
The 25‑kg bag that turned milk into poison and wrecked thousands

In this episode, we trace how melamine entered China's infant formula supply and the decisions - corporate, municipal, and journalistic - that allowed contaminated milk to keep moving. What choices were made while hospitals filled and parents waited for answers?

Date: August 11, 2008
Company: Sanlu Group
Chemical: Melamine (with cyanuric acid)
Count: 300,000 children harmed; 51,900 hospitalized; 6 deaths
Product samples: up to 2,563 mg/kg melamine (vs 1 mg/kg safe threshold)

- A PR firm delivered a three‑million‑yuan proposal to Baidu asking to erase news linking Sanlu to sick infants.
- Raw milk priced by protein content created an incentive for adding nitrogen-rich melamine at aggregation stations.
- Scrap industrial melamine arrived in unmarked 25‑kg bags described as “protein powder,” costing about 700 yuan per tonne.
- Melamine mixed with cyanuric acid forms crystals that can block infant kidney tubules, causing kidney stones and failure.
- By December 2007 Sanlu had received the first kidney‑stone complaints but did not test for melamine or alert regulators.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911416Fri, 04 Sep 2026 22:16:00 +0000Creator at ObomediaA leaked memo shows a PR firm asked Baidu to bury reports about Sanlu-how did that expose them? The 25‑kg bag that turned milk into poison and wrecked thousands In this episode, we trace how melamine entered China's infant formula supply and the...
The 25‑kg bag that turned milk into poison and wrecked thousands

In this episode, we trace how melamine entered China's infant formula supply and the decisions - corporate, municipal, and journalistic - that allowed contaminated milk to keep moving. What choices were made while hospitals filled and parents waited for answers?

Date: August 11, 2008
Company: Sanlu Group
Chemical: Melamine (with cyanuric acid)
Count: 300,000 children harmed; 51,900 hospitalized; 6 deaths
Product samples: up to 2,563 mg/kg melamine (vs 1 mg/kg safe threshold)

- A PR firm delivered a three‑million‑yuan proposal to Baidu asking to erase news linking Sanlu to sick infants.
- Raw milk priced by protein content created an incentive for adding nitrogen-rich melamine at aggregation stations.
- Scrap industrial melamine arrived in unmarked 25‑kg bags described as “protein powder,” costing about 700 yuan per tonne.
- Melamine mixed with cyanuric acid forms crystals that can block infant kidney tubules, causing kidney stones and failure.
- By December 2007 Sanlu had received the first kidney‑stone complaints but did not test for melamine or alert regulators.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>958falsefullhttps://www.spreaker.com/episode/the-strawberry-needle-that-emptied-supermarket-shelves--74911415
The strawberry needle that emptied supermarket shelves

In this episode, we follow the early days of a food contamination crisis that began with a single three-centimetre sewing needle in a punnet and unfolded across supply chains, farms and retailers. We map how delays, industry practices and local labor shaped the spread of fear and ask how those gaps were exposed.

Date: 9 September 2018
Location: Queensland, Australia
Person: My Ut Trinh
Topic: Needle contamination in strawberries
Event: Supermarket shelves cleared

- A berry buyer bit into a Berry Obsession strawberry and found a 3 cm sewing needle, then a Facebook post spread the news before any official warning.
- Three days passed between the first reports and a public health warning, while trade-level recalls circulated within industry channels.
- Queensland’s Sunshine Coast region, the engine of Australia’s strawberry supply, ships fruit to major chains within 48 hours via growers, packers and supervisors.
- Picking supervisors like 50-year-old My Ut Trinh worked close to the product flow between field and punnet, a proximity that later shaped prosecutorial focus.
- Within six days one Sunshine Coast farm ceased operations, workers lost jobs and buyers stopped calling as retailers pulled orders and shelves emptied.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911415Fri, 04 Sep 2026 22:15:56 +0000Creator at ObomediaA sewing needle hidden in a strawberry in Queensland sparks a nationwide supermarket panic and threatens an entire strawberry industry. The strawberry needle that emptied supermarket shelves In this episode, we follow the early days of a food...
The strawberry needle that emptied supermarket shelves

In this episode, we follow the early days of a food contamination crisis that began with a single three-centimetre sewing needle in a punnet and unfolded across supply chains, farms and retailers. We map how delays, industry practices and local labor shaped the spread of fear and ask how those gaps were exposed.

Date: 9 September 2018
Location: Queensland, Australia
Person: My Ut Trinh
Topic: Needle contamination in strawberries
Event: Supermarket shelves cleared

- A berry buyer bit into a Berry Obsession strawberry and found a 3 cm sewing needle, then a Facebook post spread the news before any official warning.
- Three days passed between the first reports and a public health warning, while trade-level recalls circulated within industry channels.
- Queensland’s Sunshine Coast region, the engine of Australia’s strawberry supply, ships fruit to major chains within 48 hours via growers, packers and supervisors.
- Picking supervisors like 50-year-old My Ut Trinh worked close to the product flow between field and punnet, a proximity that later shaped prosecutorial focus.
- Within six days one Sunshine Coast farm ceased operations, workers lost jobs and buyers stopped calling as retailers pulled orders and shelves emptied.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>844falsefullhttps://www.spreaker.com/episode/the-file-review-that-shrank-garlock-s-liability-by-90--74911414
The File Review That Shrank Garlock's Liability by 90%

In this episode, we lay out how a gasket maker became the focal point of four thousand mesothelioma claims and a bankruptcy that recalculated billions in liability. We follow the decisions, documents, and courtroom moves that forced a judge to cut Garlock’s remaining exposure by roughly ninety percent and ask what the file review actually revealed.

Company: Garlock Sealing Technologies
Event: Chapter 11 bankruptcy filing under Section 524(g)
Location: Federal bankruptcy court, Charlotte, North Carolina
Judge: George Hodges
Claims: ~4,000 mesothelioma claimants

- Garlock manufactured asbestos-containing chrysotile gaskets stamped with the company name and sold into shipyards, refineries, and industrial plants.
- Workers removing gaskets first disturbed pipe insulation made by other companies that contained amphibole asbestos, a far more carcinogenic fiber.
- Over thirty-five years Garlock and its insurers paid roughly $1.3 billion in judgments, settlements, and defense costs before insurance coverage ran out in 2010.
- Facing continuing claims, Garlock filed for Chapter 11 protection, putting thousands of pending mesothelioma cases into bankruptcy procedure.
- Judge Hodges allowed Garlock’s lawyers to review full plaintiff case files, then reduced the estimated remaining liability from about $1.25 billion to $125 million, prompting dispute over the meaning of the files.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911414Fri, 04 Sep 2026 22:15:52 +0000Creator at ObomediaA federal judge let lawyers review mesothelioma files about Garlock gaskets - how did that file review expose them? The File Review That Shrank Garlock's Liability by 90% In this episode, we lay out how a gasket maker became the focal point of...
The File Review That Shrank Garlock's Liability by 90%

In this episode, we lay out how a gasket maker became the focal point of four thousand mesothelioma claims and a bankruptcy that recalculated billions in liability. We follow the decisions, documents, and courtroom moves that forced a judge to cut Garlock’s remaining exposure by roughly ninety percent and ask what the file review actually revealed.

Company: Garlock Sealing Technologies
Event: Chapter 11 bankruptcy filing under Section 524(g)
Location: Federal bankruptcy court, Charlotte, North Carolina
Judge: George Hodges
Claims: ~4,000 mesothelioma claimants

- Garlock manufactured asbestos-containing chrysotile gaskets stamped with the company name and sold into shipyards, refineries, and industrial plants.
- Workers removing gaskets first disturbed pipe insulation made by other companies that contained amphibole asbestos, a far more carcinogenic fiber.
- Over thirty-five years Garlock and its insurers paid roughly $1.3 billion in judgments, settlements, and defense costs before insurance coverage ran out in 2010.
- Facing continuing claims, Garlock filed for Chapter 11 protection, putting thousands of pending mesothelioma cases into bankruptcy procedure.
- Judge Hodges allowed Garlock’s lawyers to review full plaintiff case files, then reduced the estimated remaining liability from about $1.25 billion to $125 million, prompting dispute over the meaning of the files.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>901falsefullhttps://www.spreaker.com/episode/the-tape-he-mailed-convicted-jack-kevorkian--74911411
The Tape He Mailed Convicted Jack Kevorkian

In this episode, we present the documented record of Jack Kevorkian’s years assisting suicides, the devices he built, the patients he met, and the actions that led prosecutors a critical piece of evidence. What do the machines, the ads, and the short timelines between meeting and death reveal about his practice?

Person: Jack Kevorkian
Date: September 17, 1998
Location: Michigan
Topic: Assisted suicide devices and practices
Case: Mailing of videotaped assisted death

- He built two euthanasia devices in his home: the Thanatron (intravenous drug delivery) and the Mercitron (carbon monoxide mask activated by the patient).
- He placed newspaper advertisements offering “death counseling” and met many patients through those ads.
- At least nineteen patients died within twenty-four hours of meeting him for the first time.
- Investigations found at least sixty percent of his assisted patients were not terminally ill and several had no pain or no disease on autopsy.
- On September 17, 1998, a taped injection of Thomas Youk was recorded, packaged, and mailed by the man who administered it to a television network.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911411Fri, 04 Sep 2026 22:15:48 +0000Creator at ObomediaA man in a Michigan room films a fatal injection, then mails the tape to a TV network-how did Jack Kevorkian’s actions expose him? The Tape He Mailed Convicted Jack Kevorkian In this episode, we present the documented record of Jack Kevorkian’s...
The Tape He Mailed Convicted Jack Kevorkian

In this episode, we present the documented record of Jack Kevorkian’s years assisting suicides, the devices he built, the patients he met, and the actions that led prosecutors a critical piece of evidence. What do the machines, the ads, and the short timelines between meeting and death reveal about his practice?

Person: Jack Kevorkian
Date: September 17, 1998
Location: Michigan
Topic: Assisted suicide devices and practices
Case: Mailing of videotaped assisted death

- He built two euthanasia devices in his home: the Thanatron (intravenous drug delivery) and the Mercitron (carbon monoxide mask activated by the patient).
- He placed newspaper advertisements offering “death counseling” and met many patients through those ads.
- At least nineteen patients died within twenty-four hours of meeting him for the first time.
- Investigations found at least sixty percent of his assisted patients were not terminally ill and several had no pain or no disease on autopsy.
- On September 17, 1998, a taped injection of Thomas Youk was recorded, packaged, and mailed by the man who administered it to a television network.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1054falsefullhttps://www.spreaker.com/episode/the-keys-that-opened-his-naples-flat-revealed-billions-in-hidden-assets--74911410
The keys that opened his Naples flat revealed billions in hidden assets

In this episode, we follow the documented record of Duilio Poggiolini’s career inside Italy’s health bureaucracy and the discovery at his Naples apartment that exposed vast unseen wealth. What did investigators find behind the ordinary door, and how did those finds intersect with decades of control over medicines and pricing?

Person: Duilio Poggiolini
Date: 20 September 1993
Location: Naples apartment
Topic: Hidden assets discovered during police search
Event: Twelve-hour inventory of gold, jewels, coins and assets

- Investigators used a search warrant to enter Poggiolini’s Naples flat and spent twelve hours cataloguing its contents.
- The inventory included gold ingots, jewels, oil paintings, Tsar-era gold rubles, South African Krugerrands, and assets valued at several billion francs.
- Poggiolini had authority to decide which drugs appeared on Italy’s national formulary and at what price for nearly thirty years.
- Court records documented twenty confirmed kickback incidents tied to drug pricing between 1982 and 1992, with forty alleged payments examined.
- His wife, Maria Di Pierr Poggiolini, received direct payments and held a Swiss account with over fifteen billion lire at the time of arrest.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911410Fri, 04 Sep 2026 22:15:44 +0000Creator at ObomediaA set of keys opens a Naples flat and twelve hours of cataloguing reveal gold, jewels and billions in hidden assets tied to a powerful drug regulator. The keys that opened his Naples flat revealed billions in hidden assets In this episode, we...
The keys that opened his Naples flat revealed billions in hidden assets

In this episode, we follow the documented record of Duilio Poggiolini’s career inside Italy’s health bureaucracy and the discovery at his Naples apartment that exposed vast unseen wealth. What did investigators find behind the ordinary door, and how did those finds intersect with decades of control over medicines and pricing?

Person: Duilio Poggiolini
Date: 20 September 1993
Location: Naples apartment
Topic: Hidden assets discovered during police search
Event: Twelve-hour inventory of gold, jewels, coins and assets

- Investigators used a search warrant to enter Poggiolini’s Naples flat and spent twelve hours cataloguing its contents.
- The inventory included gold ingots, jewels, oil paintings, Tsar-era gold rubles, South African Krugerrands, and assets valued at several billion francs.
- Poggiolini had authority to decide which drugs appeared on Italy’s national formulary and at what price for nearly thirty years.
- Court records documented twenty confirmed kickback incidents tied to drug pricing between 1982 and 1992, with forty alleged payments examined.
- His wife, Maria Di Pierr Poggiolini, received direct payments and held a Swiss account with over fifteen billion lire at the time of arrest.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>845falsefullhttps://www.spreaker.com/episode/the-serum-vial-in-the-fridge-poisoned-eighteen-children--74911409
The serum vial in the fridge poisoned eighteen children

In this episode we lay out the morning of January 27, 1928 in Bundaberg, when twenty-one children were inoculated and eighteen fell critically ill within hours. We follow the local immunization program, the refrigerated vial used by Dr. Ewing Thomson, and the early medical and investigative questions that drove a five-month inquiry into how a protective medicine became lethal.

Date: January 27, 1928
Location: Bundaberg, Queensland, Australia
Person: Dr. Ewing Thomson
Event: Toxin-antitoxin diphtheria inoculation session
Status: Eighteen critically ill within seven hours; twelve dead by the following evening

- Twenty-one children aged one to nine lined up for routine diphtheria toxin-antitoxin injections administered by Dr. Thomson.
- The serum bottle used that morning was stored in Thomson’s refrigerator and showed no visible defects: clear glass, sealed, no discoloration or odor.
- The affected children’s illness onset was sudden and concentrated: healthy at noon, convulsing and critically ill within hours.
- The same serum batch had been used elsewhere in Australia without adverse effects, complicating a factory-origin explanation.
- Dr. Egmont Schmidt performed post-mortems and recorded “acute toxaemia of unknown cause,” highlighting limits of local resources and the mystery investigators faced.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911409Fri, 04 Sep 2026 22:15:40 +0000Creator at ObomediaA refrigerated serum vial in Dr. Thomson’s Bundaberg fridge caused mass poisoning-how did a clear bottle expose eighteen children? The serum vial in the fridge poisoned eighteen children In this episode we lay out the morning of January 27, 1928...
The serum vial in the fridge poisoned eighteen children

In this episode we lay out the morning of January 27, 1928 in Bundaberg, when twenty-one children were inoculated and eighteen fell critically ill within hours. We follow the local immunization program, the refrigerated vial used by Dr. Ewing Thomson, and the early medical and investigative questions that drove a five-month inquiry into how a protective medicine became lethal.

Date: January 27, 1928
Location: Bundaberg, Queensland, Australia
Person: Dr. Ewing Thomson
Event: Toxin-antitoxin diphtheria inoculation session
Status: Eighteen critically ill within seven hours; twelve dead by the following evening

- Twenty-one children aged one to nine lined up for routine diphtheria toxin-antitoxin injections administered by Dr. Thomson.
- The serum bottle used that morning was stored in Thomson’s refrigerator and showed no visible defects: clear glass, sealed, no discoloration or odor.
- The affected children’s illness onset was sudden and concentrated: healthy at noon, convulsing and critically ill within hours.
- The same serum batch had been used elsewhere in Australia without adverse effects, complicating a factory-origin explanation.
- Dr. Egmont Schmidt performed post-mortems and recorded “acute toxaemia of unknown cause,” highlighting limits of local resources and the mystery investigators faced.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1200falsefullhttps://www.spreaker.com/episode/the-needle-through-an-infant-s-nose-that-betrayed-kobe-s-hidden-experiments--74911407
The needle through an infant's nose that betrayed Kobe's hidden experiments

In this episode, we follow a chain of medical cases that stretches from Kobe in 1958 back through colonial medicine, wartime programs, and published studies to ask how credentialed scientists normalized experiments on unwitting humans. What was the logic inside institutions that allowed routine procedures to become instruments of inquiry?

Person: Henry Beecher
Date: 1958
Location: Kobe, Japan
Event: covert medical experiments on infants
Period: 1932-1966

- Healthy infants admitted for routine checkups had needles pushed through their noses and rectal tubes inserted without parental consent.
- Henry Beecher identified twenty-two published studies conducted without consent, anchoring the pattern in medical literature.
- Experiments traced back through a network of hospitals, military units, and residential institutions influenced by colonial and wartime practices.
- Nazi programs (sterilization laws, Auschwitz experiments, Dachau hypothermia and high-altitude studies) contributed data that circulated in postwar journals.
- Unit 731 in Manchukuo ran extensive prisoner experiments with meticulous records that were never prosecuted in a Nuremberg-style trial.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911407Fri, 04 Sep 2026 22:15:36 +0000Creator at ObomediaA doctor in Kobe pushes a needle through an infant’s nose during a “checkup” - how did that needle betray them? The needle through an infant's nose that betrayed Kobe's hidden experiments In this episode, we follow a chain of medical cases that...
The needle through an infant's nose that betrayed Kobe's hidden experiments

In this episode, we follow a chain of medical cases that stretches from Kobe in 1958 back through colonial medicine, wartime programs, and published studies to ask how credentialed scientists normalized experiments on unwitting humans. What was the logic inside institutions that allowed routine procedures to become instruments of inquiry?

Person: Henry Beecher
Date: 1958
Location: Kobe, Japan
Event: covert medical experiments on infants
Period: 1932-1966

- Healthy infants admitted for routine checkups had needles pushed through their noses and rectal tubes inserted without parental consent.
- Henry Beecher identified twenty-two published studies conducted without consent, anchoring the pattern in medical literature.
- Experiments traced back through a network of hospitals, military units, and residential institutions influenced by colonial and wartime practices.
- Nazi programs (sterilization laws, Auschwitz experiments, Dachau hypothermia and high-altitude studies) contributed data that circulated in postwar journals.
- Unit 731 in Manchukuo ran extensive prisoner experiments with meticulous records that were never prosecuted in a Nuremberg-style trial.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1036falsefullhttps://www.spreaker.com/episode/the-propofol-injection-that-stopped-his-breath-and-paved-a-conviction--74911405
The Propofol Injection That Stopped His Breath and Paved a Conviction

In this episode, we present the sequence of medical decisions, timing, and actions inside a North Carolwood Drive bedroom the morning a world-famous entertainer stopped breathing. What choices were made, what equipment and protocols were absent, and how did those gaps shape the aftermath?

Person: Michael Jackson
Person: Conrad Murray
Date: June 25, 2009
Location: 100 North Carolwood Drive, Holmby Hills, Los Angeles
Drug: Propofol (25 mg) with lidocaine

- A cardiologist administered diazepam, lorazepam, midazolam, then a 25 mg propofol injection in a private residence, not a hospital.
- Standard-of-care monitors and a second trained clinician were not present; propofol has no pharmacologic reversal and requires mechanical airway support.
- The patient, 136 pounds with a healthy heart per autopsy, had been requesting propofol for sleep for years and called it “milk.”
- The physician stepped away after the injection, found the patient unresponsive, and did not call 911 immediately, citing no landline and not knowing the address.
- Cell phone records showed multiple personal calls during the ninety-minute period before the first emergency call, and those call timings were introduced at trial.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911405Fri, 04 Sep 2026 22:15:32 +0000Creator at ObomediaA cardiologist injects propofol into a famous entertainer in a Holmby Hills bedroom; will medicine and ethics answer the unanswered? The Propofol Injection That Stopped His Breath and Paved a Conviction In this episode, we present the sequence...
The Propofol Injection That Stopped His Breath and Paved a Conviction

In this episode, we present the sequence of medical decisions, timing, and actions inside a North Carolwood Drive bedroom the morning a world-famous entertainer stopped breathing. What choices were made, what equipment and protocols were absent, and how did those gaps shape the aftermath?

Person: Michael Jackson
Person: Conrad Murray
Date: June 25, 2009
Location: 100 North Carolwood Drive, Holmby Hills, Los Angeles
Drug: Propofol (25 mg) with lidocaine

- A cardiologist administered diazepam, lorazepam, midazolam, then a 25 mg propofol injection in a private residence, not a hospital.
- Standard-of-care monitors and a second trained clinician were not present; propofol has no pharmacologic reversal and requires mechanical airway support.
- The patient, 136 pounds with a healthy heart per autopsy, had been requesting propofol for sleep for years and called it “milk.”
- The physician stepped away after the injection, found the patient unresponsive, and did not call 911 immediately, citing no landline and not knowing the address.
- Cell phone records showed multiple personal calls during the ninety-minute period before the first emergency call, and those call timings were introduced at trial.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>928falsefullhttps://www.spreaker.com/episode/the-nurse-s-notebook-that-forced-authorities-to-act--74911403
The nurse's notebook that forced authorities to act

In this episode, we follow how frontline staff in a rural Queensland hospital documented disturbing surgical practice and escalating patient harm. The episode traces the nurses’ responses, the background medical records left unchecked, and the decision that pushed the case into public view.

Person: Jayant Patel
Person: Toni Hoffman
Location: Bundaberg Base Hospital, regional Queensland
Date: 2003-2005
Event: Area-of-need appointment of a surgeon with prior disciplinary records

- Nurses developed a covert system: when they heard his footsteps they moved patients, wheeled beds into side rooms and drew curtains.
- Public disciplinary records from New York and Oregon documented restrictions, probation and revoked licence before his appointment.
- Queensland Health’s area-of-need program appointed him as Director of Surgery despite lacking recognised specialist surgical qualifications.
- Staff noticed outdated techniques, hygiene concerns and postoperative outcomes outside normal ranges within months of his arrival.
- One nurse kept detailed notes over time; her decision about those notes later pushed the matter into public scrutiny.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911403Fri, 04 Sep 2026 22:15:29 +0000Creator at ObomediaA nurse’s hidden notebook in a regional Queensland hospital tracks a surgeon. How did those notes force authorities to act? The nurse's notebook that forced authorities to act In this episode, we follow how frontline staff in a rural Queensland...
The nurse's notebook that forced authorities to act

In this episode, we follow how frontline staff in a rural Queensland hospital documented disturbing surgical practice and escalating patient harm. The episode traces the nurses’ responses, the background medical records left unchecked, and the decision that pushed the case into public view.

Person: Jayant Patel
Person: Toni Hoffman
Location: Bundaberg Base Hospital, regional Queensland
Date: 2003-2005
Event: Area-of-need appointment of a surgeon with prior disciplinary records

- Nurses developed a covert system: when they heard his footsteps they moved patients, wheeled beds into side rooms and drew curtains.
- Public disciplinary records from New York and Oregon documented restrictions, probation and revoked licence before his appointment.
- Queensland Health’s area-of-need program appointed him as Director of Surgery despite lacking recognised specialist surgical qualifications.
- Staff noticed outdated techniques, hygiene concerns and postoperative outcomes outside normal ranges within months of his arrival.
- One nurse kept detailed notes over time; her decision about those notes later pushed the matter into public scrutiny.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1257falsefullhttps://www.spreaker.com/episode/the-session-camera-recorded-him-spoon-her-and-it-exposed-him--74911402
The Session Camera Recorded Him Spoon Her - and It Exposed Him

In this episode, we follow the recorded sessions from a phase-two MDMA-assisted psychotherapy trial that enrolled Meaghan Buisson as patient number one and trace the decisions, movements, and protocols that shaped her experience. What did the session footage reveal about the boundary between care and harm?

Person: Meaghan Buisson
Study: Phase-two MDMA-assisted psychotherapy clinical trial
Sponsor: MAPS (Multidisciplinary Association for Psychedelic Studies)
Enrollment Date: December 2014
Location: Cortes Island (move in June 2015)

- The sessions were video-recorded as standard clinical documentation and those tapes later became central evidence.
- Buisson entered the trial with treatment-resistant PTSD after referrals and a long history of abuse and athletic career trauma.
- Her therapy team included Richard Yensen (psychotherapist with a lapsed license) and Donna Dryer (licensed psychiatrist and Yensen’s spouse).
- Protocols required therapists not to touch patients in vulnerable MDMA sessions, but Buisson alleges repeated spooning while she was under the drug.
- Buisson moved to Cortes Island mid-trial, placing her in close geographic proximity and dependency on the therapists.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911402Fri, 04 Sep 2026 22:15:24 +0000Creator at ObomediaA clinical trial camera catches therapist spooning patient Meaghan Buisson during an MDMA session - how did that footage expose him? The Session Camera Recorded Him Spoon Her - and It Exposed Him In this episode, we follow the recorded sessions...
The Session Camera Recorded Him Spoon Her - and It Exposed Him

In this episode, we follow the recorded sessions from a phase-two MDMA-assisted psychotherapy trial that enrolled Meaghan Buisson as patient number one and trace the decisions, movements, and protocols that shaped her experience. What did the session footage reveal about the boundary between care and harm?

Person: Meaghan Buisson
Study: Phase-two MDMA-assisted psychotherapy clinical trial
Sponsor: MAPS (Multidisciplinary Association for Psychedelic Studies)
Enrollment Date: December 2014
Location: Cortes Island (move in June 2015)

- The sessions were video-recorded as standard clinical documentation and those tapes later became central evidence.
- Buisson entered the trial with treatment-resistant PTSD after referrals and a long history of abuse and athletic career trauma.
- Her therapy team included Richard Yensen (psychotherapist with a lapsed license) and Donna Dryer (licensed psychiatrist and Yensen’s spouse).
- Protocols required therapists not to touch patients in vulnerable MDMA sessions, but Buisson alleges repeated spooning while she was under the drug.
- Buisson moved to Cortes Island mid-trial, placing her in close geographic proximity and dependency on the therapists.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1138falsefullhttps://www.spreaker.com/episode/the-hidden-camera-that-recorded-thirteen-hours-of-abuse-exposed-his-crimes--74911401
The hidden camera that recorded thirteen hours of abuse exposed his crimes

In this episode, we lay out the timeline and evidence that brought renewed scrutiny to a pediatric practice that looked like a child’s paradise. We follow the warnings, internal reports, and the yearlong probe that led investigators back into the office - what questions remained about institutional responses?

Person: Earl Bradley
Location: Lewes, Delaware
Date: December 16, 2009
Topic: Recordings of abuse in a pediatric office
Case: BayBees Pediatrics

- The practice used carnival rides, a Buzz Lightyear statue, a small theater, and bumblebee Volkswagen Beetles to create trust and draw families from afar.
- Complaints began years earlier: 1994-1995 investigations at Thomas Jefferson Hospital, records sealed and outcomes unconfirmed.
- Office manager Lynda Barnes reported inappropriate touching, missing antidepressants, and allegations involving Bradley’s son starting in 2004.
- In 2005 nurses and fellow physicians reported videotaping and unnecessary lengthy vaginal exams; Milford police sought a warrant that the attorney general declined.
- A 12-month undercover investigation in 2009 culminated in an arrest and the discovery of more than thirteen hours of footage recorded in exam rooms and an outbuilding.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911401Fri, 04 Sep 2026 22:15:20 +0000Creator at ObomediaA pediatrician’s themed office in Lewes hid secret recordings suggesting decades of abuse - how did that expose him? The hidden camera that recorded thirteen hours of abuse exposed his crimes In this episode, we lay out the timeline and evidence...
The hidden camera that recorded thirteen hours of abuse exposed his crimes

In this episode, we lay out the timeline and evidence that brought renewed scrutiny to a pediatric practice that looked like a child’s paradise. We follow the warnings, internal reports, and the yearlong probe that led investigators back into the office - what questions remained about institutional responses?

Person: Earl Bradley
Location: Lewes, Delaware
Date: December 16, 2009
Topic: Recordings of abuse in a pediatric office
Case: BayBees Pediatrics

- The practice used carnival rides, a Buzz Lightyear statue, a small theater, and bumblebee Volkswagen Beetles to create trust and draw families from afar.
- Complaints began years earlier: 1994-1995 investigations at Thomas Jefferson Hospital, records sealed and outcomes unconfirmed.
- Office manager Lynda Barnes reported inappropriate touching, missing antidepressants, and allegations involving Bradley’s son starting in 2004.
- In 2005 nurses and fellow physicians reported videotaping and unnecessary lengthy vaginal exams; Milford police sought a warrant that the attorney general declined.
- A 12-month undercover investigation in 2009 culminated in an arrest and the discovery of more than thirteen hours of footage recorded in exam rooms and an outbuilding.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1234falsefullhttps://www.spreaker.com/episode/the-cadmium-in-their-rice-broke-bones-and-lives--74911400
The Cadmium in Their Rice Broke Bones and Lives

In this episode, we trace how slow industrial discharge into rivers became daily doses in food and water across Japan and the long path to accountability. What did investigators have to piece together to link rivers, rice, and disease?

Person: Mitsui Mining and Smelting Company
Location: Jinzū River, Toyama Prefecture
Date: 1910-1968 (operations to lawsuit)
Disease: Itai-itai (cadmium poisoning)
Exposure route: Cadmium in irrigation water absorbed by rice and drinking water

- Doctors recorded progressive spinal and bone pain in mostly female farmers beginning by 1912, including fractures from coughing.
- Local communities relied on the Jinzū River for irrigation, drinking water, and rice that formed a dietary staple.
- Mitsui Mining and Smelting discharged cadmium-laden wastewater upstream for decades before legal action.
- Cadmium bioaccumulated slowly in kidneys and bone, causing anemia, bone demineralization, and immobility over years.
- Similar patterns of industrial wastewater, bioaccumulation, and delayed recognition emerged later in separate outbreaks elsewhere in Japan.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911400Fri, 04 Sep 2026 22:15:16 +0000Creator at ObomediaA woman in Toyama coughed and broke ribs from cadmium in rice and river water - how did the contamination expose entire communities? The Cadmium in Their Rice Broke Bones and Lives In this episode, we trace how slow industrial discharge into...
The Cadmium in Their Rice Broke Bones and Lives

In this episode, we trace how slow industrial discharge into rivers became daily doses in food and water across Japan and the long path to accountability. What did investigators have to piece together to link rivers, rice, and disease?

Person: Mitsui Mining and Smelting Company
Location: Jinzū River, Toyama Prefecture
Date: 1910-1968 (operations to lawsuit)
Disease: Itai-itai (cadmium poisoning)
Exposure route: Cadmium in irrigation water absorbed by rice and drinking water

- Doctors recorded progressive spinal and bone pain in mostly female farmers beginning by 1912, including fractures from coughing.
- Local communities relied on the Jinzū River for irrigation, drinking water, and rice that formed a dietary staple.
- Mitsui Mining and Smelting discharged cadmium-laden wastewater upstream for decades before legal action.
- Cadmium bioaccumulated slowly in kidneys and bone, causing anemia, bone demineralization, and immobility over years.
- Similar patterns of industrial wastewater, bioaccumulation, and delayed recognition emerged later in separate outbreaks elsewhere in Japan.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>826falsefullhttps://www.spreaker.com/episode/the-routine-lab-test-that-exposed-diethylene-glycol-and-toppled-an-industry--74911399
The Routine Lab Test That Exposed Diethylene Glycol and Toppled an Industry

In this episode, we follow the chain from a single bottle pulled from a Stuttgart supermarket shelf to the industry-wide shock it triggered. You’ll hear how commercial contracts, a failed harvest, and one chemist’s formula intersected to create a problem that routine testing finally uncovered.

Person: Otto Nadrasky
Date: summer of 1985
Location: Stuttgart, West Germany
Product: 1981 Welschriesling Beerenauslese from Burgenland, Austria
Chemical: diethylene glycol (industrial antifreeze)

- A 1981 Beerenauslese bottle on a Stuttgart shelf contained 48 grams of diethylene glycol per litre, above the lethal dose.
- Austrian producers had long-term contracts with German buyers specifying Beerenauslese sweetness and body they were obliged to meet.
- The poor 1982 harvest left insufficient natural sugar and body to make genuine late-harvest wines at contracted volumes.
- Otto Nadrasky, a trained chemist in the Wagram region, applied diethylene glycol to mimic sweetness and viscosity that sugar could not provide.
- The adulterated wines moved in millions of litres across the German border for nearly three years until a routine West German lab test detected the contaminant.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911399Fri, 04 Sep 2026 22:15:12 +0000Creator at ObomediaA Stuttgart lab finds antifreeze in a bottle of Austrian Beerenauslese-how did that expose the wine trade and everyone who supplied it? The Routine Lab Test That Exposed Diethylene Glycol and Toppled an Industry In this episode, we follow the...
The Routine Lab Test That Exposed Diethylene Glycol and Toppled an Industry

In this episode, we follow the chain from a single bottle pulled from a Stuttgart supermarket shelf to the industry-wide shock it triggered. You’ll hear how commercial contracts, a failed harvest, and one chemist’s formula intersected to create a problem that routine testing finally uncovered.

Person: Otto Nadrasky
Date: summer of 1985
Location: Stuttgart, West Germany
Product: 1981 Welschriesling Beerenauslese from Burgenland, Austria
Chemical: diethylene glycol (industrial antifreeze)

- A 1981 Beerenauslese bottle on a Stuttgart shelf contained 48 grams of diethylene glycol per litre, above the lethal dose.
- Austrian producers had long-term contracts with German buyers specifying Beerenauslese sweetness and body they were obliged to meet.
- The poor 1982 harvest left insufficient natural sugar and body to make genuine late-harvest wines at contracted volumes.
- Otto Nadrasky, a trained chemist in the Wagram region, applied diethylene glycol to mimic sweetness and viscosity that sugar could not provide.
- The adulterated wines moved in millions of litres across the German border for nearly three years until a routine West German lab test detected the contaminant.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>874falsefullhttps://www.spreaker.com/episode/the-lab-dose-that-turned-gw501516-into-cancer--74911398
The lab dose that turned GW501516 into cancer

In this episode, we follow the story of GW501516 from corporate labs to independent research and into athletic subcultures. The episode traces the compound’s development, the decisions that halted its clinical program, and the consequences that unfolded when other scientists pushed doses beyond the original trials - what questions did that silence leave unanswered?

Person: Ronald M. Evans
Company: GlaxoSmithKline (GSK)
Compound: GW501516
Event: Cell cover story on endurance performance (2007)
Finding: Animal toxicology showed rapid multi-organ cancers at 3 mg/kg/day

- GSK and Ligand Pharmaceuticals developed GW501516 over 15 years and ran Phase I and II human trials before quietly stopping the program in 2007.
- The molecule had exceptional selectivity and one-nanomolar binding affinity targeting the PPARδ receptor, with early data improving HDL and lowering VLDL in obese rhesus monkeys.
- Ronald M. Evans purchased GW501516 independently and gave higher doses to mice, producing dramatic endurance gains that were framed as "exercise in a bottle."
- Published performance coverage spread GW501516 into cycling, track-and-field, and bodybuilding communities despite the original clinical silence.
- Toxicology studies ending GSK’s program showed tumors across liver, stomach, skin, tongue and bladder in rodents at 3 mg/kg/day, implicating PPARδ-driven cancer mechanisms.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911398Fri, 04 Sep 2026 22:15:08 +0000Creator at ObomediaA scientist gives discarded drug GW501516 to mice and endurance soars - secret toxicology linked it to tumors; how did that expose them? The lab dose that turned GW501516 into cancer In this episode, we follow the story of GW501516 from...
The lab dose that turned GW501516 into cancer

In this episode, we follow the story of GW501516 from corporate labs to independent research and into athletic subcultures. The episode traces the compound’s development, the decisions that halted its clinical program, and the consequences that unfolded when other scientists pushed doses beyond the original trials - what questions did that silence leave unanswered?

Person: Ronald M. Evans
Company: GlaxoSmithKline (GSK)
Compound: GW501516
Event: Cell cover story on endurance performance (2007)
Finding: Animal toxicology showed rapid multi-organ cancers at 3 mg/kg/day

- GSK and Ligand Pharmaceuticals developed GW501516 over 15 years and ran Phase I and II human trials before quietly stopping the program in 2007.
- The molecule had exceptional selectivity and one-nanomolar binding affinity targeting the PPARδ receptor, with early data improving HDL and lowering VLDL in obese rhesus monkeys.
- Ronald M. Evans purchased GW501516 independently and gave higher doses to mice, producing dramatic endurance gains that were framed as "exercise in a bottle."
- Published performance coverage spread GW501516 into cycling, track-and-field, and bodybuilding communities despite the original clinical silence.
- Toxicology studies ending GSK’s program showed tumors across liver, stomach, skin, tongue and bladder in rodents at 3 mg/kg/day, implicating PPARδ-driven cancer mechanisms.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>834falsefullhttps://www.spreaker.com/episode/the-super-glue-that-sealed-his-wound-and-let-gangrene-take-him--74911396
The super glue that sealed his wound and let gangrene take him

In this episode, we follow the decisions that led a healthy man to seek amputation and the unlicensed surgeon who agreed to perform it. The episode traces the professional histories, the refused medical pathways, and the makeshift operating setup that preceded a catastrophic infection - how did that expose them?

Person: Philip Bondy
Date: May 9, 1998
Location: Tijuana / National City, California
Person: John Ronald Brown
Topic: Body Integrity Identity Disorder

- Philip Bondy, a 79-year-old retired satellite engineer, crossed from San Diego into Tijuana seeking removal of a healthy leg.
- Bondy and fellow sufferer Gregg Furth had both been refused elective amputation by licensed medical institutions, including teams like Johns Hopkins.
- John Ronald Brown, born July 4, 1922, lost his California medical license in 1977 for gross negligence and continued operating without a license for decades.
- Brown’s Tijuana operating space left no official record; investigators reconstructed the scene from physical evidence after the fact.
- Hundreds of tubes of super glue were found beside surgical instruments in a San Diego apartment, identified as part of Brown’s amputation kit.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911396Fri, 04 Sep 2026 22:15:04 +0000Creator at ObomediaA retired engineer travels to Tijuana for an illegal amputation-will the unlicensed surgeon’s super glue kit risk gangrene? The super glue that sealed his wound and let gangrene take him In this episode, we follow the decisions that led a...
The super glue that sealed his wound and let gangrene take him

In this episode, we follow the decisions that led a healthy man to seek amputation and the unlicensed surgeon who agreed to perform it. The episode traces the professional histories, the refused medical pathways, and the makeshift operating setup that preceded a catastrophic infection - how did that expose them?

Person: Philip Bondy
Date: May 9, 1998
Location: Tijuana / National City, California
Person: John Ronald Brown
Topic: Body Integrity Identity Disorder

- Philip Bondy, a 79-year-old retired satellite engineer, crossed from San Diego into Tijuana seeking removal of a healthy leg.
- Bondy and fellow sufferer Gregg Furth had both been refused elective amputation by licensed medical institutions, including teams like Johns Hopkins.
- John Ronald Brown, born July 4, 1922, lost his California medical license in 1977 for gross negligence and continued operating without a license for decades.
- Brown’s Tijuana operating space left no official record; investigators reconstructed the scene from physical evidence after the fact.
- Hundreds of tubes of super glue were found beside surgical instruments in a San Diego apartment, identified as part of Brown’s amputation kit.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>901falsefullhttps://www.spreaker.com/episode/the-plus-sign-that-turned-medical-files-into-death-warrants--74911394
The Plus Sign That Turned Medical Files into Death Warrants

In this episode, we follow the documented path from bedside diagnoses to signed, bureaucratic decisions. The episode lays out how medical paperwork, legal foundations, and state orders combined to turn physicians into an execution apparatus - and asks how a tiny mark on a form could carry the weight of life and death.

Person: Gerhard Kretschmar
Location: Tiergartenstraße 4, Berlin-Tiergarten
Period: 1933-1945
Event: State-sponsored medical killing programs
Case: children's program and adult selection forms

- A single physician in Berlin reviewed stacks of patient files without examinations and marked a plus, minus, or question mark to decide fate.
- The plus sign on the selection form was treated as a definitive ruling: plus meant death, minus meant life, question mark meant further review.
- The legal and academic groundwork included the 1933 Law for Prevention of Hereditarily Diseased Offspring and a 1920 tract that labeled some lives lebensunwertes Leben.
- The children's program began after Hitler authorized Karl Brandt following the case of Gerhard Kretschmar; reports of disabled newborns were routed to a central committee.
- Parents like Anna Wödl petitioned officials to stop transfers, but children sent to special wards such as Am Spiegelgrund were killed and their brains preserved for research.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911394Fri, 04 Sep 2026 22:15:00 +0000Creator at ObomediaA physician in Berlin marked one plus on a file - a medical note that became a death warrant from Tiergartenstraße 4. What happened next? The Plus Sign That Turned Medical Files into Death Warrants In this episode, we follow the documented path...
The Plus Sign That Turned Medical Files into Death Warrants

In this episode, we follow the documented path from bedside diagnoses to signed, bureaucratic decisions. The episode lays out how medical paperwork, legal foundations, and state orders combined to turn physicians into an execution apparatus - and asks how a tiny mark on a form could carry the weight of life and death.

Person: Gerhard Kretschmar
Location: Tiergartenstraße 4, Berlin-Tiergarten
Period: 1933-1945
Event: State-sponsored medical killing programs
Case: children's program and adult selection forms

- A single physician in Berlin reviewed stacks of patient files without examinations and marked a plus, minus, or question mark to decide fate.
- The plus sign on the selection form was treated as a definitive ruling: plus meant death, minus meant life, question mark meant further review.
- The legal and academic groundwork included the 1933 Law for Prevention of Hereditarily Diseased Offspring and a 1920 tract that labeled some lives lebensunwertes Leben.
- The children's program began after Hitler authorized Karl Brandt following the case of Gerhard Kretschmar; reports of disabled newborns were routed to a central committee.
- Parents like Anna Wödl petitioned officials to stop transfers, but children sent to special wards such as Am Spiegelgrund were killed and their brains preserved for research.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>833falsefullhttps://www.spreaker.com/episode/the-beetle-in-the-frog-s-diet-supplied-the-killer-painkiller--74911393
The beetle in the frog's diet supplied the killer painkiller

In this episode, we follow the seventeen-year hunt for a mysterious analgesic molecule found in a poison arrow frog and the baffling failures to reproduce it. The narrative traces fieldwork, lab limits, and a dietary clue that reframed the whole search; can a frog’s food chain explain the missing compound?

Person: John W. Daly
Person: Charles Myers
Species: Epipedobates anthonyi
Date: 1974-1992
Topic: epibatidine isolation and reproducibility

- Daly and Myers collected about three thousand frog skins from Ecuador between 1974 and 1979 to pursue an analgesic signal.
- Initial extracts in 1974 showed strong analgesic activity but lacked enough material to confirm a single responsible molecule.
- In 1976, frogs from an original collection site produced no detectable epibatidine despite the species’ continued presence.
- Captive-bred Epipedobates anthonyi did not produce epibatidine, indicating the compound was not synthesized by the frog itself.
- Investigation pointed to the frogs’ wild diet-beetles, ants, mites, and other leaf-litter invertebrates-as the source or precursor of the molecule.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911393Fri, 04 Sep 2026 22:14:56 +0000Creator at ObomediaA scientist holds the last trace of a frog skin extract that might contain a painkiller 200 times stronger than morphine - how did that expose them? The beetle in the frog's diet supplied the killer painkiller In this episode, we follow the...
The beetle in the frog's diet supplied the killer painkiller

In this episode, we follow the seventeen-year hunt for a mysterious analgesic molecule found in a poison arrow frog and the baffling failures to reproduce it. The narrative traces fieldwork, lab limits, and a dietary clue that reframed the whole search; can a frog’s food chain explain the missing compound?

Person: John W. Daly
Person: Charles Myers
Species: Epipedobates anthonyi
Date: 1974-1992
Topic: epibatidine isolation and reproducibility

- Daly and Myers collected about three thousand frog skins from Ecuador between 1974 and 1979 to pursue an analgesic signal.
- Initial extracts in 1974 showed strong analgesic activity but lacked enough material to confirm a single responsible molecule.
- In 1976, frogs from an original collection site produced no detectable epibatidine despite the species’ continued presence.
- Captive-bred Epipedobates anthonyi did not produce epibatidine, indicating the compound was not synthesized by the frog itself.
- Investigation pointed to the frogs’ wild diet-beetles, ants, mites, and other leaf-litter invertebrates-as the source or precursor of the molecule.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>871falsefullhttps://www.spreaker.com/episode/the-612-pharmacy-receipt-forced-parents-to-choose-a-child-s-life--74911392
The $612 Pharmacy Receipt Forced Parents to Choose a Child's Life

In this episode, we look into a summer in 2015 when parents across the United States faced the same $612 receipt for a two-pack of epinephrine injectors. The episode traces how laws, regulatory delays, and industry strategies widened the gap between manufacturing cost and retail price, and asks who benefited from that system.

Person: Peter Bach
Date: Summer 2015
Drug: Epinephrine auto-injectors
Event: FDA backlog of 4,036 generic applications in July 2016
Fact: Thirty-five largest pharma companies made $11.5 trillion revenue (2000-2018)

- Parents stood at pharmacy counters in 2015 holding identical $612 receipts for two epinephrine injectors and had to choose whether to pay.
- A law passed in 2003 prohibits the U.S. government from negotiating drug prices, removing a potential market constraint.
- The FDA backlog (4,036 pending generics in July 2016, median 47-month wait) slowed generic competition that normally lowers prices.
- Manufacturers set launch prices and raised them with minimal external constraint, according to researchers like Peter Bach.
- Tactics such as patents, evergreening, withholding reference samples, and contractual risk programs created layered barriers to generic entry.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911392Fri, 04 Sep 2026 22:14:52 +0000Creator at ObomediaA $612 pharmacy receipt forces a parent to decide whether to buy epinephrine that could save their child's life - how did drug pricing expose them? The $612 Pharmacy Receipt Forced Parents to Choose a Child's Life In this episode, we look into a...
The $612 Pharmacy Receipt Forced Parents to Choose a Child's Life

In this episode, we look into a summer in 2015 when parents across the United States faced the same $612 receipt for a two-pack of epinephrine injectors. The episode traces how laws, regulatory delays, and industry strategies widened the gap between manufacturing cost and retail price, and asks who benefited from that system.

Person: Peter Bach
Date: Summer 2015
Drug: Epinephrine auto-injectors
Event: FDA backlog of 4,036 generic applications in July 2016
Fact: Thirty-five largest pharma companies made $11.5 trillion revenue (2000-2018)

- Parents stood at pharmacy counters in 2015 holding identical $612 receipts for two epinephrine injectors and had to choose whether to pay.
- A law passed in 2003 prohibits the U.S. government from negotiating drug prices, removing a potential market constraint.
- The FDA backlog (4,036 pending generics in July 2016, median 47-month wait) slowed generic competition that normally lowers prices.
- Manufacturers set launch prices and raised them with minimal external constraint, according to researchers like Peter Bach.
- Tactics such as patents, evergreening, withholding reference samples, and contractual risk programs created layered barriers to generic entry.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1071falsefullhttps://www.spreaker.com/episode/the-delivery-ward-that-refused-labor-unless-women-took-sterilization--74911391
The Delivery Ward That Refused Labor Unless Women Took Sterilization

In this episode, we present a documented account of hospital practice and public policy that shaped sterilization on Puerto Rico from the early 20th century through the 1970s. We trace how census data, colonial governance, and medical routines intersected to make sterilization a routine condition of care - and ask how that policy was implemented at the bedside.

Person: Harriet Presser
Date: 1949; 1955; 1965; 1977
Location: Puerto Rico; Presbyterian Hospital (delivery ward)
Topic: sterilization rates and hospital admission policies
Event: denial of delivery ward admission unless women consented to sterilization

- Colonial census data framed high birth rates as the cause of poverty and set fertility reduction as policy.
- In 1937 Puerto Rico created a Eugenics Board with authority to order sterilizations and to legitimize population-control infrastructure.
- By 1949 surveys reported 21% of women of childbearing age sterilized; by 1965 that rate had more than doubled in some measures.
- Presbyterian Hospital enforced an unofficial rule denying laboring women with three or more living children admission unless they agreed to sterilization.
- Sociological analysis shows the average age at sterilization was 26, with nearly half having three to four children when sterilized.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/74911391Fri, 04 Sep 2026 22:14:48 +0000Creator at ObomediaA Puerto Rican delivery ward refused admission unless women accepted sterilization - how did hospital policy normalize coercive sterilization? The Delivery Ward That Refused Labor Unless Women Took Sterilization In this episode, we present a...
The Delivery Ward That Refused Labor Unless Women Took Sterilization

In this episode, we present a documented account of hospital practice and public policy that shaped sterilization on Puerto Rico from the early 20th century through the 1970s. We trace how census data, colonial governance, and medical routines intersected to make sterilization a routine condition of care - and ask how that policy was implemented at the bedside.

Person: Harriet Presser
Date: 1949; 1955; 1965; 1977
Location: Puerto Rico; Presbyterian Hospital (delivery ward)
Topic: sterilization rates and hospital admission policies
Event: denial of delivery ward admission unless women consented to sterilization

- Colonial census data framed high birth rates as the cause of poverty and set fertility reduction as policy.
- In 1937 Puerto Rico created a Eugenics Board with authority to order sterilizations and to legitimize population-control infrastructure.
- By 1949 surveys reported 21% of women of childbearing age sterilized; by 1965 that rate had more than doubled in some measures.
- Presbyterian Hospital enforced an unofficial rule denying laboring women with three or more living children admission unless they agreed to sterilization.
- Sociological analysis shows the average age at sterilization was 26, with nearly half having three to four children when sterilized.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>880falsefullhttps://www.spreaker.com/episode/they-cut-her-without-consent-how-a-banned-doctor-kept-operating--73098370
Trust is shattered: a surgeon banned from obstetrics since 1997 continued to perform gynecological and obstetric work, and one patient woke up without her clitoris after being told-not asked-what would be done. How did a doctor with 35 formal complaints, multiple hospital limits, and a 2004 deregistration keep being rehired and allowed to operate?

In this episode, we lay out the documented timeline and institutional decisions that let Graeme Stephen Reeves move between hospitals and keep treating patients, culminating in the case of Carolyn DeWaegeneire and the wider 185 incident complaints reported later; who read the warnings and chose to do nothing?

Person: Graeme Stephen Reeves
Date of birth: 1949
Period of complaints: 1986-2000 (35 formal complaints over 15 years)
Event: Deregistration for gross misconduct in 2004
Case: Carolyn DeWaegeneire - clitoral removal without consent

- 35 formal complaints were lodged against Reeves over a 15-year period.
- Ten babies and seven women are recorded deaths linked in his record, with most babies classified as stillborn.
- A 1997 Professional Standards Committee decision limited his obstetrics practice rather than removing it.
- In April 2002 the Greater Southern Area Health Service hired Reeves despite a reference check revealing the 1997 obstetrics restriction.
- After Carolyn DeWaegeneire's public story on 17 February 2008, the Medical Errors Action Group reported 185 incident complaints connected to Reeves.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098370Fri, 04 Sep 2026 13:00:02 +0000Creator at ObomediaThey Cut Her Without Consent: How a Banned Doctor Kept Operating Trust is shattered: a surgeon banned from obstetrics since 1997 continued to perform gynecological and obstetric work, and one patient woke up without her clitoris after being...
Trust is shattered: a surgeon banned from obstetrics since 1997 continued to perform gynecological and obstetric work, and one patient woke up without her clitoris after being told-not asked-what would be done. How did a doctor with 35 formal complaints, multiple hospital limits, and a 2004 deregistration keep being rehired and allowed to operate?

In this episode, we lay out the documented timeline and institutional decisions that let Graeme Stephen Reeves move between hospitals and keep treating patients, culminating in the case of Carolyn DeWaegeneire and the wider 185 incident complaints reported later; who read the warnings and chose to do nothing?

Person: Graeme Stephen Reeves
Date of birth: 1949
Period of complaints: 1986-2000 (35 formal complaints over 15 years)
Event: Deregistration for gross misconduct in 2004
Case: Carolyn DeWaegeneire - clitoral removal without consent

- 35 formal complaints were lodged against Reeves over a 15-year period.
- Ten babies and seven women are recorded deaths linked in his record, with most babies classified as stillborn.
- A 1997 Professional Standards Committee decision limited his obstetrics practice rather than removing it.
- In April 2002 the Greater Southern Area Health Service hired Reeves despite a reference check revealing the 1997 obstetrics restriction.
- After Carolyn DeWaegeneire's public story on 17 February 2008, the Medical Errors Action Group reported 185 incident complaints connected to Reeves.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1086falsefullhttps://www.spreaker.com/episode/he-used-his-own-sperm-94-children-no-prison-a-law-too-late--73098369
Curiosity turned into a discovery that unraveled 94 families: an at-home DNA test in 2014 revealed eight unknown half-siblings and a trail pointing to their fertility doctor, who had used his own sperm for decades. How did a trusted reproductive endocrinologist secretly become the genetic father of so many, and why did the law at the time leave victims with no criminal remedy?

In this episode, we follow how Jacoba Ballard's DNA results connected strangers into a pattern, how she took her findings to the Indiana Attorney General and to local media, and how the absence of a fertility-fraud statute shaped the case and its consequences. What happens when medical betrayal outpaces legislation?

Person: Jacoba Ballard
Person: Donald Lee Cline
Period: 1974-1987
Event: At-home DNA test revealing eight half-siblings (2014)
Location: Indianapolis, Indiana

- 2014: Jacoba Ballard’s at-home DNA test returned eight previously unknown half-siblings.
- 1974-1987: Years during which Dr. Donald Cline inseminated patients with his own sperm.
- 2009: Donald Cline retired after roughly three decades of practice.
- 2015: Indiana Attorney General Tim DeLaney’s office declined to prosecute due to lack of relevant law.
- 94: The number of families ultimately affected in a single American city.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098369Thu, 03 Sep 2026 13:00:02 +0000Creator at ObomediaHe Used His Own Sperm: 94 Children, No Prison, A Law Too Late Curiosity turned into a discovery that unraveled 94 families: an at-home DNA test in 2014 revealed eight unknown half-siblings and a trail pointing to their fertility doctor, who had...
Curiosity turned into a discovery that unraveled 94 families: an at-home DNA test in 2014 revealed eight unknown half-siblings and a trail pointing to their fertility doctor, who had used his own sperm for decades. How did a trusted reproductive endocrinologist secretly become the genetic father of so many, and why did the law at the time leave victims with no criminal remedy?

In this episode, we follow how Jacoba Ballard's DNA results connected strangers into a pattern, how she took her findings to the Indiana Attorney General and to local media, and how the absence of a fertility-fraud statute shaped the case and its consequences. What happens when medical betrayal outpaces legislation?

Person: Jacoba Ballard
Person: Donald Lee Cline
Period: 1974-1987
Event: At-home DNA test revealing eight half-siblings (2014)
Location: Indianapolis, Indiana

- 2014: Jacoba Ballard’s at-home DNA test returned eight previously unknown half-siblings.
- 1974-1987: Years during which Dr. Donald Cline inseminated patients with his own sperm.
- 2009: Donald Cline retired after roughly three decades of practice.
- 2015: Indiana Attorney General Tim DeLaney’s office declined to prosecute due to lack of relevant law.
- 94: The number of families ultimately affected in a single American city.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1067falsefullhttps://www.spreaker.com/episode/the-doctor-who-fathered-94-children-betrayal-at-2020-w-86th--73098368
A calm, measured voicemail revealed a doctor admitting he used his own sperm to inseminate patients - and asking one newly discovered daughter to help him manage the fallout. Ninety-four people, as of May 2022, have tested positive as biological children of that same physician; how did decades of secrecy persist and what does that mean for the families involved?

In this episode, we map the chain of events from clinic consultations on West Eighty-Sixth Street to at-home DNA tests that unraveled the story, following the woman who first connected the matches and the legal response that failed to criminalize the betrayal - what happens when science outpaces the law?

Person: Donald Lee Cline
Date of birth: December 10, 1938
Location: West Eighty-Sixth Street, Indianapolis
Period: 1974-1987 (fraudulent inseminations)
Status: 94 confirmed biological children as of May 2022

- Cline opened his clinic on West Eighty-Sixth Street in 1979 and practiced for approximately thirty years, retiring in 2009.
- Between 1974 and 1987, Cline used his own sperm to inseminate patients without their knowledge or consent.
- Cline had documented rheumatoid arthritis, a heritable autoimmune disorder that would have disqualified him as a donor under his clinic’s standards.
- In 2014 Jacoba Ballard took an at-home DNA test that connected her to eight half-siblings and began tracing leads to Cline and the Indianapolis clinic.
- In 2015 the Indiana Attorney General’s office declined to prosecute because there was no statute criminalizing a physician’s use of his own sperm without patient consent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098368Wed, 02 Sep 2026 13:00:02 +0000Creator at ObomediaThe Doctor Who Fathered 94 Children: Betrayal at 2020 W. 86th A calm, measured voicemail revealed a doctor admitting he used his own sperm to inseminate patients - and asking one newly discovered daughter to help him manage the fallout. Ninety-four...
A calm, measured voicemail revealed a doctor admitting he used his own sperm to inseminate patients - and asking one newly discovered daughter to help him manage the fallout. Ninety-four people, as of May 2022, have tested positive as biological children of that same physician; how did decades of secrecy persist and what does that mean for the families involved?

In this episode, we map the chain of events from clinic consultations on West Eighty-Sixth Street to at-home DNA tests that unraveled the story, following the woman who first connected the matches and the legal response that failed to criminalize the betrayal - what happens when science outpaces the law?

Person: Donald Lee Cline
Date of birth: December 10, 1938
Location: West Eighty-Sixth Street, Indianapolis
Period: 1974-1987 (fraudulent inseminations)
Status: 94 confirmed biological children as of May 2022

- Cline opened his clinic on West Eighty-Sixth Street in 1979 and practiced for approximately thirty years, retiring in 2009.
- Between 1974 and 1987, Cline used his own sperm to inseminate patients without their knowledge or consent.
- Cline had documented rheumatoid arthritis, a heritable autoimmune disorder that would have disqualified him as a donor under his clinic’s standards.
- In 2014 Jacoba Ballard took an at-home DNA test that connected her to eight half-siblings and began tracing leads to Cline and the Indianapolis clinic.
- In 2015 the Indiana Attorney General’s office declined to prosecute because there was no statute criminalizing a physician’s use of his own sperm without patient consent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1024falsefullhttps://www.spreaker.com/episode/he-used-his-own-sperm-the-94-children-of-dr-cline--73098367
A single phone call revealed a secret that would reshape dozens of families: a fertility doctor in Indianapolis fathered 94 children using his own sperm, often telling patients the donor was anonymous. How did one clinic, one address and one physician produce nearly a century of hidden biological ties?

In this episode, we trace the timeline from the clinic’s opening through the DNA confirmations, recount the voicemail Dr. Cline left the woman who identified him, and follow how at-home testing and genealogical mapping raised the central question: how did so many lives become connected without consent?

Person: Donald Lee Cline
Location: 2020 West 86th Street, Indianapolis
Period: approximately 1974-1987
Date: May 11, 2022 (DNA confirmed count)
Event: voicemail in which Cline said he had "donated his own sample nine or ten times"

- The clinic at 2020 West 86th Street opened in 1979 and operated for thirty years.
- Donald Lee Cline was born December 10, 1938, and earned degrees from Indiana University.
- Jacoba Ballard ordered an at‑home DNA test in 2014 and initially found eight half-siblings.
- The Indiana Attorney General’s office reported a paternity probability of 99.99997% for one tested child.
- By May 11, 2022, DNA confirmations established 94 children fathered by Cline.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098367Tue, 01 Sep 2026 13:00:02 +0000Creator at ObomediaHe Used His Own Sperm: The 94 Children of Dr. Cline A single phone call revealed a secret that would reshape dozens of families: a fertility doctor in Indianapolis fathered 94 children using his own sperm, often telling patients the donor was...
A single phone call revealed a secret that would reshape dozens of families: a fertility doctor in Indianapolis fathered 94 children using his own sperm, often telling patients the donor was anonymous. How did one clinic, one address and one physician produce nearly a century of hidden biological ties?

In this episode, we trace the timeline from the clinic’s opening through the DNA confirmations, recount the voicemail Dr. Cline left the woman who identified him, and follow how at-home testing and genealogical mapping raised the central question: how did so many lives become connected without consent?

Person: Donald Lee Cline
Location: 2020 West 86th Street, Indianapolis
Period: approximately 1974-1987
Date: May 11, 2022 (DNA confirmed count)
Event: voicemail in which Cline said he had "donated his own sample nine or ten times"

- The clinic at 2020 West 86th Street opened in 1979 and operated for thirty years.
- Donald Lee Cline was born December 10, 1938, and earned degrees from Indiana University.
- Jacoba Ballard ordered an at‑home DNA test in 2014 and initially found eight half-siblings.
- The Indiana Attorney General’s office reported a paternity probability of 99.99997% for one tested child.
- By May 11, 2022, DNA confirmations established 94 children fathered by Cline.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>951falsefullhttps://www.spreaker.com/episode/he-fathered-nearly-100-children-the-doctor-who-lied-under-oath--73098366
A respected fertility doctor in Indianapolis secretly fathered nearly 100 children over thirteen years, and when confronted under oath he denied it - yet DNA later returned a 99.999997% probability of paternity. How did a physician trusted by desperate families turn the most intimate moment of care into a secret that would bind strangers into siblings, and what happened when the law had no word for his actions?

In this episode, we follow the thread from a phone call that revealed one man's true fatherhood to decades of clinic records, DNA tests, and an official investigation. We cover the timeline, the evidence, the denials under oath, and the legal limbo that followed as the question of accountability grew louder.

Person: Donald Lee Cline
Date: born December 10, 1938
Location: clinic at 2020 West 86th Street, Indianapolis
Period: donor inseminations between 1974 and 1987
Official: Indiana Attorney General investigator Tim DeLaney

- Cline opened his clinic at 2020 West 86th Street in Indianapolis in 1979.
- The inseminations in question took place from approximately 1974 through 1987, a span of 13 years.
- Jacoba Ballard’s home DNA kit in 2014 returned matches to eight unknown half-siblings.
- The Attorney General’s paternity test returned a 99.999997% probability that Cline was the biological father.
- Cline told investigators in 2015: "I can emphatically say that at no time did I ever use my own sample for insemination, nor was I a donor."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098366Mon, 31 Aug 2026 13:00:03 +0000Creator at ObomediaHe Fathered Nearly 100 Children - The Doctor Who Lied Under Oath A respected fertility doctor in Indianapolis secretly fathered nearly 100 children over thirteen years, and when confronted under oath he denied it - yet DNA later returned a...
A respected fertility doctor in Indianapolis secretly fathered nearly 100 children over thirteen years, and when confronted under oath he denied it - yet DNA later returned a 99.999997% probability of paternity. How did a physician trusted by desperate families turn the most intimate moment of care into a secret that would bind strangers into siblings, and what happened when the law had no word for his actions?

In this episode, we follow the thread from a phone call that revealed one man's true fatherhood to decades of clinic records, DNA tests, and an official investigation. We cover the timeline, the evidence, the denials under oath, and the legal limbo that followed as the question of accountability grew louder.

Person: Donald Lee Cline
Date: born December 10, 1938
Location: clinic at 2020 West 86th Street, Indianapolis
Period: donor inseminations between 1974 and 1987
Official: Indiana Attorney General investigator Tim DeLaney

- Cline opened his clinic at 2020 West 86th Street in Indianapolis in 1979.
- The inseminations in question took place from approximately 1974 through 1987, a span of 13 years.
- Jacoba Ballard’s home DNA kit in 2014 returned matches to eight unknown half-siblings.
- The Attorney General’s paternity test returned a 99.999997% probability that Cline was the biological father.
- Cline told investigators in 2015: "I can emphatically say that at no time did I ever use my own sample for insemination, nor was I a donor."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1248falsefullhttps://www.spreaker.com/episode/when-a-healing-drug-became-her-newest-harm-the-first-patient--73098363
She was a world-record athlete turned first patient, filmed during every session as the drug meant to heal her trauma coincided with repeated physical contact by a therapist on camera. The same footage later helped shape a federal rejection of the treatment - but how did taped sessions become central evidence in that vote?

In this episode, we tell the story of Meaghan Buisson and the clinical trial she joined, describing who she was, where the trial took place, and the recorded moments that later reverberated through regulators’ deliberations. What do the trial recordings reveal about responsibility when a therapy becomes a source of further harm?

Person: Meaghan Buisson
Date (enrollment): December 2014
Location: Cortes Island, British Columbia
Organization: MAPS (Multidisciplinary Association for Psychedelic Studies)
Therapists: Richard Yensen and Donna Dryer

- Buisson was enrolled in the trial in December 2014 and began sessions in summer 2015.
- She lived on Cortes Island for 23 months while participating in the trial.
- The original plan was to treat 12 patients; ultimately 6 were treated.
- Yensen’s psychology license had lapsed in 2009, five years before the trial began.
- All therapy sessions were continuously video-recorded as part of the trial protocol.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098363Sun, 30 Aug 2026 13:00:02 +0000Creator at ObomediaWhen a Healing Drug Became Her Newest Harm: The First Patient She was a world-record athlete turned first patient, filmed during every session as the drug meant to heal her trauma coincided with repeated physical contact by a therapist on camera....
She was a world-record athlete turned first patient, filmed during every session as the drug meant to heal her trauma coincided with repeated physical contact by a therapist on camera. The same footage later helped shape a federal rejection of the treatment - but how did taped sessions become central evidence in that vote?

In this episode, we tell the story of Meaghan Buisson and the clinical trial she joined, describing who she was, where the trial took place, and the recorded moments that later reverberated through regulators’ deliberations. What do the trial recordings reveal about responsibility when a therapy becomes a source of further harm?

Person: Meaghan Buisson
Date (enrollment): December 2014
Location: Cortes Island, British Columbia
Organization: MAPS (Multidisciplinary Association for Psychedelic Studies)
Therapists: Richard Yensen and Donna Dryer

- Buisson was enrolled in the trial in December 2014 and began sessions in summer 2015.
- She lived on Cortes Island for 23 months while participating in the trial.
- The original plan was to treat 12 patients; ultimately 6 were treated.
- Yensen’s psychology license had lapsed in 2009, five years before the trial began.
- All therapy sessions were continuously video-recorded as part of the trial protocol.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1155falsefullhttps://www.spreaker.com/episode/the-first-patient-how-mdma-therapy-betrayed-an-elite-athlete--73098362
A world-record holder and forty-seven-time national champion entered an MDMA therapy trial in December 2014 as Patient Number One - and the video camera in the room recorded repeated physical contact and a sexual relationship that MAPS later described as sexual abuse. How did a clinical trial meant to treat treatment-resistant PTSD become a setting where professional boundaries dissolved and a patient was harmed?

In this episode, we tell the story of Meaghan Buisson, what happened during her participation in an MDMA-assisted psychotherapy trial, and the decisions by therapists and an organization that changed medicine in unexpected ways. What does Buisson’s experience reveal about ethics, oversight, and the risks when experimental therapy blurs into personal life?

Person: Meaghan Buisson
Event: Enrollment as Patient Number One in MDMA-assisted psychotherapy trial
Organization: MAPS (Multidisciplinary Association for Psychedelic Studies)
Therapists: Richard Yensen (license lapsed 2009) and Donna Dryer (licensed)
Location: Cortes Island, British Columbia (population ~1,000; no hospital)

- 2014-12: Buisson enrolled in the clinical trial and was designated Patient Number One.
- 2006: Buisson set a world record in the inline marathon that still stands.
- 47: number of national championships Buisson won in her skating career.
- 2015-05 to 2017-05: Buisson lived on Cortes Island for nearly two years while undergoing treatment there.
- 2009: year Richard Yensen’s professional license lapsed, five years before Buisson’s treatment began.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098362Sat, 29 Aug 2026 13:00:02 +0000Creator at ObomediaThe First Patient: How MDMA Therapy Betrayed an Elite Athlete A world-record holder and forty-seven-time national champion entered an MDMA therapy trial in December 2014 as Patient Number One - and the video camera in the room recorded repeated...
A world-record holder and forty-seven-time national champion entered an MDMA therapy trial in December 2014 as Patient Number One - and the video camera in the room recorded repeated physical contact and a sexual relationship that MAPS later described as sexual abuse. How did a clinical trial meant to treat treatment-resistant PTSD become a setting where professional boundaries dissolved and a patient was harmed?

In this episode, we tell the story of Meaghan Buisson, what happened during her participation in an MDMA-assisted psychotherapy trial, and the decisions by therapists and an organization that changed medicine in unexpected ways. What does Buisson’s experience reveal about ethics, oversight, and the risks when experimental therapy blurs into personal life?

Person: Meaghan Buisson
Event: Enrollment as Patient Number One in MDMA-assisted psychotherapy trial
Organization: MAPS (Multidisciplinary Association for Psychedelic Studies)
Therapists: Richard Yensen (license lapsed 2009) and Donna Dryer (licensed)
Location: Cortes Island, British Columbia (population ~1,000; no hospital)

- 2014-12: Buisson enrolled in the clinical trial and was designated Patient Number One.
- 2006: Buisson set a world record in the inline marathon that still stands.
- 47: number of national championships Buisson won in her skating career.
- 2015-05 to 2017-05: Buisson lived on Cortes Island for nearly two years while undergoing treatment there.
- 2009: year Richard Yensen’s professional license lapsed, five years before Buisson’s treatment began.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1142falsefullhttps://www.spreaker.com/episode/when-the-first-patient-became-the-evidence-mdma-trial-that-broke-trust--73098361
A woman who set a world record and won 47 national championships became Patient Number One in a Phase Two MDMA-assisted psychotherapy trial for treatment-resistant PTSD; the study was planned for 12 participants but stopped at six with no public explanation - who was watching as the rules bent around her? What did the video record of her treatment reveal about the gap between safeguards and accountability?

In this episode, we follow Meaghan Buisson from elite inline speed skating through retirement and trauma into a clinical trial overseen by MAPS and an affiliate later known as Lykos Therapeutics, tracing the decisions, personnel, and missing explanations that shaped her experience; could the trial’s staffing and reduced cohort size explain the failures in protection?

Person: Meaghan Buisson
Event: Phase Two MDMA-assisted psychotherapy trial
Year Enrolled: December 2014
Planned Cohort Size: 12
Actual Cohort Size: 6

- 47 national championships won by Meaghan Buisson during her skating career.
- 16 national records and 11 international medals attributed to Buisson.
- Buisson set a world record in the solo marathon in 2006 that still stands.
- The trial Buisson entered was a Phase Two MDMA-assisted psychotherapy study overseen by MAPS and an affiliate later known as Lykos Therapeutics.
- The therapeutic team at the site consisted of Donna Dryer (licensed psychiatrist) and Richard Yensen (whose psychologist license had lapsed in 2009).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098361Fri, 28 Aug 2026 13:00:03 +0000Creator at ObomediaWhen the First Patient Became the Evidence: MDMA Trial That Broke Trust A woman who set a world record and won 47 national championships became Patient Number One in a Phase Two MDMA-assisted psychotherapy trial for treatment-resistant PTSD; the...
A woman who set a world record and won 47 national championships became Patient Number One in a Phase Two MDMA-assisted psychotherapy trial for treatment-resistant PTSD; the study was planned for 12 participants but stopped at six with no public explanation - who was watching as the rules bent around her? What did the video record of her treatment reveal about the gap between safeguards and accountability?

In this episode, we follow Meaghan Buisson from elite inline speed skating through retirement and trauma into a clinical trial overseen by MAPS and an affiliate later known as Lykos Therapeutics, tracing the decisions, personnel, and missing explanations that shaped her experience; could the trial’s staffing and reduced cohort size explain the failures in protection?

Person: Meaghan Buisson
Event: Phase Two MDMA-assisted psychotherapy trial
Year Enrolled: December 2014
Planned Cohort Size: 12
Actual Cohort Size: 6

- 47 national championships won by Meaghan Buisson during her skating career.
- 16 national records and 11 international medals attributed to Buisson.
- Buisson set a world record in the solo marathon in 2006 that still stands.
- The trial Buisson entered was a Phase Two MDMA-assisted psychotherapy study overseen by MAPS and an affiliate later known as Lykos Therapeutics.
- The therapeutic team at the site consisted of Donna Dryer (licensed psychiatrist) and Richard Yensen (whose psychologist license had lapsed in 2009).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>999falsefullhttps://www.spreaker.com/episode/he-chose-the-scalpel-the-amputation-that-killed-a-man--73098360
A retired engineer flew from New York to Tijuana for a voluntary amputation and died the next day from a catastrophic bacterial infection while no licensed clinician was present; the surgeon had been unlicensed for over twenty years and investigators later found hundreds of tubes of super glue used instead of sutures. How did a man barred from practice for decades continue to operate across borders, and why would patients still choose him?

In this episode, we tell the story of the patient, the unlicensed surgeon, and the medical and ethical failures that intersected in 1998, laying out the conditions that brought them together and the consequences that followed. What drove patients to seek out an outlaw practitioner, and what did investigators find in his apartment that spoke to decades of improvised surgery?

Person: Philip Bondy
Date: May 10, 1998
Person: John Ronald Brown
Event: voluntary amputation and subsequent fatal infection
Item found: hundreds of tubes of super glue

- Philip Bondy was seventy-nine years old when his left leg was amputated the day before he was found dead.
- John Ronald Brown was born on July 4, 1922 and graduated from the University of Utah School of Medicine in 1947.
- Brown's medical license was revoked in 1977 in California and later in Hawaii, Alaska, and Saint Lucia.
- Investigators found blood-soaked towels, anesthetizing drugs, surgical instruments, videotapes of operations, and hundreds of tubes of super glue in Brown's apartment.
- Brown claimed to have performed approximately six hundred procedures over his career and was imprisoned for nineteen months in 1990 for operating without a license.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098360Thu, 27 Aug 2026 13:00:02 +0000Creator at ObomediaHe Chose the Scalpel: The Amputation That Killed a Man A retired engineer flew from New York to Tijuana for a voluntary amputation and died the next day from a catastrophic bacterial infection while no licensed clinician was present; the surgeon...
A retired engineer flew from New York to Tijuana for a voluntary amputation and died the next day from a catastrophic bacterial infection while no licensed clinician was present; the surgeon had been unlicensed for over twenty years and investigators later found hundreds of tubes of super glue used instead of sutures. How did a man barred from practice for decades continue to operate across borders, and why would patients still choose him?

In this episode, we tell the story of the patient, the unlicensed surgeon, and the medical and ethical failures that intersected in 1998, laying out the conditions that brought them together and the consequences that followed. What drove patients to seek out an outlaw practitioner, and what did investigators find in his apartment that spoke to decades of improvised surgery?

Person: Philip Bondy
Date: May 10, 1998
Person: John Ronald Brown
Event: voluntary amputation and subsequent fatal infection
Item found: hundreds of tubes of super glue

- Philip Bondy was seventy-nine years old when his left leg was amputated the day before he was found dead.
- John Ronald Brown was born on July 4, 1922 and graduated from the University of Utah School of Medicine in 1947.
- Brown's medical license was revoked in 1977 in California and later in Hawaii, Alaska, and Saint Lucia.
- Investigators found blood-soaked towels, anesthetizing drugs, surgical instruments, videotapes of operations, and hundreds of tubes of super glue in Brown's apartment.
- Brown claimed to have performed approximately six hundred procedures over his career and was imprisoned for nineteen months in 1990 for operating without a license.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1008falsefullhttps://www.spreaker.com/episode/when-a-doctor-became-butcher-the-hotel-room-amputation-murder--73098359
The idea that a licensed medical degree could coexist with a butcher’s tools is chilling: investigators found hundreds of tubes of hardware-store super glue, surgical instruments, blood-soaked towels and anesthetizing drugs in a San Ysidro apartment after Philip Bondy’s death. Why would a man trained in anatomy seal a wound with hardware-store adhesive, and who bears responsibility when medical gatekeeping leaves desperate patients with only dangerous alternatives?

In this episode, we tell the sequence of events that brought a retired New York satellite engineer to a hotel room in National City, California on May 9, 1998, and how the pursuit of an elective amputation led to a fatal outcome; what happened during that night, and how a controversial surgeon’s history factored into the tragedy?

Person: Philip Bondy
Date: May 9, 1998
Location: National City, California
Age: 79
Condition: Body integrity identity disorder (BIID)

- Investigators recovered hundreds of tubes of hardware-store super glue alongside surgical instruments and anesthetizing drugs.
- Philip Bondy was 79 years old and a retired satellite engineer from New York at the time of death.
- Bondy traveled to Tijuana, Mexico and to National City on May 9, 1998 to undergo an amputation procedure.
- The surgeon, John Ronald Brown, earned a medical degree in 1947 but had his California medical license revoked in 1977 for gross negligence and other charges.
- Brown had been convicted in 1990 of practicing medicine without a license and served 19 months in prison before resuming practice.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098359Wed, 26 Aug 2026 13:00:02 +0000Creator at ObomediaWhen a Doctor Became Butcher: The Hotel Room Amputation Murder The idea that a licensed medical degree could coexist with a butcher’s tools is chilling: investigators found hundreds of tubes of hardware-store super glue, surgical instruments,...
The idea that a licensed medical degree could coexist with a butcher’s tools is chilling: investigators found hundreds of tubes of hardware-store super glue, surgical instruments, blood-soaked towels and anesthetizing drugs in a San Ysidro apartment after Philip Bondy’s death. Why would a man trained in anatomy seal a wound with hardware-store adhesive, and who bears responsibility when medical gatekeeping leaves desperate patients with only dangerous alternatives?

In this episode, we tell the sequence of events that brought a retired New York satellite engineer to a hotel room in National City, California on May 9, 1998, and how the pursuit of an elective amputation led to a fatal outcome; what happened during that night, and how a controversial surgeon’s history factored into the tragedy?

Person: Philip Bondy
Date: May 9, 1998
Location: National City, California
Age: 79
Condition: Body integrity identity disorder (BIID)

- Investigators recovered hundreds of tubes of hardware-store super glue alongside surgical instruments and anesthetizing drugs.
- Philip Bondy was 79 years old and a retired satellite engineer from New York at the time of death.
- Bondy traveled to Tijuana, Mexico and to National City on May 9, 1998 to undergo an amputation procedure.
- The surgeon, John Ronald Brown, earned a medical degree in 1947 but had his California medical license revoked in 1977 for gross negligence and other charges.
- Brown had been convicted in 1990 of practicing medicine without a license and served 19 months in prison before resuming practice.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1210falsefullhttps://www.spreaker.com/episode/when-the-pediatrician-became-predator-the-baybees-betrayal--73098356
Trust betrayed in plain sight: a pediatric clinic with carnival rides, a Buzz Lightyear guard, and bumblebee cars hid more than a cheerful facade - investigators seized over 13 hours of videotaped assaults and identified more than 100 children in a single indictment. How did warnings over 15 years fail to stop a man who saw an estimated 7,000 patients?

In this episode, we lay out the facts of the BayBees case, the timeline of complaints, and the evidence uncovered after the December 2009 search that changed the narrative - what do the records reveal about who knew and when?

Person: Earl Brian Bradley
Date: October 10, 2011 (building demolition)
Event: Arrest and search warrant returns in December 2009
Location: Lewes, Delaware
Period: 1995-2009

- Investigators seized more than 13 hours of videotaped recordings from an outbuilding on Bradley’s property.
- The single indictment identified more than 100 children as alleged victims.
- The youngest alleged victim was three months old.
- Bradley was estimated to have seen approximately 7,000 pediatric patients over his career.
- Four separate warnings were reported over a 15-year span before decisive action.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098356Tue, 25 Aug 2026 13:00:02 +0000Creator at ObomediaWhen the Pediatrician Became Predator: The BayBees Betrayal Trust betrayed in plain sight: a pediatric clinic with carnival rides, a Buzz Lightyear guard, and bumblebee cars hid more than a cheerful facade - investigators seized over 13 hours of...
Trust betrayed in plain sight: a pediatric clinic with carnival rides, a Buzz Lightyear guard, and bumblebee cars hid more than a cheerful facade - investigators seized over 13 hours of videotaped assaults and identified more than 100 children in a single indictment. How did warnings over 15 years fail to stop a man who saw an estimated 7,000 patients?

In this episode, we lay out the facts of the BayBees case, the timeline of complaints, and the evidence uncovered after the December 2009 search that changed the narrative - what do the records reveal about who knew and when?

Person: Earl Brian Bradley
Date: October 10, 2011 (building demolition)
Event: Arrest and search warrant returns in December 2009
Location: Lewes, Delaware
Period: 1995-2009

- Investigators seized more than 13 hours of videotaped recordings from an outbuilding on Bradley’s property.
- The single indictment identified more than 100 children as alleged victims.
- The youngest alleged victim was three months old.
- Bradley was estimated to have seen approximately 7,000 pediatric patients over his career.
- Four separate warnings were reported over a 15-year span before decisive action.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1202falsefullhttps://www.spreaker.com/episode/the-pediatrician-s-carnival-how-a-doctor-hid-horrors-behind-joy--73098352
The waiting room smelled like popcorn and plastic, a giant Buzz Lightyear statue stood by the desk, and carnival rides lit up to distract children - but inside that cheerful façade thirteen hours of videotape documented unthinkable acts. How did a pediatrician with sealed prior complaints and a carnival office evade scrutiny while seven thousand children passed through his care?

In this episode, we tell the story of Earl Brian Bradley and the BayBees Pediatrics practice in Lewes, Delaware, describing the office, the sealed complaints from Philadelphia, the internal warnings, and the moment investigators recovered evidence - and ask: how long did the system look the other way?

Person: Earl Brian Bradley
Location: Lewes, Delaware
Period: 1983-2009 (medical career highlights and Delaware practice timeline)
Case: Thirteen hours of videotape recovered December 16, 2009
Institution: Temple University School of Medicine (graduated 1983); Thomas Jefferson University Hospital (residency completed 1986)

- 7,000 children estimated to have been patients at Bradley’s Delaware practice
- 13 hours of videotape recovered from his home and office on December 16, 2009
- First documented alert in Delaware filed by his sister, Lynda Barnes, in 2004
- Two complaints investigated and records sealed at Thomas Jefferson University Hospital in 1994 and 1995
- A warrant request in Milford, Delaware, was dropped after the Attorney General’s office found insufficient evidence

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098352Mon, 24 Aug 2026 13:00:02 +0000Creator at ObomediaThe Pediatrician's Carnival: How a Doctor Hid Horrors Behind Joy The waiting room smelled like popcorn and plastic, a giant Buzz Lightyear statue stood by the desk, and carnival rides lit up to distract children - but inside that cheerful façade...
The waiting room smelled like popcorn and plastic, a giant Buzz Lightyear statue stood by the desk, and carnival rides lit up to distract children - but inside that cheerful façade thirteen hours of videotape documented unthinkable acts. How did a pediatrician with sealed prior complaints and a carnival office evade scrutiny while seven thousand children passed through his care?

In this episode, we tell the story of Earl Brian Bradley and the BayBees Pediatrics practice in Lewes, Delaware, describing the office, the sealed complaints from Philadelphia, the internal warnings, and the moment investigators recovered evidence - and ask: how long did the system look the other way?

Person: Earl Brian Bradley
Location: Lewes, Delaware
Period: 1983-2009 (medical career highlights and Delaware practice timeline)
Case: Thirteen hours of videotape recovered December 16, 2009
Institution: Temple University School of Medicine (graduated 1983); Thomas Jefferson University Hospital (residency completed 1986)

- 7,000 children estimated to have been patients at Bradley’s Delaware practice
- 13 hours of videotape recovered from his home and office on December 16, 2009
- First documented alert in Delaware filed by his sister, Lynda Barnes, in 2004
- Two complaints investigated and records sealed at Thomas Jefferson University Hospital in 1994 and 1995
- A warrant request in Milford, Delaware, was dropped after the Attorney General’s office found insufficient evidence

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1112falsefullhttps://www.spreaker.com/episode/the-pediatrician-behind-the-smile-how-silence-built-a-monster--73098349
Trust turned lethal: a pediatrician with an estimated 7,000 patients built a kid-friendly practice with Buzz Lightyear and Disney films, while more than thirteen hours of recorded video later showed assaults on infants and children - why did five separate warnings over fifteen years fail to stop him?

In this episode, we lay out the timeline, the institutional reports, and the chilling contrast between BayBees Pediatrics' family-friendly facade and the evidence found in Bradley's office and home; what allowed complaints from hospitals, colleagues, a sister who was the office manager, and nurses to go unacted on for years?

Person: Earl Brian Bradley
Location: Lewes, Delaware
Period: 1994-approximately 2010s
Education: Temple University School of Medicine (MD, 1983); Pediatrics residency at Thomas Jefferson University Hospital (completed 1986)
Allegations: 471 charges; at least 127 victims; youngest victim 3 months old

- Estimated 7,000 pediatric patients accrued over Bradley's career in Lewes.
- First complaint recorded in 1994 at Thomas Jefferson University Hospital; records were not verified and were sealed.
- Bradley moved to Lewes around 1995-1996 after closing his Philadelphia practice without notifying patients.
- Sister and office manager Lynda Barnes reported inappropriate touching, concerns about his conduct toward his son, and theft of antidepressants in 2004 to the Delaware state medical society.
- Investigators later discovered more than 13 hours of video recordings documenting assaults, including footage deemed by Dr. Eli Newberger a worst-case pediatric abuse example.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098349Sun, 23 Aug 2026 13:00:02 +0000Creator at ObomediaThe Pediatrician Behind the Smile: How Silence Built a Monster Trust turned lethal: a pediatrician with an estimated 7,000 patients built a kid-friendly practice with Buzz Lightyear and Disney films, while more than thirteen hours of recorded video...
Trust turned lethal: a pediatrician with an estimated 7,000 patients built a kid-friendly practice with Buzz Lightyear and Disney films, while more than thirteen hours of recorded video later showed assaults on infants and children - why did five separate warnings over fifteen years fail to stop him?

In this episode, we lay out the timeline, the institutional reports, and the chilling contrast between BayBees Pediatrics' family-friendly facade and the evidence found in Bradley's office and home; what allowed complaints from hospitals, colleagues, a sister who was the office manager, and nurses to go unacted on for years?

Person: Earl Brian Bradley
Location: Lewes, Delaware
Period: 1994-approximately 2010s
Education: Temple University School of Medicine (MD, 1983); Pediatrics residency at Thomas Jefferson University Hospital (completed 1986)
Allegations: 471 charges; at least 127 victims; youngest victim 3 months old

- Estimated 7,000 pediatric patients accrued over Bradley's career in Lewes.
- First complaint recorded in 1994 at Thomas Jefferson University Hospital; records were not verified and were sealed.
- Bradley moved to Lewes around 1995-1996 after closing his Philadelphia practice without notifying patients.
- Sister and office manager Lynda Barnes reported inappropriate touching, concerns about his conduct toward his son, and theft of antidepressants in 2004 to the Delaware state medical society.
- Investigators later discovered more than 13 hours of video recordings documenting assaults, including footage deemed by Dr. Eli Newberger a worst-case pediatric abuse example.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>998falsefullhttps://www.spreaker.com/episode/the-doctor-who-built-a-playground-to-hide-his-crimes--73098346
A pediatrician created a carnival-like office with Disney films and Bumblebee Volkswagens while, unbeknownst to most, he secretly filmed children in diapers for years - the state later seized more than thirteen hours of footage. How did warnings from hospitals, a sister who worked as his office manager, nurses and police all fail to stop him?

In this episode, we tell how that pediatric practice was built, what institutions saw and did not act on, and how investigators finally uncovered an archive of recorded assaults that forced the case into the open. What changed between sealed complaints in Philadelphia and the unsealed search warrants in Delaware?

Person: Earl Brian Brian
Practice: BayBees Pediatrics
Date of search warrants unsealed: December 2009
Recorded footage seized: more than 13 hours
Estimated number of patients seen: 7,000 children

- Brian was born May 10, 1953, and graduated from Temple University School of Medicine in 1983.
- He completed his pediatrics residency at Thomas Jefferson University Hospital in 1986 and practiced in Morrell Park, Philadelphia until 1995.
- In 1994 and 1995 Thomas Jefferson University Hospital investigated complaints that were sealed and ended without formal action.
- In 2004 Brian’s sister, Lynda Barnes, reported parents’ complaints and alleged he had abused his own son and stolen antidepressants from the office.
- In 2009 Delaware state police executed search warrants and removed more than thirteen hours of videotape; the Attorney General later bought a storage locker’s contents for one dollar to ensure their destruction.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098346Sat, 22 Aug 2026 13:00:02 +0000Creator at ObomediaThe Doctor Who Built a Playground to Hide His Crimes A pediatrician created a carnival-like office with Disney films and Bumblebee Volkswagens while, unbeknownst to most, he secretly filmed children in diapers for years - the state later seized...
A pediatrician created a carnival-like office with Disney films and Bumblebee Volkswagens while, unbeknownst to most, he secretly filmed children in diapers for years - the state later seized more than thirteen hours of footage. How did warnings from hospitals, a sister who worked as his office manager, nurses and police all fail to stop him?

In this episode, we tell how that pediatric practice was built, what institutions saw and did not act on, and how investigators finally uncovered an archive of recorded assaults that forced the case into the open. What changed between sealed complaints in Philadelphia and the unsealed search warrants in Delaware?

Person: Earl Brian Brian
Practice: BayBees Pediatrics
Date of search warrants unsealed: December 2009
Recorded footage seized: more than 13 hours
Estimated number of patients seen: 7,000 children

- Brian was born May 10, 1953, and graduated from Temple University School of Medicine in 1983.
- He completed his pediatrics residency at Thomas Jefferson University Hospital in 1986 and practiced in Morrell Park, Philadelphia until 1995.
- In 1994 and 1995 Thomas Jefferson University Hospital investigated complaints that were sealed and ended without formal action.
- In 2004 Brian’s sister, Lynda Barnes, reported parents’ complaints and alleged he had abused his own son and stolen antidepressants from the office.
- In 2009 Delaware state police executed search warrants and removed more than thirteen hours of videotape; the Attorney General later bought a storage locker’s contents for one dollar to ensure their destruction.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1160falsefullhttps://www.spreaker.com/episode/the-pediatrician-who-turned-a-carnival-clinic-into-a-crime-scene--73098344
Trust betrayed: a pediatrician who welcomed roughly 7,000 children into a carnival-themed office is now linked to 127 identified victims and more than 13 hours of recorded abuse-how did so many institutions miss the warning signs for over a decade, and what finally stopped him?

In this episode, we lay out the sequence of events, the warnings from nurses, doctors, police and family members, and the stalled investigations that allowed the practice to continue - culminating in the December 2009 action that finally brought the case into focus. What did investigators uncover that previous inquiries missed?

Person: Earl Brian Bradley
Date of birth: May 10, 1953
Education: Temple University School of Medicine (MD 1983); Pediatrics residency at Thomas Jefferson University Hospital (completed 1986)
Victims identified: 127 children
Recorded evidence recovered: more than 13 hours of footage

- Approximately 7,000 children were seen at Bradley’s practice over his career.
- The youngest victim named in the indictment was three months old.
- In 1994 Thomas Jefferson University Hospital investigated a complaint of sexual misconduct; records were sealed.
- In 2004 Bradley’s sister Lynda Barnes reported parental complaints and allegations including abuse of his son and stolen antidepressants.
- Police in Milford sought an arrest warrant in 2005; the Delaware attorney general’s office found insufficient evidence to prosecute.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098344Fri, 21 Aug 2026 13:00:02 +0000Creator at ObomediaThe Pediatrician Who Turned a Carnival Clinic into a Crime Scene Trust betrayed: a pediatrician who welcomed roughly 7,000 children into a carnival-themed office is now linked to 127 identified victims and more than 13 hours of recorded abuse-how...
Trust betrayed: a pediatrician who welcomed roughly 7,000 children into a carnival-themed office is now linked to 127 identified victims and more than 13 hours of recorded abuse-how did so many institutions miss the warning signs for over a decade, and what finally stopped him?

In this episode, we lay out the sequence of events, the warnings from nurses, doctors, police and family members, and the stalled investigations that allowed the practice to continue - culminating in the December 2009 action that finally brought the case into focus. What did investigators uncover that previous inquiries missed?

Person: Earl Brian Bradley
Date of birth: May 10, 1953
Education: Temple University School of Medicine (MD 1983); Pediatrics residency at Thomas Jefferson University Hospital (completed 1986)
Victims identified: 127 children
Recorded evidence recovered: more than 13 hours of footage

- Approximately 7,000 children were seen at Bradley’s practice over his career.
- The youngest victim named in the indictment was three months old.
- In 1994 Thomas Jefferson University Hospital investigated a complaint of sexual misconduct; records were sealed.
- In 2004 Bradley’s sister Lynda Barnes reported parental complaints and allegations including abuse of his son and stolen antidepressants.
- Police in Milford sought an arrest warrant in 2005; the Delaware attorney general’s office found insufficient evidence to prosecute.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1160falsefullhttps://www.spreaker.com/episode/a-heart-pill-taken-by-9-million-americans-quietly-won-and-erased-two-olympic-medals--73098342
A commonplace cardiac drug quietly ended two Olympic medals in Beijing 2008 by removing the tremor that gives a shooter away - and by 2023 more than 9 million Americans filled prescriptions for that same pill. What exactly does propranolol do in the brain that made it both a lifesaving medicine and a performance-altering substance?

In this episode, we trace the drug’s path from James W. Black’s 1960s invention for angina to its sudden role in sport and performance, and we follow the medical and neuroscientific details that explain why it can steady a hand and alter memory. How far does propranolol’s reach extend once it floods brain tissue at concentrations many times higher than in blood?

Person: James W. Black
Date: 1962 (patent) and 1964 (approved for medical use)
Event: Beijing Olympics drug test stripping two medals
Topic: Propranolol crossing blood-brain barrier at 15-33:1 ratio
Country: United States (9 million prescriptions in 2023)

- Two Olympic shooting medals (silver and bronze) won by Kim Jong-su in Beijing 2008 were stripped after a drug test detected propranolol.
- Propranolol was patented in 1962 and approved for medical use in 1964 after James W. Black’s work on beta-blockers.
- By 2023, Americans filled more than 9,000,000 prescriptions for propranolol in a single year, ranking it 69th among prescribed drugs in the U.S.
- Propranolol crosses into brain tissue at a ratio reported between 15:1 and 33:1 relative to blood concentration, far higher than atenolol’s ~0.2:1.
- A 1987 study found 27% of orchestral and opera musicians reported using beta blockers for performance anxiety, with 10-16% experiencing pathological stage fright.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098342Thu, 20 Aug 2026 13:00:03 +0000Creator at ObomediaA heart pill taken by 9 million Americans quietly won and erased two Olympic medals A commonplace cardiac drug quietly ended two Olympic medals in Beijing 2008 by removing the tremor that gives a shooter away - and by 2023 more than 9 million...
A commonplace cardiac drug quietly ended two Olympic medals in Beijing 2008 by removing the tremor that gives a shooter away - and by 2023 more than 9 million Americans filled prescriptions for that same pill. What exactly does propranolol do in the brain that made it both a lifesaving medicine and a performance-altering substance?

In this episode, we trace the drug’s path from James W. Black’s 1960s invention for angina to its sudden role in sport and performance, and we follow the medical and neuroscientific details that explain why it can steady a hand and alter memory. How far does propranolol’s reach extend once it floods brain tissue at concentrations many times higher than in blood?

Person: James W. Black
Date: 1962 (patent) and 1964 (approved for medical use)
Event: Beijing Olympics drug test stripping two medals
Topic: Propranolol crossing blood-brain barrier at 15-33:1 ratio
Country: United States (9 million prescriptions in 2023)

- Two Olympic shooting medals (silver and bronze) won by Kim Jong-su in Beijing 2008 were stripped after a drug test detected propranolol.
- Propranolol was patented in 1962 and approved for medical use in 1964 after James W. Black’s work on beta-blockers.
- By 2023, Americans filled more than 9,000,000 prescriptions for propranolol in a single year, ranking it 69th among prescribed drugs in the U.S.
- Propranolol crosses into brain tissue at a ratio reported between 15:1 and 33:1 relative to blood concentration, far higher than atenolol’s ~0.2:1.
- A 1987 study found 27% of orchestral and opera musicians reported using beta blockers for performance anxiety, with 10-16% experiencing pathological stage fright.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1117falsefullhttps://www.spreaker.com/episode/a-heart-drug-prescribed-9-million-times-yearly-can-also-erase-traumatic-memories-legally--73098339
A commonplace white tablet taken nine million times a year in the United States quietly crosses the blood-brain barrier at rates up to 33:1, doing more than slow a racing heart - it can blunt the body's broadcast of fear and, in some cases, erase the emotional charge of traumatic memories. How did a drug developed to treat heart disease become a tool for silencing trauma, and what does that mean for memory, identity, and the law?

In this episode, we trace propranolol from its invention at Alderley Park by James W. Black to its spread into concert halls, emergency rooms, and psychiatric experiments, following the surprising shift from cardiac medicine to a drug that alters how fear is expressed and remembered. What happens when a medication removes the bodily cues of fear but leaves the feeling intact - and can that change the past?

Person: James W. Black
Location: Alderley Park, Cheshire
Date (patent): 1962
Date (first marketed): 1965
Prescriptions (US, 2023): over 9,000,000

- Propranolol was patented in 1962 and first marketed in 1965 under the brand name Inderal.
- By 2023 propranolol was dispensed more than nine million times in the United States and ranked 69th most prescribed medication.
- Propranolol crosses the blood-brain barrier with a brain-to-blood ratio between 15:1 and 33:1, compared with atenolol’s ~0.2:1.
- A 1987 survey found 27% of professional symphony and opera musicians were using beta blockers before performances.
- Approved indications include hypertension, angina, atrial fibrillation, migraine prevention, essential tremor, pheochromocytoma, infantile hemangioma, thyrotoxicosis, hyperhidrosis, glaucoma, and acute toxicity from sympathomimetic drugs.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098339Wed, 19 Aug 2026 13:00:04 +0000Creator at ObomediaA heart drug prescribed 9 million times yearly can also erase traumatic memories - legally A commonplace white tablet taken nine million times a year in the United States quietly crosses the blood-brain barrier at rates up to 33:1, doing more than...
A commonplace white tablet taken nine million times a year in the United States quietly crosses the blood-brain barrier at rates up to 33:1, doing more than slow a racing heart - it can blunt the body's broadcast of fear and, in some cases, erase the emotional charge of traumatic memories. How did a drug developed to treat heart disease become a tool for silencing trauma, and what does that mean for memory, identity, and the law?

In this episode, we trace propranolol from its invention at Alderley Park by James W. Black to its spread into concert halls, emergency rooms, and psychiatric experiments, following the surprising shift from cardiac medicine to a drug that alters how fear is expressed and remembered. What happens when a medication removes the bodily cues of fear but leaves the feeling intact - and can that change the past?

Person: James W. Black
Location: Alderley Park, Cheshire
Date (patent): 1962
Date (first marketed): 1965
Prescriptions (US, 2023): over 9,000,000

- Propranolol was patented in 1962 and first marketed in 1965 under the brand name Inderal.
- By 2023 propranolol was dispensed more than nine million times in the United States and ranked 69th most prescribed medication.
- Propranolol crosses the blood-brain barrier with a brain-to-blood ratio between 15:1 and 33:1, compared with atenolol’s ~0.2:1.
- A 1987 survey found 27% of professional symphony and opera musicians were using beta blockers before performances.
- Approved indications include hypertension, angina, atrial fibrillation, migraine prevention, essential tremor, pheochromocytoma, infantile hemangioma, thyrotoxicosis, hyperhidrosis, glaucoma, and acute toxicity from sympathomimetic drugs.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1042falsefullhttps://www.spreaker.com/episode/how-a-failed-testosterone-pill-became-the-first-oral-progestin-and-why-it-mattered--73098337
A single chemical tweak in 1938 turned a failed attempt at oral testosterone into the first orally active progestogen - a pill that let women avoid repeated injections but carried a hidden androgenic legacy. How did a drug designed for men become a global breakthrough for women's reproductive care, and what were the consequences when its testosterone origins showed up in patients and fetuses?

In this episode, we tell the story of the molecule synthesized in a Berlin lab and trace its clinical rise from Proluton C in 1939 to more than twenty brand names worldwide, asking how a pharmacological accident reshaped treatment and risk in the decades that followed.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (synthesis), 1939 (launch in Germany), 1945 (arrival in United States as Pranone)
Location: Berlin laboratory of Schering AG
Topic: ethisterone - first orally active progestogen
Event: documented fetal masculinization in exposed pregnancies

- The chemists synthesized ethisterone in winter 1938 while attempting to create oral testosterone.
- Schering AG launched ethisterone in Germany in 1939 under the name Proluton C.
- Ethisterone arrived in the United States in 1945 as Pranone.
- The compound bound progesterone receptors with roughly 44% of progesterone’s binding affinity.
- Over the following decade ethisterone accumulated more than twenty brand names internationally.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098337Tue, 18 Aug 2026 13:00:03 +0000Creator at ObomediaHow a Failed Testosterone Pill Became the First Oral Progestin-and Why It Mattered A single chemical tweak in 1938 turned a failed attempt at oral testosterone into the first orally active progestogen - a pill that let women avoid repeated...
A single chemical tweak in 1938 turned a failed attempt at oral testosterone into the first orally active progestogen - a pill that let women avoid repeated injections but carried a hidden androgenic legacy. How did a drug designed for men become a global breakthrough for women's reproductive care, and what were the consequences when its testosterone origins showed up in patients and fetuses?

In this episode, we tell the story of the molecule synthesized in a Berlin lab and trace its clinical rise from Proluton C in 1939 to more than twenty brand names worldwide, asking how a pharmacological accident reshaped treatment and risk in the decades that followed.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (synthesis), 1939 (launch in Germany), 1945 (arrival in United States as Pranone)
Location: Berlin laboratory of Schering AG
Topic: ethisterone - first orally active progestogen
Event: documented fetal masculinization in exposed pregnancies

- The chemists synthesized ethisterone in winter 1938 while attempting to create oral testosterone.
- Schering AG launched ethisterone in Germany in 1939 under the name Proluton C.
- Ethisterone arrived in the United States in 1945 as Pranone.
- The compound bound progesterone receptors with roughly 44% of progesterone’s binding affinity.
- Over the following decade ethisterone accumulated more than twenty brand names internationally.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1060falsefullhttps://www.spreaker.com/episode/the-accidental-pill-how-1938-s-testosterone-mistake-changed-women-s-bodies--73098333
A single laboratory tweak in 1938 turned a failed attempt to make oral testosterone into the first orally active progestogen, ethisterone - a compound that survived digestion and bound the progesterone receptor despite being synthesized from testosterone. How did a deliberate chemical experiment intended for men become the drug that redefined hormonal treatment for women, and what consequences lay hidden in its origins?

In this episode, we trace the discovery at Schering AG, the rapid clinical adoption across six countries, and the dosing and receptor data that made ethisterone both revolutionary and risky - all leading to the question of when its full biological costs became visible.

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Company: Schering AG
Compound: Ethisterone
First marketed (Germany): 1939 as Proluton C
Minimum therapeutic dose: 200 mg

- Four chemists at Schering AG synthesized the compound in Berlin in 1938.
- The ethynylation modification was applied at carbon 17-alpha on testosterone.
- Ethisterone was introduced in Germany in 1939 and in the United States in 1945 as Pranone.
- The compound was sold under more than a dozen brand names across France, Germany, Italy, Japan, the UK, and the US.
- Ethisterone bound the progesterone receptor at roughly 44% of progesterone’s affinity and required minimum doses of about 200 mg.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098333Mon, 17 Aug 2026 13:00:03 +0000Creator at ObomediaThe Accidental Pill: How 1938's Testosterone Mistake Changed Women's Bodies A single laboratory tweak in 1938 turned a failed attempt to make oral testosterone into the first orally active progestogen, ethisterone - a compound that survived...
A single laboratory tweak in 1938 turned a failed attempt to make oral testosterone into the first orally active progestogen, ethisterone - a compound that survived digestion and bound the progesterone receptor despite being synthesized from testosterone. How did a deliberate chemical experiment intended for men become the drug that redefined hormonal treatment for women, and what consequences lay hidden in its origins?

In this episode, we trace the discovery at Schering AG, the rapid clinical adoption across six countries, and the dosing and receptor data that made ethisterone both revolutionary and risky - all leading to the question of when its full biological costs became visible.

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Company: Schering AG
Compound: Ethisterone
First marketed (Germany): 1939 as Proluton C
Minimum therapeutic dose: 200 mg

- Four chemists at Schering AG synthesized the compound in Berlin in 1938.
- The ethynylation modification was applied at carbon 17-alpha on testosterone.
- Ethisterone was introduced in Germany in 1939 and in the United States in 1945 as Pranone.
- The compound was sold under more than a dozen brand names across France, Germany, Italy, Japan, the UK, and the US.
- Ethisterone bound the progesterone receptor at roughly 44% of progesterone’s affinity and required minimum doses of about 200 mg.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1222falsefullhttps://www.spreaker.com/episode/the-accidental-pill-that-gave-women-a-voice-then-vanished--73098331
A tiny chemical tweak in a Berlin lab produced ethisterone, the first oral progestin that let women avoid injections - yet it required doses of 200-700 mg over 10-14 days and later revealed metabolic mysteries that left no pregnanediol trace. How did a drug that changed access to care also carry risks that would make it disappear?

In this episode, we trace how four chemists at Schering AG accidentally created a mouthable hormone in 1938, how that molecule spread under more than a dozen brand names across six countries, and why its unpredictable dosing and unusual metabolism forced clinicians to keep asking whether convenience outweighed safety.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938
Location: Schering AG, Berlin
Event: Creation and market introduction of ethisterone (Proluton C/Pranone)
Dose range: 200-700 mg over 10-14 days

- The chemists' goal was to make testosterone orally active by ethynylation at carbon-17 alpha.
- Ethisterone reached the German market in 1939 as Proluton C and the U.S, by 1945 as Pranone.
- The molecule carried more than a dozen brand names across France, Germany, Italy, Japan, the UK, and the United States.
- Therapeutic effect required between 200 and 700 milligrams administered over ten to fourteen days.
- Researchers found no pregnanediol in urine, the metabolite expected if it metabolized like progesterone.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098331Sun, 16 Aug 2026 13:00:03 +0000Creator at ObomediaThe Accidental Pill That Gave Women a Voice - Then Vanished A tiny chemical tweak in a Berlin lab produced ethisterone, the first oral progestin that let women avoid injections - yet it required doses of 200-700 mg over 10-14 days and later...
A tiny chemical tweak in a Berlin lab produced ethisterone, the first oral progestin that let women avoid injections - yet it required doses of 200-700 mg over 10-14 days and later revealed metabolic mysteries that left no pregnanediol trace. How did a drug that changed access to care also carry risks that would make it disappear?

In this episode, we trace how four chemists at Schering AG accidentally created a mouthable hormone in 1938, how that molecule spread under more than a dozen brand names across six countries, and why its unpredictable dosing and unusual metabolism forced clinicians to keep asking whether convenience outweighed safety.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938
Location: Schering AG, Berlin
Event: Creation and market introduction of ethisterone (Proluton C/Pranone)
Dose range: 200-700 mg over 10-14 days

- The chemists' goal was to make testosterone orally active by ethynylation at carbon-17 alpha.
- Ethisterone reached the German market in 1939 as Proluton C and the U.S, by 1945 as Pranone.
- The molecule carried more than a dozen brand names across France, Germany, Italy, Japan, the UK, and the United States.
- Therapeutic effect required between 200 and 700 milligrams administered over ten to fourteen days.
- Researchers found no pregnanediol in urine, the metabolite expected if it metabolized like progesterone.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1105falsefullhttps://www.spreaker.com/episode/the-accidental-pill-that-rewrote-women-s-hormones--73098328
A single laboratory "mistake" in Berlin produced the first orally active progestogen that would be prescribed to millions of women under more than twenty brand names - but the molecule was never what the chemists intended. How did an attempt to make an oral testosterone become a compound that mimicked progesterone with about 44% receptor affinity, and what dangers rode with that accidental success?

In this episode, we trace the path from a 1938 Schering AG lab to clinics worldwide, detailing the chemical technique that made oral steroid therapy possible and the clinical choices that followed. What did the team of four chemists discover, how did the drug enter markets from 1939 onward, and what unresolved risks remained as the molecule spread?

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (discovery); 1939 (clinical use in Germany); 1945 (arrival in United States)
Location: Schering AG laboratory, Berlin
Topic: development of the first orally active progestogen (ethisterone/Pranone/Proluton C)
Dosage: commonly 25 mg up to four times a day; cumulative courses of 200-700 mg over 10-14 days

- Four chemists at Schering AG synthesized the molecule in Berlin in 1938.
- The ethynylation technique at C17α, borrowed from earlier estrogen work, created an orally active steroid.
- The molecule bound progesterone receptors with approximately 44% of natural progesterone’s affinity.
- By 1939 it was marketed in Germany as Proluton C and in 1945 in the U.S. as Pranone.
- The compound was sold under more than twenty brand names and used across Europe, Japan, and other markets.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098328Sat, 15 Aug 2026 13:00:02 +0000Creator at ObomediaThe Accidental Pill That Rewrote Women's Hormones A single laboratory "mistake" in Berlin produced the first orally active progestogen that would be prescribed to millions of women under more than twenty brand names - but the molecule was never...
A single laboratory "mistake" in Berlin produced the first orally active progestogen that would be prescribed to millions of women under more than twenty brand names - but the molecule was never what the chemists intended. How did an attempt to make an oral testosterone become a compound that mimicked progesterone with about 44% receptor affinity, and what dangers rode with that accidental success?

In this episode, we trace the path from a 1938 Schering AG lab to clinics worldwide, detailing the chemical technique that made oral steroid therapy possible and the clinical choices that followed. What did the team of four chemists discover, how did the drug enter markets from 1939 onward, and what unresolved risks remained as the molecule spread?

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (discovery); 1939 (clinical use in Germany); 1945 (arrival in United States)
Location: Schering AG laboratory, Berlin
Topic: development of the first orally active progestogen (ethisterone/Pranone/Proluton C)
Dosage: commonly 25 mg up to four times a day; cumulative courses of 200-700 mg over 10-14 days

- Four chemists at Schering AG synthesized the molecule in Berlin in 1938.
- The ethynylation technique at C17α, borrowed from earlier estrogen work, created an orally active steroid.
- The molecule bound progesterone receptors with approximately 44% of natural progesterone’s affinity.
- By 1939 it was marketed in Germany as Proluton C and in 1945 in the U.S. as Pranone.
- The compound was sold under more than twenty brand names and used across Europe, Japan, and other markets.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1205falsefullhttps://www.spreaker.com/episode/the-accidental-pill-how-chemists-invented-progesterone-by-mistake--73098325
Fear and astonishment collide: four Berlin chemists in 1938 set out to make oral testosterone and instead created the first synthetic oral progestin that rewrote hormonal medicine for sixty-one years - yet its original name, ethisterone, is almost forgotten. How did a molecule meant to be an androgen survive digestion only to bind progesterone receptors at 44% potency, and what did that compromise mean for patients?

In this episode, we tell the story of the Schering AG team and the chain of events from lab accident to market, describing the chemical modification, clinical realities, and early dosing practices that followed - can a drug’s accidental origin explain decades of medical practice?

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Date: 1938
Location: Schering AG laboratory, Berlin
Event: Synthesis of ethisterone (first synthetic oral progestin)
Dose: standard tablet 25 mg; clinical regimens up to 200-700 mg over 10-14 days

- The chemists applied a C17α ethinyl group to testosterone in 1938 to try to make oral testosterone.
- The resulting compound survived digestion and entered the bloodstream intact, becoming orally active.
- Biological assays showed the compound bound progesterone receptors at 44% of natural progesterone’s strength.
- Schering marketed the compound as Proluton C in Germany in 1939 and as Pranone in the US in 1945 under the name ethisterone.
- Some patients required between 200 and 700 milligrams of ethisterone over 10-14 days to achieve endometrial transformation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098325Fri, 14 Aug 2026 13:00:04 +0000Creator at ObomediaThe Accidental Pill: How Chemists Invented Progesterone by Mistake Fear and astonishment collide: four Berlin chemists in 1938 set out to make oral testosterone and instead created the first synthetic oral progestin that rewrote hormonal medicine...
Fear and astonishment collide: four Berlin chemists in 1938 set out to make oral testosterone and instead created the first synthetic oral progestin that rewrote hormonal medicine for sixty-one years - yet its original name, ethisterone, is almost forgotten. How did a molecule meant to be an androgen survive digestion only to bind progesterone receptors at 44% potency, and what did that compromise mean for patients?

In this episode, we tell the story of the Schering AG team and the chain of events from lab accident to market, describing the chemical modification, clinical realities, and early dosing practices that followed - can a drug’s accidental origin explain decades of medical practice?

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Date: 1938
Location: Schering AG laboratory, Berlin
Event: Synthesis of ethisterone (first synthetic oral progestin)
Dose: standard tablet 25 mg; clinical regimens up to 200-700 mg over 10-14 days

- The chemists applied a C17α ethinyl group to testosterone in 1938 to try to make oral testosterone.
- The resulting compound survived digestion and entered the bloodstream intact, becoming orally active.
- Biological assays showed the compound bound progesterone receptors at 44% of natural progesterone’s strength.
- Schering marketed the compound as Proluton C in Germany in 1939 and as Pranone in the US in 1945 under the name ethisterone.
- Some patients required between 200 and 700 milligrams of ethisterone over 10-14 days to achieve endometrial transformation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1186falsefullhttps://www.spreaker.com/episode/how-childproof-caps-ended-500-annual-childhood-poisonings--73098323
Five hundred children under five were dying each year from ordinary household bottles - aspirin, furniture polish, turpentine - items found in millions of postwar American homes. The answer wasn't a warning label but a physical barrier; how did the U.S. move from skull-and-crossbones labels to a law mandating child-resistant caps, and why did it take until December 30, 1970?

In this episode, we trace the shift from information-based fixes to engineered safety, following the data collected by the National Clearinghouse for Poison Control Centers and the policy steps that led to a federal mandate; what made a cap the decisive solution?

Person: President Richard Nixon
Date: December 30, 1970
Event: Signing of child-resistant cap law
Organization: National Clearinghouse for Poison Control Centers
Law: Hazardous Substances Labeling Act of 1960s

- Approximately 500 children aged five and younger died each year from swallowing household products in the 1950s-1960s.
- The National Clearinghouse for Poison Control Centers was established in 1957 to collect and distribute poison incident data.
- The Hazardous Substances Labeling Act passed in the 1960s required warning labels but did not prevent child access.
- A standard pill bottle cap could be unscrewed by a toddler in roughly four seconds.
- December 30, 1970 is the date President Richard Nixon signed the law mandating a physical barrier (child-resistant caps).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098323Thu, 13 Aug 2026 13:00:02 +0000Creator at ObomediaHow Childproof Caps Ended 500 Annual Childhood Poisonings Five hundred children under five were dying each year from ordinary household bottles - aspirin, furniture polish, turpentine - items found in millions of postwar American homes. The answer...
Five hundred children under five were dying each year from ordinary household bottles - aspirin, furniture polish, turpentine - items found in millions of postwar American homes. The answer wasn't a warning label but a physical barrier; how did the U.S. move from skull-and-crossbones labels to a law mandating child-resistant caps, and why did it take until December 30, 1970?

In this episode, we trace the shift from information-based fixes to engineered safety, following the data collected by the National Clearinghouse for Poison Control Centers and the policy steps that led to a federal mandate; what made a cap the decisive solution?

Person: President Richard Nixon
Date: December 30, 1970
Event: Signing of child-resistant cap law
Organization: National Clearinghouse for Poison Control Centers
Law: Hazardous Substances Labeling Act of 1960s

- Approximately 500 children aged five and younger died each year from swallowing household products in the 1950s-1960s.
- The National Clearinghouse for Poison Control Centers was established in 1957 to collect and distribute poison incident data.
- The Hazardous Substances Labeling Act passed in the 1960s required warning labels but did not prevent child access.
- A standard pill bottle cap could be unscrewed by a toddler in roughly four seconds.
- December 30, 1970 is the date President Richard Nixon signed the law mandating a physical barrier (child-resistant caps).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1113falsefullhttps://www.spreaker.com/episode/24-month-window-forcing-industry-wide-paper-abandonment--73098318
The thought of entire drug dossiers arriving by truck-binders stacked floor to ceiling-evokes a bureaucratic weight that shaped modern medicine; the eCTD standard sat available for 15 years before May 5, 2017 forced electronic-only submissions, but why did the industry wait until that deadline to abandon paper? What broke the long inertia between a solution and its adoption?

In this episode, we trace the administrative shift from paper CTDs to the electronic Common Technical Document and explain how a file specification published in 2002 set a 15-year stage for a regulatory revolution; how did a specification become a hard deadline that reshaped every drug, vaccine, and biologic dossier?

Person: ICH M2 Expert Working Group
Date: February 12, 2002
Event: eCTD version 2.0 publication
Date: October 8, 2002
Event: eCTD version 3.0 publication

- May 5, 2017 was the date after which the FDA required electronic-only submissions for new drugs, biologics, and generics.
- The eCTD specification existed since February 12, 2002 (version 2.0) and was followed by version 3.0 on October 8, 2002.
- The CTD structure is organized into five modules, with Module 1 containing regional administrative information and Modules 2-5 carrying technical content.
- Before the eCTD, full drug applications were physically delivered by truck and could fill entire rooms of binders.
- The CTD harmonized the scientific package across the US, Europe, and Japan but left Module 1 as region-specific, reducing three separate documents to one core dossier with regional adaptations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098318Wed, 12 Aug 2026 13:00:02 +0000Creator at Obomedia24-month window forcing industry-wide paper abandonment The thought of entire drug dossiers arriving by truck-binders stacked floor to ceiling-evokes a bureaucratic weight that shaped modern medicine; the eCTD standard sat available for 15 years...
The thought of entire drug dossiers arriving by truck-binders stacked floor to ceiling-evokes a bureaucratic weight that shaped modern medicine; the eCTD standard sat available for 15 years before May 5, 2017 forced electronic-only submissions, but why did the industry wait until that deadline to abandon paper? What broke the long inertia between a solution and its adoption?

In this episode, we trace the administrative shift from paper CTDs to the electronic Common Technical Document and explain how a file specification published in 2002 set a 15-year stage for a regulatory revolution; how did a specification become a hard deadline that reshaped every drug, vaccine, and biologic dossier?

Person: ICH M2 Expert Working Group
Date: February 12, 2002
Event: eCTD version 2.0 publication
Date: October 8, 2002
Event: eCTD version 3.0 publication

- May 5, 2017 was the date after which the FDA required electronic-only submissions for new drugs, biologics, and generics.
- The eCTD specification existed since February 12, 2002 (version 2.0) and was followed by version 3.0 on October 8, 2002.
- The CTD structure is organized into five modules, with Module 1 containing regional administrative information and Modules 2-5 carrying technical content.
- Before the eCTD, full drug applications were physically delivered by truck and could fill entire rooms of binders.
- The CTD harmonized the scientific package across the US, Europe, and Japan but left Module 1 as region-specific, reducing three separate documents to one core dossier with regional adaptations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1221falsefullhttps://www.spreaker.com/episode/the-comic-genius-who-died-before-his-masterpiece-hit-shelves--73098314
A comic that arrived on shelves February 22, 2011 was written by a man who died the night before - he was forty-nine, had turned forty-nine the day before, and his film arrived into a world he would never see. What did Dwayne McDuffie build in life so that others could be seen as whole people, and how did that work change comics and animation?

In this episode, we trace the life and career described in the transcript, outlining his education, early industry roles, the founding of a publishing company, and the ideas that drove him - asking how one creator reshaped representation and why he felt compelled to build from the outside.

Person: Dwayne McDuffie
Date of arrival on shelves: February 22, 2011
Date of death: February 21, 2011
Age at death: 49
Founding partners: Denys Cowan, Michael Davis, Derek Dingle

- Copies of All-Star Superman arrived on store shelves on February 22, 2011.
- Dwayne McDuffie died on the morning of February 21, 2011 from complications after emergency heart surgery.
- He was born on February 20, 1962 and turned forty-nine the day before he died.
- He earned a Bachelor of Arts in English in 1983, then a Master of Science in Physics, and later studied film at NYU's Tisch School of the Arts.
- In the early 1990s he co-founded Milestone Media with Denys Cowan, Michael Davis, and Derek Dingle to create a shared universe set in Dakota.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098314Tue, 11 Aug 2026 13:00:03 +0000Creator at ObomediaThe Comic Genius Who Died Before His Masterpiece Hit Shelves A comic that arrived on shelves February 22, 2011 was written by a man who died the night before - he was forty-nine, had turned forty-nine the day before, and his film arrived into a...
A comic that arrived on shelves February 22, 2011 was written by a man who died the night before - he was forty-nine, had turned forty-nine the day before, and his film arrived into a world he would never see. What did Dwayne McDuffie build in life so that others could be seen as whole people, and how did that work change comics and animation?

In this episode, we trace the life and career described in the transcript, outlining his education, early industry roles, the founding of a publishing company, and the ideas that drove him - asking how one creator reshaped representation and why he felt compelled to build from the outside.

Person: Dwayne McDuffie
Date of arrival on shelves: February 22, 2011
Date of death: February 21, 2011
Age at death: 49
Founding partners: Denys Cowan, Michael Davis, Derek Dingle

- Copies of All-Star Superman arrived on store shelves on February 22, 2011.
- Dwayne McDuffie died on the morning of February 21, 2011 from complications after emergency heart surgery.
- He was born on February 20, 1962 and turned forty-nine the day before he died.
- He earned a Bachelor of Arts in English in 1983, then a Master of Science in Physics, and later studied film at NYU's Tisch School of the Arts.
- In the early 1990s he co-founded Milestone Media with Denys Cowan, Michael Davis, and Derek Dingle to create a shared universe set in Dakota.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>986falsefullhttps://www.spreaker.com/episode/he-survived-a-pioneering-double-lung-transplant-died-after-routine-surgery--73098311
A man who lived nearly thirteen years on the world’s longest-surviving standalone double-lung transplant died after a routine brain procedure for facial pain; how did the lungs that defied every expectation fail to protect him from a different, ordinary complication? This episode centers on the startling contrast between a historic medical triumph and the commonplace surgery that ended it.

In this episode, we tell the life and medical arc of Floyd Davidson Spence, from his birth in 1928 through a pioneering bilateral lung transplant at age sixty, to the 2001 hospital admission for nerve pain that led to brain surgery and his death - what happened between those milestones that kept him alive for so long, and what went wrong at the end?

Person: Floyd Davidson Spence
Date of birth: April 9, 1928
Event: Bilateral lung transplantation in 1988 at age 60
Duration: Lungs functioning for nearly 13 years (1988-2001)
Event leading to death: Brain surgery for facial nerve pain, summer 2001

- Spence received a bilateral lung transplant in 1988 at age 60.
- He was the oldest patient to receive that procedure at the time.
- His transplanted lungs functioned without re-transplant for nearly 13 years.
- He served 15 terms in the U.S. House of Representatives, including as chairman of the House Armed Services Committee.
- He was admitted to St. Dominic Memorial Hospital in Jackson, Mississippi in summer 2001 for facial pain and died after brain surgery.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098311Mon, 10 Aug 2026 13:00:03 +0000Creator at ObomediaHe Survived a Pioneering Double-Lung Transplant - Died After Routine Surgery A man who lived nearly thirteen years on the world’s longest-surviving standalone double-lung transplant died after a routine brain procedure for facial pain; how did the...
A man who lived nearly thirteen years on the world’s longest-surviving standalone double-lung transplant died after a routine brain procedure for facial pain; how did the lungs that defied every expectation fail to protect him from a different, ordinary complication? This episode centers on the startling contrast between a historic medical triumph and the commonplace surgery that ended it.

In this episode, we tell the life and medical arc of Floyd Davidson Spence, from his birth in 1928 through a pioneering bilateral lung transplant at age sixty, to the 2001 hospital admission for nerve pain that led to brain surgery and his death - what happened between those milestones that kept him alive for so long, and what went wrong at the end?

Person: Floyd Davidson Spence
Date of birth: April 9, 1928
Event: Bilateral lung transplantation in 1988 at age 60
Duration: Lungs functioning for nearly 13 years (1988-2001)
Event leading to death: Brain surgery for facial nerve pain, summer 2001

- Spence received a bilateral lung transplant in 1988 at age 60.
- He was the oldest patient to receive that procedure at the time.
- His transplanted lungs functioned without re-transplant for nearly 13 years.
- He served 15 terms in the U.S. House of Representatives, including as chairman of the House Armed Services Committee.
- He was admitted to St. Dominic Memorial Hospital in Jackson, Mississippi in summer 2001 for facial pain and died after brain surgery.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1137falsefullhttps://www.spreaker.com/episode/the-ambassador-who-died-on-the-operating-table-44-days-in-madrid--73098309
A German ambassador dies on an operating table in Madrid six weeks after arriving in Spain in the spring of 1943 - the official cause: a failed appendix surgery, but his widow believed otherwise, and the question she raised would remain unsettled for more than sixty years. How did a man who delivered ultimatums linked to deportations to Auschwitz and described his embassy as "a hydra with many heads" end up dead in 44 days - accident, conspiracy, or something in between?

In this episode, we follow the forty-four days between Hans-Adolf von Moltke's arrival in Madrid on 6 February 1943 and his death on 22 March 1943, tracing his decades-long diplomatic career, his family background, and the actions he took in those final weeks that tied him to deportations and embassy crises. What do those forty-four days reveal about the man who served a murderous regime with competence and occasional hesitation?

Person: Hans-Adolf von Moltke
Date of birth: 29 November 1884
Arrival in Madrid: 6 February 1943
Date of death: 22 March 1943
Departure of coffin: 26 March 1943 (to Breslau)

- Moltke arrived in Madrid on 6 February 1943 and died on 22 March 1943, a span of forty-four days.
- The official cause of death recorded was a failed appendix surgery.
- On 26 March 1943 a sealed coffin left Madrid bound for Breslau, the family crypt.
- Moltke joined the Nazi Party on 1 October 1937.
- He negotiated the German-Polish Non-Aggression Pact in January 1934 while posted in Warsaw.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098309Sun, 09 Aug 2026 13:00:04 +0000Creator at ObomediaThe Ambassador Who Died on the Operating Table: 44 Days in Madrid A German ambassador dies on an operating table in Madrid six weeks after arriving in Spain in the spring of 1943 - the official cause: a failed appendix surgery, but his widow...
A German ambassador dies on an operating table in Madrid six weeks after arriving in Spain in the spring of 1943 - the official cause: a failed appendix surgery, but his widow believed otherwise, and the question she raised would remain unsettled for more than sixty years. How did a man who delivered ultimatums linked to deportations to Auschwitz and described his embassy as "a hydra with many heads" end up dead in 44 days - accident, conspiracy, or something in between?

In this episode, we follow the forty-four days between Hans-Adolf von Moltke's arrival in Madrid on 6 February 1943 and his death on 22 March 1943, tracing his decades-long diplomatic career, his family background, and the actions he took in those final weeks that tied him to deportations and embassy crises. What do those forty-four days reveal about the man who served a murderous regime with competence and occasional hesitation?

Person: Hans-Adolf von Moltke
Date of birth: 29 November 1884
Arrival in Madrid: 6 February 1943
Date of death: 22 March 1943
Departure of coffin: 26 March 1943 (to Breslau)

- Moltke arrived in Madrid on 6 February 1943 and died on 22 March 1943, a span of forty-four days.
- The official cause of death recorded was a failed appendix surgery.
- On 26 March 1943 a sealed coffin left Madrid bound for Breslau, the family crypt.
- Moltke joined the Nazi Party on 1 October 1937.
- He negotiated the German-Polish Non-Aggression Pact in January 1934 while posted in Warsaw.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1292falsefullhttps://www.spreaker.com/episode/how-carman-filled-an-nfl-stadium-with-free-faith-and-why-it-mattered--73098303
A single night in October 1994 saw 71,132 people enter Texas Stadium without paying a ticket - the documented world record for the largest single Christian concert in history. How did a high-school dropout from Trenton, with no corporate backing and a nonprofit model that kept shows free, build an audience that massive on those exact terms?

In this episode, we tell the story of Carman Licciardello’s rise from Atlantic City casino stages to stadium-sized Christian performances, tracing the career choices, conversions, and industry setbacks that shaped his approach to ministry and music. What choices and experiences turned a casino performer into the most attended solo Christian artist in recorded history?

Person: Carman Licciardello Licciardello
Date: October 22, 1994
Location: Texas Stadium
Event: Largest single Christian concert (71,132 attendees)
Age at final performance mentioned: 65

- 71,132 people attended Carman’s Texas Stadium concert on October 22, 1994, without paying a single dollar.
- Carman was born January 19, 1956, in Trenton, New Jersey, and learned drums at about age five.
- He dropped out of high school at seventeen and performed in Atlantic City casinos as a teenager.
- By 1985, his song “The Champion” became the number one CCM song in the country and earned RIAA gold certification.
- Charisma magazine named him Favorite Male Vocalist three consecutive years: 1987, 1988, and 1989.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098303Sat, 08 Aug 2026 13:00:04 +0000Creator at ObomediaHow Carman Filled an NFL Stadium with Free Faith-and Why It Mattered A single night in October 1994 saw 71,132 people enter Texas Stadium without paying a ticket - the documented world record for the largest single Christian concert in history. How...
A single night in October 1994 saw 71,132 people enter Texas Stadium without paying a ticket - the documented world record for the largest single Christian concert in history. How did a high-school dropout from Trenton, with no corporate backing and a nonprofit model that kept shows free, build an audience that massive on those exact terms?

In this episode, we tell the story of Carman Licciardello’s rise from Atlantic City casino stages to stadium-sized Christian performances, tracing the career choices, conversions, and industry setbacks that shaped his approach to ministry and music. What choices and experiences turned a casino performer into the most attended solo Christian artist in recorded history?

Person: Carman Licciardello Licciardello
Date: October 22, 1994
Location: Texas Stadium
Event: Largest single Christian concert (71,132 attendees)
Age at final performance mentioned: 65

- 71,132 people attended Carman’s Texas Stadium concert on October 22, 1994, without paying a single dollar.
- Carman was born January 19, 1956, in Trenton, New Jersey, and learned drums at about age five.
- He dropped out of high school at seventeen and performed in Atlantic City casinos as a teenager.
- By 1985, his song “The Champion” became the number one CCM song in the country and earned RIAA gold certification.
- Charisma magazine named him Favorite Male Vocalist three consecutive years: 1987, 1988, and 1989.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1017falsefullhttps://www.spreaker.com/episode/how-a-1960s-safety-panic-killed-a-car-then-history-vindicated-it--73098301
The Corvair went from selling 26,000 cars in its first two days to a 93% collapse in sales within three years, and a 143‑page government study later found it handled at least as well as contemporaries. What sequence of decisions - an engineering fix rejected on cost grounds, a tire‑pressure workaround, lawsuits and a bestselling book - turned a commercial success into a cautionary legend?

In this episode, we tell the story of the Chevrolet Corvair, the engineering choices behind its rear‑engine swing axle, the rejected front anti‑roll bar, and how those choices, plus public controversy, reshaped consumer protection-ending with a government report that arrived seven years too late and raised the question: how did belief overtake engineering facts?

Person: Ed Cole
Date: October 2, 1959
Location: Willow Run plant, Ypsilanti, Michigan
Event: Initial two‑day sales of 26,000 cars
Status: Government study published three years after final production concluded

- 26,000 Corvairs sold in the first two days on the market (October 1959).
- The Corvair accounted for 35% of GM's total two‑day sales that opening weekend.
- Monza trim sold 11,926 units before the model year ended (by April 1960).
- Corvair sales collapsed by 93% over a three‑year period after initial success.
- A 143‑page government study concluded the Corvair handled at least as well as its contemporaries, published seven years after the last car rolled out.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098301Fri, 07 Aug 2026 13:00:04 +0000Creator at ObomediaHow a 1960s Safety Panic Killed a Car - Then History Vindicated It The Corvair went from selling 26,000 cars in its first two days to a 93% collapse in sales within three years, and a 143‑page government study later found it handled at least as...
The Corvair went from selling 26,000 cars in its first two days to a 93% collapse in sales within three years, and a 143‑page government study later found it handled at least as well as contemporaries. What sequence of decisions - an engineering fix rejected on cost grounds, a tire‑pressure workaround, lawsuits and a bestselling book - turned a commercial success into a cautionary legend?

In this episode, we tell the story of the Chevrolet Corvair, the engineering choices behind its rear‑engine swing axle, the rejected front anti‑roll bar, and how those choices, plus public controversy, reshaped consumer protection-ending with a government report that arrived seven years too late and raised the question: how did belief overtake engineering facts?

Person: Ed Cole
Date: October 2, 1959
Location: Willow Run plant, Ypsilanti, Michigan
Event: Initial two‑day sales of 26,000 cars
Status: Government study published three years after final production concluded

- 26,000 Corvairs sold in the first two days on the market (October 1959).
- The Corvair accounted for 35% of GM's total two‑day sales that opening weekend.
- Monza trim sold 11,926 units before the model year ended (by April 1960).
- Corvair sales collapsed by 93% over a three‑year period after initial success.
- A 143‑page government study concluded the Corvair handled at least as well as its contemporaries, published seven years after the last car rolled out.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1105falsefullhttps://www.spreaker.com/episode/the-bakery-that-tried-to-kill-hong-kong-but-failed-spectacularly--73098298
Violence and survival collided over breakfast: between 300 and 500 people in Hong Kong were violently poisoned on January 15, 1857 after eating bread from a single bakery, yet zero people died because the arsenic dose was so massive it forced vomiting and expulsion. Who put enough arsenic in those loaves to “kill half the European population” and why did the man who baked them leave the city before anyone could arrest him?

In this episode, we lay out the sequence of events, the forensic tests that identified arsenic trioxide in the finished bread, and the legal aftermath that detained dozens of men while the bakery proprietor fled - but still left no convictions. How did a dose calculated at 60-64 grains per pound fail to become a massacre, and what did that paradox mean for colonial Hong Kong?

Person: Cheong Ah-lum
Date: January 15, 1857
Toxin: Arsenic trioxide
Victims: 300-500 people fell ill
Detentions: 52 Chinese men detained; 10 committed for trial

- Surgeon General Aurelius Harland instructed victims to induce vomiting and consume raw eggs, a treatment that helped prevent deaths.
- Three chemists confirmed arsenic in the finished loaves: Justus von Liebig calculated 64 grains per pound; John Ivor Murray calculated 62.3 grains per pound.
- No arsenic was found in flour, yeast, pastry, or table scrapings; contamination was present only in the baked bread.
- Cheong Ah-lum, proprietor of Esing Bakery, had already left Hong Kong before arrests began.
- The arsenic-laden bread was kept in the Chief Justice’s office for the next seventy-odd years without producing a final answer.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098298Thu, 06 Aug 2026 13:00:03 +0000Creator at ObomediaThe Bakery That Tried to Kill Hong Kong - But Failed Spectacularly Violence and survival collided over breakfast: between 300 and 500 people in Hong Kong were violently poisoned on January 15, 1857 after eating bread from a single bakery, yet zero...
Violence and survival collided over breakfast: between 300 and 500 people in Hong Kong were violently poisoned on January 15, 1857 after eating bread from a single bakery, yet zero people died because the arsenic dose was so massive it forced vomiting and expulsion. Who put enough arsenic in those loaves to “kill half the European population” and why did the man who baked them leave the city before anyone could arrest him?

In this episode, we lay out the sequence of events, the forensic tests that identified arsenic trioxide in the finished bread, and the legal aftermath that detained dozens of men while the bakery proprietor fled - but still left no convictions. How did a dose calculated at 60-64 grains per pound fail to become a massacre, and what did that paradox mean for colonial Hong Kong?

Person: Cheong Ah-lum
Date: January 15, 1857
Toxin: Arsenic trioxide
Victims: 300-500 people fell ill
Detentions: 52 Chinese men detained; 10 committed for trial

- Surgeon General Aurelius Harland instructed victims to induce vomiting and consume raw eggs, a treatment that helped prevent deaths.
- Three chemists confirmed arsenic in the finished loaves: Justus von Liebig calculated 64 grains per pound; John Ivor Murray calculated 62.3 grains per pound.
- No arsenic was found in flour, yeast, pastry, or table scrapings; contamination was present only in the baked bread.
- Cheong Ah-lum, proprietor of Esing Bakery, had already left Hong Kong before arrests began.
- The arsenic-laden bread was kept in the Chief Justice’s office for the next seventy-odd years without producing a final answer.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1264falsefullhttps://www.spreaker.com/episode/the-croquette-that-exposed-japan-s-biggest-food-fraud--73098293
A single DNA test in spring 2007 found pork, chicken, and unexplained meats inside a frozen beef croquette labeled “one hundred percent ground beef,” revealing an operation that shipped 9,838 tons of adulterated meat across 22 prefectures. How did a company lauded by the Ministry one month later secretly supply school lunches, military bases, and hospitals with contaminated and relabeled product for nearly three decades?

In this episode, we tell the documented story of Meat Hope Incorporated: what the company produced, the internal orders and government commendations that coexisted, and the whistleblower who filed anonymous complaints for six years. How did the system of concealment work, and why did reporting fail until that DNA test?

Person: Minoru Tanaka
Person: Kiroku Akahane
Date: Spring 2007
Event: DNA test on frozen beef croquette
Quantity: 9,838 tons of adulterated meat

- The package label claimed “one hundred percent ground beef” while the croquette contained pork, chicken, and other unexplained meats.
- The adulterated meat had reached recipients across 22 Japanese prefectures, including school lunch programs, military bases, and hospitals.
- In April 2006 Tanaka received a formal commendation from Japan’s Minister of Education, Culture, Sports, Science and Technology for a ground beef technique.
- In the same month managers issued an internal order to halt char siu pork production because additive levels exceeded permissible limits.
- Whistleblower Kiroku Akahane filed anonymous complaints repeatedly from 2000 through 2006 after observing relabeling, color correction with blood, reuse of returned product, and use of expired and decomposed meat.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098293Wed, 05 Aug 2026 13:00:02 +0000Creator at ObomediaThe Croquette That Exposed Japan's Biggest Food Fraud A single DNA test in spring 2007 found pork, chicken, and unexplained meats inside a frozen beef croquette labeled “one hundred percent ground beef,” revealing an operation that shipped 9,838...
A single DNA test in spring 2007 found pork, chicken, and unexplained meats inside a frozen beef croquette labeled “one hundred percent ground beef,” revealing an operation that shipped 9,838 tons of adulterated meat across 22 prefectures. How did a company lauded by the Ministry one month later secretly supply school lunches, military bases, and hospitals with contaminated and relabeled product for nearly three decades?

In this episode, we tell the documented story of Meat Hope Incorporated: what the company produced, the internal orders and government commendations that coexisted, and the whistleblower who filed anonymous complaints for six years. How did the system of concealment work, and why did reporting fail until that DNA test?

Person: Minoru Tanaka
Person: Kiroku Akahane
Date: Spring 2007
Event: DNA test on frozen beef croquette
Quantity: 9,838 tons of adulterated meat

- The package label claimed “one hundred percent ground beef” while the croquette contained pork, chicken, and other unexplained meats.
- The adulterated meat had reached recipients across 22 Japanese prefectures, including school lunch programs, military bases, and hospitals.
- In April 2006 Tanaka received a formal commendation from Japan’s Minister of Education, Culture, Sports, Science and Technology for a ground beef technique.
- In the same month managers issued an internal order to halt char siu pork production because additive levels exceeded permissible limits.
- Whistleblower Kiroku Akahane filed anonymous complaints repeatedly from 2000 through 2006 after observing relabeling, color correction with blood, reuse of returned product, and use of expired and decomposed meat.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1152falsefullhttps://www.spreaker.com/episode/one-tunnel-found-nearly-three-thousand-eight-hundred-people-made-homeless-the-zoo-was-gone--73098291
One tunnel, twenty-five feet deep and packed with explosives, triggered an operation that left nearly 3,800 people homeless and wiped out a zoo in Rafah - how did a single discovery justify demolishing seventy hectares of farmland and hundreds of homes? What sequence of orders, reversals, and actions turned a targeted mission into mass displacement?

In this episode, we lay out the documented record of Operation Rainbow in Rafah in May 2004, tracing the timeline, casualties, and demolitions that followed the tunnel discovery to ask whether the operation was a continuation of earlier policies or a distinct escalation.

Person: Sheikh Ahmed Yassin
Date: May 2004
Location: Rafah, Gaza Strip
Event: Operation Rainbow
Period: May 12-June 1, 2004

- One tunnel found: 25 feet deep, packed with explosives, at the southern edge of the Gaza Strip.
- Nearly 3,800 people made homeless and 70 hectares of farmland scraped from the earth after the operation.
- Fifty-nine Palestinians killed between May 12 and May 24, including 11 under the age of 18.
- Nearly 300 buildings destroyed during and around Operation Rainbow.
- Between April 1, 2003 and April 30, 2004, 487 houses in Rafah were demolished prior to the operation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098291Tue, 04 Aug 2026 13:00:02 +0000Creator at ObomediaOne tunnel found. Nearly three thousand eight hundred people made homeless. The zoo was gone One tunnel, twenty-five feet deep and packed with explosives, triggered an operation that left nearly 3,800 people homeless and wiped out a zoo in Rafah -...
One tunnel, twenty-five feet deep and packed with explosives, triggered an operation that left nearly 3,800 people homeless and wiped out a zoo in Rafah - how did a single discovery justify demolishing seventy hectares of farmland and hundreds of homes? What sequence of orders, reversals, and actions turned a targeted mission into mass displacement?

In this episode, we lay out the documented record of Operation Rainbow in Rafah in May 2004, tracing the timeline, casualties, and demolitions that followed the tunnel discovery to ask whether the operation was a continuation of earlier policies or a distinct escalation.

Person: Sheikh Ahmed Yassin
Date: May 2004
Location: Rafah, Gaza Strip
Event: Operation Rainbow
Period: May 12-June 1, 2004

- One tunnel found: 25 feet deep, packed with explosives, at the southern edge of the Gaza Strip.
- Nearly 3,800 people made homeless and 70 hectares of farmland scraped from the earth after the operation.
- Fifty-nine Palestinians killed between May 12 and May 24, including 11 under the age of 18.
- Nearly 300 buildings destroyed during and around Operation Rainbow.
- Between April 1, 2003 and April 30, 2004, 487 houses in Rafah were demolished prior to the operation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1109falsefullhttps://www.spreaker.com/episode/how-antibiotics-taught-bacteria-to-kill-again-by-2050--73098289
Antibiotics turned once-common killers into manageable illnesses, yet by 2050 ten million people could die each year from infections medicine can no longer treat - caused not by new plagues but by ordinary bacteria taught to survive our drugs. How did a tool hailed as the twentieth century’s greatest medical achievement become the engine of a slow-moving catastrophe?

In this episode, we trace the history and mechanics of antibiotic resistance from Alexander Fleming’s 1928 discovery of penicillin through decades of clinical and agricultural practice, and ask how repeated use in hospitals and feedlots created strains that modern medicine struggles to control. What critical decisions and routine habits accelerated resistance until it became a global threat?

Person: Alexander Fleming
Date: 1928
Event: Discovery of penicillin
Topic: Antibiotic resistance spread via clinical overprescription and agricultural growth promotion
Program: National Antimicrobial Resistance Monitoring System (established 1996)

- By 2050, an estimated ten million people will die each year from untreatable infections.
- In roughly 75% of acute respiratory infection cases in outpatient clinics, patients leave with an antibiotic prescription.
- Between 90 and 90- (transcript cuts off) indicates extremely high antibiotic prescribing rates for bronchitis.
- More than 150 peer-reviewed articles have emerged from the National Antimicrobial Resistance Monitoring System documenting transmission links.
- The National Antimicrobial Resistance Monitoring System was established in 1996 involving the FDA, the CDC, and the USDA.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098289Mon, 03 Aug 2026 13:00:02 +0000Creator at ObomediaHow Antibiotics Taught Bacteria to Kill Again by 2050 Antibiotics turned once-common killers into manageable illnesses, yet by 2050 ten million people could die each year from infections medicine can no longer treat - caused not by new plagues but...
Antibiotics turned once-common killers into manageable illnesses, yet by 2050 ten million people could die each year from infections medicine can no longer treat - caused not by new plagues but by ordinary bacteria taught to survive our drugs. How did a tool hailed as the twentieth century’s greatest medical achievement become the engine of a slow-moving catastrophe?

In this episode, we trace the history and mechanics of antibiotic resistance from Alexander Fleming’s 1928 discovery of penicillin through decades of clinical and agricultural practice, and ask how repeated use in hospitals and feedlots created strains that modern medicine struggles to control. What critical decisions and routine habits accelerated resistance until it became a global threat?

Person: Alexander Fleming
Date: 1928
Event: Discovery of penicillin
Topic: Antibiotic resistance spread via clinical overprescription and agricultural growth promotion
Program: National Antimicrobial Resistance Monitoring System (established 1996)

- By 2050, an estimated ten million people will die each year from untreatable infections.
- In roughly 75% of acute respiratory infection cases in outpatient clinics, patients leave with an antibiotic prescription.
- Between 90 and 90- (transcript cuts off) indicates extremely high antibiotic prescribing rates for bronchitis.
- More than 150 peer-reviewed articles have emerged from the National Antimicrobial Resistance Monitoring System documenting transmission links.
- The National Antimicrobial Resistance Monitoring System was established in 1996 involving the FDA, the CDC, and the USDA.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1086falsefullhttps://www.spreaker.com/episode/the-note-that-stopped-a-cremation-nurse-morphine-forged-will--73098284
A single handwritten note halted a cremation and exposed a tangled web of false titles, a forged will, and a cache of morphine in an interwar nursing home; who really spoke for Ada Baguley, and why was a document sworn to her wishes convincing enough to almost let a body be cremated without question? The Medical Officer for Health's suspicion of that note led to a post-mortem that turned a routine death into one of the most disturbing medical-legal cases of 1935.

In this episode, we follow the sequence of events at 32 Devon Drive and the people who lived there, from Ada and her mother Louisa to Dorothea Nancy Waddingham and Ronald Joseph Joseph, tracing how a rewritten will, unused morphine, and a claimed nursing title reshaped the fate of an estate and raised urgent legal and medical questions: what did the post-mortem reveal, and who profited?

Person: Ada Baguley
Date: 12 September 1935
Location: 32 Devon Drive, Nottingham
Topic: forged will, unregistered nurse, morphine
Event: post-mortem ordered before cremation

- Ada Baguley was 32 years old and living with multiple sclerosis at the time of her death.
- Ada's estate was originally valued at £1,600 and held in trust for her mother Louisa with remainder to cousins.
- In May 1935 the will was rewritten to leave the entire estate to Dorothea Waddingham and Ronald Joseph.
- Louisa Baguley died in May 1935 at age 88 and was buried without a post-mortem.
- Morphine used by a previous patient, Mrs. Kemp, in February 1935 remained in the house and was unaccounted for.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098284Sun, 02 Aug 2026 13:00:02 +0000Creator at ObomediaThe Note That Stopped a Cremation: Nurse, Morphine, Forged Will A single handwritten note halted a cremation and exposed a tangled web of false titles, a forged will, and a cache of morphine in an interwar nursing home; who really spoke for Ada...
A single handwritten note halted a cremation and exposed a tangled web of false titles, a forged will, and a cache of morphine in an interwar nursing home; who really spoke for Ada Baguley, and why was a document sworn to her wishes convincing enough to almost let a body be cremated without question? The Medical Officer for Health's suspicion of that note led to a post-mortem that turned a routine death into one of the most disturbing medical-legal cases of 1935.

In this episode, we follow the sequence of events at 32 Devon Drive and the people who lived there, from Ada and her mother Louisa to Dorothea Nancy Waddingham and Ronald Joseph Joseph, tracing how a rewritten will, unused morphine, and a claimed nursing title reshaped the fate of an estate and raised urgent legal and medical questions: what did the post-mortem reveal, and who profited?

Person: Ada Baguley
Date: 12 September 1935
Location: 32 Devon Drive, Nottingham
Topic: forged will, unregistered nurse, morphine
Event: post-mortem ordered before cremation

- Ada Baguley was 32 years old and living with multiple sclerosis at the time of her death.
- Ada's estate was originally valued at £1,600 and held in trust for her mother Louisa with remainder to cousins.
- In May 1935 the will was rewritten to leave the entire estate to Dorothea Waddingham and Ronald Joseph.
- Louisa Baguley died in May 1935 at age 88 and was buried without a post-mortem.
- Morphine used by a previous patient, Mrs. Kemp, in February 1935 remained in the house and was unaccounted for.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1106falsefullhttps://www.spreaker.com/episode/when-trust-killed-canada-s-tainted-blood-and-the-5-000-verdict--73098282
Trust in a public system turned deadly: thirty thousand people were infected and eight thousand died or were expected to die, yet a court fine in May 2005 was only five thousand dollars - the statutory maximum. How did a trusted, decades-old blood system, run by the Canadian Red Cross and tied to Connaught Laboratories, allow preventable infections from HIV and hepatitis C to spread through hospitals and hemophilia treatments?

In this episode, we trace the timeline and decisions that shaped the tainted blood crisis, from the Red Cross’s dual role as operator and standard-setter to delayed testing and faulty processing, and ask whether warnings and alternatives were repeatedly ignored.

Person: Canadian Red Cross Society
Event: Tainted blood crisis
Date: May 2005 (five thousand dollar fine)
Period: 1940s-1990s
Case: Krever Commission inquiry

- Between 1985 and 1989 an estimated 1,250 Canadians were known to have contracted HIV through blood products.
- From March to November 1985 an estimated 133 Canadians were infected with HIV via transfusions before antibody screening began.
- The Red Cross delayed adopting the hepatitis C test from 1986 until 1990, a four-year gap.
- The Krever Commission estimated that 85% of hepatitis C infections between 1986 and 1990 were preventable.
- Seven children were infected after faulty heat-treatment was applied to Factor VIII plasma products in 1986-1987.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098282Sat, 01 Aug 2026 13:00:02 +0000Creator at ObomediaWhen Trust Killed: Canada's Tainted Blood-and the $5,000 Verdict Trust in a public system turned deadly: thirty thousand people were infected and eight thousand died or were expected to die, yet a court fine in May 2005 was only five thousand...
Trust in a public system turned deadly: thirty thousand people were infected and eight thousand died or were expected to die, yet a court fine in May 2005 was only five thousand dollars - the statutory maximum. How did a trusted, decades-old blood system, run by the Canadian Red Cross and tied to Connaught Laboratories, allow preventable infections from HIV and hepatitis C to spread through hospitals and hemophilia treatments?

In this episode, we trace the timeline and decisions that shaped the tainted blood crisis, from the Red Cross’s dual role as operator and standard-setter to delayed testing and faulty processing, and ask whether warnings and alternatives were repeatedly ignored.

Person: Canadian Red Cross Society
Event: Tainted blood crisis
Date: May 2005 (five thousand dollar fine)
Period: 1940s-1990s
Case: Krever Commission inquiry

- Between 1985 and 1989 an estimated 1,250 Canadians were known to have contracted HIV through blood products.
- From March to November 1985 an estimated 133 Canadians were infected with HIV via transfusions before antibody screening began.
- The Red Cross delayed adopting the hepatitis C test from 1986 until 1990, a four-year gap.
- The Krever Commission estimated that 85% of hepatitis C infections between 1986 and 1990 were preventable.
- Seven children were infected after faulty heat-treatment was applied to Factor VIII plasma products in 1986-1987.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1024falsefullhttps://www.spreaker.com/episode/before-dawn-the-pearl-roundabout-killings-that-left-no-justice--73098280
Before dawn, knives slit tent fabric and a fourteen-year-old named Jaffar slept beside his father - by 9:30 a.m. four peaceful protesters were dead and no one was ever convicted. How did a government security operation at Pearl Roundabout become, in witnesses' words, a massacre that left families with no justice?

In this episode, we lay out the timeline, the people, and the official findings that describe what happened between 3:00 a.m. and 9:30 a.m. on February 17, 2011, and ask how documented conclusions can coexist with unanswered questions about accountability.

Date: February 17, 2011
Location: Pearl Roundabout, Manama
Event: Dawn raid by security forces
Case: Four protesters killed; no convictions
Commission: Royal investigative commission created by the king

- Approximately 1,000 officers moved in from two directions at about 3:00 a.m., carrying sticks, shields, sound bombs, tear gas, and shotguns.
- More than 100 officers wore plainclothes; the National Security Agency and the Bahrain Defence Force were present.
- Four people who had gathered peacefully were killed between 3:00 a.m. and 9:30 a.m., and none of their killers were ever convicted.
- One victim, Ali Ahmed Moumen, 22, posted "My blood is sacrificed for my country" on Facebook hours before he was killed.
- The commission created by the king found that the four victims were unarmed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098280Fri, 31 Jul 2026 13:00:02 +0000Creator at ObomediaBefore Dawn: The Pearl Roundabout Killings That Left No Justice Before dawn, knives slit tent fabric and a fourteen-year-old named Jaffar slept beside his father - by 9:30 a.m. four peaceful protesters were dead and no one was ever convicted. How...
Before dawn, knives slit tent fabric and a fourteen-year-old named Jaffar slept beside his father - by 9:30 a.m. four peaceful protesters were dead and no one was ever convicted. How did a government security operation at Pearl Roundabout become, in witnesses' words, a massacre that left families with no justice?

In this episode, we lay out the timeline, the people, and the official findings that describe what happened between 3:00 a.m. and 9:30 a.m. on February 17, 2011, and ask how documented conclusions can coexist with unanswered questions about accountability.

Date: February 17, 2011
Location: Pearl Roundabout, Manama
Event: Dawn raid by security forces
Case: Four protesters killed; no convictions
Commission: Royal investigative commission created by the king

- Approximately 1,000 officers moved in from two directions at about 3:00 a.m., carrying sticks, shields, sound bombs, tear gas, and shotguns.
- More than 100 officers wore plainclothes; the National Security Agency and the Bahrain Defence Force were present.
- Four people who had gathered peacefully were killed between 3:00 a.m. and 9:30 a.m., and none of their killers were ever convicted.
- One victim, Ali Ahmed Moumen, 22, posted "My blood is sacrificed for my country" on Facebook hours before he was killed.
- The commission created by the king found that the four victims were unarmed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1197falsefullhttps://www.spreaker.com/episode/the-pin-that-proved-a-villain-how-thani-oruvan-was-born--73098278
A single displaced pin in a photograph of a former Miss World became the quietly terrifying image at the center of Thani Oruvan, a Tamil thriller released on August 28, 2015. The film was conceived in 2008, shot on celluloid across multiple Indian locations, and overcame a collapsed budget and a distributor who later walked away - so how did a tiny detail and massive obstacles create one of that year's most unsettling villains?

In this episode, we tell how a project greenlit by AGS Entertainment moved from a seven‑year concept to a finished film, following casting choices, production decisions, and financial crises, and we ask what the team sacrificed to keep their vision intact.

Person: Director Mohan Raja
Person: Lead actor Ravi Mohan
Person: Antagonist actor Arvind Swamy
Date: August 28, 2015 (film release)
Budget: Planned 15 crore rupees; final exceeded 20 crore rupees

- The concept for Thani Oruvan was first put into motion as early as 2008.
- Principal photography began on December 6, 2013, at Binny Mills in Chennai.
- Nayanthara was signed in Tamil 2013 to play opposite Ravi Mohan.
- Arvind Swamy was confirmed as the antagonist in Tamil 2014 after nearly two decades away from Tamil cinema.
- Director Mohan Raja and lead actor Ravi Mohan forfeited their salaries when the budget shortfall threatened production.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098278Thu, 30 Jul 2026 13:00:02 +0000Creator at ObomediaThe Pin That Proved a Villain: How Thani Oruvan Was Born A single displaced pin in a photograph of a former Miss World became the quietly terrifying image at the center of Thani Oruvan, a Tamil thriller released on August 28, 2015. The film was...
A single displaced pin in a photograph of a former Miss World became the quietly terrifying image at the center of Thani Oruvan, a Tamil thriller released on August 28, 2015. The film was conceived in 2008, shot on celluloid across multiple Indian locations, and overcame a collapsed budget and a distributor who later walked away - so how did a tiny detail and massive obstacles create one of that year's most unsettling villains?

In this episode, we tell how a project greenlit by AGS Entertainment moved from a seven‑year concept to a finished film, following casting choices, production decisions, and financial crises, and we ask what the team sacrificed to keep their vision intact.

Person: Director Mohan Raja
Person: Lead actor Ravi Mohan
Person: Antagonist actor Arvind Swamy
Date: August 28, 2015 (film release)
Budget: Planned 15 crore rupees; final exceeded 20 crore rupees

- The concept for Thani Oruvan was first put into motion as early as 2008.
- Principal photography began on December 6, 2013, at Binny Mills in Chennai.
- Nayanthara was signed in Tamil 2013 to play opposite Ravi Mohan.
- Arvind Swamy was confirmed as the antagonist in Tamil 2014 after nearly two decades away from Tamil cinema.
- Director Mohan Raja and lead actor Ravi Mohan forfeited their salaries when the budget shortfall threatened production.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1147falsefullhttps://www.spreaker.com/episode/they-gave-prisoners-lsd-for-77-days-who-consented--73098275
Astonishingly, for seventy-seven consecutive days in 1956 incarcerated men at the U.S. Public Health Service Hospital in Lexington, Kentucky, were dosed daily with LSD until by day three the drug stopped working and the researchers quadrupled the dose. Who were these men, how were they compensated, and what did "consent" mean inside a locked federal ward where access to opiates depended on cooperation?

In this episode, we lay out the facts documented in the record: the institutional setting, the lead researcher, the daily dosing schedule, and the missing disclosures that followed these experiments. How did published papers that shaped global drug policy omit the way subjects were paid, and what question about voluntary consent does that omission leave unanswered?

Person: Harris Isbell
Location: U.S. Public Health Service Hospital, Lexington, Kentucky
Period: 1956 (LSD dosing), Isbell director for 18 years starting 1945
Topic: Daily LSD dosing of incarcerated men and nondisclosure of compensation
Status: Research findings cited by World Health Organization and governments

- Seventy-seven consecutive days: daily LSD dosing occurred in 1956 inside a locked federal ward.
- By day three of dosing, the clinical record reports that LSD effects had nearly vanished due to rapid tolerance.
- Researchers responded to tolerance by quadrupling the LSD dose after the effect diminished.
- The Addiction Research Center published more than 125 papers while not disclosing that subjects were compensated with morphine and heroin.
- In 1962 Harris Isbell received the U.S. Public Health Service Meritorious Service Award and praise from Attorney General Robert F. Kennedy.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098275Wed, 29 Jul 2026 13:00:02 +0000Creator at ObomediaThey Gave Prisoners LSD for 77 Days - Who Consented? Astonishingly, for seventy-seven consecutive days in 1956 incarcerated men at the U.S. Public Health Service Hospital in Lexington, Kentucky, were dosed daily with LSD until by day three the drug...
Astonishingly, for seventy-seven consecutive days in 1956 incarcerated men at the U.S. Public Health Service Hospital in Lexington, Kentucky, were dosed daily with LSD until by day three the drug stopped working and the researchers quadrupled the dose. Who were these men, how were they compensated, and what did "consent" mean inside a locked federal ward where access to opiates depended on cooperation?

In this episode, we lay out the facts documented in the record: the institutional setting, the lead researcher, the daily dosing schedule, and the missing disclosures that followed these experiments. How did published papers that shaped global drug policy omit the way subjects were paid, and what question about voluntary consent does that omission leave unanswered?

Person: Harris Isbell
Location: U.S. Public Health Service Hospital, Lexington, Kentucky
Period: 1956 (LSD dosing), Isbell director for 18 years starting 1945
Topic: Daily LSD dosing of incarcerated men and nondisclosure of compensation
Status: Research findings cited by World Health Organization and governments

- Seventy-seven consecutive days: daily LSD dosing occurred in 1956 inside a locked federal ward.
- By day three of dosing, the clinical record reports that LSD effects had nearly vanished due to rapid tolerance.
- Researchers responded to tolerance by quadrupling the LSD dose after the effect diminished.
- The Addiction Research Center published more than 125 papers while not disclosing that subjects were compensated with morphine and heroin.
- In 1962 Harris Isbell received the U.S. Public Health Service Meritorious Service Award and praise from Attorney General Robert F. Kennedy.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1227falsefullhttps://www.spreaker.com/episode/when-routine-care-breaks-bones-the-case-that-made-medicine-law--73098271
A single hospital procedure left a voluntary patient with fractures of both acetabula after electroconvulsive therapy, and the court found no one at fault - a ruling that became the legal standard for medical negligence in England and Wales for six decades. What did the judge tell the jury that allowed routine omissions - no muscle relaxant, no restraints, and no warning - to be lawful, and who paid the price for that claim named only by a surname?

In this episode, we tell the story of the Bolam case, laying out the facts of the treatment, the missing safeguards, and the courtroom testimony that set a precedent. We track how professional norms about ECT, restraints, muscle relaxants and disclosure shaped the decision and ask whether following standard practice should ever be the last word in negligence.

Person: Mr Bolam
Event: Electroconvulsive therapy (ECT)
Injury: Fractures of both acetabula
Date: 1957
Location: Friern Hospital

- The patient was a voluntary inpatient who agreed to receive ECT.
- After the procedure he sustained fractures of the acetabula on both sides.
- Three measures were not used: no muscle relaxant drugs, no physical restraints, and no warning of fracture risk.
- By 1957, muscle relaxants were available but not universally used in ECT practice.
- The judge’s instruction to the jury produced a rule governing nearly every medical negligence claim in England and Wales for the next six decades.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098271Tue, 28 Jul 2026 13:00:02 +0000Creator at ObomediaWhen Routine Care Breaks Bones: The Case That Made Medicine Law A single hospital procedure left a voluntary patient with fractures of both acetabula after electroconvulsive therapy, and the court found no one at fault - a ruling that became the...
A single hospital procedure left a voluntary patient with fractures of both acetabula after electroconvulsive therapy, and the court found no one at fault - a ruling that became the legal standard for medical negligence in England and Wales for six decades. What did the judge tell the jury that allowed routine omissions - no muscle relaxant, no restraints, and no warning - to be lawful, and who paid the price for that claim named only by a surname?

In this episode, we tell the story of the Bolam case, laying out the facts of the treatment, the missing safeguards, and the courtroom testimony that set a precedent. We track how professional norms about ECT, restraints, muscle relaxants and disclosure shaped the decision and ask whether following standard practice should ever be the last word in negligence.

Person: Mr Bolam
Event: Electroconvulsive therapy (ECT)
Injury: Fractures of both acetabula
Date: 1957
Location: Friern Hospital

- The patient was a voluntary inpatient who agreed to receive ECT.
- After the procedure he sustained fractures of the acetabula on both sides.
- Three measures were not used: no muscle relaxant drugs, no physical restraints, and no warning of fracture risk.
- By 1957, muscle relaxants were available but not universally used in ECT practice.
- The judge’s instruction to the jury produced a rule governing nearly every medical negligence claim in England and Wales for the next six decades.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1078falsefullhttps://www.spreaker.com/episode/the-dollar-that-turned-orphans-into-patients-duplessis-quiet-theft--73098269
Fear and outrage: in 1940s Quebec a bureaucratic twist turned thousands of healthy children into certified psychiatric patients for an extra $1.50 a day-on paper, overnight. How did a law from 1909, a government order-in-council, and a higher federal psychiatric subsidy combine to reclassify entire orphanages and funnel millions to religious institutions, while the children remained trapped and unpaid?

In this episode, we tell the episode’s account of how policy, money, and authority reshaped lives in mid-century Quebec and outline the key events and actors that made reclassification possible. What exactly did the Loi sur les Asiles d'aliénés and the Duplessis government enable, and why were so many safeguards absent or complicit?

Person: Maurice Duplessis
Period: 1944-1959 (Duplessis’ final term)
Law: Loi sur les Asiles d'aliénés (enacted 1909)
Subsidy difference: $1.50 per child per day
Estimate received: ~70 million Canadian dollars (religious groups, per 1999 report)

- Federal subsidy for orphan care was $1.25 per child per day.
- Federal subsidy for psychiatric patients was $2.75 per patient per day.
- An order-in-council reclassified orphanages as psychiatric hospitals overnight.
- A 1960s commission found one third of 22,000 patients were certified for financial reasons.
- Lauzon and Poirier (1999) estimated religious groups received approximately $70,000,000 through the mechanism.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098269Mon, 27 Jul 2026 13:00:02 +0000Creator at ObomediaThe Dollar That Turned Orphans into Patients: Duplessis' Quiet Theft Fear and outrage: in 1940s Quebec a bureaucratic twist turned thousands of healthy children into certified psychiatric patients for an extra $1.50 a day-on paper, overnight. How...
Fear and outrage: in 1940s Quebec a bureaucratic twist turned thousands of healthy children into certified psychiatric patients for an extra $1.50 a day-on paper, overnight. How did a law from 1909, a government order-in-council, and a higher federal psychiatric subsidy combine to reclassify entire orphanages and funnel millions to religious institutions, while the children remained trapped and unpaid?

In this episode, we tell the episode’s account of how policy, money, and authority reshaped lives in mid-century Quebec and outline the key events and actors that made reclassification possible. What exactly did the Loi sur les Asiles d'aliénés and the Duplessis government enable, and why were so many safeguards absent or complicit?

Person: Maurice Duplessis
Period: 1944-1959 (Duplessis’ final term)
Law: Loi sur les Asiles d'aliénés (enacted 1909)
Subsidy difference: $1.50 per child per day
Estimate received: ~70 million Canadian dollars (religious groups, per 1999 report)

- Federal subsidy for orphan care was $1.25 per child per day.
- Federal subsidy for psychiatric patients was $2.75 per patient per day.
- An order-in-council reclassified orphanages as psychiatric hospitals overnight.
- A 1960s commission found one third of 22,000 patients were certified for financial reasons.
- Lauzon and Poirier (1999) estimated religious groups received approximately $70,000,000 through the mechanism.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1245falsefullhttps://www.spreaker.com/episode/000-silent-deaths-why-malpractice-cases-vanish-in-hospitals--73098263
Four hundred thousand preventable hospital deaths occur in the U.S. every year, while only seventeen thousand malpractice claims are filed - leaving roughly three hundred and eighty-three thousand deaths without legal action. How did a system emerge that filters out so many grieving families before they even reach a courtroom?

In this episode, we trace the gap between documented preventable deaths and filed claims, showing what families must prove to bring a malpractice case and why decades of reforms have failed to narrow that gap. What exactly are the five legal elements that keep most cases from ever being litigated?

Person: John T. James, PhD
Date: 1984 estimate and 2008 cost analysis
Event: First systemic estimate of preventable hospital deaths
Topic: Five legal elements required for malpractice claims
Country: United States

- Estimate in 1984: between 44,000 and 98,000 preventable hospital deaths per year
- Later analysis by John T. James, PhD: 400,000 preventable hospital deaths annually
- CDC estimate: 75,000 annual deaths from hospital-acquired infections
- Medicare data (2000-2002): 1.14 million patient-safety incidents among beneficiaries
- Filed malpractice claims per year: 17,000 compared with approximately 400,000 preventable deaths

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098263Sun, 26 Jul 2026 13:00:02 +0000Creator at Obomedia,000 Silent Deaths: Why Malpractice Cases Vanish in Hospitals Four hundred thousand preventable hospital deaths occur in the U.S. every year, while only seventeen thousand malpractice claims are filed - leaving roughly three hundred and...
Four hundred thousand preventable hospital deaths occur in the U.S. every year, while only seventeen thousand malpractice claims are filed - leaving roughly three hundred and eighty-three thousand deaths without legal action. How did a system emerge that filters out so many grieving families before they even reach a courtroom?

In this episode, we trace the gap between documented preventable deaths and filed claims, showing what families must prove to bring a malpractice case and why decades of reforms have failed to narrow that gap. What exactly are the five legal elements that keep most cases from ever being litigated?

Person: John T. James, PhD
Date: 1984 estimate and 2008 cost analysis
Event: First systemic estimate of preventable hospital deaths
Topic: Five legal elements required for malpractice claims
Country: United States

- Estimate in 1984: between 44,000 and 98,000 preventable hospital deaths per year
- Later analysis by John T. James, PhD: 400,000 preventable hospital deaths annually
- CDC estimate: 75,000 annual deaths from hospital-acquired infections
- Medicare data (2000-2002): 1.14 million patient-safety incidents among beneficiaries
- Filed malpractice claims per year: 17,000 compared with approximately 400,000 preventable deaths

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1153falsefullhttps://www.spreaker.com/episode/000-dead-17-000-lawsuits-why-justice-fails-hospital-victims--73098261
Nearly 400,000 Americans die in hospitals each year from preventable errors, while only about 17,000 malpractice lawsuits are filed annually-what stops grieving families from reaching a courtroom? How can a system meant to deliver accountability and compensation allow such a gap to persist?

In this episode, we lay out the evidence and narratives that trace the gap between patient harm and legal redress, from landmark studies in 1984 to Medicare and CDC data in the early 2000s, and ask what structural features of the medical liability system produce this outcome.

Person: John T. James, PhD
Date: 1984 study cited; Medicare data from 2000-2002; October 2008 cost analysis
Event: Estimated 400,000 preventable hospital deaths per year
Case: Approximately 17,000 malpractice lawsuits filed per year

- 400,000 is the estimated number of unnecessary deaths inside American hospitals per year, according to John T. James.
- 17,000 is the approximate number of medical malpractice lawsuits filed across the United States in the same year.
- 44,000-98,000 was the 1984 estimated annual deaths from preventable hospital errors reported in the medical literature.
- 1.14 million patient-safety incidents were recorded in Medicare data across 37 million hospitalizations between 2000 and 2002.
- 75,000 patients were estimated by the CDC to die annually from hospital-acquired infections.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098261Sat, 25 Jul 2026 13:00:02 +0000Creator at Obomedia,000 Dead, 17,000 Lawsuits: Why Justice Fails Hospital Victims Nearly 400,000 Americans die in hospitals each year from preventable errors, while only about 17,000 malpractice lawsuits are filed annually-what stops grieving families from reaching a...
Nearly 400,000 Americans die in hospitals each year from preventable errors, while only about 17,000 malpractice lawsuits are filed annually-what stops grieving families from reaching a courtroom? How can a system meant to deliver accountability and compensation allow such a gap to persist?

In this episode, we lay out the evidence and narratives that trace the gap between patient harm and legal redress, from landmark studies in 1984 to Medicare and CDC data in the early 2000s, and ask what structural features of the medical liability system produce this outcome.

Person: John T. James, PhD
Date: 1984 study cited; Medicare data from 2000-2002; October 2008 cost analysis
Event: Estimated 400,000 preventable hospital deaths per year
Case: Approximately 17,000 malpractice lawsuits filed per year

- 400,000 is the estimated number of unnecessary deaths inside American hospitals per year, according to John T. James.
- 17,000 is the approximate number of medical malpractice lawsuits filed across the United States in the same year.
- 44,000-98,000 was the 1984 estimated annual deaths from preventable hospital errors reported in the medical literature.
- 1.14 million patient-safety incidents were recorded in Medicare data across 37 million hospitalizations between 2000 and 2002.
- 75,000 patients were estimated by the CDC to die annually from hospital-acquired infections.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1282falsefullhttps://www.spreaker.com/episode/000-silent-deaths-how-hospitals-hide-preventable-patient-killings--73098259
More Americans die each year inside hospitals from preventable errors than from stroke or diabetes - a peer‑reviewed estimate puts the toll at 400,000 - yet only about 17,000 malpractice lawsuits are processed annually; how can a system that costs billions fail to account for most of these deaths?

In this episode, we lay out the data behind estimates of preventable hospital deaths, track how those numbers changed from 1984 to the 2000s, and explain the legal architecture that often leaves documented negligence without remedy; what explains the gap between the scale of harm and the number of cases pursued?

Person: John T. James
Topic: Preventable hospital deaths
Date: 1984-2004 (studies cited across these years)
Event: 17,000 malpractice lawsuits processed per year
Estimate: 400,000 annual deaths (peer‑reviewed aggregation)

- 400,000 annual deaths is John T. James’s peer‑reviewed estimate of preventable deaths inside American hospitals.
- 17,000 malpractice lawsuits are processed in the United States each year, according to the transcript.
- The CDC’s figure for hospital deaths from infections is 75,000, a smaller, more narrowly defined count.
- A 1984 study originally estimated between 44,000 and 98,000 annual hospital deaths from medical errors.
- One third of malpractice claims in a 2013 BMJ Open study involve failure to diagnose, with death being the most common outcome.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098259Fri, 24 Jul 2026 13:00:04 +0000Creator at Obomedia,000 Silent Deaths: How Hospitals Hide Preventable Patient Killings More Americans die each year inside hospitals from preventable errors than from stroke or diabetes - a peer‑reviewed estimate puts the toll at 400,000 - yet only about 17,000...
More Americans die each year inside hospitals from preventable errors than from stroke or diabetes - a peer‑reviewed estimate puts the toll at 400,000 - yet only about 17,000 malpractice lawsuits are processed annually; how can a system that costs billions fail to account for most of these deaths?

In this episode, we lay out the data behind estimates of preventable hospital deaths, track how those numbers changed from 1984 to the 2000s, and explain the legal architecture that often leaves documented negligence without remedy; what explains the gap between the scale of harm and the number of cases pursued?

Person: John T. James
Topic: Preventable hospital deaths
Date: 1984-2004 (studies cited across these years)
Event: 17,000 malpractice lawsuits processed per year
Estimate: 400,000 annual deaths (peer‑reviewed aggregation)

- 400,000 annual deaths is John T. James’s peer‑reviewed estimate of preventable deaths inside American hospitals.
- 17,000 malpractice lawsuits are processed in the United States each year, according to the transcript.
- The CDC’s figure for hospital deaths from infections is 75,000, a smaller, more narrowly defined count.
- A 1984 study originally estimated between 44,000 and 98,000 annual hospital deaths from medical errors.
- One third of malpractice claims in a 2013 BMJ Open study involve failure to diagnose, with death being the most common outcome.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1102falsefullhttps://www.spreaker.com/episode/000-preventable-hospital-deaths-why-only-17-000-sued--73098256
Four hundred thousand preventable hospital deaths occur every year in the United States, yet courts see only seventeen thousand medical malpractice claims in the same period - a gap that exposes how ordinary acts like a missed diagnosis become legally invisible. How can routine errors that researchers traced for decades translate into so few lawsuits?

In this episode, we lay out the scale of preventable harm documented by researchers from 1984 onward and explain the legal requirements that filter most cases out of court, asking why the architecture of tort law leaves so many deaths unaddressed.

Person: John T. James
Date: 1984
Topic: Preventable hospital deaths
Event: Journal of Patient Safety publication
Country: United States

- John T. James published an analysis in the Journal of Patient Safety estimating 400,000 preventable hospital deaths per year.
- A 1984 study estimated between 44,000 and 98,000 preventable deaths annually.
- The CDC found 75,000 deaths per year from hospital-acquired infections alone.
- Researchers using Medicare data identified 1.14 million adverse incidents across 37 million hospitalizations.
- Approximately 17,000 medical malpractice claims are recorded annually in American courts, not all resulting in compensation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098256Thu, 23 Jul 2026 13:00:13 +0000Creator at Obomedia,000 Preventable Hospital Deaths - Why Only 17,000 Sued? Four hundred thousand preventable hospital deaths occur every year in the United States, yet courts see only seventeen thousand medical malpractice claims in the same period - a gap that...
Four hundred thousand preventable hospital deaths occur every year in the United States, yet courts see only seventeen thousand medical malpractice claims in the same period - a gap that exposes how ordinary acts like a missed diagnosis become legally invisible. How can routine errors that researchers traced for decades translate into so few lawsuits?

In this episode, we lay out the scale of preventable harm documented by researchers from 1984 onward and explain the legal requirements that filter most cases out of court, asking why the architecture of tort law leaves so many deaths unaddressed.

Person: John T. James
Date: 1984
Topic: Preventable hospital deaths
Event: Journal of Patient Safety publication
Country: United States

- John T. James published an analysis in the Journal of Patient Safety estimating 400,000 preventable hospital deaths per year.
- A 1984 study estimated between 44,000 and 98,000 preventable deaths annually.
- The CDC found 75,000 deaths per year from hospital-acquired infections alone.
- Researchers using Medicare data identified 1.14 million adverse incidents across 37 million hospitalizations.
- Approximately 17,000 medical malpractice claims are recorded annually in American courts, not all resulting in compensation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1088falsefullhttps://www.spreaker.com/episode/000-dead-17-000-lawsuits-america-s-invisible-medical-justice-gap--73098254
Four hundred thousand people die in American hospitals every year from preventable causes, yet only seventeen thousand malpractice lawsuits are filed annually - a gap of 383,000 deaths with no legal reckoning. How can peer-reviewed science, CDC infection tallies, and documented patient-safety incidents coexist with a legal system that processes so few claims?

In this episode, we lay out the data and the system that produces that discrepancy, drawing on peer-reviewed research by John T. James, CDC figures, and large-sample Medicare analyses to ask why the law captures so little of the harm: is it procedural barriers, evidence rules, or something else?

Person: John T. James, PhD
Date: October 2008 (one-month hospital error cost study)
Period: 1984-2010s (history of patient-safety estimates)
Event: CDC documented 75,000 hospital-acquired infection deaths per year
Case: 2000-2002 study of 37 million Medicare hospitalizations identifying 1.14 million patient-safety incidents

- Peer-reviewed estimate: 400,000 preventable hospital deaths per year (John T. James)
- Lawsuits filed: approximately 17,000 malpractice claims per year nationwide
- One-month cost: $324,000,000 in additional hospital costs from medical errors (October 2008)
- CDC figure: 75,000 deaths per year from hospital-acquired infections alone
- Medicare study: 1.14 million patient-safety incidents found in 37 million hospitalizations (2000-2002)

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098254Wed, 22 Jul 2026 13:00:03 +0000Creator at Obomedia,000 Dead, 17,000 Lawsuits: America's Invisible Medical Justice Gap Four hundred thousand people die in American hospitals every year from preventable causes, yet only seventeen thousand malpractice lawsuits are filed annually - a gap of 383,000...
Four hundred thousand people die in American hospitals every year from preventable causes, yet only seventeen thousand malpractice lawsuits are filed annually - a gap of 383,000 deaths with no legal reckoning. How can peer-reviewed science, CDC infection tallies, and documented patient-safety incidents coexist with a legal system that processes so few claims?

In this episode, we lay out the data and the system that produces that discrepancy, drawing on peer-reviewed research by John T. James, CDC figures, and large-sample Medicare analyses to ask why the law captures so little of the harm: is it procedural barriers, evidence rules, or something else?

Person: John T. James, PhD
Date: October 2008 (one-month hospital error cost study)
Period: 1984-2010s (history of patient-safety estimates)
Event: CDC documented 75,000 hospital-acquired infection deaths per year
Case: 2000-2002 study of 37 million Medicare hospitalizations identifying 1.14 million patient-safety incidents

- Peer-reviewed estimate: 400,000 preventable hospital deaths per year (John T. James)
- Lawsuits filed: approximately 17,000 malpractice claims per year nationwide
- One-month cost: $324,000,000 in additional hospital costs from medical errors (October 2008)
- CDC figure: 75,000 deaths per year from hospital-acquired infections alone
- Medicare study: 1.14 million patient-safety incidents found in 37 million hospitalizations (2000-2002)

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1204falsefullhttps://www.spreaker.com/episode/midnight-collapse-how-simufilam-s-science-vanished-and-patients-waited--73098251
There is a slow-motion intellectual horror in this story: a drug tested by hundreds of Alzheimer's patients rested almost entirely on data from one lab, and by November 25, 2024 the Phase III trials had failed and simufilam was declared dead - but the original data was never produced. How did a molecule called simufilam and a protein called filamin A come to carry sixteen million dollars of public research investment, only to evaporate alongside a criminal case dropped at midnight?

In this episode, we trace the arc from laboratory claims to clinical trials and a midnight legal collapse. We lay out how a single research program shaped a company's entire strategy, how co-authorship linked academia to industry, and why investigators kept finding the same missing piece: no underlying data. What does it mean for patients and science when the foundation cannot be verified?

Person: Hoau-Yan Wang
Person: Lindsay Burns
Company: Cassava Sciences
Event: Phase III trials failed and simufilam discontinued
Date: November 25, 2024

- Simufilam (PTI-125) was named by the United States Adopted Names council in August 2020.
- More than hundreds of patients enrolled in open-label studies beginning March 2020.
- The foundational mechanism was described in two papers published in 2012 (Journal of Neuroscience) and 2017 (Neurobiology of Aging).
- The NIH granted Cassava Sciences funding in 2018 to pursue early clinical trials.
- Sixteen million dollars in public research funds were connected to the work centered on filamin A.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098251Wed, 22 Jul 2026 02:57:43 +0000Creator at ObomediaMidnight Collapse: How Simufilam's Science Vanished and Patients Waited There is a slow-motion intellectual horror in this story: a drug tested by hundreds of Alzheimer's patients rested almost entirely on data from one lab, and by November 25,...
There is a slow-motion intellectual horror in this story: a drug tested by hundreds of Alzheimer's patients rested almost entirely on data from one lab, and by November 25, 2024 the Phase III trials had failed and simufilam was declared dead - but the original data was never produced. How did a molecule called simufilam and a protein called filamin A come to carry sixteen million dollars of public research investment, only to evaporate alongside a criminal case dropped at midnight?

In this episode, we trace the arc from laboratory claims to clinical trials and a midnight legal collapse. We lay out how a single research program shaped a company's entire strategy, how co-authorship linked academia to industry, and why investigators kept finding the same missing piece: no underlying data. What does it mean for patients and science when the foundation cannot be verified?

Person: Hoau-Yan Wang
Person: Lindsay Burns
Company: Cassava Sciences
Event: Phase III trials failed and simufilam discontinued
Date: November 25, 2024

- Simufilam (PTI-125) was named by the United States Adopted Names council in August 2020.
- More than hundreds of patients enrolled in open-label studies beginning March 2020.
- The foundational mechanism was described in two papers published in 2012 (Journal of Neuroscience) and 2017 (Neurobiology of Aging).
- The NIH granted Cassava Sciences funding in 2018 to pursue early clinical trials.
- Sixteen million dollars in public research funds were connected to the work centered on filamin A.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1187falsefullhttps://www.spreaker.com/episode/where-did-the-simufilam-data-vanish-the-filamin-a-mystery--73098249
Hope for months of life was funded with sixteen million dollars in federal grants-yet investigators later found zero original data to support the mechanism behind simufilam. How did a drug program that enrolled hundreds, sparked four simultaneous investigations, and ended with the announcement “the drug did not work” come to rest on no surviving primary records?

In this episode, we tell the story of the filamin A hypothesis and the simufilam program, tracing how a single laboratory’s data became the foundation for clinical trials and multimillion-dollar NIH funding. What exactly vanished from the record, and what does that mean for the patients and science that relied on it?

Person: Hoau-Yan Wang
Person: Lindsay Burns
Institution: City University of New York (CUNY)
Company: Pain Therapeutics / Cassava Sciences
Amount: $16,000,000

- The NIH funding related to this program totaled sixteen million dollars.
- The filamin A mechanism was primarily reported by one lab led by Hoau-Yan Wang.
- Foundational papers on filamin A’s role were published in 2008 and 2009 in PLOS One.
- By March 2020 Cassava Sciences launched open-label studies of simufilam with enrolled patients.
- The program ended on November 25, 2024 with the announcement that the drug did not work.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098249Wed, 22 Jul 2026 02:57:31 +0000Creator at ObomediaWhere Did the Simufilam Data Vanish? The Filamin A Mystery Hope for months of life was funded with sixteen million dollars in federal grants-yet investigators later found zero original data to support the mechanism behind simufilam. How did a drug...
Hope for months of life was funded with sixteen million dollars in federal grants-yet investigators later found zero original data to support the mechanism behind simufilam. How did a drug program that enrolled hundreds, sparked four simultaneous investigations, and ended with the announcement “the drug did not work” come to rest on no surviving primary records?

In this episode, we tell the story of the filamin A hypothesis and the simufilam program, tracing how a single laboratory’s data became the foundation for clinical trials and multimillion-dollar NIH funding. What exactly vanished from the record, and what does that mean for the patients and science that relied on it?

Person: Hoau-Yan Wang
Person: Lindsay Burns
Institution: City University of New York (CUNY)
Company: Pain Therapeutics / Cassava Sciences
Amount: $16,000,000

- The NIH funding related to this program totaled sixteen million dollars.
- The filamin A mechanism was primarily reported by one lab led by Hoau-Yan Wang.
- Foundational papers on filamin A’s role were published in 2008 and 2009 in PLOS One.
- By March 2020 Cassava Sciences launched open-label studies of simufilam with enrolled patients.
- The program ended on November 25, 2024 with the announcement that the drug did not work.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1149falsefullhttps://www.spreaker.com/episode/0-5-mg-sic-vs-400-mg-aspirin-compound-unnamed-human-stakes-potential-psychedelic-antidepressant-but-unconfirmed--73098247
A single line in a paper flagged with a Latin mark calls out an impossible dose: half a milligram - one-eightieth the weight of an aspirin - and that unexplained number has haunted six decades of research into a drug that made rodents act like they'd taken LSD. How did a molecule that produced clear psychedelic-like effects in animals, yet caused uncontrollable vomiting and produced no psychedelic reports in humans at 25 mg, remain a pharmacological ghost in the literature?

In this episode, we trace the molecule’s arc from its first synthesis in 1966 through animal studies, receptor mapping, and the sparse human data, and we ask what stalled its path to clinical clarity - is the answer buried in an embargoed doctoral thesis or in the messy biology of serotonin receptors?

Person: quipazine
Date: first reported 1966
Event: registered head-twitch response in rodents by 1977
Dose reported in human volunteers: 25 mg orally with nausea and no LSD-like effects
Embargoed record: doctoral thesis at Columbia University embargoed until 2030

- The paper lists a dose of 0.5 mg, annotated with a Latin mark indicating doubt.
- Quipazine was first synthesized and reported in 1966.
- By 1977, quipazine produced the head-twitch response in rodents, a marker of 5-HT2A activation.
- Human volunteers given 25 mg orally reported nausea, flatulence, gastrointestinal discomfort, and diarrhea with no psychedelic subjective effects.
- A 1994 theoretical proposal suggested an anti-nausea drug could enable human testing, but the proposed test appears only in an anonymous, unverified report and a Columbia thesis embargoed until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098247Wed, 22 Jul 2026 02:57:19 +0000Creator at Obomedia0.5 mg "sic" vs 400 mg aspirin; compound unnamed; human stakes: potential psychedelic/antidepressant but unconfirmed A single line in a paper flagged with a Latin mark calls out an impossible dose: half a milligram - one-eightieth the weight of an...
A single line in a paper flagged with a Latin mark calls out an impossible dose: half a milligram - one-eightieth the weight of an aspirin - and that unexplained number has haunted six decades of research into a drug that made rodents act like they'd taken LSD. How did a molecule that produced clear psychedelic-like effects in animals, yet caused uncontrollable vomiting and produced no psychedelic reports in humans at 25 mg, remain a pharmacological ghost in the literature?

In this episode, we trace the molecule’s arc from its first synthesis in 1966 through animal studies, receptor mapping, and the sparse human data, and we ask what stalled its path to clinical clarity - is the answer buried in an embargoed doctoral thesis or in the messy biology of serotonin receptors?

Person: quipazine
Date: first reported 1966
Event: registered head-twitch response in rodents by 1977
Dose reported in human volunteers: 25 mg orally with nausea and no LSD-like effects
Embargoed record: doctoral thesis at Columbia University embargoed until 2030

- The paper lists a dose of 0.5 mg, annotated with a Latin mark indicating doubt.
- Quipazine was first synthesized and reported in 1966.
- By 1977, quipazine produced the head-twitch response in rodents, a marker of 5-HT2A activation.
- Human volunteers given 25 mg orally reported nausea, flatulence, gastrointestinal discomfort, and diarrhea with no psychedelic subjective effects.
- A 1994 theoretical proposal suggested an anti-nausea drug could enable human testing, but the proposed test appears only in an anonymous, unverified report and a Columbia thesis embargoed until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1216falsefullhttps://www.spreaker.com/episode/a-sealed-doctoral-thesis-at-columbia-holds-quipazine-s-secrets-until-2030-unreadable-by-anyone--73098245
A single molecule can feel like a locked room: quipazine is chemically simple yet, for sixty years, it has produced both antidepressant-like signals and full psychedelic-like effects while also causing severe projectile vomiting in primates - and a doctoral thesis submitted to Columbia in August 2025 that no one may read until 2030 claims to hold new answers. What did that researcher find about quipazine’s double-edged pharmacology, and why was the work sealed for five years?

In this episode, we follow the episode’s recorded timeline and experiments to show what is documented about quipazine’s history, its behavioral effects in animal models, and the specific pharmacological puzzle that stopped its development, asking whether the sealed thesis finally resolves why quipazine both mimics LSD in drug discrimination tests and provokes unmanageable emesis.

Person: James Winter
Date: August 2025
Event: Thesis submission to Columbia University library system
Period: 1960s-1994 (research history described)
Topic: Quipazine dual-receptor activity (5-HT2A and 5-HT3)

- Quipazine is synthesized from two compounds: two-chloroquinoline and piperazine.
- The doctoral thesis was submitted in August 2025 and sealed until 2030.
- By 1971 quipazine had published data showing antidepressant-like effects in animal models.
- In rodent drug discrimination tests quipazine fully substituted for LSD.
- In primate studies quipazine produced reliable projectile vomiting linked to 5-HT3 activation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098245Wed, 22 Jul 2026 02:57:07 +0000Creator at ObomediaA sealed doctoral thesis at Columbia holds quipazine's secrets until 2030 - unreadable by anyone A single molecule can feel like a locked room: quipazine is chemically simple yet, for sixty years, it has produced both antidepressant-like signals...
A single molecule can feel like a locked room: quipazine is chemically simple yet, for sixty years, it has produced both antidepressant-like signals and full psychedelic-like effects while also causing severe projectile vomiting in primates - and a doctoral thesis submitted to Columbia in August 2025 that no one may read until 2030 claims to hold new answers. What did that researcher find about quipazine’s double-edged pharmacology, and why was the work sealed for five years?

In this episode, we follow the episode’s recorded timeline and experiments to show what is documented about quipazine’s history, its behavioral effects in animal models, and the specific pharmacological puzzle that stopped its development, asking whether the sealed thesis finally resolves why quipazine both mimics LSD in drug discrimination tests and provokes unmanageable emesis.

Person: James Winter
Date: August 2025
Event: Thesis submission to Columbia University library system
Period: 1960s-1994 (research history described)
Topic: Quipazine dual-receptor activity (5-HT2A and 5-HT3)

- Quipazine is synthesized from two compounds: two-chloroquinoline and piperazine.
- The doctoral thesis was submitted in August 2025 and sealed until 2030.
- By 1971 quipazine had published data showing antidepressant-like effects in animal models.
- In rodent drug discrimination tests quipazine fully substituted for LSD.
- In primate studies quipazine produced reliable projectile vomiting linked to 5-HT3 activation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1190falsefullhttps://www.spreaker.com/episode/a-40-year-obstacle-nausea-kept-a-potentially-novel-psychedelic-class-from-being-tested-in-humans--73098242
The idea that a single side effect could block a whole line of psychedelic discovery is chilling: quipazine produced clear LSD-like signals in rodents and monkeys yet caused uncontrollable nausea in primates and humans. How did a molecule described in 1966, active at five distinct serotonin receptors, point toward psychedelic potential for forty years and still fail to open the door for human testing?

In this episode, we tell the story of quipazine from its first synthesis to the human trials that halted its promise, tracing why animal models misled researchers and what the simultaneous emergence of psychedelic behavior and violent vomiting in primates meant for translational science. Could a receptor profile that looks psychedelic on paper be rendered moot by a single dominant physiological response?

Person: anonymous human subject in 2007
Date: 1966 (first appearance in literature)
Compound: one-(2-quinolinyl)piperazine (quipazine, 2-QP)
Receptor targets: 5-HT3 agonism plus activity at 5-HT2A, 5-HT2B, 5-HT2C, and 5-HT1B
Dose in human trial: 25 mg orally

- Quipazine first appeared in the scientific literature in 1966 and was called one-(2-quinolinyl)piperazine (2-QP).
- In 1977, rodents dosed with quipazine displayed the head-twitch response, a reliable marker of 5-HT2A activation.
- Rodent drug-discrimination studies showed quipazine fully substituted for LSD, and LSD fully substituted for quipazine.
- Monkeys given quipazine showed LSD-like behavioral changes concurrently with projectile vomiting.
- Human subjects given 25 mg orally reported nausea, flatulence, gastrointestinal discomfort, and diarrhea with no perceptual alterations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098242Wed, 22 Jul 2026 02:56:55 +0000Creator at ObomediaA 40-year obstacle (nausea) kept a potentially novel psychedelic class from being tested in humans The idea that a single side effect could block a whole line of psychedelic discovery is chilling: quipazine produced clear LSD-like signals in...
The idea that a single side effect could block a whole line of psychedelic discovery is chilling: quipazine produced clear LSD-like signals in rodents and monkeys yet caused uncontrollable nausea in primates and humans. How did a molecule described in 1966, active at five distinct serotonin receptors, point toward psychedelic potential for forty years and still fail to open the door for human testing?

In this episode, we tell the story of quipazine from its first synthesis to the human trials that halted its promise, tracing why animal models misled researchers and what the simultaneous emergence of psychedelic behavior and violent vomiting in primates meant for translational science. Could a receptor profile that looks psychedelic on paper be rendered moot by a single dominant physiological response?

Person: anonymous human subject in 2007
Date: 1966 (first appearance in literature)
Compound: one-(2-quinolinyl)piperazine (quipazine, 2-QP)
Receptor targets: 5-HT3 agonism plus activity at 5-HT2A, 5-HT2B, 5-HT2C, and 5-HT1B
Dose in human trial: 25 mg orally

- Quipazine first appeared in the scientific literature in 1966 and was called one-(2-quinolinyl)piperazine (2-QP).
- In 1977, rodents dosed with quipazine displayed the head-twitch response, a reliable marker of 5-HT2A activation.
- Rodent drug-discrimination studies showed quipazine fully substituted for LSD, and LSD fully substituted for quipazine.
- Monkeys given quipazine showed LSD-like behavioral changes concurrently with projectile vomiting.
- Human subjects given 25 mg orally reported nausea, flatulence, gastrointestinal discomfort, and diarrhea with no perceptual alterations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1188falsefullhttps://www.spreaker.com/episode/the-drug-that-made-animals-trip-humans-couldn-t-stomach-it--73098237
Quipazine produced head-twitches and full drug-discrimination substitution in rodents and monkeys, yet in humans even 25 mg caused vomiting and intolerable gastrointestinal distress-could a molecule that clearly acted like a psychedelic in animals ever be tested safely in people?

In this episode, we trace quipazine’s six-decade arc from a 1966 antidepressant candidate to a legal, unscheduled compound that elicited LSD-like signatures in animals but failed every human escalation; can the gap between animal signals and human tolerability be bridged?

Person: quipazine
Date: 1966 (first literature appearance)
Date: 1977 (head-twitch results reported)
Date: 2007 (single anonymous human account reported)
Date: August 2025 (Columbia thesis completed; embargoed until 2030)

- Quipazine’s full systematic name is one-(two-quinolinyl)piperazine (two-QP).
- Quipazine is a strong agonist at the 5-HT3 receptor and weaker agonist at 5-HT2A, 5-HT2B, and 5-HT2C.
- In 1977 quipazine produced the head-twitch response in mice and rats, blocked by the 5-HT2A antagonist ketanserin.
- Quipazine fully substituted for LSD in drug-discrimination studies in rodents and substituted for DOM in rodents and monkeys.
- A documented human dose of 25 mg orally produced nausea, flatulence, gastrointestinal discomfort, diarrhea and prevented escalation to psychedelic thresholds.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098237Wed, 22 Jul 2026 02:56:43 +0000Creator at ObomediaThe Drug That Made Animals Trip - Humans Couldn't Stomach It Quipazine produced head-twitches and full drug-discrimination substitution in rodents and monkeys, yet in humans even 25 mg caused vomiting and intolerable gastrointestinal distress-could...
Quipazine produced head-twitches and full drug-discrimination substitution in rodents and monkeys, yet in humans even 25 mg caused vomiting and intolerable gastrointestinal distress-could a molecule that clearly acted like a psychedelic in animals ever be tested safely in people?

In this episode, we trace quipazine’s six-decade arc from a 1966 antidepressant candidate to a legal, unscheduled compound that elicited LSD-like signatures in animals but failed every human escalation; can the gap between animal signals and human tolerability be bridged?

Person: quipazine
Date: 1966 (first literature appearance)
Date: 1977 (head-twitch results reported)
Date: 2007 (single anonymous human account reported)
Date: August 2025 (Columbia thesis completed; embargoed until 2030)

- Quipazine’s full systematic name is one-(two-quinolinyl)piperazine (two-QP).
- Quipazine is a strong agonist at the 5-HT3 receptor and weaker agonist at 5-HT2A, 5-HT2B, and 5-HT2C.
- In 1977 quipazine produced the head-twitch response in mice and rats, blocked by the 5-HT2A antagonist ketanserin.
- Quipazine fully substituted for LSD in drug-discrimination studies in rodents and substituted for DOM in rodents and monkeys.
- A documented human dose of 25 mg orally produced nausea, flatulence, gastrointestinal discomfort, diarrhea and prevented escalation to psychedelic thresholds.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1162falsefullhttps://www.spreaker.com/episode/the-compound-that-vomited-before-it-could-become-magic--73098234
A lone human report claims a full psychedelic response to quipazine, a molecule that triggered LSD-like effects in rodents and primates for 60 years yet produced almost exclusively severe nausea in human tests - so how close did science come to a psychedelic that the body refused to tolerate? What stopped researchers from separating its emetic action from its serotonin two-A effects?

In this episode, we lay out the history and data around quipazine across decades of literature, showing what animal models predicted and what the single human record actually reported - and ask whether the nausea and psychedelic action could ever have been disentangled.

Person: Jerrold C. Winter
Date (first literature appearance): 1966
Chemical name: one-(2-quinolinyl)piperazine
Dose (human test): 25 mg orally
Reported human effects: nausea, flatulence, gastrointestinal discomfort, diarrhea

- First published in the scientific literature in 1966 and described as antidepressant-like by 1971.
- In 1977, animal studies showed quipazine produced head-twitch responses linked to serotonin 2A receptor activation.
- Ketanserin blocked quipazine’s head-twitch response, tying its psychedelic-like action to the 5-HT2A receptor.
- Human administration of 25 mg produced nausea, flatulence, gastrointestinal discomfort and diarrhea with no reported LSD-like subjective effects.
- A contested anecdote reported 0.5 mg producing mild mescaline-like effects plus dysphoria and nausea, noted as likely erroneous in the scientific record.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098234Wed, 22 Jul 2026 02:56:31 +0000Creator at ObomediaThe Compound That Vomited Before It Could Become Magic A lone human report claims a full psychedelic response to quipazine, a molecule that triggered LSD-like effects in rodents and primates for 60 years yet produced almost exclusively severe...
A lone human report claims a full psychedelic response to quipazine, a molecule that triggered LSD-like effects in rodents and primates for 60 years yet produced almost exclusively severe nausea in human tests - so how close did science come to a psychedelic that the body refused to tolerate? What stopped researchers from separating its emetic action from its serotonin two-A effects?

In this episode, we lay out the history and data around quipazine across decades of literature, showing what animal models predicted and what the single human record actually reported - and ask whether the nausea and psychedelic action could ever have been disentangled.

Person: Jerrold C. Winter
Date (first literature appearance): 1966
Chemical name: one-(2-quinolinyl)piperazine
Dose (human test): 25 mg orally
Reported human effects: nausea, flatulence, gastrointestinal discomfort, diarrhea

- First published in the scientific literature in 1966 and described as antidepressant-like by 1971.
- In 1977, animal studies showed quipazine produced head-twitch responses linked to serotonin 2A receptor activation.
- Ketanserin blocked quipazine’s head-twitch response, tying its psychedelic-like action to the 5-HT2A receptor.
- Human administration of 25 mg produced nausea, flatulence, gastrointestinal discomfort and diarrhea with no reported LSD-like subjective effects.
- A contested anecdote reported 0.5 mg producing mild mescaline-like effects plus dysphoria and nausea, noted as likely erroneous in the scientific record.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1241falsefullhttps://www.spreaker.com/episode/the-molecule-that-should-have-been-a-psychedelic-but-broke-researchers-stomachs--73098231
Half a milligram supposedly produced mescaline-like effects, but the same compound triggered dysphoria and relentless nausea instead; why did a molecule that activated classic psychedelic receptors become defined by stomach-upsetting side effects? What happened to quipazine between a 1966 synthesis and a thesis sealed until 2030?

In this episode, we trace quipazine’s fifty-year scientific arc from a 1966 arylpiperazine synthesis to animal and fragmentary human reports, and ask whether its mixed pharmacology doomed its clinical promise or simply redirected research toward its derivatives.

Person: quipazine (one-parenthesis-two-quinolinyl-parenthesis-piperazine)
Date: 1966 (synthesis)
Event: head-twitch response in rodents starting 1977
Receptor: primary agonism at 5-HT3 and agonism at 5-HT2A/2B/2C
Status: doctoral thesis on descendants embargoed until 2030

- Reported human dose anomaly: half a milligram claimed to produce low-dose mescaline-like effects, flagged with “sic.”
- Animal behavioral finding: quipazine produced a rapid, involuntary head-twitch response in mice, rats, and monkeys.
- Receptor-specific evidence: ketanserin blockade abolished quipazine-induced head-twitch response, implicating 5-HT2A activation.
- Pharmacological profile: notable potency at 5-HT3 plus agonism at 5-HT2A, 2B, 2C, inhibition of serotonin reuptake, and affinity at 5-HT1B and dopamine receptors.
- Archive detail: a 2025 doctoral thesis with the most detailed recent analysis of quipazine’s descendants is embargoed and sealed until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098231Wed, 22 Jul 2026 02:56:18 +0000Creator at ObomediaThe Molecule That Should Have Been a Psychedelic - But Broke Researchers' Stomachs Half a milligram supposedly produced mescaline-like effects, but the same compound triggered dysphoria and relentless nausea instead; why did a molecule that...
Half a milligram supposedly produced mescaline-like effects, but the same compound triggered dysphoria and relentless nausea instead; why did a molecule that activated classic psychedelic receptors become defined by stomach-upsetting side effects? What happened to quipazine between a 1966 synthesis and a thesis sealed until 2030?

In this episode, we trace quipazine’s fifty-year scientific arc from a 1966 arylpiperazine synthesis to animal and fragmentary human reports, and ask whether its mixed pharmacology doomed its clinical promise or simply redirected research toward its derivatives.

Person: quipazine (one-parenthesis-two-quinolinyl-parenthesis-piperazine)
Date: 1966 (synthesis)
Event: head-twitch response in rodents starting 1977
Receptor: primary agonism at 5-HT3 and agonism at 5-HT2A/2B/2C
Status: doctoral thesis on descendants embargoed until 2030

- Reported human dose anomaly: half a milligram claimed to produce low-dose mescaline-like effects, flagged with “sic.”
- Animal behavioral finding: quipazine produced a rapid, involuntary head-twitch response in mice, rats, and monkeys.
- Receptor-specific evidence: ketanserin blockade abolished quipazine-induced head-twitch response, implicating 5-HT2A activation.
- Pharmacological profile: notable potency at 5-HT3 plus agonism at 5-HT2A, 2B, 2C, inhibition of serotonin reuptake, and affinity at 5-HT1B and dopamine receptors.
- Archive detail: a 2025 doctoral thesis with the most detailed recent analysis of quipazine’s descendants is embargoed and sealed until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1136falsefullhttps://www.spreaker.com/episode/the-drug-that-turned-champions-into-cancer-labs--73098229
A drug abandoned by its maker for causing cancer in rodents reappeared years later as a performance miracle for athletes - and by 2011 it was selling on the black market for $1,000 per 10 grams. How did a compound with no approved human dose, hidden toxicity data, and links to multi-organ cancer end up in the bloodstream of champions across continents?

In this episode, we trace the compound's journey from GlaxoSmithKline and Ligand's lab work in 1992 through clinical trials and quiet abandonment in 2007, to Salk Institute research that revealed dramatic endurance gains and to its spread into professional sport. What sequence of discoveries, publications, and market forces turned a shelved pharmaceutical into a banned athletic drug?

Person: Ronald M. Evans
Date: 1992
Location: Salk Institute, California
Event: World Anti-Doping Agency ban in 2009
Topic: GW501516 (PPARδ agonist)

- GW501516 was first synthesized by GlaxoSmithKline and Ligand Pharmaceuticals in 1992.
- At 3 mg/kg/day, mice and rats developed rapid, multi-organ cancer during preclinical studies.
- Phase one and phase two human trials ran in 2000-2003, with program abandonment by GSK in 2007.
- Salk Institute published 2007 Cell papers showing dramatic increases in mice endurance via PGC-1α recruitment.
- By 2011 GW501516 sold on the black market for $1,000 per 10 grams and athletes in at least five sports across four continents tested positive.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098229Wed, 22 Jul 2026 02:56:07 +0000Creator at ObomediaThe Drug That Turned Champions Into Cancer Labs A drug abandoned by its maker for causing cancer in rodents reappeared years later as a performance miracle for athletes - and by 2011 it was selling on the black market for $1,000 per 10 grams. How...
A drug abandoned by its maker for causing cancer in rodents reappeared years later as a performance miracle for athletes - and by 2011 it was selling on the black market for $1,000 per 10 grams. How did a compound with no approved human dose, hidden toxicity data, and links to multi-organ cancer end up in the bloodstream of champions across continents?

In this episode, we trace the compound's journey from GlaxoSmithKline and Ligand's lab work in 1992 through clinical trials and quiet abandonment in 2007, to Salk Institute research that revealed dramatic endurance gains and to its spread into professional sport. What sequence of discoveries, publications, and market forces turned a shelved pharmaceutical into a banned athletic drug?

Person: Ronald M. Evans
Date: 1992
Location: Salk Institute, California
Event: World Anti-Doping Agency ban in 2009
Topic: GW501516 (PPARδ agonist)

- GW501516 was first synthesized by GlaxoSmithKline and Ligand Pharmaceuticals in 1992.
- At 3 mg/kg/day, mice and rats developed rapid, multi-organ cancer during preclinical studies.
- Phase one and phase two human trials ran in 2000-2003, with program abandonment by GSK in 2007.
- Salk Institute published 2007 Cell papers showing dramatic increases in mice endurance via PGC-1α recruitment.
- By 2011 GW501516 sold on the black market for $1,000 per 10 grams and athletes in at least five sports across four continents tested positive.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1123falsefullhttps://www.spreaker.com/episode/the-drug-that-made-champions-and-grew-tumors-in-mice--73098227
A single molecule could turn a human into an endurance machine while triggering rapid, multi-organ cancer in rodents; GW501516 was developed by a major pharmaceutical company, tested on human volunteers, and abandoned after animal studies showed tumors - so how did it become a black-market performance enhancer anyway?

In this episode, we tell the sequence of events from the lab bench to elite sport, showing the compound's development, clinical testing, abandoned program, and later high-profile endurance studies - and we ask how a cancer-flagged drug circulated to athletes without public warning.

Person: GlaxoSmithKline
Date: 2007
Location: Salk Institute
Topic: GW501516 / PPARδ agonist
Event: Phase I and II human trials completed

- GW501516 was first developed in 1992 in a collaboration between GlaxoSmithKline and Ligand Pharmaceuticals.
- Its potency was approximately 1 nanomolar and selectivity greater than 1,000-fold.
- Two phase two clinical studies had been completed by 2007 with human volunteers.
- Animal studies showed rapid multi-organ cancer in mice and rats at 3 mg/kg/day.
- Ronald M. Evans's Salk Institute study reported dramatic increases in endurance in mice using higher doses and was published in Cell.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098227Wed, 22 Jul 2026 02:55:55 +0000Creator at ObomediaThe Drug That Made Champions - and Grew Tumors in Mice A single molecule could turn a human into an endurance machine while triggering rapid, multi-organ cancer in rodents; GW501516 was developed by a major pharmaceutical company, tested on human...
A single molecule could turn a human into an endurance machine while triggering rapid, multi-organ cancer in rodents; GW501516 was developed by a major pharmaceutical company, tested on human volunteers, and abandoned after animal studies showed tumors - so how did it become a black-market performance enhancer anyway?

In this episode, we tell the sequence of events from the lab bench to elite sport, showing the compound's development, clinical testing, abandoned program, and later high-profile endurance studies - and we ask how a cancer-flagged drug circulated to athletes without public warning.

Person: GlaxoSmithKline
Date: 2007
Location: Salk Institute
Topic: GW501516 / PPARδ agonist
Event: Phase I and II human trials completed

- GW501516 was first developed in 1992 in a collaboration between GlaxoSmithKline and Ligand Pharmaceuticals.
- Its potency was approximately 1 nanomolar and selectivity greater than 1,000-fold.
- Two phase two clinical studies had been completed by 2007 with human volunteers.
- Animal studies showed rapid multi-organ cancer in mice and rats at 3 mg/kg/day.
- Ronald M. Evans's Salk Institute study reported dramatic increases in endurance in mice using higher doses and was published in Cell.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1287falsefullhttps://www.spreaker.com/episode/the-abandoned-mushroom-drug-that-perfected-deep-sleep-and-vanished--73098221
A single compound increased slow-wave sleep dramatically while matching morphine's pain relief without causing respiratory depression-yet it was abandoned twice. Derived conceptually from muscimol in Amanita muscaria and engineered as THIP/gaboxadol, it targeted a distinct delta-containing GABA-A receptor that mediates tonic inhibition; why did a drug that deepened restorative sleep and avoided typical sedative harms disappear from the clinic?

In this episode, we trace the documented history of gaboxadol: its chemical origins from work in the 1970s, early human trials across chronic pain, spasticity, anxiety and Huntington's disease, and the 1996 findings showing increased slow-wave sleep-so how did a molecule with such unique effects get set aside?

Person: Povl Krogsgaard-Larsen
Person: Alf Lancel
Event: Early human trials in the 1970s and early 1980s
Date: 1996 (publication of gaboxadol sleep results)
Compound: THIP (gaboxadol; 4,5,6,7-tetrahydroisoxazolo-pyridinol-3-ol)

- Gaboxadol was synthesized from insights about muscimol, the active agent in Amanita muscaria.
- Early trials in the 1970s and early 1980s tested gaboxadol for chronic pain, spasticity, anxiety, and Huntington's disease.
- Gaboxadol acts on GABA-A receptors containing the delta subunit, mediating tonic inhibition rather than synaptic phasic inhibition.
- The drug matched morphine's painkilling power without triggering respiratory depression, according to the transcript.
- In 1996 Alf Lancel reported that gaboxadol dramatically increased the duration and depth of slow-wave sleep in healthy volunteers.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098221Wed, 22 Jul 2026 02:55:43 +0000Creator at ObomediaThe Abandoned Mushroom Drug That Perfected Deep Sleep-and Vanished A single compound increased slow-wave sleep dramatically while matching morphine's pain relief without causing respiratory depression-yet it was abandoned twice. Derived...
A single compound increased slow-wave sleep dramatically while matching morphine's pain relief without causing respiratory depression-yet it was abandoned twice. Derived conceptually from muscimol in Amanita muscaria and engineered as THIP/gaboxadol, it targeted a distinct delta-containing GABA-A receptor that mediates tonic inhibition; why did a drug that deepened restorative sleep and avoided typical sedative harms disappear from the clinic?

In this episode, we trace the documented history of gaboxadol: its chemical origins from work in the 1970s, early human trials across chronic pain, spasticity, anxiety and Huntington's disease, and the 1996 findings showing increased slow-wave sleep-so how did a molecule with such unique effects get set aside?

Person: Povl Krogsgaard-Larsen
Person: Alf Lancel
Event: Early human trials in the 1970s and early 1980s
Date: 1996 (publication of gaboxadol sleep results)
Compound: THIP (gaboxadol; 4,5,6,7-tetrahydroisoxazolo-pyridinol-3-ol)

- Gaboxadol was synthesized from insights about muscimol, the active agent in Amanita muscaria.
- Early trials in the 1970s and early 1980s tested gaboxadol for chronic pain, spasticity, anxiety, and Huntington's disease.
- Gaboxadol acts on GABA-A receptors containing the delta subunit, mediating tonic inhibition rather than synaptic phasic inhibition.
- The drug matched morphine's painkilling power without triggering respiratory depression, according to the transcript.
- In 1996 Alf Lancel reported that gaboxadol dramatically increased the duration and depth of slow-wave sleep in healthy volunteers.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1185falsefullhttps://www.spreaker.com/episode/the-strange-rise-and-vanishing-of-urine-derived-estrone-treatments--73098218
Pregnancy urine became a pharmaceutical goldmine: by 1929 crystalline estrone was purified from pregnant women's urine and sold worldwide under names like Theelin and Progynon - yet estrone binds the estrogen receptor at only about 4% of estradiol's strength. How did a molecule so weak produce clear clinical reversals of surgical menopause, then disappear from most markets?

In this episode, we tell the story of how estrone moved from a 1927 discovery in a Berlin lab to a global medical product, the documented clinical successes in ovariectomized women, and the unresolved contradiction between clinical effect and receptor data. What hidden process explained the results that estrone itself could not?

Person: Bernhard Zondek and Selmar Aschheim
Date: 1927-1929
Location: Berlin; Europe and North America
Event: Purification and sale of crystalline estrone from pregnancy urine
Topic: Clinical use of estrone in ovariectomized women

- In 1927 researchers in Berlin discovered large quantities of estrogenic substances in pregnancy urine.
- By 1929 three manufacturers (Parke‑Davis, Schering, Squibb) were selling crystalline estrone as Theelin, Progynon, and Amniotin.
- Clinical trials in the 1930s recorded reversal of vaginal atrophy and reduction of vasomotor symptoms in ovariectomized women after estrone injections.
- Estrone's binding affinity to the estrogen receptor measured roughly 4% of estradiol's binding strength.
- Multiple companies (Abbott, Lilly, British Drug Houses, Organon, Paines and Byrne) marketed estrone products under different names across Europe, North America, and Asia.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098218Wed, 22 Jul 2026 02:55:30 +0000Creator at ObomediaThe Strange Rise and Vanishing of Urine‑Derived Estrone Treatments Pregnancy urine became a pharmaceutical goldmine: by 1929 crystalline estrone was purified from pregnant women's urine and sold worldwide under names like Theelin and Progynon - yet...
Pregnancy urine became a pharmaceutical goldmine: by 1929 crystalline estrone was purified from pregnant women's urine and sold worldwide under names like Theelin and Progynon - yet estrone binds the estrogen receptor at only about 4% of estradiol's strength. How did a molecule so weak produce clear clinical reversals of surgical menopause, then disappear from most markets?

In this episode, we tell the story of how estrone moved from a 1927 discovery in a Berlin lab to a global medical product, the documented clinical successes in ovariectomized women, and the unresolved contradiction between clinical effect and receptor data. What hidden process explained the results that estrone itself could not?

Person: Bernhard Zondek and Selmar Aschheim
Date: 1927-1929
Location: Berlin; Europe and North America
Event: Purification and sale of crystalline estrone from pregnancy urine
Topic: Clinical use of estrone in ovariectomized women

- In 1927 researchers in Berlin discovered large quantities of estrogenic substances in pregnancy urine.
- By 1929 three manufacturers (Parke‑Davis, Schering, Squibb) were selling crystalline estrone as Theelin, Progynon, and Amniotin.
- Clinical trials in the 1930s recorded reversal of vaginal atrophy and reduction of vasomotor symptoms in ovariectomized women after estrone injections.
- Estrone's binding affinity to the estrogen receptor measured roughly 4% of estradiol's binding strength.
- Multiple companies (Abbott, Lilly, British Drug Houses, Organon, Paines and Byrne) marketed estrone products under different names across Europe, North America, and Asia.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1129falsefullhttps://www.spreaker.com/episode/the-slow-release-drug-that-killed-healthy-hearts-one-injection-at-a-time--73098216
A slow-release estrogen injection raised estradiol in healthy men nearly seventeenfold within ninety days and left 16 of 21 developing cardiovascular complications despite pre-trial screening for heart disease. Which chemical design decision turned a therapeutic advantage-months-long dosing from a single injection-into a hidden cardiovascular hazard?

In this episode, we trace the molecule’s journey from a 1953 chemist’s paper to clinical use in 1956 and its role across indications, closing on the Mainz trial where men with advanced prostate cancer received monthly injections and unexpected vascular harm emerged. How did estradiol undecylate’s depot chemistry, dosage choices, and clinical uses conspire to produce those outcomes?

Person: Karl Junkmann
Date: 1953
Location: Mainz, Germany
Trial: Jacobi study (phase three multicenter randomized controlled trial)
Dose range: 10-12.5 mg (40-60 days), 25-50 mg (2-4 months), 100 mg/month (prostate cancer studies)

- One injection of 10-12.5 mg remained active for 40-60 days due to depot formation in muscle.
- A single 100 mg/month regimen reduced testosterone from ~416 ng/dL to 38 ng/dL at three months (93% reduction).
- In the Mainz subgroup estradiol rose from 36 pg/mL baseline to 486 pg/mL at three months and 598 pg/mL at six months (≈17× increase).
- The Jacobi trial enrolled 191 patients across 12 centers and ran for six months comparing estradiol undecylate to cyproterone acetate.
- Sixteen of twenty-one men in the Mainz subgroup developed cardiovascular complications despite being screened as free of prior heart disease.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098216Wed, 22 Jul 2026 02:55:19 +0000Creator at ObomediaThe Slow-Release Drug That Killed Healthy Hearts, One Injection at a Time A slow-release estrogen injection raised estradiol in healthy men nearly seventeenfold within ninety days and left 16 of 21 developing cardiovascular complications despite...
A slow-release estrogen injection raised estradiol in healthy men nearly seventeenfold within ninety days and left 16 of 21 developing cardiovascular complications despite pre-trial screening for heart disease. Which chemical design decision turned a therapeutic advantage-months-long dosing from a single injection-into a hidden cardiovascular hazard?

In this episode, we trace the molecule’s journey from a 1953 chemist’s paper to clinical use in 1956 and its role across indications, closing on the Mainz trial where men with advanced prostate cancer received monthly injections and unexpected vascular harm emerged. How did estradiol undecylate’s depot chemistry, dosage choices, and clinical uses conspire to produce those outcomes?

Person: Karl Junkmann
Date: 1953
Location: Mainz, Germany
Trial: Jacobi study (phase three multicenter randomized controlled trial)
Dose range: 10-12.5 mg (40-60 days), 25-50 mg (2-4 months), 100 mg/month (prostate cancer studies)

- One injection of 10-12.5 mg remained active for 40-60 days due to depot formation in muscle.
- A single 100 mg/month regimen reduced testosterone from ~416 ng/dL to 38 ng/dL at three months (93% reduction).
- In the Mainz subgroup estradiol rose from 36 pg/mL baseline to 486 pg/mL at three months and 598 pg/mL at six months (≈17× increase).
- The Jacobi trial enrolled 191 patients across 12 centers and ran for six months comparing estradiol undecylate to cyproterone acetate.
- Sixteen of twenty-one men in the Mainz subgroup developed cardiovascular complications despite being screened as free of prior heart disease.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1200falsefullhttps://www.spreaker.com/episode/the-one-injection-that-silenced-hearts-the-long-acting-estrogen-tragedy--73098198
A single 100 mg oil-suspended injection promised up to four months of estradiol release, yet a clinical trial reported 76% cardiovascular complications and two deaths in one arm-what went wrong with a drug once hailed as elegant? How did a molecule designed to cling to fat and release predictably become lethal to the heart?

In this episode, we lay out the clinical record, patents, and trial data that chart estradiol undecylate’s rise from 1953 chemistry to worldwide use and its catastrophic trial results-what does the Mainz trial reveal about the risks of long-acting estrogens?

Person: Karl Junkmann
Date: 1953 (description of estradiol undecylate)
Location: University of Mainz (trial site)
Status: No longer manufactured anywhere in the world
Topic: Estradiol undecylate clinical use and trial outcomes

- One injection contained 100 milligrams of estradiol undecylate suspended in oil.
- The compound could release estrogen into the bloodstream for up to four months from a single dose.
- In the Mainz trial, 76% of men in one treatment arm suffered cardiovascular complications.
- Two participants in that treatment arm died.
- Women with breast cancer were treated with doses of 200 mg injected three times per week, totaling roughly 2400 mg per month.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098198Wed, 22 Jul 2026 02:55:07 +0000Creator at ObomediaThe One Injection That Silenced Hearts: The Long‑Acting Estrogen Tragedy A single 100 mg oil-suspended injection promised up to four months of estradiol release, yet a clinical trial reported 76% cardiovascular complications and two deaths in one...
A single 100 mg oil-suspended injection promised up to four months of estradiol release, yet a clinical trial reported 76% cardiovascular complications and two deaths in one arm-what went wrong with a drug once hailed as elegant? How did a molecule designed to cling to fat and release predictably become lethal to the heart?

In this episode, we lay out the clinical record, patents, and trial data that chart estradiol undecylate’s rise from 1953 chemistry to worldwide use and its catastrophic trial results-what does the Mainz trial reveal about the risks of long-acting estrogens?

Person: Karl Junkmann
Date: 1953 (description of estradiol undecylate)
Location: University of Mainz (trial site)
Status: No longer manufactured anywhere in the world
Topic: Estradiol undecylate clinical use and trial outcomes

- One injection contained 100 milligrams of estradiol undecylate suspended in oil.
- The compound could release estrogen into the bloodstream for up to four months from a single dose.
- In the Mainz trial, 76% of men in one treatment arm suffered cardiovascular complications.
- Two participants in that treatment arm died.
- Women with breast cancer were treated with doses of 200 mg injected three times per week, totaling roughly 2400 mg per month.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1333falsefullhttps://www.spreaker.com/episode/the-tiny-frog-that-almost-rewrote-pain-medicine-and-vanished--73098194
A tiny Ecuadorian frog carried less than one milligram of a compound more than 200 times as potent as morphine, non‑addictive in effect, and possibly capable of changing pain medicine - yet science still cannot confirm the substance’s molecular identity. How did three thousand collected frog skins yield a pharmacological miracle that vanished into a chemical ghost, and what stopped it from becoming a drug?

In this episode, we trace the fieldwork, laboratory struggles, and legal and ecological limits that shaped the discovery and disappearance of epibatidine. We follow John W. Daly’s decades-long path from forest collections to mouse analgesia tests, and ask whether the promise locked on a frog’s skin could ever have been realized.

Person: John W. Daly
Species: Epipedobates anthonyi
Compound: epibatidine (unconfirmed molecular structure)
Total extract recovered: less than 1 milligram
Fieldwork span: 1974-1979

- Daly and colleague Charles Myers processed approximately 3,000 frog skins across multiple Ecuador sites.
- Initial skin preparations injected into mice produced clear, reproducible opioid-like analgesia.
- The compound observed was reported as over 200 times as potent as morphine and described as non‑addictive in action.
- In 1976, frogs from one collection site produced zero analgesic effect, indicating the compound depended on diet.
- By 1984 Epipedobates anthonyi received protected IUCN status, severely restricting further wild collection.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098194Wed, 22 Jul 2026 02:54:55 +0000Creator at ObomediaThe Tiny Frog That Almost Rewrote Pain Medicine-and Vanished A tiny Ecuadorian frog carried less than one milligram of a compound more than 200 times as potent as morphine, non‑addictive in effect, and possibly capable of changing pain medicine -...
A tiny Ecuadorian frog carried less than one milligram of a compound more than 200 times as potent as morphine, non‑addictive in effect, and possibly capable of changing pain medicine - yet science still cannot confirm the substance’s molecular identity. How did three thousand collected frog skins yield a pharmacological miracle that vanished into a chemical ghost, and what stopped it from becoming a drug?

In this episode, we trace the fieldwork, laboratory struggles, and legal and ecological limits that shaped the discovery and disappearance of epibatidine. We follow John W. Daly’s decades-long path from forest collections to mouse analgesia tests, and ask whether the promise locked on a frog’s skin could ever have been realized.

Person: John W. Daly
Species: Epipedobates anthonyi
Compound: epibatidine (unconfirmed molecular structure)
Total extract recovered: less than 1 milligram
Fieldwork span: 1974-1979

- Daly and colleague Charles Myers processed approximately 3,000 frog skins across multiple Ecuador sites.
- Initial skin preparations injected into mice produced clear, reproducible opioid-like analgesia.
- The compound observed was reported as over 200 times as potent as morphine and described as non‑addictive in action.
- In 1976, frogs from one collection site produced zero analgesic effect, indicating the compound depended on diet.
- By 1984 Epipedobates anthonyi received protected IUCN status, severely restricting further wild collection.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1220falsefullhttps://www.spreaker.com/episode/the-vial-that-vanished-the-painkiller-hidden-in-a-grain-of-dust--73098192
The smallest residue in a glass vial-less than one milligram, smaller than a grain of salt-might be the only remaining trace of a natural painkiller up to 2,900 times more potent than morphine. If the frogs never produced it themselves but accumulated it from their diet, then every milligram ever extracted came from a finite wild harvest-so what really lived in that vial, and did it ever exist in nature at all?

In this episode, we follow the timeline from John W. Daly's 1974 fieldwork in Ecuador to the last fragile sample in 1991, tracing how a compound named epibatidine moved from amphibian skins to laboratory vials and into scientific controversy, and asking whether the molecule could be recreated or was lost to environmental circumstance.

Person: John W. Daly
Location: Ecuador
Species: Epipedobates anthonyi
Period: 1974-1991
Event: Less than 1 milligram remaining in 1991 vial

- Approximately 3,000 frog skins were collected across Ecuador between 1974 and 1979.
- Epibatidine showed analgesic efficacy measured as about 2,900 times greater than morphine in one rodent study.
- A more conservative potency estimate placed epibatidine at about 200 times the strength of morphine.
- In 1976, frogs from one collection site produced no epibatidine, indicating dietary acquisition rather than endogenous production.
- By 1984 the IUCN had moved to protect the species, effectively halting large-scale collection and fixing natural supply.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098192Wed, 22 Jul 2026 02:54:42 +0000Creator at ObomediaThe Vial That Vanished: The Painkiller Hidden in a Grain of Dust The smallest residue in a glass vial-less than one milligram, smaller than a grain of salt-might be the only remaining trace of a natural painkiller up to 2,900 times more potent than...
The smallest residue in a glass vial-less than one milligram, smaller than a grain of salt-might be the only remaining trace of a natural painkiller up to 2,900 times more potent than morphine. If the frogs never produced it themselves but accumulated it from their diet, then every milligram ever extracted came from a finite wild harvest-so what really lived in that vial, and did it ever exist in nature at all?

In this episode, we follow the timeline from John W. Daly's 1974 fieldwork in Ecuador to the last fragile sample in 1991, tracing how a compound named epibatidine moved from amphibian skins to laboratory vials and into scientific controversy, and asking whether the molecule could be recreated or was lost to environmental circumstance.

Person: John W. Daly
Location: Ecuador
Species: Epipedobates anthonyi
Period: 1974-1991
Event: Less than 1 milligram remaining in 1991 vial

- Approximately 3,000 frog skins were collected across Ecuador between 1974 and 1979.
- Epibatidine showed analgesic efficacy measured as about 2,900 times greater than morphine in one rodent study.
- A more conservative potency estimate placed epibatidine at about 200 times the strength of morphine.
- In 1976, frogs from one collection site produced no epibatidine, indicating dietary acquisition rather than endogenous production.
- By 1984 the IUCN had moved to protect the species, effectively halting large-scale collection and fixing natural supply.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1098falsefullhttps://www.spreaker.com/episode/how-a-perfectly-safe-drug-became-america-s-most-forbidden-molecule--73098190
A single chemist's small molecular tweak produced a compound that never failed a clinical safety test yet was placed on the United States' most restricted roster in February 1973 - how did that happen, and who decided the science no longer mattered? This episode traces DOET from Alexander Shulgin's lab notes and three favorable peer-reviewed trials to a vanished patent and a legal collapse that derailed its development.

In this episode, we follow the timeline of DOET's discovery, the institutional research path at Dow and Johns Hopkins, and the external events that altered the social and legal landscape for related compounds, asking how nonclinical events overturned clinical promise.

Person: Alexander Shulgin
Person: Solomon H. Snyder
Date: February 1973
Date: 1966 (patent filing for DOET)
Event: Distribution of DOM as STP in summer 1967

- Shulgin synthesized DOM in 1963 and confirmed its psychedelic effects by self-testing in 1964.
- In 1966 Dow filed a patent for DOET and described its potential pharmaceutical applications.
- Three peer-reviewed human trials on DOET returned favorable results with no documented clinical harms.
- LSD was made illegal in California in 1966, the same year DOET's patent was filed.
- In summer 1967 Owsley Stanley distributed DOM as STP at doses two to three times higher than clinical levels.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098190Wed, 22 Jul 2026 02:54:31 +0000Creator at ObomediaHow a Perfectly Safe Drug Became America's Most Forbidden Molecule A single chemist's small molecular tweak produced a compound that never failed a clinical safety test yet was placed on the United States' most restricted roster in February 1973 -...
A single chemist's small molecular tweak produced a compound that never failed a clinical safety test yet was placed on the United States' most restricted roster in February 1973 - how did that happen, and who decided the science no longer mattered? This episode traces DOET from Alexander Shulgin's lab notes and three favorable peer-reviewed trials to a vanished patent and a legal collapse that derailed its development.

In this episode, we follow the timeline of DOET's discovery, the institutional research path at Dow and Johns Hopkins, and the external events that altered the social and legal landscape for related compounds, asking how nonclinical events overturned clinical promise.

Person: Alexander Shulgin
Person: Solomon H. Snyder
Date: February 1973
Date: 1966 (patent filing for DOET)
Event: Distribution of DOM as STP in summer 1967

- Shulgin synthesized DOM in 1963 and confirmed its psychedelic effects by self-testing in 1964.
- In 1966 Dow filed a patent for DOET and described its potential pharmaceutical applications.
- Three peer-reviewed human trials on DOET returned favorable results with no documented clinical harms.
- LSD was made illegal in California in 1966, the same year DOET's patent was filed.
- In summer 1967 Owsley Stanley distributed DOM as STP at doses two to three times higher than clinical levels.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1283falsefullhttps://www.spreaker.com/episode/the-molecule-that-should-have-been-a-medicine-then-vanished--73098188
A molecule tested at Johns Hopkins showed no open‑eyed hallucinations across three published trials, yet it was scheduled as a controlled substance before the final paper appeared - how did a compound that seemed safer than other psychedelics disappear from development? This episode traces the unlikely arc from a Dow chemist’s laboratory to the streets of San Francisco and asks: which decisions - legal, personal, or accidental - truly ended this drug's future?

In this episode, we lay out the chronological facts behind the compound's discovery, early human testing, corporate development, and abrupt regulatory fate, following the people and events that intersected with that history and asking how the science and the law came to such different conclusions.

Person: Alexander Shulgin
Person: Solomon Snyder
Date: 1963 (synthesis of DOM); 1964 (discovery of DOM effects); 1965 (Dow selected DOET for development); 1966 (patent filed; LSD illegal in California)
Location: Johns Hopkins University (clinical trials); Dow Chemical (research)
Event: Publication of three trials showing no open‑eyed hallucinations; scheduling before third trial printed

- Shulgin synthesized DOM in 1963 and altered its 4‑position methyl group to an ethyl to create DOET.
- Shulgin self‑administered DOET and reported mood brightening and sharpened attention without hallucinations at low doses.
- A colleague given approximately the same dose reported profound lethargy and depression, documenting individual variability.
- Dow selected DOET for clinical development and assigned trials to Solomon Snyder around 1965.
- The compound was scheduled as a dangerous controlled substance before the third published trial had appeared; the patent appeared in 1970.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098188Wed, 22 Jul 2026 02:54:19 +0000Creator at ObomediaThe Molecule That Should Have Been a Medicine - Then Vanished A molecule tested at Johns Hopkins showed no open‑eyed hallucinations across three published trials, yet it was scheduled as a controlled substance before the final paper appeared - how...
A molecule tested at Johns Hopkins showed no open‑eyed hallucinations across three published trials, yet it was scheduled as a controlled substance before the final paper appeared - how did a compound that seemed safer than other psychedelics disappear from development? This episode traces the unlikely arc from a Dow chemist’s laboratory to the streets of San Francisco and asks: which decisions - legal, personal, or accidental - truly ended this drug's future?

In this episode, we lay out the chronological facts behind the compound's discovery, early human testing, corporate development, and abrupt regulatory fate, following the people and events that intersected with that history and asking how the science and the law came to such different conclusions.

Person: Alexander Shulgin
Person: Solomon Snyder
Date: 1963 (synthesis of DOM); 1964 (discovery of DOM effects); 1965 (Dow selected DOET for development); 1966 (patent filed; LSD illegal in California)
Location: Johns Hopkins University (clinical trials); Dow Chemical (research)
Event: Publication of three trials showing no open‑eyed hallucinations; scheduling before third trial printed

- Shulgin synthesized DOM in 1963 and altered its 4‑position methyl group to an ethyl to create DOET.
- Shulgin self‑administered DOET and reported mood brightening and sharpened attention without hallucinations at low doses.
- A colleague given approximately the same dose reported profound lethargy and depression, documenting individual variability.
- Dow selected DOET for clinical development and assigned trials to Solomon Snyder around 1965.
- The compound was scheduled as a dangerous controlled substance before the third published trial had appeared; the patent appeared in 1970.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1355falsefullhttps://www.spreaker.com/episode/when-a-street-panic-silenced-a-potential-psychedelic-medicine--73098184
A single corporate decision erased a patent for a compound that promised antidepressant effects without hallucinations. DOET, nicknamed Hecate, showed a therapeutic window estimated at five-fold or greater and produced no open-eye hallucinations in controlled tests - so why was it abandoned before it could become medicine?

In this episode, we trace the timeline from a 1966 patent filing through company withdrawal and a 1968 Johns Hopkins trial, asking how external social panic over a related street drug redirected scientific progress. What happened between bench notes and boardroom memos that ended DOET’s chances?

Person: Alexander Shulgin
Organization: Dow Chemical
Person: Solomon Snyder
Date: 1966
Date: 1968

- DOET (Hecate) patent filed by Dow Chemical in 1966.
- Shulgin estimated DOET’s therapeutic window at five-fold or greater compared to LSD and DOM’s two-to-three-fold.
- Johns Hopkins trial published in 1968 used 1.5 mg DOET hydrochloride orally.
- Reported onset in trial: 1 to 1.5 hours; peak duration: 3 to 4 hours; total resolution: 5 to 6 hours.
- Dow terminated the DOET program in 1968 after public crises linked to high-dose DOM (STP) in San Francisco.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098184Wed, 22 Jul 2026 02:54:07 +0000Creator at ObomediaWhen a Street Panic Silenced a Potential Psychedelic Medicine A single corporate decision erased a patent for a compound that promised antidepressant effects without hallucinations. DOET, nicknamed Hecate, showed a therapeutic window estimated at...
A single corporate decision erased a patent for a compound that promised antidepressant effects without hallucinations. DOET, nicknamed Hecate, showed a therapeutic window estimated at five-fold or greater and produced no open-eye hallucinations in controlled tests - so why was it abandoned before it could become medicine?

In this episode, we trace the timeline from a 1966 patent filing through company withdrawal and a 1968 Johns Hopkins trial, asking how external social panic over a related street drug redirected scientific progress. What happened between bench notes and boardroom memos that ended DOET’s chances?

Person: Alexander Shulgin
Organization: Dow Chemical
Person: Solomon Snyder
Date: 1966
Date: 1968

- DOET (Hecate) patent filed by Dow Chemical in 1966.
- Shulgin estimated DOET’s therapeutic window at five-fold or greater compared to LSD and DOM’s two-to-three-fold.
- Johns Hopkins trial published in 1968 used 1.5 mg DOET hydrochloride orally.
- Reported onset in trial: 1 to 1.5 hours; peak duration: 3 to 4 hours; total resolution: 5 to 6 hours.
- Dow terminated the DOET program in 1968 after public crises linked to high-dose DOM (STP) in San Francisco.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1243falsefullhttps://www.spreaker.com/episode/when-a-single-carbon-killed-a-drug-the-doet-molecule-s-lost-promise--73098182
A single-carbon change turned DOM into DOET - a molecule that produced clear-headed euphoria in one test and deep lethargy in another - yet it never reached patients because a separate street crisis exploded. How did a San Francisco outbreak tied to an entirely different compound bury a promising pharmaceutical before science could finish it?

In this episode, we trace the path from a Dow Chemical lab to a Schedule I classification, following patent filings, a contested disclosure to a clandestine manufacturer, and a halted clinical program. What was lost to medicine when DOET vanished under the weight of a public health scandal?

Person: Alexander Shulgin
Person: Owsley Stanley
Institution: Dow Chemical
Date: 1966
Dose: 1.5 milligrams

- Shulgin synthesized DOM in 1963 and discovered its psychedelic properties in 1964.
- Shulgin modified DOM at the four-position (methyl to ethyl) to create DOET in 1964-1965.
- Shulgin filed a patent for DOET with Dow Chemical in 1966.
- Owsley Stanley synthesized high-dose DOM tablets distributed in San Francisco in 1967 under the name STP, causing hospitalizations and a public health crisis.
- Johns Hopkins neuroscientist Solomon H. Snyder administered 1.5 mg of DOET in the first controlled human trial and reported mild euphoria.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098182Wed, 22 Jul 2026 02:53:55 +0000Creator at ObomediaWhen a Single Carbon Killed a Drug: The DOET Molecule's Lost Promise A single-carbon change turned DOM into DOET - a molecule that produced clear-headed euphoria in one test and deep lethargy in another - yet it never reached patients because a...
A single-carbon change turned DOM into DOET - a molecule that produced clear-headed euphoria in one test and deep lethargy in another - yet it never reached patients because a separate street crisis exploded. How did a San Francisco outbreak tied to an entirely different compound bury a promising pharmaceutical before science could finish it?

In this episode, we trace the path from a Dow Chemical lab to a Schedule I classification, following patent filings, a contested disclosure to a clandestine manufacturer, and a halted clinical program. What was lost to medicine when DOET vanished under the weight of a public health scandal?

Person: Alexander Shulgin
Person: Owsley Stanley
Institution: Dow Chemical
Date: 1966
Dose: 1.5 milligrams

- Shulgin synthesized DOM in 1963 and discovered its psychedelic properties in 1964.
- Shulgin modified DOM at the four-position (methyl to ethyl) to create DOET in 1964-1965.
- Shulgin filed a patent for DOET with Dow Chemical in 1966.
- Owsley Stanley synthesized high-dose DOM tablets distributed in San Francisco in 1967 under the name STP, causing hospitalizations and a public health crisis.
- Johns Hopkins neuroscientist Solomon H. Snyder administered 1.5 mg of DOET in the first controlled human trial and reported mild euphoria.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1150falsefullhttps://www.spreaker.com/episode/the-drug-that-shouldn-t-exist-how-ariadne-vanished-after-300mg--73098178
A single extra carbon atom turned a known psychedelic into a molecule that, at 300 mg, produced clarity instead of hallucinations - and then disappeared from public view. What happened when Ariadne did something science said was impossible, and why was all trial data withheld?

In this episode, we tell the story of the molecule Ariadne and the scientist who created it, following the compound from synthesis through Phase Three trials and into the unexplained gap in the public record. How did a change of one carbon yield therapeutic effects without hallucination, and why did development stop?

Person: Alexander Shulgin
Date: 1968
Compound: Ariadne
Dose reported: 300 mg
Company involved: Bristol Laboratories

- Shulgin synthesized Ariadne in 1968 by replacing a methyl group with an ethyl group on DOM.
- DOM produces full psychedelia above 3 mg, while Ariadne at 300 mg produced no hallucinations.
- At 25-50 mg Ariadne caused increased mental alertness and well-being in subjects.
- At 50-100 mg researchers noted improvements in manic depression and psychotic presentations.
- At 100 mg per day Ariadne appeared to address symptoms of Parkinson’s disease.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098178Wed, 22 Jul 2026 02:53:43 +0000Creator at ObomediaThe Drug That Shouldn't Exist: How Ariadne Vanished After 300mg A single extra carbon atom turned a known psychedelic into a molecule that, at 300 mg, produced clarity instead of hallucinations - and then disappeared from public view. What happened...
A single extra carbon atom turned a known psychedelic into a molecule that, at 300 mg, produced clarity instead of hallucinations - and then disappeared from public view. What happened when Ariadne did something science said was impossible, and why was all trial data withheld?

In this episode, we tell the story of the molecule Ariadne and the scientist who created it, following the compound from synthesis through Phase Three trials and into the unexplained gap in the public record. How did a change of one carbon yield therapeutic effects without hallucination, and why did development stop?

Person: Alexander Shulgin
Date: 1968
Compound: Ariadne
Dose reported: 300 mg
Company involved: Bristol Laboratories

- Shulgin synthesized Ariadne in 1968 by replacing a methyl group with an ethyl group on DOM.
- DOM produces full psychedelia above 3 mg, while Ariadne at 300 mg produced no hallucinations.
- At 25-50 mg Ariadne caused increased mental alertness and well-being in subjects.
- At 50-100 mg researchers noted improvements in manic depression and psychotic presentations.
- At 100 mg per day Ariadne appeared to address symptoms of Parkinson’s disease.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1177falsefullhttps://www.spreaker.com/episode/the-girl-who-broke-hormones-how-an-epilepsy-drug-became-cancer-s-key--73098174
Aminoglutethimide silenced seizures - and within weeks it nearly silenced a young girl's adrenal glands, producing a clinical picture indistinguishable from Addison's disease. What began as an anticonvulsant trial turned into the first hint that a brain drug could dismantle the body's hormonal architecture; how did a molecule meant for neurons stop hormone production at its source?

In this episode, we tell how clinicians in 1963 documented a patient whose adrenal function collapsed after taking aminoglutethimide, and how that observation redirected thinking about the drug's effects on endocrine systems. Follow the clinical notes and chemical history that turned an epilepsy medication into a clue about steroid synthesis - and ask what mechanism could link a glutarimide to adrenal suppression?

Person: unnamed young female patient
Date: 1963
Drug: aminoglutethimide (Ba 16038, Ciba 16038; brand name Elipten)
Adverse effect frequency: 45-85% experienced at least one adverse effect
Specific severe effect frequency: ~10% experienced circulatory collapse/adrenal insufficiency

- Aminoglutethimide was introduced in 1960 and marketed as the anticonvulsant Elipten for petit mal epilepsy.
- Lethargy occurred in 31-70% of patients depending on dose.
- Approximately 10% of patients developed circulatory collapse with signs of adrenal insufficiency.
- Clinicians in 1963 recorded a patient with near-complete suppression of adrenal hormone production resembling Addison's disease.
- The compound belonged to the nonsteroidal glutarimide family and was chemically related to glutethimide and, more distantly, thalidomide.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098174Wed, 22 Jul 2026 02:53:31 +0000Creator at ObomediaThe Girl Who Broke Hormones: How an Epilepsy Drug Became Cancer's Key Aminoglutethimide silenced seizures - and within weeks it nearly silenced a young girl's adrenal glands, producing a clinical picture indistinguishable from Addison's disease....
Aminoglutethimide silenced seizures - and within weeks it nearly silenced a young girl's adrenal glands, producing a clinical picture indistinguishable from Addison's disease. What began as an anticonvulsant trial turned into the first hint that a brain drug could dismantle the body's hormonal architecture; how did a molecule meant for neurons stop hormone production at its source?

In this episode, we tell how clinicians in 1963 documented a patient whose adrenal function collapsed after taking aminoglutethimide, and how that observation redirected thinking about the drug's effects on endocrine systems. Follow the clinical notes and chemical history that turned an epilepsy medication into a clue about steroid synthesis - and ask what mechanism could link a glutarimide to adrenal suppression?

Person: unnamed young female patient
Date: 1963
Drug: aminoglutethimide (Ba 16038, Ciba 16038; brand name Elipten)
Adverse effect frequency: 45-85% experienced at least one adverse effect
Specific severe effect frequency: ~10% experienced circulatory collapse/adrenal insufficiency

- Aminoglutethimide was introduced in 1960 and marketed as the anticonvulsant Elipten for petit mal epilepsy.
- Lethargy occurred in 31-70% of patients depending on dose.
- Approximately 10% of patients developed circulatory collapse with signs of adrenal insufficiency.
- Clinicians in 1963 recorded a patient with near-complete suppression of adrenal hormone production resembling Addison's disease.
- The compound belonged to the nonsteroidal glutarimide family and was chemically related to glutethimide and, more distantly, thalidomide.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1223falsefullhttps://www.spreaker.com/episode/the-number-is-fifteen-human-stakes-households-discarding-meds-foreign-hospitals-denied-donations--73098171
Imagine learning a federal study found roughly nine out of ten drugs remain safe and effective up to fifteen years past their printed date - yet that finding has been hidden from the public for four decades. How did a program that could change what we throw away become locked behind a government nondisclosure?

In this episode, we walk through the origin, findings, and secrecy of the Shelf Life Extension Program and why its results about expired medications were never released, leaving households and humanitarian actors in the dark. What happens when government science about drugs becomes classified, and who pays the price?

Person: Joel Davis
Program: Shelf Life Extension Program (SLEP)
Agencies: U.S. Department of Defense and Food and Drug Administration
Study size: more than 100 drugs tested
Key finding: roughly 90% effective up to 15 years past label under controlled storage

- A federal study tested over 100 drugs and found about 9 out of 10 remained effective up to 15 years after their printed expiration.
- The program began in the mid-1980s after DoD faced unsustainable costs discarding medications from global stockpiles.
- Cipro was shown effective 9 years past its labeled shelf life in controlled testing on stockpiled samples.
- The memorandum founding SLEP formally barred disclosure of the data to the public, other agencies, manufacturers, or foreign governments.
- Temperature was identified as the dominant variable in degradation, with chemical reaction rates roughly doubling for every 10°C increase.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098171Wed, 22 Jul 2026 02:53:19 +0000Creator at ObomediaThe number is fifteen. Human stakes: households discarding meds; foreign hospitals denied donations Imagine learning a federal study found roughly nine out of ten drugs remain safe and effective up to fifteen years past their printed date - yet...
Imagine learning a federal study found roughly nine out of ten drugs remain safe and effective up to fifteen years past their printed date - yet that finding has been hidden from the public for four decades. How did a program that could change what we throw away become locked behind a government nondisclosure?

In this episode, we walk through the origin, findings, and secrecy of the Shelf Life Extension Program and why its results about expired medications were never released, leaving households and humanitarian actors in the dark. What happens when government science about drugs becomes classified, and who pays the price?

Person: Joel Davis
Program: Shelf Life Extension Program (SLEP)
Agencies: U.S. Department of Defense and Food and Drug Administration
Study size: more than 100 drugs tested
Key finding: roughly 90% effective up to 15 years past label under controlled storage

- A federal study tested over 100 drugs and found about 9 out of 10 remained effective up to 15 years after their printed expiration.
- The program began in the mid-1980s after DoD faced unsustainable costs discarding medications from global stockpiles.
- Cipro was shown effective 9 years past its labeled shelf life in controlled testing on stockpiled samples.
- The memorandum founding SLEP formally barred disclosure of the data to the public, other agencies, manufacturers, or foreign governments.
- Temperature was identified as the dominant variable in degradation, with chemical reaction rates roughly doubling for every 10°C increase.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1181falsefullhttps://www.spreaker.com/episode/the-iron-lung-that-made-a-drug-safety-rebel-and-a-missing-memo--73098168
A Cambridge medical student spent nearly two years sealed inside an iron lung in the early 1950s, later delivering fifty babies from an adapted wheelchair and building a national drug safety system after thalidomide crippled thousands; yet a corporate memo decades later claimed he had destroyed his own review records-what really happened to those files?

In this episode, we trace his life from Banstead to Cambridge and through a career that moved from hospital wards to the heart of Britain’s drug-safety apparatus, asking how a man who survived paralysis became an agitator for systems that could prevent another catastrophe and what the missing memo implies about his legacy.

Person: William Howard Wallace Inman
Date of birth: 1 August 1929
Condition: Polio with two years in an iron lung in the early 1950s
Event: Thalidomide disaster with more than 10,000 children affected worldwide and approximately 2,000 in Britain
Initiative: Yellow Card reporting system commissioned by Sir Derrick Dunlop for the Committee on Safety of Medicines

- He spent approximately two years in an iron lung, a negative-pressure ventilator that enclosed the body from the neck down.
- He became the first clinical medical graduate of Cambridge University to complete training while affected by his condition, finishing in 1956.
- He delivered fifty babies from an adapted wheelchair while working at Addenbrooke’s Hospital.
- He worked as a medical adviser at ICI’s Pharmaceutical Division from 1959 to 1964.
- The thalidomide disaster caused limb malformations in more than 10,000 children worldwide and about 2,000 in Britain, prompting the Yellow Card system in 1964.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098168Wed, 22 Jul 2026 02:53:07 +0000Creator at ObomediaThe Iron Lung That Made a Drug-Safety Rebel-and a Missing Memo A Cambridge medical student spent nearly two years sealed inside an iron lung in the early 1950s, later delivering fifty babies from an adapted wheelchair and building a national drug...
A Cambridge medical student spent nearly two years sealed inside an iron lung in the early 1950s, later delivering fifty babies from an adapted wheelchair and building a national drug safety system after thalidomide crippled thousands; yet a corporate memo decades later claimed he had destroyed his own review records-what really happened to those files?

In this episode, we trace his life from Banstead to Cambridge and through a career that moved from hospital wards to the heart of Britain’s drug-safety apparatus, asking how a man who survived paralysis became an agitator for systems that could prevent another catastrophe and what the missing memo implies about his legacy.

Person: William Howard Wallace Inman
Date of birth: 1 August 1929
Condition: Polio with two years in an iron lung in the early 1950s
Event: Thalidomide disaster with more than 10,000 children affected worldwide and approximately 2,000 in Britain
Initiative: Yellow Card reporting system commissioned by Sir Derrick Dunlop for the Committee on Safety of Medicines

- He spent approximately two years in an iron lung, a negative-pressure ventilator that enclosed the body from the neck down.
- He became the first clinical medical graduate of Cambridge University to complete training while affected by his condition, finishing in 1956.
- He delivered fifty babies from an adapted wheelchair while working at Addenbrooke’s Hospital.
- He worked as a medical adviser at ICI’s Pharmaceutical Division from 1959 to 1964.
- The thalidomide disaster caused limb malformations in more than 10,000 children worldwide and about 2,000 in Britain, prompting the Yellow Card system in 1964.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1161falsefullhttps://www.spreaker.com/episode/a-small-bottle-labeled-soothing-condemned-as-baby-killers--73098166
A small apron-pocket bottle sold for teething promised relief but was publicly branded "Baby Killers" by the American Medical Association in 1911 - yet it stayed on UK shelves until 1930. How could a product condemned by doctors remain legally available and reshape generations before regulators caught up?

In this episode, we trace the circulation of Mrs. Winslow's Soothing Syrup, its marketing and everyday use, the 1911 AMA condemnation, and the regulatory gaps that allowed legal sale in the United Kingdom until 1930. What does the syrup's longevity reveal about the limits of professional censure and the mechanics of recalls?

Person: Mrs. Winslow's Soothing Syrup
Date: 1911 AMA article condemning the product
Location: United Kingdom (legal availability until 1930)
Event: Continued legal sale despite AMA condemnation
Topic: Misbranding as largest cause of modern drug recalls

- The American Medical Association published an article titled "Baby Killers" about the syrup in 1911.
- Mrs. Winslow's Soothing Syrup remained legally available in the United Kingdom until 1930.
- In 2015, misbranding accounted for 42% of all drug recall cases in the United Kingdom.
- The FDA assigns recall classes I, II, and III based on the severity of harm and evidence from a Health Hazard Assessment.
- Over-the-counter products often lack a direct manufacturer-to-patient link, complicating targeted recalls that rely on lot numbers.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098166Wed, 22 Jul 2026 02:52:54 +0000Creator at Obomediaa small bottle labeled soothing, condemned as Baby Killers A small apron-pocket bottle sold for teething promised relief but was publicly branded "Baby Killers" by the American Medical Association in 1911 - yet it stayed on UK shelves until 1930....
A small apron-pocket bottle sold for teething promised relief but was publicly branded "Baby Killers" by the American Medical Association in 1911 - yet it stayed on UK shelves until 1930. How could a product condemned by doctors remain legally available and reshape generations before regulators caught up?

In this episode, we trace the circulation of Mrs. Winslow's Soothing Syrup, its marketing and everyday use, the 1911 AMA condemnation, and the regulatory gaps that allowed legal sale in the United Kingdom until 1930. What does the syrup's longevity reveal about the limits of professional censure and the mechanics of recalls?

Person: Mrs. Winslow's Soothing Syrup
Date: 1911 AMA article condemning the product
Location: United Kingdom (legal availability until 1930)
Event: Continued legal sale despite AMA condemnation
Topic: Misbranding as largest cause of modern drug recalls

- The American Medical Association published an article titled "Baby Killers" about the syrup in 1911.
- Mrs. Winslow's Soothing Syrup remained legally available in the United Kingdom until 1930.
- In 2015, misbranding accounted for 42% of all drug recall cases in the United Kingdom.
- The FDA assigns recall classes I, II, and III based on the severity of harm and evidence from a Health Hazard Assessment.
- Over-the-counter products often lack a direct manufacturer-to-patient link, complicating targeted recalls that rely on lot numbers.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1114falsefullhttps://www.spreaker.com/episode/a-paralyzed-dropout-became-a-billionaire-then-the-government-destroyed-everything-he-built--73098164
Fear and astonishment: a man doctors declared permanently paralyzed at 17 walked out of that prognosis, later chartered twenty-seven Boeing 747s to fly his entire company to Disney, and then watched a federal indictment obliterate a business that had helped 4.5 million people; how did a staircase and a jury verdict lead to those jets? What happened between the conviction that never came and the jobs that never returned?

In this episode, we tell the life and rise of Bill Bartmann and the corporate saga that followed, from a carnival dropout in Dubuque to a debt-relief company that altered how charge-off loans were handled - and the federal case that destroyed his company even after he was acquitted. How did his method of buying and restructuring defaulted loans scale into a business that employed thousands and then vanish after indictment?

Person: Bill Bartmann
Location: Dubuque, Iowa and Muskogee, Oklahoma
Event: Purchase and restructuring of defaulted federal loan portfolio
Case: Federal indictment followed by jury acquittal on every charge
Impact: 3,900 jobs lost and 4.5 million people helped prior to shutdown

- At 14, Bartmann dropped out of school in approximately 1962 to join a travelling carnival.
- At 17 he fell down a staircase, was told his paralysis was permanent, and later regained use of his legs through nightly physical regimen.
- By buying a portfolio of defaulted federal loans he repaid a $1,000,000 personal liability and founded a debt-restructuring business model.
- His company chartered twenty-seven Boeing 747s to fly every employee to Walt Disney World for a corporate celebration.
- After a federal indictment the company folded: 3,900 jobs did not return despite Bartmann’s later acquittal on all charges.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098164Wed, 22 Jul 2026 02:52:42 +0000Creator at ObomediaA paralyzed dropout became a billionaire - then the government destroyed everything he built Fear and astonishment: a man doctors declared permanently paralyzed at 17 walked out of that prognosis, later chartered twenty-seven Boeing 747s to fly his...
Fear and astonishment: a man doctors declared permanently paralyzed at 17 walked out of that prognosis, later chartered twenty-seven Boeing 747s to fly his entire company to Disney, and then watched a federal indictment obliterate a business that had helped 4.5 million people; how did a staircase and a jury verdict lead to those jets? What happened between the conviction that never came and the jobs that never returned?

In this episode, we tell the life and rise of Bill Bartmann and the corporate saga that followed, from a carnival dropout in Dubuque to a debt-relief company that altered how charge-off loans were handled - and the federal case that destroyed his company even after he was acquitted. How did his method of buying and restructuring defaulted loans scale into a business that employed thousands and then vanish after indictment?

Person: Bill Bartmann
Location: Dubuque, Iowa and Muskogee, Oklahoma
Event: Purchase and restructuring of defaulted federal loan portfolio
Case: Federal indictment followed by jury acquittal on every charge
Impact: 3,900 jobs lost and 4.5 million people helped prior to shutdown

- At 14, Bartmann dropped out of school in approximately 1962 to join a travelling carnival.
- At 17 he fell down a staircase, was told his paralysis was permanent, and later regained use of his legs through nightly physical regimen.
- By buying a portfolio of defaulted federal loans he repaid a $1,000,000 personal liability and founded a debt-restructuring business model.
- His company chartered twenty-seven Boeing 747s to fly every employee to Walt Disney World for a corporate celebration.
- After a federal indictment the company folded: 3,900 jobs did not return despite Bartmann’s later acquittal on all charges.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1058falsefullhttps://www.spreaker.com/episode/the-teacher-the-flood-and-the-four-men-who-stole-a-nation-s-bank--73098162
A tiny nation of roughly ten thousand people lost three villages to the Alpine Rhine on September 25, 1927, while at the same time a coordinated theft drained four million Swiss francs from its bank. Who were the four men who emptied the treasury, and why did the scandal end Gustav Schädler's career within a single week in June 1928?

In this episode, we tell how a schoolteacher turned prime minister managed floods, emergency loans, and the creation of Liechtenstein's first power plant, even as insiders looted the national bank; could the same political reshaping that stabilized the country also have enabled its undoing?

Person: Gustav Schädler
Date: September 25, 1927
Event: Alpine Rhine flood swallowed three villages
Amount: 4,000,000 Swiss francs stolen
Persons: Franz Thöny, Anton Walser, Niko Beck, Rudolf Carbone

- Liechtenstein's population was roughly ten thousand people in the 1920s.
- The flood occurred on the morning of September 25, 1927, and resulted in two deaths.
- Prince Johann II donated one million Swiss francs from his personal fortune after the flood.
- Gustav Schädler became Prime Minister on June 6, 1922, at age thirty-eight.
- Four million Swiss francs were drained through speculative transactions between 1926 and 1928.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098162Wed, 22 Jul 2026 02:52:30 +0000Creator at ObomediaThe Teacher, The Flood, and the Four Men Who Stole a Nation's Bank A tiny nation of roughly ten thousand people lost three villages to the Alpine Rhine on September 25, 1927, while at the same time a coordinated theft drained four million Swiss...
A tiny nation of roughly ten thousand people lost three villages to the Alpine Rhine on September 25, 1927, while at the same time a coordinated theft drained four million Swiss francs from its bank. Who were the four men who emptied the treasury, and why did the scandal end Gustav Schädler's career within a single week in June 1928?

In this episode, we tell how a schoolteacher turned prime minister managed floods, emergency loans, and the creation of Liechtenstein's first power plant, even as insiders looted the national bank; could the same political reshaping that stabilized the country also have enabled its undoing?

Person: Gustav Schädler
Date: September 25, 1927
Event: Alpine Rhine flood swallowed three villages
Amount: 4,000,000 Swiss francs stolen
Persons: Franz Thöny, Anton Walser, Niko Beck, Rudolf Carbone

- Liechtenstein's population was roughly ten thousand people in the 1920s.
- The flood occurred on the morning of September 25, 1927, and resulted in two deaths.
- Prince Johann II donated one million Swiss francs from his personal fortune after the flood.
- Gustav Schädler became Prime Minister on June 6, 1922, at age thirty-eight.
- Four million Swiss francs were drained through speculative transactions between 1926 and 1928.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1025falsefullhttps://www.spreaker.com/episode/the-president-who-died-abroad-zambia-s-unsettled-funeral-war--73098158
Grief turned into courtroom conflict the morning Edgar Chagwa Lungu died on June 5, 2025, at Mediclinic Medforum in Pretoria, and Zambia declared seven days of mourning for a body it could not yet bring home. How did a surgical death trigger a months-long legal and political battle that still hasn't settled where his coffin should rest?

In this episode, we trace the arc of Lungu’s life from Ndola Central Hospital in 1956 through a career as lawyer, soldier, and president, and then into the contested hours after his death - a family banning a sitting head of state from the coffin, a court order halting a funeral, and the national fallout that followed. What does this unsettled funeral war reveal about Zambia’s politics and institutions?

Person: Edgar Chagwa Lungu
Date of death: June 5, 2025
Location of death: Mediclinic Medforum, Pretoria, South Africa
Age: 68
Period as president: sworn in January 26, 2015

- Lungu was born on November 11, 1956, at Ndola Central Hospital in the Copperbelt.
- He married Esther in 1986 and they had six children, including Tasila Lungu.
- Tasila Lungu won the parliamentary seat for Chawama constituency in 2021.
- Lungu finished seventh with 2.43% of the vote in Chawama in 2001.
- He won the 2015 presidential by-election by 27,757 votes with a turnout of 32.36% and a margin of 1.66%.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098158Wed, 22 Jul 2026 02:52:18 +0000Creator at ObomediaThe President Who Died Abroad - Zambia's Unsettled Funeral War Grief turned into courtroom conflict the morning Edgar Chagwa Lungu died on June 5, 2025, at Mediclinic Medforum in Pretoria, and Zambia declared seven days of mourning for a body it...
Grief turned into courtroom conflict the morning Edgar Chagwa Lungu died on June 5, 2025, at Mediclinic Medforum in Pretoria, and Zambia declared seven days of mourning for a body it could not yet bring home. How did a surgical death trigger a months-long legal and political battle that still hasn't settled where his coffin should rest?

In this episode, we trace the arc of Lungu’s life from Ndola Central Hospital in 1956 through a career as lawyer, soldier, and president, and then into the contested hours after his death - a family banning a sitting head of state from the coffin, a court order halting a funeral, and the national fallout that followed. What does this unsettled funeral war reveal about Zambia’s politics and institutions?

Person: Edgar Chagwa Lungu
Date of death: June 5, 2025
Location of death: Mediclinic Medforum, Pretoria, South Africa
Age: 68
Period as president: sworn in January 26, 2015

- Lungu was born on November 11, 1956, at Ndola Central Hospital in the Copperbelt.
- He married Esther in 1986 and they had six children, including Tasila Lungu.
- Tasila Lungu won the parliamentary seat for Chawama constituency in 2021.
- Lungu finished seventh with 2.43% of the vote in Chawama in 2001.
- He won the 2015 presidential by-election by 27,757 votes with a turnout of 32.36% and a margin of 1.66%.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1106falsefullhttps://www.spreaker.com/episode/when-safety-explodes-the-takata-airbag-that-killed-a-pregnant-woman--73098155
A pregnant driver and her newborn died after a Takata airbag sent a metal fragment through her neck when the car impacted at 30 kilometers per hour; the inflator ruptured in an 11-year-old Honda City exposed to Malaysian heat and humidity. How did a safety company’s decades-long choice to use ammonium nitrate - a cheaper, moisture-sensitive propellant - turn into a predictable chain of fatal ruptures across more than 100 million vehicles?

In this episode, we trace Takata’s origins as a parachute fabric maker through its rise to holding roughly 20 percent of the global airbag market, the decision in the late 1990s to adopt ammonium nitrate, and the sequence of recalls, injuries, and deaths that followed - asking how many documented warnings it took before action was effective.

Person: Unnamed 42-year-old woman (driver)
Event: Airbag inflator rupture that sent metal fragment into neck
Date: July 2014 (fatal crash in Malaysia); recalls noted June 2014
Location: Malaysia; vehicle was a 2003 Honda City, 11 years old
Topic: Takata airbag defect using ammonium nitrate propellant

- Airbag deployed at 30 kilometers per hour in a minor collision while the car remained drivable.
- The driver was 42 years old and eight months pregnant; she died before reaching the hospital.
- The infant was delivered after the mother’s death and lived three days.
- Takata held roughly 20 percent of the worldwide airbag market by 2014, installed in over 100 million vehicles across more than 20 carmakers.
- By September 2024, investigators attributed 35 worldwide deaths to Takata airbags, with 28 in the United States and recalls still being issued.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098155Wed, 22 Jul 2026 02:52:07 +0000Creator at ObomediaWhen Safety Explodes: The Takata Airbag That Killed a Pregnant Woman A pregnant driver and her newborn died after a Takata airbag sent a metal fragment through her neck when the car impacted at 30 kilometers per hour; the inflator ruptured in an...
A pregnant driver and her newborn died after a Takata airbag sent a metal fragment through her neck when the car impacted at 30 kilometers per hour; the inflator ruptured in an 11-year-old Honda City exposed to Malaysian heat and humidity. How did a safety company’s decades-long choice to use ammonium nitrate - a cheaper, moisture-sensitive propellant - turn into a predictable chain of fatal ruptures across more than 100 million vehicles?

In this episode, we trace Takata’s origins as a parachute fabric maker through its rise to holding roughly 20 percent of the global airbag market, the decision in the late 1990s to adopt ammonium nitrate, and the sequence of recalls, injuries, and deaths that followed - asking how many documented warnings it took before action was effective.

Person: Unnamed 42-year-old woman (driver)
Event: Airbag inflator rupture that sent metal fragment into neck
Date: July 2014 (fatal crash in Malaysia); recalls noted June 2014
Location: Malaysia; vehicle was a 2003 Honda City, 11 years old
Topic: Takata airbag defect using ammonium nitrate propellant

- Airbag deployed at 30 kilometers per hour in a minor collision while the car remained drivable.
- The driver was 42 years old and eight months pregnant; she died before reaching the hospital.
- The infant was delivered after the mother’s death and lived three days.
- Takata held roughly 20 percent of the worldwide airbag market by 2014, installed in over 100 million vehicles across more than 20 carmakers.
- By September 2024, investigators attributed 35 worldwide deaths to Takata airbags, with 28 in the United States and recalls still being issued.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1245falsefullhttps://www.spreaker.com/episode/when-the-sea-poisoned-a-town-the-slow-horror-of-minamata--73098151
The sea that fed Minamata became a silent killer: by the mid-1950s fish catches in Minamata Bay had fallen by 91% while a factory discharged methylmercury that bioaccumulated in seafood. How did a company that provided over 25% of local jobs and more than half the city's tax revenue become the epicenter of one of the worst industrial poisoning disasters in recorded history?

In this episode, we tell the sequence of events from the opening of Chisso's plant in 1908 through the spike in acetaldehyde production and the 1951 catalyst change that created methylmercury, asking how economic dependency and slow environmental change allowed thousands to be poisoned before the truth emerged.

Person: Chisso Corporation factory director (reported epidemic)
Location: Minamata, Kyūshū, Japan
Date: May 1, 1956 (epidemic reported)
Period: 1932-1956 (acetaldehyde production growth)
Event: Kumamoto University Research Group formed August 1956

- Chisso provided more than 25% of local jobs and more than half the city's tax revenue.
- Acetaldehyde output rose from 210 tons in 1932 to 6,000 tons by 1951.
- In August 1951 Chisso changed its catalyst to ferric sulfide, producing roughly 5% of outflow as methylmercury.
- Between 1953 and 1957 fish catches in Minamata Bay fell by 91%.
- By October 1956 the Kumamoto University Research Group had documented 40 patients, 14 of whom were dead (a 35% case fatality rate).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098151Wed, 22 Jul 2026 02:51:54 +0000Creator at ObomediaWhen the Sea Poisoned a Town: The Slow Horror of Minamata The sea that fed Minamata became a silent killer: by the mid-1950s fish catches in Minamata Bay had fallen by 91% while a factory discharged methylmercury that bioaccumulated in seafood. How...
The sea that fed Minamata became a silent killer: by the mid-1950s fish catches in Minamata Bay had fallen by 91% while a factory discharged methylmercury that bioaccumulated in seafood. How did a company that provided over 25% of local jobs and more than half the city's tax revenue become the epicenter of one of the worst industrial poisoning disasters in recorded history?

In this episode, we tell the sequence of events from the opening of Chisso's plant in 1908 through the spike in acetaldehyde production and the 1951 catalyst change that created methylmercury, asking how economic dependency and slow environmental change allowed thousands to be poisoned before the truth emerged.

Person: Chisso Corporation factory director (reported epidemic)
Location: Minamata, Kyūshū, Japan
Date: May 1, 1956 (epidemic reported)
Period: 1932-1956 (acetaldehyde production growth)
Event: Kumamoto University Research Group formed August 1956

- Chisso provided more than 25% of local jobs and more than half the city's tax revenue.
- Acetaldehyde output rose from 210 tons in 1932 to 6,000 tons by 1951.
- In August 1951 Chisso changed its catalyst to ferric sulfide, producing roughly 5% of outflow as methylmercury.
- Between 1953 and 1957 fish catches in Minamata Bay fell by 91%.
- By October 1956 the Kumamoto University Research Group had documented 40 patients, 14 of whom were dead (a 35% case fatality rate).

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1142falsefullhttps://www.spreaker.com/episode/shallow-crater-massive-deaths-unpacking-the-al-ahli-hospital-blast--73098149
The tiniest crater - roughly one meter long and 30-40 cm deep - became the center of a global outrage that claimed between 200 and 500 lives in hours. Why did a shallow, table-sized hole at al-Ahli Arab Hospital produce such a vast and disputed casualty count, and what does the physical evidence actually say?

In this episode, we lay out the documented timeline, the physical measurements, and the recorded warnings that framed the evening of October 17, 2023, presenting what is known and what remains unresolved: how did hundreds die beside a crater smaller than a bathtub?

Person: Reverend Hosam Naoum
Location: al-Ahli Arab Hospital compound, Gaza City
Date: October 17, 2023, 18:59 local time
Event: Courtyard explosion in hospital driveway
Period: Days after Israeli evacuation orders issued for northern Gaza

- Al Jazeera captured five explosions over Gaza City that evening, the fifth landing in the hospital courtyard.
- Approximately 1,000 displaced Palestinians were sheltering on the hospital grounds at the time.
- The crater measured roughly 1 meter long and 30-40 centimeters deep according to multiple investigations.
- Reported immediate death tolls ranged from 200 to 500 people within hours after the blast.
- On October 14, a 155-mm artillery illumination shell struck the hospital’s cancer center, injuring four staff and damaging upper floors.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098149Wed, 22 Jul 2026 02:51:43 +0000Creator at ObomediaShallow Crater, Massive Deaths: Unpacking the Al-Ahli Hospital Blast The tiniest crater - roughly one meter long and 30-40 cm deep - became the center of a global outrage that claimed between 200 and 500 lives in hours. Why did a shallow,...
The tiniest crater - roughly one meter long and 30-40 cm deep - became the center of a global outrage that claimed between 200 and 500 lives in hours. Why did a shallow, table-sized hole at al-Ahli Arab Hospital produce such a vast and disputed casualty count, and what does the physical evidence actually say?

In this episode, we lay out the documented timeline, the physical measurements, and the recorded warnings that framed the evening of October 17, 2023, presenting what is known and what remains unresolved: how did hundreds die beside a crater smaller than a bathtub?

Person: Reverend Hosam Naoum
Location: al-Ahli Arab Hospital compound, Gaza City
Date: October 17, 2023, 18:59 local time
Event: Courtyard explosion in hospital driveway
Period: Days after Israeli evacuation orders issued for northern Gaza

- Al Jazeera captured five explosions over Gaza City that evening, the fifth landing in the hospital courtyard.
- Approximately 1,000 displaced Palestinians were sheltering on the hospital grounds at the time.
- The crater measured roughly 1 meter long and 30-40 centimeters deep according to multiple investigations.
- Reported immediate death tolls ranged from 200 to 500 people within hours after the blast.
- On October 14, a 155-mm artillery illumination shell struck the hospital’s cancer center, injuring four staff and damaging upper floors.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1166falsefullhttps://www.spreaker.com/episode/the-gravy-crystals-how-melamine-turned-pet-food-deadly--73098146
Visible industrial crystals settled in the gravy of canned pet food, and more than five thousand products were pulled from shelves across the United States and Canada. How did an industrial chemical like melamine end up visible in wheat gluten and kill companion animals before anyone connected the dots?

In this episode, we trace the timeline from the first owner complaints to the March 16, 2007 voluntary recall, describe how a contract manufacturer allowed a single contaminated ingredient to spread across dozens of trusted brands, and ask how long pets had been exposed before anyone noticed.

Person: Stephen Sundlof
Company: Menu Foods
Date: March 16, 2007 (first voluntary recall announcement)
Event: Visible melamine crystals found in wheat gluten
Location: Streetsville, Ontario (Menu Foods operations)

- More than 5,000 pet food products were pulled from shelves across the United States and Canada.
- Menu Foods produced approximately 100 cat food brands and around 50 dog food brands under contract.
- First complaints to Menu Foods arrived on February 20, 2007; pets had been getting sick for at least 24 days by the March 16 announcement.
- Samples were sent to Cornell University's veterinary diagnostic laboratory March 13-15, 2007; the company announced the recall three days later on the evening of March 16.
- Stephen Sundlof and Cornell pathologists reported seeing melamine crystals visible to the naked eye in wheat gluten used in wet pet food.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098146Wed, 22 Jul 2026 02:51:30 +0000Creator at ObomediaThe Gravy Crystals: How Melamine Turned Pet Food Deadly Visible industrial crystals settled in the gravy of canned pet food, and more than five thousand products were pulled from shelves across the United States and Canada. How did an industrial...
Visible industrial crystals settled in the gravy of canned pet food, and more than five thousand products were pulled from shelves across the United States and Canada. How did an industrial chemical like melamine end up visible in wheat gluten and kill companion animals before anyone connected the dots?

In this episode, we trace the timeline from the first owner complaints to the March 16, 2007 voluntary recall, describe how a contract manufacturer allowed a single contaminated ingredient to spread across dozens of trusted brands, and ask how long pets had been exposed before anyone noticed.

Person: Stephen Sundlof
Company: Menu Foods
Date: March 16, 2007 (first voluntary recall announcement)
Event: Visible melamine crystals found in wheat gluten
Location: Streetsville, Ontario (Menu Foods operations)

- More than 5,000 pet food products were pulled from shelves across the United States and Canada.
- Menu Foods produced approximately 100 cat food brands and around 50 dog food brands under contract.
- First complaints to Menu Foods arrived on February 20, 2007; pets had been getting sick for at least 24 days by the March 16 announcement.
- Samples were sent to Cornell University's veterinary diagnostic laboratory March 13-15, 2007; the company announced the recall three days later on the evening of March 16.
- Stephen Sundlof and Cornell pathologists reported seeing melamine crystals visible to the naked eye in wheat gluten used in wet pet food.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>979falsefullhttps://www.spreaker.com/episode/when-the-vents-blew-how-armley-s-dust-killed-a-neighbourhood--73098143
A tiny industrial town became a slow-moving crime scene: blue asbestos from Midland Works settled on roughly 1,000 houses, coated windowsills, gutters and garden soil, and children played with the white dust that later killed them - so why did the vents keep blowing and the company keep quiet? What did the two people who never set foot inside the factory uncover about a neighbourhood sacrificed by profit and silence?

In this episode, we tell the story of the Midland Works on Canal Road in Armley and how its blue asbestos emissions affected ordinary residents across decades, following the legal battle brought by two locals and the internal company documents that revealed deliberate choices. How did known danger, buried waste, and corporate memos become the facts of a neighbourhood’s destruction?

Person: Arthur Margereson
Person: June Hancock
Location: Canal Road, Armley, Leeds
Period: early twentieth century to 1978
Company: Turner and Newall

- The factory processed crocidolite (blue asbestos) and employed around 250 people at its peak.
- Asbestos dust settled on about 1,000 houses in the Armley Lodge area.
- The factory developed Sprayed Limpet Asbestos by 1931 and exported it to 60 countries.
- Turner and Newall’s internal memo advised making only a “token effort” on safety to “ward off the evil day when asbestos cannot be economically applied.”
- In 1978 inspectors found a few hundred tonnes of blue asbestos waste mixed into the soil at Midland Works; Turner and Newall paid £15,000 toward the clean-up.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098143Wed, 22 Jul 2026 02:51:19 +0000Creator at ObomediaWhen the Vents Blew: How Armley's Dust Killed a Neighbourhood A tiny industrial town became a slow-moving crime scene: blue asbestos from Midland Works settled on roughly 1,000 houses, coated windowsills, gutters and garden soil, and children...
A tiny industrial town became a slow-moving crime scene: blue asbestos from Midland Works settled on roughly 1,000 houses, coated windowsills, gutters and garden soil, and children played with the white dust that later killed them - so why did the vents keep blowing and the company keep quiet? What did the two people who never set foot inside the factory uncover about a neighbourhood sacrificed by profit and silence?

In this episode, we tell the story of the Midland Works on Canal Road in Armley and how its blue asbestos emissions affected ordinary residents across decades, following the legal battle brought by two locals and the internal company documents that revealed deliberate choices. How did known danger, buried waste, and corporate memos become the facts of a neighbourhood’s destruction?

Person: Arthur Margereson
Person: June Hancock
Location: Canal Road, Armley, Leeds
Period: early twentieth century to 1978
Company: Turner and Newall

- The factory processed crocidolite (blue asbestos) and employed around 250 people at its peak.
- Asbestos dust settled on about 1,000 houses in the Armley Lodge area.
- The factory developed Sprayed Limpet Asbestos by 1931 and exported it to 60 countries.
- Turner and Newall’s internal memo advised making only a “token effort” on safety to “ward off the evil day when asbestos cannot be economically applied.”
- In 1978 inspectors found a few hundred tonnes of blue asbestos waste mixed into the soil at Midland Works; Turner and Newall paid £15,000 toward the clean-up.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1133falsefullhttps://www.spreaker.com/episode/the-surgeon-who-turned-care-into-killing-karl-brandt-s-secret-origins--73098141
A chilling conviction: Karl Brandt - once a gifted neurosurgeon and Hitler’s personal physician - died believing he was a healer even as he authorized the first state-sanctioned killing of a disabled infant that became a template for mass murder. How did medical training, academic theories of "merciful death," and intimate access to power transform a surgeon into an architect of systematic killing?

In this episode, we trace Brandt’s life from his January 8, 1904 birth in Mülhausen to his rise inside the Nazi elite, his early adoption of Nazi membership in 1932, and the July 25, 1939 decision to authorize the killing of five-month-old Gerhard Kretschmar - the act that served as the prototype for later programs. How did a physician’s clinic visit become the starting point for state euthanasia and medicalized mass murder?

Person: Karl Brandt
Date: January 8, 1904 (birth)
Location: Mülhausen
Event: Authorization of Gerhard Kretschmar’s killing on July 25, 1939
Rank: SS-Gruppenführer by April 1944

- Brandt completed his medical degree in 1928 and specialized in head and spinal injuries.
- He joined the Nazi Party in January 1932 at age 27.
- He married Anni Rehborn on March 17, 1934 and their son Karl Brandt was born October 4, 1935.
- Brandt attended courses by Alfred Hoche, a proponent of the concept of Gnadentod (merciful death).
- On July 25, 1939 Brandt examined five-month-old Gerhard Kretschmar and authorized his killing, then reported it had been carried out humanely.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098141Wed, 22 Jul 2026 02:51:06 +0000Creator at ObomediaThe Surgeon Who Turned Care into Killing: Karl Brandt's Secret Origins A chilling conviction: Karl Brandt - once a gifted neurosurgeon and Hitler’s personal physician - died believing he was a healer even as he authorized the first state-sanctioned...
A chilling conviction: Karl Brandt - once a gifted neurosurgeon and Hitler’s personal physician - died believing he was a healer even as he authorized the first state-sanctioned killing of a disabled infant that became a template for mass murder. How did medical training, academic theories of "merciful death," and intimate access to power transform a surgeon into an architect of systematic killing?

In this episode, we trace Brandt’s life from his January 8, 1904 birth in Mülhausen to his rise inside the Nazi elite, his early adoption of Nazi membership in 1932, and the July 25, 1939 decision to authorize the killing of five-month-old Gerhard Kretschmar - the act that served as the prototype for later programs. How did a physician’s clinic visit become the starting point for state euthanasia and medicalized mass murder?

Person: Karl Brandt
Date: January 8, 1904 (birth)
Location: Mülhausen
Event: Authorization of Gerhard Kretschmar’s killing on July 25, 1939
Rank: SS-Gruppenführer by April 1944

- Brandt completed his medical degree in 1928 and specialized in head and spinal injuries.
- He joined the Nazi Party in January 1932 at age 27.
- He married Anni Rehborn on March 17, 1934 and their son Karl Brandt was born October 4, 1935.
- Brandt attended courses by Alfred Hoche, a proponent of the concept of Gnadentod (merciful death).
- On July 25, 1939 Brandt examined five-month-old Gerhard Kretschmar and authorized his killing, then reported it had been carried out humanely.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1151falsefullhttps://www.spreaker.com/episode/when-the-nhs-knew-the-haemophilia-hiv-cover-up-that-killed-hundreds--73098138
Fear that the state betrayed the very patients it vowed to protect: over 100 plaintiffs were already dead while a senior judge begged the government to settle. How did pooled plasma, US paid donors, and delayed heat‑treatment turn routine haemophilia care into a mass public‑health catastrophe - and when did officials know the risk?

In this episode, we tell the story of the HIV haemophilia litigation and the institutional decisions behind it, following the record that links product sourcing, regulatory choices, and internal memos to the rising toll. Can the documents recovered from the Department of Archives show what officials knew and why the government refused to act sooner?

Person: plaintiffs numbering 1,217
Date: litigation commenced April 1989
Location: England and Wales
Event: internal Department of Archives memorandum (drafted 1995) reported publicly 4 February 2022
Status: 107 plaintiffs dead by the time any settlement was reached; 23 more died before the case closed

- 1,217 people filed suit in the HIV haemophilia group action.
- 107 of those 1,217 were already dead by the time any settlement was reached.
- 163 plaintiffs had progressed to full AIDS by November 1989, seven months after the case began.
- 600 historic Department of Archives files (covering 1972-1986) were central to the case and withheld by the Department.
- The defendants included 220 institutions, among them the Department of Archives and regional health authorities.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098138Wed, 22 Jul 2026 02:50:55 +0000Creator at ObomediaWhen the NHS Knew: The Haemophilia HIV Cover‑Up That Killed Hundreds Fear that the state betrayed the very patients it vowed to protect: over 100 plaintiffs were already dead while a senior judge begged the government to settle. How did pooled...
Fear that the state betrayed the very patients it vowed to protect: over 100 plaintiffs were already dead while a senior judge begged the government to settle. How did pooled plasma, US paid donors, and delayed heat‑treatment turn routine haemophilia care into a mass public‑health catastrophe - and when did officials know the risk?

In this episode, we tell the story of the HIV haemophilia litigation and the institutional decisions behind it, following the record that links product sourcing, regulatory choices, and internal memos to the rising toll. Can the documents recovered from the Department of Archives show what officials knew and why the government refused to act sooner?

Person: plaintiffs numbering 1,217
Date: litigation commenced April 1989
Location: England and Wales
Event: internal Department of Archives memorandum (drafted 1995) reported publicly 4 February 2022
Status: 107 plaintiffs dead by the time any settlement was reached; 23 more died before the case closed

- 1,217 people filed suit in the HIV haemophilia group action.
- 107 of those 1,217 were already dead by the time any settlement was reached.
- 163 plaintiffs had progressed to full AIDS by November 1989, seven months after the case began.
- 600 historic Department of Archives files (covering 1972-1986) were central to the case and withheld by the Department.
- The defendants included 220 institutions, among them the Department of Archives and regional health authorities.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1179falsefullhttps://www.spreaker.com/episode/when-cruisers-hit-medicine-the-missile-mistake-that-failed-tests--73098136
Fear that a single soil sample could justify destroying a nation's medicine supply: thirteen Tomahawk missiles hit a Khartoum pharmaceutical factory on August 20, 1998, after a private lab reported EMPTA at 2.5 times a trace threshold - yet no chemical weapons were ever found. How did a split sample, a classified operative, and ignored warnings lead to a strike that wiped out half of Sudan's drug production?

In this episode, we tell the recorded sequence of decisions and evidence that led to Operation Infinite Reach and its aftermath. We follow the timeline from the December 1997 soil sample and the CIA’s internal doubts to the factory's destruction and the unanswered questions about accountability.

Person: Salah Idris
Date: August 20, 1998
Location: Khartoum North
Event: Operation Infinite Reach strike on al-Shifa factory
Status: No chemical weapons found

- Thirteen Tomahawk cruise missiles struck the al-Shifa pharmaceutical factory on the evening of August 20, 1998.
- The factory produced more than half of Sudan’s pharmaceuticals, including malaria, tuberculosis, and insulin treatments.
- A soil sample collected in December 1997 showed EMPTA at roughly 2.5 times a trace threshold according to a private laboratory.
- The sample was split into three portions, lacked a verifiable chain of custody, and was analyzed by a single private lab without a second collection.
- One night watchman was killed and roughly 300 Sudanese workers lost their jobs when the factory was reduced to rubble.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098136Wed, 22 Jul 2026 02:50:43 +0000Creator at ObomediaWhen Cruisers Hit Medicine: The Missile Mistake That Failed Tests Fear that a single soil sample could justify destroying a nation's medicine supply: thirteen Tomahawk missiles hit a Khartoum pharmaceutical factory on August 20, 1998, after a...
Fear that a single soil sample could justify destroying a nation's medicine supply: thirteen Tomahawk missiles hit a Khartoum pharmaceutical factory on August 20, 1998, after a private lab reported EMPTA at 2.5 times a trace threshold - yet no chemical weapons were ever found. How did a split sample, a classified operative, and ignored warnings lead to a strike that wiped out half of Sudan's drug production?

In this episode, we tell the recorded sequence of decisions and evidence that led to Operation Infinite Reach and its aftermath. We follow the timeline from the December 1997 soil sample and the CIA’s internal doubts to the factory's destruction and the unanswered questions about accountability.

Person: Salah Idris
Date: August 20, 1998
Location: Khartoum North
Event: Operation Infinite Reach strike on al-Shifa factory
Status: No chemical weapons found

- Thirteen Tomahawk cruise missiles struck the al-Shifa pharmaceutical factory on the evening of August 20, 1998.
- The factory produced more than half of Sudan’s pharmaceuticals, including malaria, tuberculosis, and insulin treatments.
- A soil sample collected in December 1997 showed EMPTA at roughly 2.5 times a trace threshold according to a private laboratory.
- The sample was split into three portions, lacked a verifiable chain of custody, and was analyzed by a single private lab without a second collection.
- One night watchman was killed and roughly 300 Sudanese workers lost their jobs when the factory was reduced to rubble.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1307falsefullhttps://www.spreaker.com/episode/when-dissent-became-illness-the-soviet-science-of-silence--73098134
Fear that your conscience could be diagnosed as a disease: Soviet psychiatry turned dissent into "sluggish schizophrenia," a label that required no symptoms and erased people from public life. How did a diagnostic manual become a tool for indefinite detention and legal erasure?

In this episode, we trace the practice from a Moscow visit in February 1989 through earlier international precedents, following cases where political acts alone justified psychiatric confinement and asking how medicine was made to silence truth.

Person: Samuel Cartwright
Date: February 1989
Location: Moscow
Period: 19th-20th century
Case: "Sluggish schizophrenia"

- A team of American psychiatrists arrived in Moscow in February 1989 with a list of 48 names and managed to examine 27 people.
- Thirty-three names on that list correspond to patients whose ward locations no one would confirm and who exist only as names on a piece of paper.
- Samuel Cartwright published in 1851 diagnoses "drapetomania" and "dysaesthesia aethiopica" claiming conditions unique to enslaved Black people, with treatments including toe removal.
- Aurora D'Angelo attended a 1927 rally and was committed to a psychiatric institution shortly afterward; the record notes commitment based on political presence.
- Clennon King Jr. was taken from the University of Mississippi in 1958 and held secretly in a psychiatric facility for 12 days before doctors found him mentally healthy.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098134Wed, 22 Jul 2026 02:50:31 +0000Creator at ObomediaWhen Dissent Became Illness: The Soviet Science of Silence Fear that your conscience could be diagnosed as a disease: Soviet psychiatry turned dissent into "sluggish schizophrenia," a label that required no symptoms and erased people from public...
Fear that your conscience could be diagnosed as a disease: Soviet psychiatry turned dissent into "sluggish schizophrenia," a label that required no symptoms and erased people from public life. How did a diagnostic manual become a tool for indefinite detention and legal erasure?

In this episode, we trace the practice from a Moscow visit in February 1989 through earlier international precedents, following cases where political acts alone justified psychiatric confinement and asking how medicine was made to silence truth.

Person: Samuel Cartwright
Date: February 1989
Location: Moscow
Period: 19th-20th century
Case: "Sluggish schizophrenia"

- A team of American psychiatrists arrived in Moscow in February 1989 with a list of 48 names and managed to examine 27 people.
- Thirty-three names on that list correspond to patients whose ward locations no one would confirm and who exist only as names on a piece of paper.
- Samuel Cartwright published in 1851 diagnoses "drapetomania" and "dysaesthesia aethiopica" claiming conditions unique to enslaved Black people, with treatments including toe removal.
- Aurora D'Angelo attended a 1927 rally and was committed to a psychiatric institution shortly afterward; the record notes commitment based on political presence.
- Clennon King Jr. was taken from the University of Mississippi in 1958 and held secretly in a psychiatric facility for 12 days before doctors found him mentally healthy.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1263falsefullhttps://www.spreaker.com/episode/when-the-babysitter-is-the-weapon-the-hand-that-betrayed-home--73098131
Fear of the home being turned into a weapon: a graduate thesis script sold for $11.9 million and returned $140 million worldwide by turning domestic trust into menace-what happens when the person you invite in wants to destroy you? What made audiences recognize that dread so instantly?

In this episode, we tell the story of The Hand That Betrayed the Cradle from script to box office and explore how a film crafted to feel like it could happen on your block asked whether the spaces meant to protect us can be quietly turned against us. How did a thesis project become a cultural touchstone that rewired the idea of domestic safety?

Person: Amanda Silver
Director: Curtis Hanson
Opening weekend: January 10, 1992
Production budget: $11.9 million
Worldwide gross: $140 million

- The screenplay began as Amanda Silver's film school thesis and underwent roughly 30 drafts over two years.
- Interscope Communications acquired the project for Hollywood Pictures, with development reported in August 1990 and Curtis Hanson hired in October 1990.
- Principal photography began on April 15, 1991, after an original February start was delayed.
- The film opened January 10, 1992, earning $7.7 million its opening weekend and holding the top domestic box office spot for four weeks.
- Domestic gross was $88 million (United States and Canada) and international gross $52 million, a roughly 12:1 return on its $11.9 million budget.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098131Wed, 22 Jul 2026 02:50:19 +0000Creator at ObomediaWhen the Babysitter Is the Weapon: The Hand That Betrayed Home Fear of the home being turned into a weapon: a graduate thesis script sold for $11.9 million and returned $140 million worldwide by turning domestic trust into menace-what happens when...
Fear of the home being turned into a weapon: a graduate thesis script sold for $11.9 million and returned $140 million worldwide by turning domestic trust into menace-what happens when the person you invite in wants to destroy you? What made audiences recognize that dread so instantly?

In this episode, we tell the story of The Hand That Betrayed the Cradle from script to box office and explore how a film crafted to feel like it could happen on your block asked whether the spaces meant to protect us can be quietly turned against us. How did a thesis project become a cultural touchstone that rewired the idea of domestic safety?

Person: Amanda Silver
Director: Curtis Hanson
Opening weekend: January 10, 1992
Production budget: $11.9 million
Worldwide gross: $140 million

- The screenplay began as Amanda Silver's film school thesis and underwent roughly 30 drafts over two years.
- Interscope Communications acquired the project for Hollywood Pictures, with development reported in August 1990 and Curtis Hanson hired in October 1990.
- Principal photography began on April 15, 1991, after an original February start was delayed.
- The film opened January 10, 1992, earning $7.7 million its opening weekend and holding the top domestic box office spot for four weeks.
- Domestic gross was $88 million (United States and Canada) and international gross $52 million, a roughly 12:1 return on its $11.9 million budget.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1116falsefullhttps://www.spreaker.com/episode/restrained-for-ten-days-the-death-of-kelly-savage--73098127
Calm on admission yet bound at wrists, ankles and waist: a 27-year-old who spoke Japanese, held a university degree and loved the country where he taught was tied to a bed for days. Why did Yamato Hospital place a non-violent, described-as-calm patient in five-point restraints and keep him there through Golden Week?

In this episode, we tell the sequence of events from Kelly Savage’s life and hospitalization, tracing his move from Wellington to Japan, his JET teaching placement, a prior psychotic episode, and the final ten days in Yamato Hospital - and we ask how those contradictions in the medical record shaped the outcome.

Person: Kelly Robert Savage
Date of birth: 27 December 1989
Admission date: 30 April 2017
Location: Yamato Hospital, Kanagawa Prefecture, Japan
Family: Brother Patrick Savage; parents Michael and Martha Savage

- Kelly was admitted involuntarily to Yamato Hospital on 30 April 2017.
- Hospital admission records described Kelly as "calm" at the point of reception.
- Within hours of admission he was restrained at five points: wrists, ankles and waist.
- Kelly had a prior psychotic episode in 2012 and graduated from Victoria University in May 2015.
- He began taking psychiatric medication irregularly in early 2017 and stopped entirely before admission.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098127Wed, 22 Jul 2026 02:50:07 +0000Creator at ObomediaRestrained for Ten Days: The Death of Kelly Savage Calm on admission yet bound at wrists, ankles and waist: a 27-year-old who spoke Japanese, held a university degree and loved the country where he taught was tied to a bed for days. Why did Yamato...
Calm on admission yet bound at wrists, ankles and waist: a 27-year-old who spoke Japanese, held a university degree and loved the country where he taught was tied to a bed for days. Why did Yamato Hospital place a non-violent, described-as-calm patient in five-point restraints and keep him there through Golden Week?

In this episode, we tell the sequence of events from Kelly Savage’s life and hospitalization, tracing his move from Wellington to Japan, his JET teaching placement, a prior psychotic episode, and the final ten days in Yamato Hospital - and we ask how those contradictions in the medical record shaped the outcome.

Person: Kelly Robert Savage
Date of birth: 27 December 1989
Admission date: 30 April 2017
Location: Yamato Hospital, Kanagawa Prefecture, Japan
Family: Brother Patrick Savage; parents Michael and Martha Savage

- Kelly was admitted involuntarily to Yamato Hospital on 30 April 2017.
- Hospital admission records described Kelly as "calm" at the point of reception.
- Within hours of admission he was restrained at five points: wrists, ankles and waist.
- Kelly had a prior psychotic episode in 2012 and graduated from Victoria University in May 2015.
- He began taking psychiatric medication irregularly in early 2017 and stopped entirely before admission.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1191falsefullhttps://www.spreaker.com/episode/how-medical-science-built-itself-on-black-women-s-bodies-revealed--73098124
A chill of injustice runs through the history of medicine: tissue taken without consent, bodies exhibited in museums, and surgeries performed in daylight produced the very knowledge we now call progress. How did exhibitions in Paris and operating rooms in the American South set the stage for Henrietta Lacks’ cells to be taken, copied, and commodified without her knowledge?

In this episode, we trace the documented chain of three cases and three sets of women whose bodies and remains supplied material, publications, and medical practice; we follow the thread from 19th-century displays and dissections to a 1951 biopsy whose cells never died, and ask how institutions normalized taking Black bodies without consent.

Person: Henrietta Lacks
Date: January 1951 biopsy; October 1951 death
Location: Johns Hopkins Hospital, Baltimore
Event: First immortal human cell line named HeLa
Period: 1810-1815 (Sarah Baartman in Europe) through 1951 and up to 2023 settlement

- HeLa cells continued dividing in laboratories for at least seventy-two years after Henrietta Lacks’ 1951 biopsy.
- Henrietta Lacks was born in 1920, married at age 14, and had five children by age 30.
- Sarah Baartman arrived in Europe around 1810, was exhibited for five years, and died in Paris in 1815.
- Georges Cuvier dissected Baartman after death, preserved brain, genitalia, skeleton, and made a full body cast displayed at the Musée de l'Homme.
- In 2023 members of the Lacks family reached a legal settlement acknowledging Henrietta’s involuntary contribution.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73098124Wed, 22 Jul 2026 02:49:54 +0000Creator at ObomediaHow Medical Science Built Itself on Black Women's Bodies Revealed A chill of injustice runs through the history of medicine: tissue taken without consent, bodies exhibited in museums, and surgeries performed in daylight produced the very knowledge...
A chill of injustice runs through the history of medicine: tissue taken without consent, bodies exhibited in museums, and surgeries performed in daylight produced the very knowledge we now call progress. How did exhibitions in Paris and operating rooms in the American South set the stage for Henrietta Lacks’ cells to be taken, copied, and commodified without her knowledge?

In this episode, we trace the documented chain of three cases and three sets of women whose bodies and remains supplied material, publications, and medical practice; we follow the thread from 19th-century displays and dissections to a 1951 biopsy whose cells never died, and ask how institutions normalized taking Black bodies without consent.

Person: Henrietta Lacks
Date: January 1951 biopsy; October 1951 death
Location: Johns Hopkins Hospital, Baltimore
Event: First immortal human cell line named HeLa
Period: 1810-1815 (Sarah Baartman in Europe) through 1951 and up to 2023 settlement

- HeLa cells continued dividing in laboratories for at least seventy-two years after Henrietta Lacks’ 1951 biopsy.
- Henrietta Lacks was born in 1920, married at age 14, and had five children by age 30.
- Sarah Baartman arrived in Europe around 1810, was exhibited for five years, and died in Paris in 1815.
- Georges Cuvier dissected Baartman after death, preserved brain, genitalia, skeleton, and made a full body cast displayed at the Musée de l'Homme.
- In 2023 members of the Lacks family reached a legal settlement acknowledging Henrietta’s involuntary contribution.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1022falsefull